<!DOCTYPE html>
<html lang="no">
<head>
	<meta charset="iso-8859-1">
	<title>Norsk legemiddelh&aring;ndbok - Norsk legemiddelh&aring;k G8</title>
	<link rel="shortcut icon" href="../favicon.ico" type="image/x-icon">
	<script type="text/javascript" src="../js/default.js"></script>
	<link href="../css/default.css" rel="stylesheet"  media="screen" type="text/css"/>
	<link href="../css/print.css" rel="stylesheet"  media="print" type="text/css"/>
	<!--[if lt IE 9]><link href="../css/ieless9.css" rel="stylesheet" type="text/css"/><![endif]-->
	<script>
	jQuery(function($) {
		
		var setMenues = function(){
			if(menu){
				$('#navTerapi').append(menu[0]);
				$('#navLegemiddel').append(menu[1]);
				$('#navGenerel').append(menu[2]);
			}
		}		

	
		$(document).ready(function() {
			setMenues();
		});
	});

	</script>
</head>
<body>
<div id="mainframe">
	<header>
		<img src="gfx/logo_print.png" />
		<a href="../index.htm"><h1>Norsk legemiddelh&aring;ndbok</h1></a>
		<form id="search" name="searchForm" action="sok/sokresultat.htm">
            <input type="text" name="searchField" size="30" placeholder="Fritekstsøk">
	        <input type="hidden" name="srcriteria" value="all"><br>
            <button type="submit">Søk</button>
	    </form>
	    	<nav>
			<ul>
				<li id="navTerapi"><a href="../T/innhold.htm">Terapikapitler</a></li>
				<li id="navLegemiddel"><a href="../L/innhold.htm">Legemiddelkapitler</a></li>
				<li id="navGenerel"><a href="innhold.htm">Generelle kapitler</a></li>
				<li id="navStikkord"><a href="../div/stikkordA.htm">Stikkord</a></li>
				<!-- li id="navAkutt"><a href="../div/hastebehandling.htm">Hastebehandling</a></li -->
			</ul>
		</nav>
	</header>
	<div id="bodyframe">
	<section id="page">
<h1  style='color:red' id="i145255">G8&nbsp;Amming og legemidler</h1>
<div id="i145256" class="revidert">
<p class="reviderta"><p id="i238237">Publisert: 29.08.2012</p></p>
<p class="reviderta"><p id="i307070">Revidert: August 2012</p></p>
<p class="reviderta"><p id="i263821">Sist endret: 23.11.2012</p></p></div><div id="i145258" class="forfatter">
<p class="forfattera"><p id="i145259">Hedvig Nordeng, Dagny Sandnes,  Gro Nylander</p></p>
<p class="forfattera"><p id="i320351"><strong><em>Hurtigvalg til</em></strong> <a id="aSeksjon1X145254" class="xref" href="../G/G8.htm#i145332145254" title="Kryssreferanse">G8  Tabell:&#160;Amming og legemidler (alfabetisk)</a> </p></p></div><div id="i320352" class="def"><h5  id="i320353">Generelt</h5>
</div>
<p class="seksjon1a"><p id="i145260">I dette kapitlet gis  det informasjon om bruk av legemidler ved amming, særlig med tanke  på hvilke legemidler som kan gi bivirkninger hos brysternærte barn,  i hvilken grad legemidlet passerer over til morsmelk, samt om legemidlet  kan påvirke melkeproduksjonen. Hvert legemiddel er klassifisert  i én av seks risikokategorier. Risikokategoriene kan være til hjelp ved  forskrivning av legemidler til ammende. Det presiseres imidlertid  at det for hver pasient må foretas en individuell nytte-risiko-vurdering.</p></p>
<OL type='I'>
		<LI id="i145262"><p id="i145263"><strong>Behandlingsprinsipper  hos ammende.</strong></p><br><p id="i145264">Det er vanligvis ønskelig at kvinnen ammer sitt  barn, selv om hun bruker legemidler, fordi nytten av morsmelk  som regel er større enn risikoen for legemiddelpåvirkning hos barnet. Kvinner  som bruker legemidler mot kroniske sykdommer i svangerskapet, trenger  ofte å fortsette med dette under ammeperioden. Som regel er dette  mulig, fordi barnet tilføres mye mindre legemiddel via morsmelken  enn under svangerskapet. I tillegg kan ammende ha behov for legemidler  mot akutte sykdommer, særlig fordi kvinner i Norge ofte ammer lenge.</p><br><p id="i145265">De aller fleste legemidlene overføres til morsmelk i minimale mengder og kan derfor brukes av ammende. For enkelte legemidler foreligger det imidlertid en reell risiko for farmakologiske effekter i brysternærte barn. Farmakologiske/toksiske effekter hos brysternærte barn kan skyldes høy overgang av legemidlet til morsmelk og liten terapeutisk bredde eller langvarig tilførsel av små doser legemiddel. Risikoen for bivirkninger er størst om barnet er nyfødt, og spesielt hvis det er prematurt. Nesten 80 % av de bivirkningene som er rapportert hos brysternærte barn, har vært hos nyfødte og spedbarn under 2 måneder. Årsaken til dette er at barn under 2 måneder, og spesielt premature barn, omsetter og utskiller de fleste legemidler vesentlig langsommere enn barn over 1 år og voksne. I noen tilfeller vil risikoen for farmakologiske effekter hos barnet øke hvis moren i tillegg har brukt legemidlet før fødselen, slik at barnet allerede har fått overført en vesentlig mengde i fosterlivet (f.eks. diazepam, klonazepam, litium). Muligheten for akkumulering må derfor vurderes i hvert enkelt tilfelle, spesielt de første leveuker. Det er tilrådelig å måle plasmakonsentrasjonen av legemidlet hos barnet ved mistanke om bivirkninger.</p><br><p id="i145266">En del legemidler har lav peroral biotilgjengelighet, bl.a. fordi de vil brytes ned i barnets mage-tarm-kanal. Slike legemidler vil følgelig ikke gi systemiske effekter hos diebarnet og kan som regel brukes av ammende. Dette gjelder f.eks. makromolekyler som heparin og insulin.</p><br><p id="i145267">Noen ganger er man i tvil  om det er trygt å anbefale amming når mor bruker legemidler. Eksempelvis  kan dette gjelde bruk av enkelte antidepressiva, antipsykotika og antiepileptika.  Da kan blandingsernæring, dvs. å gi noe morsmelk og noe morsmelkerstatning,  være et alternativ. Dermed vil barnets legemiddeleksponering reduseres,  samtidig som det får tilført viktige spesifikke antistoffer og næringsstoffer  som bare finnes i morsmelk. Ved å forskyve ammetidspunktet i forhold  til inntak av legemiddel kan man i tillegg unngå de høyeste toppene  i plasmakonsentrasjon og dermed redusere barnets dose. I slike tilfeller  bør foreldrene få informasjon om hvordan ev. legemiddelbivirkninger  kan arte seg hos barnet.</p><br><p id="i145268">Morsmelken vil teoretisk sett ikke inneholde legemiddel når mors blod er fritt for legemiddel (ca. 5 ganger legemidlets halveringstid). Der enhver eksponering av barnet bør unngås og mor bare behandles med enkeltdose eller kurer av begrenset varighet, kan dette prinsippet brukes til å redusere eller hindre barnets eksponering via morsmelken F.eks. anbefales ammende som bruker metotreksat en gang ukentlig i behandling av revmatiske lidelser, å pumpe og kaste morsmelken det første døgnet etter tablettinntak, før ammingen gjenopptas.</p><br>		</LI>
		<LI id="i145269"><p id="i145270"><strong>Prinsipper for overgang  av legemidler til morsmelk.</strong></p><br><p id="i145271">Legemiddelkonsentrasjonen i morsmelk avhenger særlig av mors plasmakonsentrasjon foruten av legemidlets fysikalsk-kjemiske og farmakokinetiske egenskaper. Passasjen fra plasma til melk følger de vanlige prinsipper for passiv diffusjon over lipidmembraner. Ett unntak er aciklovir som transporteres aktivt over til morsmelk.</p><br><p id="i145272">Morsmelken er noe surere (pH oftest 6,8&#8211;7,0) enn plasma (pH 7,4). For basiske legemidler (f.eks. citalopram, morfin, propranolol) vil dette kunne påvirke diffusjonslikevekten i retning av økt konsentrasjon i melken, mens de samme forhold fører til lavere konsentrasjon av sure legemidler (f.eks. fenytoin, penicillin, salisylat).</p><br><p id="i145273">Uttalt binding til plasmaproteiner fører til lav konsentrasjon i vevsvæsken og dermed også i melken. Flere av de legemidlene som opptrer i høye konsetrasjoner i melken (f.eks. atenolol, etosuksimid, litium), bindes ikke eller i liten grad til plasmaproteinene.</p><br><p id="i145275">Mange legemidler (f.eks.  antidepressiva, antipsykotika, digoksin) har lav plasmakonsentrasjon  i forhold til dosen (dvs. høyt tilsynelatende distribusjonsvolum)  pga. uttalt binding i forskjellige vev og organer. Dette er også  en faktor som gjør at en mindre fraksjon av dosen overføres til  morsmelken. Lavt tilsynelatende distribusjonsvolum er medvirkende  til at en større fraksjon utskilles i morsmelken.</p><br><p id="i145276"><em>Melk/plasma ratio:</em> Det  foreligger en fordeling (likevekt) mellom legemiddel i mors blod  og morsmelken, uttrykt som forholdet mellom konsentrasjon i melk  og konsentrasjon i plasma (M/P). Når M/P-ratio er 0,5, betyr det  at halvparten av mors plasmakonsentrasjon gjenfinnes i morsmelken.  Melk/plasma-ratio er av liten praktisk nytte for beregning av barnets  dose.</p><br>		</LI>
		<LI id="i145277"><p id="i145278"><strong>Beregning av barnets  tilførsel av legemiddel via morsmelk.</strong></p><br><p id="i145279"><em>Barnets teoretiske dose (TD):</em> Den mengde som tilføres barnet, kan beregnes ved å multiplisere mengden av melk som inntas (ca. 150 ml per kg kroppsvekt per døgn) med konsentrasjonen av legemidlet i melken. Barnets dose via morsmelk kan da sammenlignes med anbefalt pediatrisk dose (hvis den er kjent) for å vurdere sannsynligheten for bivirkninger. F.eks. overføres lamotrigin via morsmelk til et fullammet spedbarn i en mengde som tilsvarer mellom 50 % og 100 % av anbefalt dose til spedbarn, noe som tilsier høy risiko for farmakologiske effekter hos barnet.</p><br>
<table border="1" cellpadding="3" cellspacing="0" width="100%"><div id="i263855" class="table"><div id="i263856" class="tgroup"><div id="i263857" class="colspec"></div><div id="i263858" class="tbody">
<tr><div id="i263859" class="row">
<td align="left" valign="top"><div id="i263860" class="entry">
<p class="entrya"><p id="i263861"><strong>TD (mg/døgn) = konsentrasjon i morsmelk (mg/L) x 0,15 L/kg/døgn x barnets kroppsvekt (kg)</strong></p></p></div>&nbsp;</td></div></tr></div></div></div></table><p id="i145280"><em>Barnets relative dose (RD):</em> Tilførsel av et legemiddel gjennom morsmelk uttrykkes ofte som den dosen barnet får i seg per kg kroppsvekt i forhold til morens dose per kg kroppsvekt. Denne dosen (som kalles barnets relative dose, <em>RD</em>) regnes ut ved å dividere barnets teoretiske dose per kg kroppsvekt (barnets) med morens døgndose per kg kroppsvekt (morens). Dette gjør det mulig å foreta en direkte sammenligning av graden av eksponering hos barnet for legemidler innenfor samme gruppe, selv om de gis i forskjellig dosering til moren. Ved relative doser over 10 % ansees det generelt at det finnes en reell risiko for farmakologiske effekter hos barnet. Når barnet er sykt eller prematurt eller legemidlet er svært toksisk (gjelder f.eks. cytostatika), bør imidlertid grensen settes lavere. I tabellen nedenfor angis overgang til morsmelk som minimal (RD: < 2 %), liten (RD: 2&#8211;5 %), moderat (RD: 5&#8211;10 %) eller høy (RD: 10&#8211;50 %).</p><br>
<table border="1" cellpadding="3" cellspacing="0" width="100%"><div id="i263885" class="table"><div id="i263886" class="tgroup"><div id="i263887" class="colspec"></div><div id="i263888" class="tbody">
<tr><div id="i263889" class="row">
<td align="left" valign="top"><div id="i263890" class="entry">
<p class="entrya"><p id="i263891"><strong>RD (prosent) = (barnets dose (mg/kg kroppsvekt) / morens dose (mg/kg kroppsvekt)) x 100 %</strong></p></p></div>&nbsp;</td></div></tr></div></div></div></table>		</LI>
		<LI id="i145281"><p id="i145282"><strong>Klassifisering av  de enkelte legemidler etter antatt risiko.</strong></p><br><p id="i145283">De  fleste data som foreligger om farmakologiske effekter hos brysternærte  barn, kommer fra kasuistiske rapporter. Det er ofte vanskelig å  avgjøre om det er sikker årsakssammenheng mellom symptomene hos  barnet og legemidlet overført via melken. Pålitelige beregninger  av den dose som kan overføres til barnet, foreligger for et mindretall av  legemidlene. Man er ofte henvist til å gi råd til mødre på grunnlag  av melkekonsentrasjoner eller melk/plasma-konsentrasjonsforhold  målt under tilfeldige og ukontrollerte betingelser. Generelt bør  det utvises tilbakeholdenhet ved bruk av nye legemidler når overgang  til morsmelk er ukjent, og klinisk erfaring mangler. Legemiddelprodusentene  måler overgangen av legemidler til brystmelk hos dyr. Resultater fra  dyreforsøk kan i liten grad ekstrapoleres til å gjelde mennesker  og er derfor ikke tatt med i vurderingene.</p><br>		</LI>
	</OL>

<p class="seksjon1a"><p id="i145284">I tabellene er legemidlene inndelt i seks ulike kategorier (MM0?MM5), basert på publiserte artikler og spesiallitteratur (se fordypningslitteratur  <a id="aSeksjon1X145254" class="ref" href="../G/G8.htm#i145322145254" title="Fordypningslitteratur">Fordypningslitteratur</a>).</p></p><table id="i145286" width="100%" class="maintable" border="0" cellpadding="5" cellspacing="0">
 <tbody>
<tr id="i145291" class="body likelinje">
	<td id="i145292"    valign="top" width="3.2%" class="startKol">

<p class="entrya">&nbsp;</p></td>
	<td id="i145294"    valign="top" width="96.8%" class="sluttKol">

<p class="entrya"><p id="i145295"><strong>MM0:</strong> Lav peroral  biotilgjengelighet tilsier liten eller ingen systemisk absorpsjon  via barnets mage-tarm-kanal. Vanligvis ingen risiko for barnet,  men se tabelltekstene.</p></p></td>
	</tr>
 <tr id="i145296" class="body oddelinje">
	<td id="i145297"    valign="top" width="3.2%" class="startKol">

<p class="entrya">&nbsp;</p></td>
	<td id="i145299"    valign="top" width="96.8%" class="sluttKol">

<p class="entrya"><p id="i145300"><strong>MM1:</strong> Kan brukes  av ammende. Legemidlet er blitt brukt i lang tid av ammende, uten  at det er rapportert om bivirkninger hos diebarn. Vitenskapelige  studier hos ammende har ikke påvist risiko for farmakologiske effekter  hos brysternærte barn.</p></p></td>
	</tr>
 <tr id="i145301" class="body likelinje">
	<td id="i145302"    valign="top" width="3.2%" class="startKol">

<p class="entrya">&nbsp;</p></td>
	<td id="i145304"    valign="top" width="96.8%" class="sluttKol">

<p class="entrya"><p id="i145305"><strong>MM2:</strong> Kan brukes  av ammende, men dokumentasjonen er svakere. Legemidlet er blitt  studert hos flere ammende uten at bivirkninger er rapportert, eller  risikoen for brysternærte barn vurderes som minimal, basert på teoretiske  betraktninger.</p></p></td>
	</tr>
 <tr id="i145306" class="body oddelinje">
	<td id="i145307"    valign="top" width="3.2%" class="startKol">

<p class="entrya">&nbsp;</p></td>
	<td id="i145309"    valign="top" width="96.8%" class="sluttKol">

<p class="entrya"><p id="i145310"><strong>MM3:</strong> Usikkert  om bruk hos ammende kan anbefales. Det foreligger ingen vitenskapelige  studier hos ammende, og det er en teoretisk mulighet for farmakologiske  effekter hos brysternærte barn, eller det finnes studier som viser  en liten risiko for lette bivirkninger. Bruk anbefales kun hvis fordelene  oppveier ulempene. <em>Alle  nye legemidler hvor overgang til morsmelk er ukjent og erfaring mangler,  plasseres automatisk i denne kategorien.</em></p></p></td>
	</tr>
 <tr id="i145311" class="body likelinje">
	<td id="i145312"    valign="top" width="3.2%" class="startKol">

<p class="entrya">&nbsp;</p></td>
	<td id="i145314"    valign="top" width="96.8%" class="sluttKol">

<p class="entrya"><p id="i145315"><strong>MM4:</strong> Mulig skadelig.  Det foreligger rapporter om bivirkninger hos brysternærte barn,  eller stoffets virkningsmekanisme tilsier høy risiko for barnet.  I enkelte tilfeller kan fordelen med amming være større enn risikoen  for bivirkninger. Blandingsernæring kan vurderes.</p></p></td>
	</tr>
 <tr id="i145316" class="body oddelinje">
	<td id="i145317"    valign="top" width="3.2%" class="startKol">

<p class="entrya">&nbsp;</p></td>
	<td id="i145319"    valign="top" width="96.8%" class="sluttKol">

<p class="entrya"><p id="i145320"><strong>MM5:</strong> Kontraindisert  hos ammende. Dokumentert høy risiko hos brysternærte barn, eller  mors sykdom gjør at amming er kontraindisert.</p></p></td>
	</tr>
 </tbody></table>
 <div id="i145321" class="def"><h5  id="i145322">Fordypningslitteratur</h5>

<p class="defa">&nbsp;</p>	<OL>
		<LI id="i145325"><p id="i307071">Nordeng H, Havnen GC, Spigset O. Legemiddelbruk ved amming. Tidsskr Nor Legeforen 2012;132:1089-93. http://tidsskriftet.no/article/2263557</p><br>		</LI>
		<LI id="i307072"><p id="i145326">Hale TW. Medications and Mothers&#39; milk 14 ed., Hale Publishing, Amarillo, Texas, USA, 2010.</p><br>		</LI>
		<LI id="i145327"><p id="i145328">Briggs GG, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation: a reference guide to fetal and neonatal risk. 9th ed. Philadelphia: Lippincott Williams & Wilkins, 2011.</p><br>		</LI>
		<LI id="i145329"><p id="i145330">American Academy of Pediatrics. Committee on Drugs. The transfer of drugs and other chemicals into human milk. Pediatrics 2001;108:776-89.</p><br>		</LI>
	</OL>
</div><div id="i228141" class="def"><h5  id="i228150">Aktuelle nettressurser</h5>
</div>	<UL type="disc">
		<LI id="i320569"><p id="i320570">www.relis.no -&#160;for helsepersonell for sp&#x00F8;rsm&#x00E5;l om legemidler i svangerskapet og ammeperioden</p><br>		</LI>
		<LI id="i228158"><p id="i228159">Drug and Lactation Database (Lactmed) <Url Id="NURLid1168951060384" Href="http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?LACT" Target="">http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?LACT</Url> &#x2013; for helsepersonell</p><br>		</LI>
		<LI id="i320571"><p id="i320572">www.tryggmammamedisin.no &#x2013; for allmennheten for sp&#x00F8;rsm&#x00E5;l om legemidler i svangerskapet og ammeperioden</p><br>		</LI>
	</UL>
<div id="i145331" class="sub2"><h2  id="i145332"> Tabell:&#160;Amming og legemidler (alfabetisk)</h2>
<div id="i243217" class="revidert">
<p class="reviderta"><p id="i243218">Publisert: 29.08.2012</p></p>
<p class="reviderta"><p id="i306903">Oppdatert: juni 2012</p></p>
<p class="reviderta"><p id="i306904">Sist endret: 15.11.2012</p></p></div><table id="i145334" width="100%" class="maintable" border="0" cellpadding="5" cellspacing="0">
 <caption> <Uth Id="NUTHid2330648" Type="Halvfet">A</Uth></caption> <thead>
	<tr class = "linjetopp">
	<th id="i145342"  colspan="3"  valign="top"  class="sluttKol">

<p class="entrya"><p id="i145343">Overgang til morsmelk angis som minimal (< 2 %), liten (2&#8211;5 %), moderat (5&#8211;10 %) eller høy (10&#8211;50 %) basert på fraksjon av morens dose/kg kroppsvekt som barnet tilføres. (Barnets relative dose.)&ML;						Over 3&#8211;4 ukers bruk ansees som langtidsbehandling.</p></p></th>
	</tr>
	<tr class = "linjetopp">
	<th id="i145346"    valign="top"  class="startKol">

<p class="entrya"><p id="i145347"><strong>Legemiddel</strong></p></p></th>
	<th id="i145348"    valign="top"  class="mellomKol">

<p class="entrya"><p id="i145349"><strong>MM kategori</strong></p></p></th>
	<th id="i145350"    valign="top"  class="sluttKol">

<p class="entrya"><p id="i145351"><strong>Dokumentasjon vedrørende bruk under amming</strong></p></p></th>
	</tr>
</thead>
<tbody>
<tr id="i145353" class="body likelinje">
	<td id="i145354"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i145355">Abakavir</p></p></td>
	<td id="i145356"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i145357">5</p></p></td>
	<td id="i145358"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i145359">Se antivirale midler  <a id="arowX145939" class="ref" href="../G/G8.htm#i145939" title="Antivirale midler">Antivirale midler</a></p></p></td>
	</tr>
 <tr id="i145360" class="body oddelinje">
	<td id="i145361"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i145362">Abatacept</p></p></td>
	<td id="i145363"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i145364">0</p></p></td>
	<td id="i145365"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i145366">Manglende klinisk erfaring tilsier tilbakeholdenhet</p></p></td>
	</tr>
 <tr id="i145367" class="body likelinje">
	<td id="i145368"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i145369">Abciximab</p></p></td>
	<td id="i145370"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i145371">0</p></p></td>
	<td id="i145372"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i145373">Manglende klinisk erfaring</p></p></td>
	</tr>
 <tr id="i145374" class="body oddelinje">
	<td id="i145375"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i145376"><em>ACE-hemmere</em></p></p></td>
	<td id="i145377"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i145378">2, 3</p></p></td>
	<td id="i145379"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i145380">Observer barnet for hypotensjon. Se de enkelte virkestoffene</p></p></td>
	</tr>
 <tr id="i145381" class="body likelinje">
	<td id="i145382"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i145383">Acetazolamid</p></p></td>
	<td id="i145384"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i145385">2</p></p></td>
	<td id="i145386"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i145387">Overgang til morsmelk er minimal. Se diuretika  <a id="arowX147247" class="ref" href="../G/G8.htm#i147247" title="Diuretika">Diuretika</a></p></p></td>
	</tr>
 <tr id="i145388" class="body oddelinje">
	<td id="i145389"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i145390">Acetylcystein</p></p></td>
	<td id="i145391"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i145392">3</p></p></td>
	<td id="i145393"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i145394">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i145395" class="body likelinje">
	<td id="i145396"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i145397">Acetylsalisylsyre</p></p></td>
	<td id="i145398"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i145399">3</p></p></td>
	<td id="i145400"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i145401">Overgang til morsmelk er liten. Kan brukes av ammende som tromboseprofylakse eller ved sporadisk bruk av inntil 2 g daglig. Paracetamol eller ibuprofen bør foretrekkes til smertebehandling hos ammende</p></p></td>
	</tr>
 <tr id="i145402" class="body oddelinje">
	<td id="i145403"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i145404">Aciklovir</p></p></td>
	<td id="i145405"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i145406">0</p></p>
<p class="entrya"><p id="i271339">2</p></p></td>
	<td id="i145407"    valign="top" width="50.7%" class="sluttKol">
	<UL type="circle">
		<LI id="i145409"><p id="i145410"><em>Lokalbehandling:</em> Lang klinisk erfaring. Kan brukes av ammende</p><br>		</LI>
		<LI id="i271340"><p id="i271341">Systemisk behandling: Overgang til morsmelk er liten</p><br>		</LI>
	</UL>
</td>
	</tr>
 <tr id="i145419" class="body likelinje">
	<td id="i145420"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i145421">Acitretin</p></p></td>
	<td id="i145422"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i145423">4</p></p></td>
	<td id="i145424"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i145425">Selv om overgang til morsmelk er liten, frarådes bruk hos ammende pga. virkestoffets toksisitet. Se retinoider  <a id="arowX151587" class="ref" href="../G/G8.htm#i151587" title="Retinoider">Retinoider</a></p></p></td>
	</tr>
 <tr id="i145426" class="body oddelinje">
	<td id="i145427"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i145428">Actinomycin (= daktinomycin)</p></p></td>
	<td id="i145429"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i145430">5</p></p></td>
	<td id="i145431"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i145432">Se cytostatika  <a id="arowX146868" class="ref" href="../G/G8.htm#i146868" title="Cytostatika">Cytostatika</a></p></p></td>
	</tr>
 <tr id="i145433" class="body likelinje">
	<td id="i145434"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i145435">Adalimumab</p></p></td>
	<td id="i145436"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i145437">3</p></p></td>
	<td id="i145438"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i145439">Opplysninger om overgang til morsmelk mangler. Se monoklonale antistoffer  <a id="arowX150370" class="ref" href="../G/G8.htm#i150370" title="Monoklonale antistoffer">Monoklonale antistoffer</a></p></p></td>
	</tr>
 <tr id="i145440" class="body oddelinje">
	<td id="i145441"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i145442">Adapalen</p></p></td>
	<td id="i145443"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i145444">3</p></p></td>
	<td id="i145445"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i145446">Se retinoider, lokalbehandling  <a id="arowX151587" class="ref" href="../G/G8.htm#i151587" title="Retinoider">Retinoider</a></p></p></td>
	</tr>
 <tr id="i145447" class="body likelinje">
	<td id="i145448"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i145449">Adefovir</p></p></td>
	<td id="i145450"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i145451">3</p></p></td>
	<td id="i145452"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i145453">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i145454" class="body oddelinje">
	<td id="i145455"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i145456">Adenosin</p></p></td>
	<td id="i145457"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i145458">3</p></p></td>
	<td id="i145459"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i145460">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i145461" class="body likelinje">
	<td id="i145462"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i145463">Adrenalin</p></p></td>
	<td id="i145464"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i145465">1</p></p></td>
	<td id="i145466"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i145467"><em>Øyedråper:</em> Kan brukes av ammende</p></p></td>
	</tr>
 <tr id="i145468" class="body oddelinje">
	<td id="i145469"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i145470"><em>Adrenerge alfa-1-reseptorantagonister</em></p></p></td>
	<td id="i145471"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i145472"> </p></p></td>
	<td id="i145473"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i145474">Se alfa-1-reseptorantagonister, adrenerge  <a id="arowX145517" class="ref" href="../G/G8.htm#i145517" title="Alfa-1-reseptorantagonister, adrenerge">Alfa-1-reseptorantagonister, adrenerge</a></p></p></td>
	</tr>
 <tr id="i145475" class="body likelinje">
	<td id="i145476"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i145477"><em>Adrenerge betareseptorantagonister</em></p></p></td>
	<td id="i145478"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i145479"> </p></p></td>
	<td id="i145480"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i145481">Se betareseptorantagonister, adrenerge  <a id="arowX146361" class="ref" href="../G/G8.htm#i146361" title="Betareseptorantagonister, adrenerge">Betareseptorantagonister, adrenerge</a></p></p></td>
	</tr>
 <tr id="i145482" class="body oddelinje">
	<td id="i145483"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i145484">Akamprosat</p></p></td>
	<td id="i145485"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i145486">0</p></p></td>
	<td id="i145487"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i145488">Manglende klinisk erfaring</p></p></td>
	</tr>
 <tr id="i145489" class="body likelinje">
	<td id="i145490"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i145491">Akarbose</p></p></td>
	<td id="i145492"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i145493">0</p></p></td>
	<td id="i145494"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i145495">Manglende klinisk erfaring. Se antidiabetika, perorale  <a id="arowX145819" class="ref" href="../G/G8.htm#i145819" title="Antidiabetika, perorale">Antidiabetika, perorale</a></p></p></td>
	</tr>
 <tr id="i145496" class="body oddelinje">
	<td id="i145497"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i145498">Albendazol</p></p></td>
	<td id="i145499"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i145500">3</p></p></td>
	<td id="i145501"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i145502">Opplysninger om overgang til morsmelk mangler. Se også mebendazol  <a id="arowX149967" class="ref" href="../G/G8.htm#i149967" title="Mebendazol">Mebendazol</a></p></p></td>
	</tr>
 <tr id="i145503" class="body likelinje">
	<td id="i145504"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i145505">Alemtuzumab</p></p></td>
	<td id="i145506"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i145507">0</p></p></td>
	<td id="i145508"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i145509">Se monoklonale antistoffer  <a id="arowX150370" class="ref" href="../G/G8.htm#i150370" title="Monoklonale antistoffer">Monoklonale antistoffer</a></p></p></td>
	</tr>
 <tr id="i145510" class="body oddelinje">
	<td id="i145511"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i145512">Alendronat</p></p></td>
	<td id="i145513"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i145514">0</p></p></td>
	<td id="i145515"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i145516">Se bisfosfonater  <a id="arowX146417" class="ref" href="../G/G8.htm#i146417" title="Bisfosfonater">Bisfosfonater</a></p></p></td>
	</tr>
 <tr id="i145517" class="body likelinje">
	<td id="i145518"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i145519"><em>Alfa-1-reseptorantagonister, adrenerge</em></p></p></td>
	<td id="i145520"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i145521"> </p></p></td>
	<td id="i145522"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i145523">Se de enkelte virkestoffene</p></p></td>
	</tr>
 <tr id="i145524" class="body oddelinje">
	<td id="i145525"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i145526">Alfakalsidol</p></p></td>
	<td id="i145527"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i145528">1</p></p></td>
	<td id="i145529"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i145530">Se vitamin D  <a id="arowX152882" class="ref" href="../G/G8.htm#i152882" title="Vitamin D og vitamin D-analoger">Vitamin D og vitamin D-analoger</a></p></p></td>
	</tr>
 <tr id="i145531" class="body likelinje">
	<td id="i145532"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i145533">Alfentanil</p></p></td>
	<td id="i145534"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i145535">2</p></p></td>
	<td id="i145536"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i145537">Overgang til morsmelk er liten. Se anestesimidler  <a id="arowX145756" class="ref" href="../G/G8.htm#i145756" title="Anestesimidler">Anestesimidler</a></p></p></td>
	</tr>
 <tr id="i145538" class="body oddelinje">
	<td id="i145539"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i145540">Alfuzosin</p></p></td>
	<td id="i145541"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i145542">3</p></p></td>
	<td id="i145543"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i145544">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i145545" class="body likelinje">
	<td id="i145546"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i145547">Alginat</p></p></td>
	<td id="i145548"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i145549">0</p></p></td>
	<td id="i145550"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i145551">Lang klinisk erfaring. Kan brukes av ammende</p></p></td>
	</tr>
 <tr id="i145552" class="body oddelinje">
	<td id="i145553"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i145554">Alimemazin</p></p></td>
	<td id="i145555"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i145556">2</p></p></td>
	<td id="i145557"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i145558">Overgang til morsmelk er minimal. Se antihistaminer  <a id="arowX145840" class="ref" href="../G/G8.htm#i145840" title="Antihistaminer (H1-antagonister)">Antihistaminer (H1-antagonister)</a></p></p></td>
	</tr>
 <tr id="i145559" class="body likelinje">
	<td id="i145560"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i145561">Aliskiren</p></p></td>
	<td id="i145562"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i145563">4</p></p></td>
	<td id="i145564"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i145565">Opplysninger om overgang til morsmelk mangler. Teoretisk risiko for hypotensjon, sedasjon og slapphet hos diebarn</p></p></td>
	</tr>
 <tr id="i221796" class="body oddelinje">
	<td id="i221797"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i221798">Alitretinoin </p></p></td>
	<td id="i221799"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i221800">5 </p></p></td>
	<td id="i221801"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i221802">Se retinoider, peroral bruk  <a id="arowX151587" class="ref" href="../G/G8.htm#i151587" title="Retinoider">Retinoider</a></p></p></td>
	</tr>
 <tr id="i145566" class="body likelinje">
	<td id="i145567"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i145568">Allopurinol</p></p></td>
	<td id="i145569"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i145570">2</p></p></td>
	<td id="i145571"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i145572">Overgang til morsmelk er liten</p></p></td>
	</tr>
 <tr id="i145573" class="body oddelinje">
	<td id="i145574"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i145575">Almotriptan</p></p></td>
	<td id="i145576"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i145577">3</p></p></td>
	<td id="i145578"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i145579">Opplysninger om overgang til morsmelk mangler. Se triptaner  <a id="arowX152605" class="ref" href="../G/G8.htm#i152605" title="Triptaner">Triptaner</a></p></p></td>
	</tr>
 <tr id="i145580" class="body likelinje">
	<td id="i145581"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i145582">Alprazolam</p></p></td>
	<td id="i145583"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i145584">4</p></p></td>
	<td id="i145585"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i145586">Overgang til morsmelk er moderat. Seponeringsproblemer er blitt rapportert etter langvarig eksponering (> 9 måneder). Alternativt benzodiazepin bør benyttes. Se benzodiazepiner  <a id="arowX146283" class="ref" href="../G/G8.htm#i146283" title="Benzodiazepiner">Benzodiazepiner</a></p></p></td>
	</tr>
 <tr id="i145587" class="body oddelinje">
	<td id="i145588"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i145589">Alprostadil</p></p></td>
	<td id="i145590"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i145591">3</p></p></td>
	<td id="i145592"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i145593">Opplysninger mangler. Kan teoretisk påvirke melkeutskillelsen</p></p></td>
	</tr>
 <tr id="i145594" class="body likelinje">
	<td id="i145595"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i145596">Alteplase</p></p></td>
	<td id="i145597"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i145598">0</p></p></td>
	<td id="i145599"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i145600">Kan brukes av ammende pga. rask nedbrytning hos mor og ingen biotilgjengelighet hos barnet</p></p></td>
	</tr>
 <tr id="i145601" class="body oddelinje">
	<td id="i145602"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i145603">Altretamin</p></p></td>
	<td id="i145604"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i145605">5</p></p></td>
	<td id="i145606"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i145607">Se cytostatika  <a id="arowX146868" class="ref" href="../G/G8.htm#i146868" title="Cytostatika">Cytostatika</a></p></p></td>
	</tr>
 <tr id="i145608" class="body likelinje">
	<td id="i145609"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i145610">Amantadin</p></p></td>
	<td id="i145611"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i145612">4</p></p></td>
	<td id="i145613"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i145614">Bør ikke brukes av ammende pga. mulighet for å hemme melkeproduksjonen</p></p></td>
	</tr>
 <tr id="i145615" class="body oddelinje">
	<td id="i145616"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i145617">Amfetamin</p></p></td>
	<td id="i145618"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i145619">4</p></p></td>
	<td id="i145620"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i145621">Overgang til morsmelk er moderat. Bruk hos ammende frarådes ikke ved behandling av narkolepsi. Ved langvarig bruk (> 3&#8211;4 uker) eller høy dosering bør barnet observeres for legemiddeleffekter. Blandingsernæring anbefales. Ved misbruk av amfetamin er amming kontraindisert</p></p></td>
	</tr>
 <tr id="i145622" class="body likelinje">
	<td id="i145623"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i145624">Amfotericin B</p></p></td>
	<td id="i145625"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i145626">3</p></p></td>
	<td id="i145627"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i145628">Tilbakeholdenhet anbefales pga. virkestoffets toksisitet</p></p></td>
	</tr>
 <tr id="i145629" class="body oddelinje">
	<td id="i145630"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i145631">Amilorid</p></p></td>
	<td id="i145632"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i145633">3</p></p></td>
	<td id="i145634"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i145635">Se diuretika  <a id="arowX147247" class="ref" href="../G/G8.htm#i147247" title="Diuretika">Diuretika</a></p></p></td>
	</tr>
 <tr id="i145636" class="body likelinje">
	<td id="i145637"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i145638">Aminoeddiksyre (= glysin)</p></p></td>
	<td id="i145639"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i145640">3</p></p></td>
	<td id="i145641"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i145642">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i145643" class="body oddelinje">
	<td id="i145644"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i145645"><em>Aminoglykosider</em></p></p></td>
	<td id="i145646"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i145647">2, 3</p></p></td>
	<td id="i145648"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i145649">Liten absorpsjon fra barnets tarmkanal. Risiko for påvirkning av barnet er liten ved bruk av terapeutiske doser. Se antibakterielle midler  <a id="arowX145756" class="ref" href="../G/G8.htm#i145756" title="Anestesimidler">Anestesimidler</a>&ML;						Nyere aminoglykosider bør brukes med forsiktighet pga. liten klinisk erfaring hos ammende</p></p></td>
	</tr>
 <tr id="i145651" class="body likelinje">
	<td id="i145652"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i145653"><em>Aminosalisylsyreforbindelser</em></p></p></td>
	<td id="i145654"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i145655">3</p></p></td>
	<td id="i145656"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i145657">Se 5-ASA-preparater  <a id="arowX146032" class="ref" href="../G/G8.htm#i146032" title="5-ASA-preparater">5-ASA-preparater</a></p></p></td>
	</tr>
 <tr id="i145658" class="body oddelinje">
	<td id="i145659"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i145660">Amiodaron</p></p></td>
	<td id="i145661"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i145662">5</p></p></td>
	<td id="i145663"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i145664">Overgang til morsmelk er høy. Bruk hos ammende frarådes. Har gitt bradykardi og hypotyreoidisme hos brysternærte barn</p></p></td>
	</tr>
 <tr id="i145665" class="body likelinje">
	<td id="i145666"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i145667">Amisulprid</p></p></td>
	<td id="i145668"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i145669">3</p></p></td>
	<td id="i145670"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i145671">Opplysninger mangler. Se antipsykotika  <a id="arowX145918" class="ref" href="../G/G8.htm#i145918" title="Antipsykotika">Antipsykotika</a></p></p></td>
	</tr>
 <tr id="i145672" class="body oddelinje">
	<td id="i145673"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i145674">Amitriptylin</p></p></td>
	<td id="i145675"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i145676">2</p></p></td>
	<td id="i145677"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i145678">Overgang til morsmelk er minimal. Doser < 150 mg kan brukes i 2&#8211;3 uker. Se også trisykliske antidepressiva  <a id="arowX152619" class="ref" href="../G/G8.htm#i152619" title="Trisykliske antidepressiva (TCA)">Trisykliske antidepressiva (TCA)</a></p></p></td>
	</tr>
 <tr id="i145679" class="body likelinje">
	<td id="i145680"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i145681">Amlodipin</p></p></td>
	<td id="i145682"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i145683">3</p></p></td>
	<td id="i145684"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i145685">Opplysninger om overgang til morsmelk mangler. Se kalsiumantagonister  <a id="arowX149110" class="ref" href="../G/G8.htm#i149110" title="Kalsiumantagonister">Kalsiumantagonister</a></p></p></td>
	</tr>
 <tr id="i145686" class="body oddelinje">
	<td id="i145687"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i145688">Amoksicillin</p></p></td>
	<td id="i145689"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i145690">1</p></p></td>
	<td id="i145691"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i145692">Se penicilliner  <a id="arowX151075" class="ref" href="../G/G8.htm#i151075" title="Penicilliner">Penicilliner</a></p></p></td>
	</tr>
 <tr id="i145693" class="body likelinje">
	<td id="i145694"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i145695">Amorolfin</p></p></td>
	<td id="i145696"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i145697">0</p></p></td>
	<td id="i145698"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i145699">Neglelakk: Kan brukes av ammende</p></p></td>
	</tr>
 <tr id="i145700" class="body oddelinje">
	<td id="i145701"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i145702">Ampicillin</p></p></td>
	<td id="i145703"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i145704">1</p></p></td>
	<td id="i145705"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i145706">Se penicilliner  <a id="arowX151075" class="ref" href="../G/G8.htm#i151075" title="Penicilliner">Penicilliner</a></p></p></td>
	</tr>
 <tr id="i145707" class="body likelinje">
	<td id="i145708"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i145709">Amprenavir</p></p></td>
	<td id="i145710"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i145711">5</p></p></td>
	<td id="i145712"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i145713">Se antivirale midler  <a id="arowX145939" class="ref" href="../G/G8.htm#i145939" title="Antivirale midler">Antivirale midler</a></p></p></td>
	</tr>
 <tr id="i145714" class="body oddelinje">
	<td id="i145715"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i145716">Amsakrin</p></p></td>
	<td id="i145717"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i145718">5</p></p></td>
	<td id="i145719"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i145720">Se cytostatika  <a id="arowX146868" class="ref" href="../G/G8.htm#i146868" title="Cytostatika">Cytostatika</a></p></p></td>
	</tr>
 <tr id="i145721" class="body likelinje">
	<td id="i145722"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i145723"><em>Anabole steroider</em></p></p></td>
	<td id="i145724"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i145725">4</p></p></td>
	<td id="i145726"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i145727">Se androgener  <a id="arowX145749" class="ref" href="../G/G8.htm#i145749" title="Androgener">Androgener</a></p></p></td>
	</tr>
 <tr id="i145728" class="body oddelinje">
	<td id="i145729"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i145730">Anagrelid</p></p></td>
	<td id="i145731"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i145732">4</p></p></td>
	<td id="i145733"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i145734">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i145735" class="body likelinje">
	<td id="i145736"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i145737">Anakinra</p></p></td>
	<td id="i145738"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i145739">0</p></p></td>
	<td id="i145740"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i145741">Tilbakeholdenhet anbefales pga. virkestoffets immunsuppressive effekt</p></p></td>
	</tr>
 <tr id="i145742" class="body oddelinje">
	<td id="i145743"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i145744">Anastrozol</p></p></td>
	<td id="i145745"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i145746">4</p></p></td>
	<td id="i145747"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i145748">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i145749" class="body likelinje">
	<td id="i145750"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i145751"><em>Androgener</em></p></p></td>
	<td id="i145752"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i145753">4</p></p></td>
	<td id="i145754"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i145755">Bruk hos ammende frarådes. Teoretisk risiko for androgen effekt på brysternærte barn. Høye doser kan hemme melkeutskillelsen</p></p></td>
	</tr>
 <tr id="i145756" class="body oddelinje">
	<td id="i145757"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i145758"><em>Anestesimidler</em></p></p></td>
	<td id="i145759"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i145760">2</p></p></td>
	<td id="i145761"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i145762">Risiko for farmakologiske effekter på barnet ansees som liten når anestetika gis som enkeltdose eller over et kort tidsrom. Tidspunkt for amming etter inngrepet bør reguleres etter hvilket anestesimiddel som er blitt brukt</p></p></td>
	</tr>
 <tr id="i145763" class="body likelinje">
	<td id="i145764"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i145765"><em>Angiotensin II-reseptorantagonister</em></p></p></td>
	<td id="i145766"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i145767">3</p></p></td>
	<td id="i145768"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i145769">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i145770" class="body oddelinje">
	<td id="i145771"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i145772">Anidulafungin</p></p></td>
	<td id="i145773"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i145774">3</p></p></td>
	<td id="i145775"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i145776">Opplysninger mangler. Teoretisk liten sannsynlighet for systemisk opptak hos barnet</p></p></td>
	</tr>
 <tr id="i145777" class="body likelinje">
	<td id="i145778"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i145779"><em>Antacida</em></p></p></td>
	<td id="i145780"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i145781">0</p></p></td>
	<td id="i145782"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i145783">Lang klinisk erfaring. Kan brukes av ammende</p></p></td>
	</tr>
 <tr id="i145784" class="body oddelinje">
	<td id="i145785"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i145786">Antazolin</p></p></td>
	<td id="i145787"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i145788">2</p></p></td>
	<td id="i145789"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i145790">Lokalbehandling: Kan brukes av ammende. Se antihistaminer  <a id="arowX145840" class="ref" href="../G/G8.htm#i145840" title="Antihistaminer (H1-antagonister)">Antihistaminer (H1-antagonister)</a></p></p></td>
	</tr>
 <tr id="i145791" class="body likelinje">
	<td id="i145792"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i145793"><em>Anthelmintika</em></p></p></td>
	<td id="i145794"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i145795">0</p></p></td>
	<td id="i145796"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i145797">Risiko for farmakologiske effekter hos barnet ansees som liten</p></p></td>
	</tr>
 <tr id="i145798" class="body oddelinje">
	<td id="i145799"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i145800"><em>Antiandrogener</em></p></p></td>
	<td id="i145801"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i145802">4</p></p></td>
	<td id="i145803"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i145804">Bruk frarådes hos ammende pga. teoretisk risiko for antiandrogen effekt på barnet</p></p></td>
	</tr>
 <tr id="i145805" class="body likelinje">
	<td id="i145806"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i145807"><em>Antibakterielle midler</em></p></p></td>
	<td id="i145808"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i145809">1, 2, 3</p></p></td>
	<td id="i145810"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i145811">Ved høye konsentrasjoner i melken kan munn- og tarmfloraen påvirkes og føre til diaré hos enkelte barn. Teoretisk kan sensibilisering oppstå. Selv små mengder antibakterielle midler kan interferere med bakteriologiske undersøkelser, som f.eks. svaberprøver fra barnets hals</p></p></td>
	</tr>
 <tr id="i145812" class="body oddelinje">
	<td id="i145813"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i145814"><em>Antidepressiva</em></p></p></td>
	<td id="i145815"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i145816">2, 3</p></p></td>
	<td id="i145817"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i145818">Langtidseffekt på atferd og psykomotorisk utvikling hos brysternærte barn er ukjent. Når mors dose er høy, kan det være aktuelt med blandingsernæring, redusert antall amminger og amming på tidspunkter med lav konsentrasjon av legemidlet i morsmelk. Se også de enkelte grupper antidepressiva og de enkelte midlene</p></p></td>
	</tr>
 <tr id="i145819" class="body likelinje">
	<td id="i145820"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i145821"><em>Antidiabetika, perorale</em></p></p></td>
	<td id="i145822"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i145823">0, 1, 3</p></p></td>
	<td id="i145824"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i145825">Opplysninger om overgang til morsmelk mangler. Barnet bør observeres for hypoglykemi og lav vektøkning. Se også de enkelte virkestoffene</p></p></td>
	</tr>
 <tr id="i145826" class="body oddelinje">
	<td id="i145827"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i145828"><em>Antidoter</em></p></p></td>
	<td id="i145829"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i145830">3</p></p></td>
	<td id="i145831"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i145832">Ammende kvinner bør få antidot ved forgiftninger</p></p></td>
	</tr>
 <tr id="i145833" class="body likelinje">
	<td id="i145834"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i145835"><em>Antiepileptika</em></p></p></td>
	<td id="i145836"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i145837">2, 3, 4</p></p></td>
	<td id="i145838"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i145839">De tradisjonelle antiepileptika slik som fenytoin, karbamazepin og valproat ansees som forenlige med amming. Opplysninger om nyere antiepileptika, som felbamat, gabapentin, lamotrigin, topiramat, okskarbazepin, vigabatrin og zonisamid hos ammende er sparsomme. Forsiktighet bør utvises når mor bruker barbiturater (fenobarbital og primidon), etosuksimid, høye doser klonazepam, felbamat eller lamotrigin. Ved tegn til sedasjon eller dårlig vektøkning uten annen årsak bør barnets plasmanivå kontrolleres, og amming ev. reduseres, legges til tidspunkter med lavest mulig nivå i melken eller avbrytes. Bruk av felbamat, topiramat, zonisamid eller eslikarbazepin bør unngås hos ammende til mer kunnskap foreligger. Se også de enkelte virkestoffene</p></p></td>
	</tr>
 <tr id="i145840" class="body oddelinje">
	<td id="i145841"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i145842"><em>Antihistaminer (H<Sub>1</Sub>-antagonister)</em></p></p></td>
	<td id="i145843"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i145844">1, 2, 3</p></p></td>
	<td id="i145845"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i145846">De vanligste bivirkningene som ammende mødre spontant har rapportert ved bruk av førstegenerasjons antihistaminer, er døsighet eller irritabilitet hos brystbarnet. Pga. de sederende egenskapene til denne legemiddelgruppen bør muligens annengenerasjons antihistaminer hvor overgangen til morsmelk er liten, benyttes ved amming. Antihistaminer kan en sjelden gang redusere melkeproduksjonen. Se også de enkelte virkestoffene&ML;						Øyedråper/nesespray: Risiko for farmakologiske effekter hos barnet ansees som liten. Når perorale legemiddelformuleringer (tabletter) kan brukes av ammende, kan også lokalbehandling (dråper, spray) brukes</p></p></td>
	</tr>
 <tr id="i145848" class="body likelinje">
	<td id="i145849"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i145850"><em>Antihypertensiva</em></p></p></td>
	<td id="i145851"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i145852">2, 3, 4</p></p></td>
	<td id="i145853"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i145854">Observer barnet for hypotensjon, sedasjon og slapphet. Se også de enkelte virkestoffene</p></p></td>
	</tr>
 <tr id="i145855" class="body oddelinje">
	<td id="i145856"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i145857"><em>Antiinflammatoriske midler, ikke steroide</em></p></p></td>
	<td id="i145858"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i145859">1, 2, 3</p></p></td>
	<td id="i145860"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i145861">Se NSAID  <a id="arowX150698" class="ref" href="../G/G8.htm#i150698" title="NSAID">NSAID</a></p></p></td>
	</tr>
 <tr id="i145862" class="body likelinje">
	<td id="i145863"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i145864"><em>Antikoagulantia, perorale</em></p></p></td>
	<td id="i145865"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i145866">2, 3</p></p></td>
	<td id="i145867"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i145868">Passerer over i morsmelk, men risiko for farmakologiske effekter hos barnet ansees som liten ved terapeutiske doser. Se også de enkelte virkestoffene</p></p></td>
	</tr>
 <tr id="i145869" class="body oddelinje">
	<td id="i145870"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i145871"><em>Antikolinergika</em></p></p></td>
	<td id="i145872"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i145873">2, 3</p></p></td>
	<td id="i145874"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i145875">Tertiære ammoniumforbindelser (skopolamin, atropin, benztropin, biperidin, orfenadrin), systemisk bruk: Observer barnet for antikolinerge effekter. Teoretisk mulighet for negativ påvirkning av melkeproduksjonen. Se også de enkelte virkestoffene</p></p></td>
	</tr>
 <tr id="i145876" class="body likelinje">
	<td id="i145877"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i145878"> </p></p></td>
	<td id="i145879"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i145880">0</p></p></td>
	<td id="i145881"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i145882">Kvartære ammoniumforbindelser (glykopyrron): Liten sannsynlighet for systemisk opptak hos brysternærte barn</p></p></td>
	</tr>
 <tr id="i145883" class="body oddelinje">
	<td id="i145884"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i145885"><em>Antikolinesteraser</em></p></p></td>
	<td id="i145886"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i145887">3</p></p></td>
	<td id="i145888"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i145889">Se de enkelte virkestoffene</p></p></td>
	</tr>
 <tr id="i145890" class="body likelinje">
	<td id="i145891"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i145892"><em>Antikonseptiva</em></p></p></td>
	<td id="i145893"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i145894">1, 2, 3</p></p></td>
	<td id="i145895"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i145896">Se p-piller  <a id="arowX151249" class="ref" href="../G/G8.htm#i151249" title="P-piller">P-piller</a></p></p></td>
	</tr>
 <tr id="i145897" class="body oddelinje">
	<td id="i145898"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i145899"><em>Antimalariamidler</em></p></p></td>
	<td id="i145900"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i145901">2, 3, 4</p></p></td>
	<td id="i145902"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i145903">De fleste antimalariamidlene har lang plasmahalveringstid og vil akkumuleres i morsmelk etter gjentatt dosering. Barnet oppnår likevel ikke malariaprofylakse gjennom morsmelken når mor ammer og bruker antimalariamidler. Barnet bør observeres for bivirkninger. Se de enkelte virkestoffene</p></p></td>
	</tr>
 <tr id="i145904" class="body likelinje">
	<td id="i145905"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i145906"><em>Antimetabolitter</em></p></p></td>
	<td id="i145907"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i145908">5</p></p></td>
	<td id="i145909"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i145910">Se cytostatika  <a id="arowX146868" class="ref" href="../G/G8.htm#i146868" title="Cytostatika">Cytostatika</a></p></p></td>
	</tr>
 <tr id="i145911" class="body oddelinje">
	<td id="i145912"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i145913"><em>Antimykotika</em></p></p></td>
	<td id="i145914"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i145915">1, 2, 3</p></p></td>
	<td id="i145916"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i145917">Se de enkelte virkestoffene</p></p></td>
	</tr>
 <tr id="i145918" class="body likelinje">
	<td id="i145919"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i145920"><em>Antipsykotika</em></p></p></td>
	<td id="i145921"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i145922">3, 4</p></p></td>
	<td id="i145923"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i145924">Risiko for påvirkning av barnet er liten ved terapeutiske doser. Ved høye doser eller langvarig bruk anbefales tilbakeholdenhet med amming pga. fare for legemiddeleffekter hos barnet. Når mors dose er høy, kan blandingsernæring bli aktuelt. Redusert antall amminger og amming på tidspunkter med lav konsentrasjon i melken, kan redusere barnets legemiddeleksponering. Langtidseffekter på atferd og psykomotorisk utvikling kan ikke utelukkes. Kan øke melkeproduksjonen ved å øke prolaktinnivået. Se også de enkelte virkestoffene</p></p></td>
	</tr>
 <tr id="i145925" class="body oddelinje">
	<td id="i145926"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i145927">Antitrombin</p></p></td>
	<td id="i145928"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i145929">0</p></p></td>
	<td id="i145930"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i145931">Risiko for farmakologiske effekter hos barnet ansees som liten. Erfaring med bruk hos ammende mangler</p></p></td>
	</tr>
 <tr id="i145932" class="body likelinje">
	<td id="i145933"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i145934">Antitymocytt immunglobulin (kanin)</p></p></td>
	<td id="i145935"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i145936">3</p></p></td>
	<td id="i145937"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i145938">Opplysninger mangler. Se immunsuppressive midler  <a id="arowX148847" class="ref" href="../G/G8.htm#i148847" title="Immunsuppressive midler">Immunsuppressive midler</a></p></p></td>
	</tr>
 <tr id="i145939" class="body oddelinje">
	<td id="i145940"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i145941"><em>Antivirale midler</em></p></p></td>
	<td id="i145942"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i271343"> </p></p>
<p class="entrya"><p id="i271419">0, 2</p></p>
<p class="entrya"><p id="i271420">5</p></p></td>
	<td id="i145943"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i145944">Se de enkelte virkestoffene</p></p>	<UL type="circle">
		<LI id="i271413"><p id="i271414"><em>Herpesinfeksjoner:</em> Aciklovir bør fortrinnsvis benyttes til ammende pga. lengre klinisk erfaring</p><br>		</LI>
		<LI id="i271411"><p id="i271412">HIV-infeksjon: Amming er kontraindisert ved HIV-infeksjon hos mor, da HIV-viruset kan overføres til barnet via morsmelken</p><br>		</LI>
	</UL>
</td>
	</tr>
 <tr id="i145962" class="body likelinje">
	<td id="i145963"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i145964">Anti-Xa (lavmolekylært heparin)</p></p></td>
	<td id="i145965"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i145966">0</p></p></td>
	<td id="i145967"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i145968">Se hepariner  <a id="arowX148576" class="ref" href="../G/G8.htm#i148576" title="Hepariner">Hepariner</a></p></p></td>
	</tr>
 <tr id="i320042" class="body oddelinje">
	<td id="i320043"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i320044">Apixaban</p></p></td>
	<td id="i320045"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i320046">3</p></p></td>
	<td id="i320047"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i320048">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i145969" class="body likelinje">
	<td id="i145970"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i145971">Apomorfin</p></p></td>
	<td id="i145972"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i145973">5</p></p></td>
	<td id="i145974"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i145975">Kan hemme melkeproduksjonen</p></p></td>
	</tr>
 <tr id="i145976" class="body oddelinje">
	<td id="i145977"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i145978">Apraklonidin</p></p></td>
	<td id="i145979"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i145980">3</p></p></td>
	<td id="i145981"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i145982">Øyedråper: Pga. manglende opplysninger om overgang til morsmelk anbefales forsiktighet med bruk hos ammende</p></p></td>
	</tr>
 <tr id="i145983" class="body likelinje">
	<td id="i145984"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i145985">Aprepitant</p></p></td>
	<td id="i145986"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i145987">3</p></p></td>
	<td id="i145988"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i145989">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i145990" class="body oddelinje">
	<td id="i145991"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i145992">Argatroban</p></p></td>
	<td id="i145993"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i145994">3</p></p></td>
	<td id="i145995"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i145996">Overgang til morsmelk er ukjent. Kort halveringstid og lav biotilgjengelighet tilsier at amming kan gjenopptas ca. 5 timer etter avsluttet infusjon</p></p></td>
	</tr>
 <tr id="i145997" class="body likelinje">
	<td id="i145998"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i145999">Arginin</p></p></td>
	<td id="i146000"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i146001">3</p></p></td>
	<td id="i146002"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i146003">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i146004" class="body oddelinje">
	<td id="i146005"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i146006">Aripiprazol</p></p></td>
	<td id="i146007"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i146008">3</p></p></td>
	<td id="i146009"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i146010">Opplysninger om overgang til morsmelk mangler. Se antipsykotika  <a id="arowX145918" class="ref" href="../G/G8.htm#i145918" title="Antipsykotika">Antipsykotika</a></p></p></td>
	</tr>
 <tr id="i146011" class="body likelinje">
	<td id="i146012"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i146013">Artemeter</p></p></td>
	<td id="i146014"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i146015">3</p></p></td>
	<td id="i146016"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i146017">Opplysninger mangler. Se antimalariamidler  <a id="arowX145897" class="ref" href="../G/G8.htm#i145897" title="Antimalariamidler">Antimalariamidler</a></p></p></td>
	</tr>
 <tr id="i146018" class="body oddelinje">
	<td id="i146019"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i146020">Artesunat</p></p></td>
	<td id="i146021"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i146022">3</p></p></td>
	<td id="i146023"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i146024">Opplysninger mangler. Se også antimalariamidler  <a id="arowX145897" class="ref" href="../G/G8.htm#i145897" title="Antimalariamidler">Antimalariamidler</a></p></p></td>
	</tr>
 <tr id="i146025" class="body likelinje">
	<td id="i146026"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i146027">Artikain</p></p></td>
	<td id="i146028"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i146029">3</p></p></td>
	<td id="i146030"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i146031">Liten klinisk erfaring. Se lokalanestetika  <a id="arowX149842" class="ref" href="../G/G8.htm#i149842" title="Lokalanestetika">Lokalanestetika</a></p></p></td>
	</tr>
 <tr id="i146032" class="body oddelinje">
	<td id="i146033"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i146034"><em>5-ASA-preparater</em></p></p></td>
	<td id="i146035"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i146036">3</p></p></td>
	<td id="i146037"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i146038">Overgang til morsmelk er moderat. Observer barnet for diaré</p></p></td>
	</tr>
 <tr id="i221803" class="body likelinje">
	<td id="i221804"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i221805">Asenapin </p></p></td>
	<td id="i221806"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i221807">3 </p></p></td>
	<td id="i221808"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i221809">Opplysninger om overgang til morsmelk mangler. Se antipsykotika  <a id="arowX145918" class="ref" href="../G/G8.htm#i145918" title="Antipsykotika">Antipsykotika</a></p></p></td>
	</tr>
 <tr id="i146039" class="body oddelinje">
	<td id="i146040"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i146041">Asparginase (= crisantapase)</p></p></td>
	<td id="i146042"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i146043">5</p></p></td>
	<td id="i146044"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i146045">Se cytostatika  <a id="arowX146868" class="ref" href="../G/G8.htm#i146868" title="Cytostatika">Cytostatika</a></p></p></td>
	</tr>
 <tr id="i146046" class="body likelinje">
	<td id="i146047"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i146048">Atazanavir</p></p></td>
	<td id="i146049"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i146050">5</p></p></td>
	<td id="i146051"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i146052">Se antivirale midler  <a id="arowX145939" class="ref" href="../G/G8.htm#i145939" title="Antivirale midler">Antivirale midler</a></p></p></td>
	</tr>
 <tr id="i146053" class="body oddelinje">
	<td id="i146054"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i146055">Atenolol</p></p></td>
	<td id="i146056"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i146057">3</p></p></td>
	<td id="i146058"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i146059">Overgang til morsmelk er moderat. Se betareseptorantagonister, adrenerge  <a id="arowX146361" class="ref" href="../G/G8.htm#i146361" title="Betareseptorantagonister, adrenerge">Betareseptorantagonister, adrenerge</a></p></p></td>
	</tr>
 <tr id="i146060" class="body likelinje">
	<td id="i146061"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i146062">Atomoksetin</p></p></td>
	<td id="i146063"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i146064">3</p></p></td>
	<td id="i146065"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i146066">Opplysninger om overgang til morsmelk mangler. Langtidseffekter på atferd og psykomotorisk utvikling kan ikke utelukkes.</p></p></td>
	</tr>
 <tr id="i146067" class="body oddelinje">
	<td id="i146068"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i146069">Atorvastatin</p></p></td>
	<td id="i146070"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i146071">3</p></p></td>
	<td id="i146072"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i146073">Se statiner  <a id="arowX151973" class="ref" href="../G/G8.htm#i151973" title="Statiner">Statiner</a></p></p></td>
	</tr>
 <tr id="i146074" class="body likelinje">
	<td id="i146075"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i146076">Atosiban</p></p></td>
	<td id="i146077"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i146078">4</p></p></td>
	<td id="i146079"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i146080">Kan muligens hemme utdrivningsrefleksen (oksytosinantagonist)</p></p></td>
	</tr>
 <tr id="i146081" class="body oddelinje">
	<td id="i146082"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i146083">Atovakvon</p></p></td>
	<td id="i146084"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i146085">3</p></p></td>
	<td id="i146086"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i146087">Opplysninger om overgang til morsmelk mangler. Se antimalariamidler  <a id="arowX145897" class="ref" href="../G/G8.htm#i145897" title="Antimalariamidler">Antimalariamidler</a></p></p></td>
	</tr>
 <tr id="i146088" class="body likelinje">
	<td id="i146089"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i146090"><em>AT1-reseptorantagonister</em></p></p></td>
	<td id="i146091"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i146092">3</p></p></td>
	<td id="i146093"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i146094">Se angiotensin II-reseptorantagonister  <a id="arowX145763" class="ref" href="../G/G8.htm#i145763" title="Angiotensin II-reseptorantagonister">Angiotensin II-reseptorantagonister</a></p></p></td>
	</tr>
 <tr id="i146095" class="body oddelinje">
	<td id="i146096"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i146097">Atropin</p></p></td>
	<td id="i146098"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i146099">3</p></p></td>
	<td id="i146100"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i146101">Passerer over i morsmelk. Enkeltdoser kan brukes til ammende. Gjentatt dosering kan muligens gi antikolinerge effekter hos brysternærte barn samt nedsette melkeproduksjonen</p></p></td>
	</tr>
 <tr id="i146102" class="body likelinje">
	<td id="i146103"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i146104">Auranofin</p></p></td>
	<td id="i146105"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i146106">5</p></p></td>
	<td id="i146107"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i146108">Se gullforbindelser  <a id="arowX148521" class="ref" href="../G/G8.htm#i148521" title="Gullforbindelser">Gullforbindelser</a></p></p></td>
	</tr>
 <tr id="i146109" class="body oddelinje">
	<td id="i146110"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i146111">Aurotiomalat</p></p></td>
	<td id="i146112"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i146113">5</p></p></td>
	<td id="i146114"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i146115">Se gullforbindelser  <a id="arowX148521" class="ref" href="../G/G8.htm#i148521" title="Gullforbindelser">Gullforbindelser</a></p></p></td>
	</tr>
 <tr id="i146116" class="body likelinje">
	<td id="i146117"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i146118">Azacitidin</p></p></td>
	<td id="i146119"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i146120">5</p></p></td>
	<td id="i146121"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i146122">Se cytostatika  <a id="arowX146868" class="ref" href="../G/G8.htm#i146868" title="Cytostatika">Cytostatika</a></p></p></td>
	</tr>
 <tr id="i146123" class="body oddelinje">
	<td id="i146124"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i146125">Azatioprin</p></p></td>
	<td id="i146126"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i146127">3,5</p></p></td>
	<td id="i146128"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i146129">Overgang til morsmelk er minimal. Forsiktighet anbefales pga. virkestoffets immunsuppressive effekt. Oppfølging av barnet anbefales hvis amming tillates. Amming er kontraindisert ved bruk i høye doser som cytostatikum</p></p></td>
	</tr>
 <tr id="i146130" class="body likelinje">
	<td id="i146131"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i146132">Azelain</p></p></td>
	<td id="i146133"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i146134">2</p></p></td>
	<td id="i146135"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i146136">Lokalbehandling: Kan brukes av ammende</p></p></td>
	</tr>
 <tr id="i146137" class="body oddelinje">
	<td id="i146138"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i146139">Azelastin</p></p></td>
	<td id="i146140"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i146141">2</p></p></td>
	<td id="i146142"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i146143">Lokalbehandling: Minimal systemisk overgang. Se antihistaminer  <a id="arowX145840" class="ref" href="../G/G8.htm#i145840" title="Antihistaminer (H1-antagonister)">Antihistaminer (H1-antagonister)</a></p></p></td>
	</tr>
 <tr id="i146144" class="body likelinje">
	<td id="i146145"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i146146">Azitromycin</p></p></td>
	<td id="i146147"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i146148">2</p></p></td>
	<td id="i146149"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i146150">Overgang til morsmelk er minimal. Se antibakterielle midler  <a id="arowX145756" class="ref" href="../G/G8.htm#i145756" title="Anestesimidler">Anestesimidler</a></p></p></td>
	</tr>
 <tr id="i146151" class="body oddelinje">
	<td id="i146152"    valign="top" width="31.1%" class="startKol">

<p class="entrya"><p id="i146153">Aztreonam</p></p></td>
	<td id="i146154"    valign="top" width="18.2%" class="mellomKol">

<p class="entrya"><p id="i146155">2</p></p></td>
	<td id="i146156"    valign="top" width="50.7%" class="sluttKol">

<p class="entrya"><p id="i146157">Overgang til morsmelk er minimal. Se antibakterielle midler  <a id="arowX145756" class="ref" href="../G/G8.htm#i145756" title="Anestesimidler">Anestesimidler</a></p></p></td>
	</tr>
 </tbody></table>
 <table id="i146159" width="100%" class="maintable" border="0" cellpadding="5" cellspacing="0">
 <caption> <Uth Id="NUTHid2331865O146160" Type="Halvfet">B</Uth></caption> <thead>
	<tr class = "linjetopp">
	<th id="i146167"  colspan="3"  valign="top"  class="sluttKol">

<p class="entrya"><p id="i146168">Overgang til morsmelk angis som minimal (< 2 %), liten (2&#x2013;5 %), moderat (5&#x2013;10 %) eller høy (10&#x2013;50 %) basert på fraksjon av morens dose/kg kroppsvekt som barnet tilføres. (Barnets relative dose.)&ML;						Over 3&#x2013;4 ukers bruk ansees som langtidsbehandling.</p></p></th>
	</tr>
	<tr class = "linjetopp">
	<th id="i146171"    valign="top"  class="startKol">

<p class="entrya"><p id="i146172"><strong>Legemiddel</strong></p></p></th>
	<th id="i146173"    valign="top"  class="mellomKol">

<p class="entrya"><p id="i146174"><strong>MM kategori</strong></p></p></th>
	<th id="i146175"    valign="top"  class="sluttKol">

<p class="entrya"><p id="i146176"><strong>Dokumentasjon vedrørende bruk under amming</strong></p></p></th>
	</tr>
</thead>
<tbody>
<tr id="i146178" class="body likelinje">
	<td id="i146179"    valign="top" width="29.5%" class="startKol">

<p class="entrya"><p id="i146180">Bacillus Calmette-Guerin</p></p></td>
	<td id="i146181"    valign="top" width="19.6%" class="mellomKol">

<p class="entrya"><p id="i146182">2</p></p></td>
	<td id="i146183"    valign="top" width="50.9%" class="sluttKol">

<p class="entrya"><p id="i146184">Se BCG  <a id="arowX146241" class="ref" href="../G/G8.htm#i146241" title="BCG">BCG</a></p></p></td>
	</tr>
 <tr id="i146185" class="body oddelinje">
	<td id="i146186"    valign="top" width="29.5%" class="startKol">

<p class="entrya"><p id="i146187">Bacitracin</p></p></td>
	<td id="i146188"    valign="top" width="19.6%" class="mellomKol">

<p class="entrya"><p id="i146189">2</p></p></td>
	<td id="i146190"    valign="top" width="50.9%" class="sluttKol">

<p class="entrya"><p id="i146191">Lokalbehandling: Kan brukes av ammende</p></p></td>
	</tr>
 <tr id="i146192" class="body likelinje">
	<td id="i146193"    valign="top" width="29.5%" class="startKol">

<p class="entrya"><p id="i146194">Baklofen</p></p></td>
	<td id="i146195"    valign="top" width="19.6%" class="mellomKol">

<p class="entrya"><p id="i146196">2</p></p></td>
	<td id="i146197"    valign="top" width="50.9%" class="sluttKol">

<p class="entrya"><p id="i146198">Overgang til morsmelk er minimal. Begrenset klinisk erfaring</p></p></td>
	</tr>
 <tr id="i146199" class="body oddelinje">
	<td id="i146200"    valign="top" width="29.5%" class="startKol">

<p class="entrya"><p id="i146201">Bambuterol</p></p></td>
	<td id="i146202"    valign="top" width="19.6%" class="mellomKol">

<p class="entrya"><p id="i146203">3</p></p></td>
	<td id="i146204"    valign="top" width="50.9%" class="sluttKol">

<p class="entrya"><p id="i146205">Opplysninger om overgang til morsmelk mangler. Se beta-2-reseptoragonister, adrenerge  <a id="arowX146354" class="ref" href="../G/G8.htm#i146354" title="Beta-2-reseptoragonister, adrenerge">Beta-2-reseptoragonister, adrenerge</a></p></p></td>
	</tr>
 <tr id="i146206" class="body likelinje">
	<td id="i146207"    valign="top" width="29.5%" class="startKol">

<p class="entrya"><p id="i146208">Barbital</p></p></td>
	<td id="i146209"    valign="top" width="19.6%" class="mellomKol">

<p class="entrya"><p id="i146210">4</p></p></td>
	<td id="i146211"    valign="top" width="50.9%" class="sluttKol">

<p class="entrya"><p id="i146212">Se barbiturater  <a id="arowX146213" class="ref" href="../G/G8.htm#i146213" title="Barbiturater">Barbiturater</a></p></p></td>
	</tr>
 <tr id="i146213" class="body oddelinje">
	<td id="i146214"    valign="top" width="29.5%" class="startKol">

<p class="entrya"><p id="i146215"><em>Barbiturater</em></p></p></td>
	<td id="i146216"    valign="top" width="19.6%" class="mellomKol">

<p class="entrya"><p id="i146217">4</p></p></td>
	<td id="i146218"    valign="top" width="50.9%" class="sluttKol">

<p class="entrya"><p id="i146219">Overgang til morsmelk er høy. Døsighet, dårlig sugeevne og lav vektøkning er rapportert hos brysternærte barn. Mulighet for akkumulering av aktive metabolitter ved langtidsbruk</p></p></td>
	</tr>
 <tr id="i146220" class="body likelinje">
	<td id="i146221"    valign="top" width="29.5%" class="startKol">

<p class="entrya"><p id="i146222">Bariumsulfat</p></p></td>
	<td id="i146223"    valign="top" width="19.6%" class="mellomKol">

<p class="entrya"><p id="i146224">0</p></p></td>
	<td id="i146225"    valign="top" width="50.9%" class="sluttKol">

<p class="entrya"><p id="i146226">Kan brukes av ammende</p></p></td>
	</tr>
 <tr id="i146227" class="body oddelinje">
	<td id="i146228"    valign="top" width="29.5%" class="startKol">

<p class="entrya"><p id="i146229">Basiliximab</p></p></td>
	<td id="i146230"    valign="top" width="19.6%" class="mellomKol">

<p class="entrya"><p id="i146231">3</p></p></td>
	<td id="i146232"    valign="top" width="50.9%" class="sluttKol">

<p class="entrya"><p id="i146233">Opplysninger om overgang til morsmelk mangler. Se monoklonale antistoffer  <a id="arowX150370" class="ref" href="../G/G8.htm#i150370" title="Monoklonale antistoffer">Monoklonale antistoffer</a></p></p></td>
	</tr>
 <tr id="i146234" class="body likelinje">
	<td id="i146235"    valign="top" width="29.5%" class="startKol">

<p class="entrya"><p id="i146236">Bazedoksifen</p></p></td>
	<td id="i146237"    valign="top" width="19.6%" class="mellomKol">

<p class="entrya"><p id="i146238">&#x2013;</p></p></td>
	<td id="i146239"    valign="top" width="50.9%" class="sluttKol">

<p class="entrya"><p id="i146240">Skal bare brukes etter menopausen</p></p></td>
	</tr>
 <tr id="i146241" class="body oddelinje">
	<td id="i146242"    valign="top" width="29.5%" class="startKol">

<p class="entrya"><p id="i146243">BCG</p></p></td>
	<td id="i146244"    valign="top" width="19.6%" class="mellomKol">

<p class="entrya"><p id="i146245">2</p></p></td>
	<td id="i146246"    valign="top" width="50.9%" class="sluttKol">

<p class="entrya"><p id="i146247">Opplysninger om overgang til morsmelk mangler. Klinisk erfaring tilsier at BCG-vaksine kan gis til ammende</p></p></td>
	</tr>
 <tr id="i146248" class="body likelinje">
	<td id="i146249"    valign="top" width="29.5%" class="startKol">

<p class="entrya"><p id="i146250">Beklometason</p></p></td>
	<td id="i146251"    valign="top" width="19.6%" class="mellomKol">

<p class="entrya"><p id="i146252">2</p></p></td>
	<td id="i146253"    valign="top" width="50.9%" class="sluttKol">

<p class="entrya"><p id="i146254">Se glukokortikoider, inhalasjonsglukokortikoider  <a id="arowX148403" class="ref" href="../G/G8.htm#i148403" title="Glukokortikoider">Glukokortikoider</a></p></p></td>
	</tr>
 <tr id="i146255" class="body oddelinje">
	<td id="i146256"    valign="top" width="29.5%" class="startKol">

<p class="entrya"><p id="i146257">Beksaroten</p></p></td>
	<td id="i146258"    valign="top" width="19.6%" class="mellomKol">

<p class="entrya"><p id="i146259">5</p></p></td>
	<td id="i146260"    valign="top" width="50.9%" class="sluttKol">

<p class="entrya"><p id="i146261">Amming frarådes pga. virkestoffets toksisitet</p></p></td>
	</tr>
 <tr id="i221810" class="body likelinje">
	<td id="i221811"    valign="top" width="29.5%" class="startKol">

<p class="entrya"><p id="i221812">Bendamustin </p></p></td>
	<td id="i221813"    valign="top" width="19.6%" class="mellomKol">

<p class="entrya"><p id="i221814">5 </p></p></td>
	<td id="i221815"    valign="top" width="50.9%" class="sluttKol">

<p class="entrya"><p id="i221816">Se cytostatika  <a id="arowX146868" class="ref" href="../G/G8.htm#i146868" title="Cytostatika">Cytostatika</a></p></p></td>
	</tr>
 <tr id="i146262" class="body oddelinje">
	<td id="i146263"    valign="top" width="29.5%" class="startKol">

<p class="entrya"><p id="i146264">Bendroflumetiazid</p></p></td>
	<td id="i146265"    valign="top" width="19.6%" class="mellomKol">

<p class="entrya"><p id="i146266">3</p></p></td>
	<td id="i146267"    valign="top" width="50.9%" class="sluttKol">

<p class="entrya"><p id="i146268">Overgang til morsmelk er liten. Se diuretika  <a id="arowX147247" class="ref" href="../G/G8.htm#i147247" title="Diuretika">Diuretika</a></p></p></td>
	</tr>
 <tr id="i146269" class="body likelinje">
	<td id="i146270"    valign="top" width="29.5%" class="startKol">

<p class="entrya"><p id="i146271">Benserazid</p></p></td>
	<td id="i146272"    valign="top" width="19.6%" class="mellomKol">

<p class="entrya"><p id="i146273">3</p></p></td>
	<td id="i146274"    valign="top" width="50.9%" class="sluttKol">

<p class="entrya"><p id="i146275">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i146276" class="body oddelinje">
	<td id="i146277"    valign="top" width="29.5%" class="startKol">

<p class="entrya"><p id="i146278">Benzatinpenicillin</p></p></td>
	<td id="i146279"    valign="top" width="19.6%" class="mellomKol">

<p class="entrya"><p id="i146280">2</p></p></td>
	<td id="i146281"    valign="top" width="50.9%" class="sluttKol">

<p class="entrya"><p id="i146282">Se penicilliner  <a id="arowX151075" class="ref" href="../G/G8.htm#i151075" title="Penicilliner">Penicilliner</a></p></p></td>
	</tr>
 <tr id="i146283" class="body likelinje">
	<td id="i146284"    valign="top" width="29.5%" class="startKol">

<p class="entrya"><p id="i146285"><em>Benzodiazepiner</em></p></p></td>
	<td id="i146286"    valign="top" width="19.6%" class="mellomKol">

<p class="entrya"><p id="i146287">3</p></p>
<p class="entrya"><p id="i317150"> </p></p>
<p class="entrya"><p id="i317151">4 &#x2013;&ML;						langtidsbruk</p></p></td>
	<td id="i146288"    valign="top" width="50.9%" class="sluttKol">

<p class="entrya"><p id="i146289">Kan brukes av ammende i lave doser i et par dager. Benzodiazepiner med kortest halveringstider foretrekkes (oksazepam)</p></p>
<p class="entrya"><p id="i317152">Ved langtidsbruk, eller hvis barnet er blitt eksponert for benzodiazepiner før eller under fødselen, bør barnet observeres for døsighet, dårlig sugeevne og hypotoni, spesielt hvis barnet også er blitt eksponert under svangerskapet</p></p></td>
	</tr>
 <tr id="i146298" class="body oddelinje">
	<td id="i146299"    valign="top" width="29.5%" class="startKol">

<p class="entrya"><p id="i146300">Benzokain</p></p></td>
	<td id="i146301"    valign="top" width="19.6%" class="mellomKol">

<p class="entrya"><p id="i146302">2</p></p></td>
	<td id="i146303"    valign="top" width="50.9%" class="sluttKol">

<p class="entrya"><p id="i146304">Se lokalanestetika  <a id="arowX149842" class="ref" href="../G/G8.htm#i149842" title="Lokalanestetika">Lokalanestetika</a></p></p></td>
	</tr>
 <tr id="i146305" class="body likelinje">
	<td id="i146306"    valign="top" width="29.5%" class="startKol">

<p class="entrya"><p id="i146307">Benzoylperoksid</p></p></td>
	<td id="i146308"    valign="top" width="19.6%" class="mellomKol">

<p class="entrya"><p id="i146309">1</p></p></td>
	<td id="i146310"    valign="top" width="50.9%" class="sluttKol">

<p class="entrya"><p id="i146311">Lokalbehandling: Kan brukes av ammende</p></p></td>
	</tr>
 <tr id="i146312" class="body oddelinje">
	<td id="i146313"    valign="top" width="29.5%" class="startKol">

<p class="entrya"><p id="i146314">Benztropin</p></p></td>
	<td id="i146315"    valign="top" width="19.6%" class="mellomKol">

<p class="entrya"><p id="i146316">3</p></p></td>
	<td id="i146317"    valign="top" width="50.9%" class="sluttKol">

<p class="entrya"><p id="i146318">Opplysninger mangler. Se antikolinergika  <a id="arowX145869" class="ref" href="../G/G8.htm#i145869" title="Antikolinergika">Antikolinergika</a></p></p></td>
	</tr>
 <tr id="i146319" class="body likelinje">
	<td id="i146320"    valign="top" width="29.5%" class="startKol">

<p class="entrya"><p id="i146321">Benzylbenzoat</p></p></td>
	<td id="i146322"    valign="top" width="19.6%" class="mellomKol">

<p class="entrya"><p id="i146323">1</p></p></td>
	<td id="i146324"    valign="top" width="50.9%" class="sluttKol">

<p class="entrya"><p id="i146325">Lokalbehandling: Kan brukes av ammend</p></p></td>
	</tr>
 <tr id="i146326" class="body oddelinje">
	<td id="i146327"    valign="top" width="29.5%" class="startKol">

<p class="entrya"><p id="i146328">Benzylpenicillin</p></p></td>
	<td id="i146329"    valign="top" width="19.6%" class="mellomKol">

<p class="entrya"><p id="i146330">1</p></p></td>
	<td id="i146331"    valign="top" width="50.9%" class="sluttKol">

<p class="entrya"><p id="i146332">Se penicilliner  <a id="arowX151075" class="ref" href="../G/G8.htm#i151075" title="Penicilliner">Penicilliner</a></p></p></td>
	</tr>
 <tr id="i146333" class="body likelinje">
	<td id="i146334"    valign="top" width="29.5%" class="startKol">

<p class="entrya"><p id="i146335">Betaksolol</p></p></td>
	<td id="i146336"    valign="top" width="19.6%" class="mellomKol">

<p class="entrya"><p id="i146337">3</p></p></td>
	<td id="i146338"    valign="top" width="50.9%" class="sluttKol">

<p class="entrya"><p id="i146339">Opplysninger om overgang til morsmelk mangler. Se betareseptorantagonister, øyedråper  <a id="arowX146361" class="ref" href="../G/G8.htm#i146361" title="Betareseptorantagonister, adrenerge">Betareseptorantagonister, adrenerge</a></p></p></td>
	</tr>
 <tr id="i146340" class="body oddelinje">
	<td id="i146341"    valign="top" width="29.5%" class="startKol">

<p class="entrya"><p id="i146342"><em>Betalaktamantibiotika</em></p></p></td>
	<td id="i146343"    valign="top" width="19.6%" class="mellomKol">

<p class="entrya"><p id="i146344">1, 2</p></p></td>
	<td id="i146345"    valign="top" width="50.9%" class="sluttKol">

<p class="entrya"><p id="i146346">Se de enkelte virkestoffene</p></p></td>
	</tr>
 <tr id="i146347" class="body likelinje">
	<td id="i146348"    valign="top" width="29.5%" class="startKol">

<p class="entrya"><p id="i146349">Betametason</p></p></td>
	<td id="i146350"    valign="top" width="19.6%" class="mellomKol">

<p class="entrya"><p id="i146351">3</p></p></td>
	<td id="i146352"    valign="top" width="50.9%" class="sluttKol">

<p class="entrya"><p id="i146353">Opplysninger om overgang til morsmelk mangler. Se glukokortikoider  <a id="arowX148403" class="ref" href="../G/G8.htm#i148403" title="Glukokortikoider">Glukokortikoider</a></p></p></td>
	</tr>
 <tr id="i146354" class="body oddelinje">
	<td id="i146355"    valign="top" width="29.5%" class="startKol">

<p class="entrya"><p id="i146356"><em>Beta-2-reseptoragonister, adrenerge</em></p></p></td>
	<td id="i146357"    valign="top" width="19.6%" class="mellomKol">

<p class="entrya"><p id="i146358">2, 3</p></p></td>
	<td id="i146359"    valign="top" width="50.9%" class="sluttKol">

<p class="entrya"><p id="i146360">Lokalbehandling: Risiko for farmakologiske effekter hos brysternærte barn ansees som liten. Klinisk erfaring mangler for de nyeste midlene. Se også de enkelte virkestoffene</p></p></td>
	</tr>
 <tr id="i146361" class="body likelinje">
	<td id="i146362"    valign="top" width="29.5%" class="startKol">

<p class="entrya"><p id="i146363"><em>Betareseptorantagonister, adrenerge</em></p></p></td>
	<td id="i146364"    valign="top" width="19.6%" class="mellomKol">

<p class="entrya"><p id="i146365">2, 3</p></p></td>
	<td id="i146366"    valign="top" width="50.9%" class="sluttKol">

<p class="entrya"><p id="i146367">De fleste betareseptorantagonister går over i morsmelk. Risiko for farmakologiske effekter på barnet er liten ved bruk av terapeutiske doser. Barnet bør for sikkerhets skyld observeres for bradykardi og andre symptomer på betablokade (hypotensjon, slapphet). Fordi sotalol og atenolol går over i morsmelk i større grad enn de andre betareseptorantagonistene, bør ammende fortrinnsvis bruke andre betareseptorantagonister.&ML;						Øyedråper: Når opplysninger om overgang til morsmelk mangler, anbefales forsiktighet. Når perorale legemiddelformuleringer (tabletter) kan brukes av ammende, ansees lokalbehandling (øyedråper) for akseptabelt</p></p></td>
	</tr>
 <tr id="i146369" class="body oddelinje">
	<td id="i146370"    valign="top" width="29.5%" class="startKol">

<p class="entrya"><p id="i146371">Bevacizumab</p></p></td>
	<td id="i146372"    valign="top" width="19.6%" class="mellomKol">

<p class="entrya"><p id="i146373">3</p></p></td>
	<td id="i146374"    valign="top" width="50.9%" class="sluttKol">

<p class="entrya"><p id="i146375">Opplysninger om overgang til morsmelk mangler. Immunglobuliner utskilles i morsmelk. Tilbakeholdenhet anbefales pga. virkningsmekanismen</p></p></td>
	</tr>
 <tr id="i146376" class="body likelinje">
	<td id="i146377"    valign="top" width="29.5%" class="startKol">

<p class="entrya"><p id="i146378">Bicalutamid</p></p></td>
	<td id="i146379"    valign="top" width="19.6%" class="mellomKol">

<p class="entrya"><p id="i146380">&#x2013;</p></p></td>
	<td id="i146381"    valign="top" width="50.9%" class="sluttKol">

<p class="entrya"><p id="i146382">Ikke aktuelt til bruk hos ammende. Se antiandrogener  <a id="arowX145798" class="ref" href="../G/G8.htm#i145798" title="Antiandrogener">Antiandrogener</a></p></p></td>
	</tr>
 <tr id="i146383" class="body oddelinje">
	<td id="i146384"    valign="top" width="29.5%" class="startKol">

<p class="entrya"><p id="i146385">Bifonazol</p></p></td>
	<td id="i146386"    valign="top" width="19.6%" class="mellomKol">

<p class="entrya"><p id="i146387">2</p></p></td>
	<td id="i146388"    valign="top" width="50.9%" class="sluttKol">

<p class="entrya"><p id="i146389">Se fungicider til lokal bruk  <a id="arowX148164" class="ref" href="../G/G8.htm#i148164" title="Fungicider til lokal bruk">Fungicider til lokal bruk</a></p></p></td>
	</tr>
 <tr id="i146390" class="body likelinje">
	<td id="i146391"    valign="top" width="29.5%" class="startKol">

<p class="entrya"><p id="i146392"><em>Biguanidderivater</em></p></p></td>
	<td id="i146393"    valign="top" width="19.6%" class="mellomKol">

<p class="entrya"><p id="i146394">1</p></p></td>
	<td id="i146395"    valign="top" width="50.9%" class="sluttKol">

<p class="entrya"><p id="i146396">Se metformin  <a id="arowX150118" class="ref" href="../G/G8.htm#i150118" title="Metformin">Metformin</a></p></p></td>
	</tr>
 <tr id="i146397" class="body oddelinje">
	<td id="i146398"    valign="top" width="29.5%" class="startKol">

<p class="entrya"><p id="i146399">Bimatoprost</p></p></td>
	<td id="i146400"    valign="top" width="19.6%" class="mellomKol">

<p class="entrya"><p id="i218842">3</p></p></td>
	<td id="i146401"    valign="top" width="50.9%" class="sluttKol">

<p class="entrya"><p id="i146402">Øyedråper: Lav systemisk dose og kort halveringstid tilsier at bimatoprost kan brukes av ammende</p></p></td>
	</tr>
 <tr id="i146403" class="body likelinje">
	<td id="i146404"    valign="top" width="29.5%" class="startKol">

<p class="entrya"><p id="i146405">Biperiden</p></p></td>
	<td id="i146406"    valign="top" width="19.6%" class="mellomKol">

<p class="entrya"><p id="i146407">3</p></p></td>
	<td id="i146408"    valign="top" width="50.9%" class="sluttKol">

<p class="entrya"><p id="i146409">Se antikolinergika  <a id="arowX145869" class="ref" href="../G/G8.htm#i145869" title="Antikolinergika">Antikolinergika</a></p></p></td>
	</tr>
 <tr id="i146410" class="body oddelinje">
	<td id="i146411"    valign="top" width="29.5%" class="startKol">

<p class="entrya"><p id="i146412">Bisakodyl</p></p></td>
	<td id="i146413"    valign="top" width="19.6%" class="mellomKol">

<p class="entrya"><p id="i146414">0</p></p></td>
	<td id="i146415"    valign="top" width="50.9%" class="sluttKol">

<p class="entrya"><p id="i146416">Kan brukes av ammende</p></p></td>
	</tr>
 <tr id="i146417" class="body likelinje">
	<td id="i146418"    valign="top" width="29.5%" class="startKol">

<p class="entrya"><p id="i146419"><em>Bisfosfonater</em></p></p></td>
	<td id="i146420"    valign="top" width="19.6%" class="mellomKol">

<p class="entrya"><p id="i146421">0</p></p></td>
	<td id="i146422"    valign="top" width="50.9%" class="sluttKol">

<p class="entrya"><p id="i146423">Lav peroral biotilgjengelighet og lave plasmakonsentrasjoner hos mor tilsier minimal eksponering av diebarn. Svært liten klinisk erfaring</p></p></td>
	</tr>
 <tr id="i146424" class="body oddelinje">
	<td id="i146425"    valign="top" width="29.5%" class="startKol">

<p class="entrya"><p id="i146426">Bisoprolol</p></p></td>
	<td id="i146427"    valign="top" width="19.6%" class="mellomKol">

<p class="entrya"><p id="i146428">3</p></p></td>
	<td id="i146429"    valign="top" width="50.9%" class="sluttKol">

<p class="entrya"><p id="i146430">Opplysninger om overgang til morsmelk mangler. Se betareseptorantagonister, adrenerge  <a id="arowX146361" class="ref" href="../G/G8.htm#i146361" title="Betareseptorantagonister, adrenerge">Betareseptorantagonister, adrenerge</a></p></p></td>
	</tr>
 <tr id="i146431" class="body likelinje">
	<td id="i146432"    valign="top" width="29.5%" class="startKol">

<p class="entrya"><p id="i146433">Bivalirudin</p></p></td>
	<td id="i146434"    valign="top" width="19.6%" class="mellomKol">

<p class="entrya"><p id="i146435">3</p></p></td>
	<td id="i146436"    valign="top" width="50.9%" class="sluttKol">

<p class="entrya"><p id="i146437">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i146438" class="body oddelinje">
	<td id="i146439"    valign="top" width="29.5%" class="startKol">

<p class="entrya"><p id="i146440">Bleomycin</p></p></td>
	<td id="i146441"    valign="top" width="19.6%" class="mellomKol">

<p class="entrya"><p id="i146442">5</p></p></td>
	<td id="i146443"    valign="top" width="50.9%" class="sluttKol">

<p class="entrya"><p id="i146444">Se cytostatika  <a id="arowX146868" class="ref" href="../G/G8.htm#i146868" title="Cytostatika">Cytostatika</a></p></p></td>
	</tr>
 <tr id="i320049" class="body likelinje">
	<td id="i320050"    valign="top" width="29.5%" class="startKol">

<p class="entrya"><p id="i320051">Boceprevir</p></p></td>
	<td id="i320052"    valign="top" width="19.6%" class="mellomKol">

<p class="entrya"><p id="i320053">3</p></p></td>
	<td id="i320054"    valign="top" width="50.9%" class="sluttKol">

<p class="entrya"><p id="i320055">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i146445" class="body oddelinje">
	<td id="i146446"    valign="top" width="29.5%" class="startKol">

<p class="entrya"><p id="i146447">Bortezomid</p></p></td>
	<td id="i146448"    valign="top" width="19.6%" class="mellomKol">

<p class="entrya"><p id="i146449">3</p></p></td>
	<td id="i146450"    valign="top" width="50.9%" class="sluttKol">

<p class="entrya"><p id="i146451">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i146452" class="body likelinje">
	<td id="i146453"    valign="top" width="29.5%" class="startKol">

<p class="entrya"><p id="i146454">Bosentan</p></p></td>
	<td id="i146455"    valign="top" width="19.6%" class="mellomKol">

<p class="entrya"><p id="i146456">3</p></p></td>
	<td id="i146457"    valign="top" width="50.9%" class="sluttKol">

<p class="entrya"><p id="i146458">Opplysninger mangler. Se antihypertensiva  <a id="arowX145848" class="ref" href="../G/G8.htm#i145848" title="Antihypertensiva">Antihypertensiva</a></p></p></td>
	</tr>
 <tr id="i146459" class="body oddelinje">
	<td id="i146460"    valign="top" width="29.5%" class="startKol">

<p class="entrya"><p id="i146461">Botulinumtoksin</p></p></td>
	<td id="i146462"    valign="top" width="19.6%" class="mellomKol">

<p class="entrya"><p id="i146463">3</p></p></td>
	<td id="i146464"    valign="top" width="50.9%" class="sluttKol">

<p class="entrya"><p id="i146465">Farmakokinetiske egenskaper tilsier minimal eksponering av brysternærte barn</p></p></td>
	</tr>
 <tr id="i146466" class="body likelinje">
	<td id="i146467"    valign="top" width="29.5%" class="startKol">

<p class="entrya"><p id="i146468">Bretylium</p></p></td>
	<td id="i146469"    valign="top" width="19.6%" class="mellomKol">

<p class="entrya"><p id="i146470">3</p></p></td>
	<td id="i146471"    valign="top" width="50.9%" class="sluttKol">

<p class="entrya"><p id="i146472">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i146473" class="body oddelinje">
	<td id="i146474"    valign="top" width="29.5%" class="startKol">

<p class="entrya"><p id="i146475">Brimonidin</p></p></td>
	<td id="i146476"    valign="top" width="19.6%" class="mellomKol">

<p class="entrya"><p id="i146477">3</p></p></td>
	<td id="i146478"    valign="top" width="50.9%" class="sluttKol">

<p class="entrya"><p id="i146479">Øyedråper: Pga. manglende opplysninger om overgang til morsmelk anbefales forsiktighet med bruk hos ammende</p></p></td>
	</tr>
 <tr id="i146480" class="body likelinje">
	<td id="i146481"    valign="top" width="29.5%" class="startKol">

<p class="entrya"><p id="i146482">Brinzolamid</p></p></td>
	<td id="i146483"    valign="top" width="19.6%" class="mellomKol">

<p class="entrya"><p id="i146484">3</p></p></td>
	<td id="i146485"    valign="top" width="50.9%" class="sluttKol">

<p class="entrya"><p id="i146486">Øyedråper: Opplysninger om overgang til morsmelk mangler. Forsiktighet anbefales</p></p></td>
	</tr>
 <tr id="i320056" class="body oddelinje">
	<td id="i320057"    valign="top" width="29.5%" class="startKol">

<p class="entrya"><p id="i320058">Bromfenak</p></p></td>
	<td id="i320059"    valign="top" width="19.6%" class="mellomKol">

<p class="entrya"><p id="i320060">3</p></p></td>
	<td id="i320061"    valign="top" width="50.9%" class="sluttKol">

<p class="entrya"><p id="i320062">Lokalbehandling: Anses som trygt</p></p></td>
	</tr>
 <tr id="i146487" class="body likelinje">
	<td id="i146488"    valign="top" width="29.5%" class="startKol">

<p class="entrya"><p id="i146489">Bromheksin</p></p></td>
	<td id="i146490"    valign="top" width="19.6%" class="mellomKol">

<p class="entrya"><p id="i146491">3</p></p></td>
	<td id="i146492"    valign="top" width="50.9%" class="sluttKol">

<p class="entrya"><p id="i146493">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i146494" class="body oddelinje">
	<td id="i146495"    valign="top" width="29.5%" class="startKol">

<p class="entrya"><p id="i146496">Bromokriptin</p></p></td>
	<td id="i146497"    valign="top" width="19.6%" class="mellomKol">

<p class="entrya"><p id="i146498">5</p></p></td>
	<td id="i146499"    valign="top" width="50.9%" class="sluttKol">

<p class="entrya"><p id="i146500">Laktasjonshemmende. Effekt oppnås etter 12 timer og varer i 8&#x2013;12 timer. Se dopaminagonister  <a id="arowX147303" class="ref" href="../G/G8.htm#i147303" title="Dopaminagonister">Dopaminagonister</a> Ved behov for laktasjonshemning anbefales fortrinnsvis kabergolin pga. bedre effekt og mindre bivirkninger enn bromokriptin</p></p></td>
	</tr>
 <tr id="i146501" class="body likelinje">
	<td id="i146502"    valign="top" width="29.5%" class="startKol">

<p class="entrya"><p id="i146503">Budesonid</p></p></td>
	<td id="i146504"    valign="top" width="19.6%" class="mellomKol">

<p class="entrya"><p id="i146505">2</p></p></td>
	<td id="i146506"    valign="top" width="50.9%" class="sluttKol">

<p class="entrya"><p id="i146507">Se glukokortikoider  <a id="arowX148403" class="ref" href="../G/G8.htm#i148403" title="Glukokortikoider">Glukokortikoider</a></p></p></td>
	</tr>
 <tr id="i146508" class="body oddelinje">
	<td id="i146509"    valign="top" width="29.5%" class="startKol">

<p class="entrya"><p id="i146510">Bumetanid</p></p></td>
	<td id="i146511"    valign="top" width="19.6%" class="mellomKol">

<p class="entrya"><p id="i146512">3</p></p></td>
	<td id="i146513"    valign="top" width="50.9%" class="sluttKol">

<p class="entrya"><p id="i146514">Opplysninger om overgang til morsmelk mangler. Se diuretika  <a id="arowX147247" class="ref" href="../G/G8.htm#i147247" title="Diuretika">Diuretika</a></p></p></td>
	</tr>
 <tr id="i146515" class="body likelinje">
	<td id="i146516"    valign="top" width="29.5%" class="startKol">

<p class="entrya"><p id="i146517">Bupivakain</p></p></td>
	<td id="i146518"    valign="top" width="19.6%" class="mellomKol">

<p class="entrya"><p id="i146519">2</p></p></td>
	<td id="i146520"    valign="top" width="50.9%" class="sluttKol">

<p class="entrya"><p id="i146521">Overgang til morsmelk er minimal. Se lokalanestetika  <a id="arowX149842" class="ref" href="../G/G8.htm#i149842" title="Lokalanestetika">Lokalanestetika</a></p></p></td>
	</tr>
 <tr id="i146522" class="body oddelinje">
	<td id="i146523"    valign="top" width="29.5%" class="startKol">

<p class="entrya"><p id="i146524">Buprenorfin</p></p></td>
	<td id="i146525"    valign="top" width="19.6%" class="mellomKol">

<p class="entrya"><p id="i146526">3</p></p></td>
	<td id="i146527"    valign="top" width="50.9%" class="sluttKol">

<p class="entrya"><p id="i146528">Overgang til morsmelk er minimal. Ved langtidsbruk foreligger det risiko for farmakologiske effekter hos det brysternærte barnet. Mulighet for reduksjon av melkeproduksjonen. Se opioidanalgetika  <a id="arowX150865" class="ref" href="../G/G8.htm#i150865" title="Opioidanalgetika">Opioidanalgetika</a></p></p></td>
	</tr>
 <tr id="i146529" class="body likelinje">
	<td id="i146530"    valign="top" width="29.5%" class="startKol">

<p class="entrya"><p id="i146531">Bupropion</p></p></td>
	<td id="i146532"    valign="top" width="19.6%" class="mellomKol">

<p class="entrya"><p id="i146533">3</p></p></td>
	<td id="i146534"    valign="top" width="50.9%" class="sluttKol">

<p class="entrya"><p id="i146535">Overgangen til morsmelk er minimal. Begrenset erfaring hos ammende</p></p></td>
	</tr>
 <tr id="i146536" class="body oddelinje">
	<td id="i146537"    valign="top" width="29.5%" class="startKol">

<p class="entrya"><p id="i146538">Buserelin</p></p></td>
	<td id="i146539"    valign="top" width="19.6%" class="mellomKol">

<p class="entrya"><p id="i146540">0</p></p></td>
	<td id="i146541"    valign="top" width="50.9%" class="sluttKol">

<p class="entrya"><p id="i146542">Se GnRH-analoger  <a id="arowX148458" class="ref" href="../G/G8.htm#i148458" title="GnRH-analoger">GnRH-analoger</a></p></p></td>
	</tr>
 <tr id="i146543" class="body likelinje">
	<td id="i146544"    valign="top" width="29.5%" class="startKol">

<p class="entrya"><p id="i146545">Buspiron</p></p></td>
	<td id="i146546"    valign="top" width="19.6%" class="mellomKol">

<p class="entrya"><p id="i146547">3</p></p></td>
	<td id="i146548"    valign="top" width="50.9%" class="sluttKol">

<p class="entrya"><p id="i146549">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i146550" class="body oddelinje">
	<td id="i146551"    valign="top" width="29.5%" class="startKol">

<p class="entrya"><p id="i146552">Busulfan</p></p></td>
	<td id="i146553"    valign="top" width="19.6%" class="mellomKol">

<p class="entrya"><p id="i146554">5</p></p></td>
	<td id="i146555"    valign="top" width="50.9%" class="sluttKol">

<p class="entrya"><p id="i146556">Se cytostatika  <a id="arowX146868" class="ref" href="../G/G8.htm#i146868" title="Cytostatika">Cytostatika</a></p></p></td>
	</tr>
 <tr id="i146557" class="body likelinje">
	<td id="i146558"    valign="top" width="29.5%" class="startKol">

<p class="entrya"><p id="i146559">Butylskopolamin</p></p></td>
	<td id="i146560"    valign="top" width="19.6%" class="mellomKol">

<p class="entrya"><p id="i146561">3</p></p></td>
	<td id="i146562"    valign="top" width="50.9%" class="sluttKol">

<p class="entrya"><p id="i146563">Virkestoffets farmakokinetiske egenskaper tilsier minimalt opptak hos brysternærte barn. Tilbakeholdenhet hos ammende anbefales likevel pga. mulige antimuskarinerge effekter hos spedbarn og mulig reduksjon av melkeproduksjonen</p></p></td>
	</tr>
 </tbody></table>
 <table id="i146565" width="100%" class="maintable" border="0" cellpadding="5" cellspacing="0">
 <caption> <Uth Id="NUTHid2330644" Type="Halvfet">C</Uth></caption> <thead>
	<tr class = "linjetopp">
	<th id="i146573"  colspan="3"  valign="top"  class="sluttKol">

<p class="entrya"><p id="i146574">Overgang til morsmelk angis som minimal (< 2 %), liten (2&#8211;5 %), moderat (5&#8211;10 %) eller høy (10&#8211;50 %) basert på fraksjon av morens dose/kg kroppsvekt som barnet tilføres. (Barnets relative dose.)&ML;						Over 3&#8211;4 ukers bruk ansees som langtidsbehandling.</p></p></th>
	</tr>
	<tr class = "linjetopp">
	<th id="i146577"    valign="top"  class="startKol">

<p class="entrya"><p id="i146578"><strong>Legemiddel</strong></p></p></th>
	<th id="i146579"    valign="top"  class="mellomKol">

<p class="entrya"><p id="i146580"><strong>MM kategori</strong></p></p></th>
	<th id="i146581"    valign="top"  class="sluttKol">

<p class="entrya"><p id="i146582"><strong>Dokumentasjon vedrørende bruk under amming</strong></p></p></th>
	</tr>
</thead>
<tbody>
<tr id="i146584" class="body likelinje">
	<td id="i146585"    valign="top" width="29.4%" class="startKol">

<p class="entrya"><p id="i146586">Canakinumab</p></p></td>
	<td id="i146587"    valign="top" width="19.7%" class="mellomKol">

<p class="entrya"><p id="i146588">3</p></p></td>
	<td id="i146589"    valign="top" width="50.9%" class="sluttKol">

<p class="entrya"><p id="i146590">Opplysninger om overgang til morsmelk mangler. Se monoklonale antistoffer  <a id="arowX150370" class="ref" href="../G/G8.htm#i150370" title="Monoklonale antistoffer">Monoklonale antistoffer</a></p></p></td>
	</tr>
 <tr id="i146591" class="body oddelinje">
	<td id="i146592"    valign="top" width="29.4%" class="startKol">

<p class="entrya"><p id="i146593">Caspofungin</p></p></td>
	<td id="i146594"    valign="top" width="19.7%" class="mellomKol">

<p class="entrya"><p id="i146595">3</p></p></td>
	<td id="i146596"    valign="top" width="50.9%" class="sluttKol">

<p class="entrya"><p id="i146597">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i146598" class="body likelinje">
	<td id="i146599"    valign="top" width="29.4%" class="startKol">

<p class="entrya"><p id="i146600">Cefaleksin</p></p></td>
	<td id="i146601"    valign="top" width="19.7%" class="mellomKol">

<p class="entrya"><p id="i146602">1</p></p></td>
	<td id="i146603"    valign="top" width="50.9%" class="sluttKol">

<p class="entrya"><p id="i146604">Se cefalosporiner  <a id="arowX146605" class="ref" href="../G/G8.htm#i146605" title="Cefalosporiner">Cefalosporiner</a></p></p></td>
	</tr>
 <tr id="i146605" class="body oddelinje">
	<td id="i146606"    valign="top" width="29.4%" class="startKol">

<p class="entrya"><p id="i146607"><em>Cefalosporiner</em></p></p></td>
	<td id="i146608"    valign="top" width="19.7%" class="mellomKol">

<p class="entrya"><p id="i146609">1, 2</p></p></td>
	<td id="i146610"    valign="top" width="50.9%" class="sluttKol">

<p class="entrya"><p id="i146611">Overgang til morsmelk er minimal. Kan brukes av ammende. Begrenset klinisk erfaring med nyere preparater. Se antibakterielle midler  <a id="arowX145756" class="ref" href="../G/G8.htm#i145756" title="Anestesimidler">Anestesimidler</a></p></p></td>
	</tr>
 <tr id="i146612" class="body likelinje">
	<td id="i146613"    valign="top" width="29.4%" class="startKol">

<p class="entrya"><p id="i146614">Cefalotin</p></p></td>
	<td id="i146615"    valign="top" width="19.7%" class="mellomKol">

<p class="entrya"><p id="i146616">2</p></p></td>
	<td id="i146617"    valign="top" width="50.9%" class="sluttKol">

<p class="entrya"><p id="i146618">Se cefalosporiner  <a id="arowX146605" class="ref" href="../G/G8.htm#i146605" title="Cefalosporiner">Cefalosporiner</a></p></p></td>
	</tr>
 <tr id="i146619" class="body oddelinje">
	<td id="i146620"    valign="top" width="29.4%" class="startKol">

<p class="entrya"><p id="i146621">Cefiksim</p></p></td>
	<td id="i146622"    valign="top" width="19.7%" class="mellomKol">

<p class="entrya"><p id="i146623">2</p></p></td>
	<td id="i146624"    valign="top" width="50.9%" class="sluttKol">

<p class="entrya"><p id="i146625">Se cefalosporiner  <a id="arowX146605" class="ref" href="../G/G8.htm#i146605" title="Cefalosporiner">Cefalosporiner</a></p></p></td>
	</tr>
 <tr id="i146626" class="body likelinje">
	<td id="i146627"    valign="top" width="29.4%" class="startKol">

<p class="entrya"><p id="i146628">Cefotaksim</p></p></td>
	<td id="i146629"    valign="top" width="19.7%" class="mellomKol">

<p class="entrya"><p id="i146630">2</p></p></td>
	<td id="i146631"    valign="top" width="50.9%" class="sluttKol">

<p class="entrya"><p id="i146632">Se cefalosporiner  <a id="arowX146605" class="ref" href="../G/G8.htm#i146605" title="Cefalosporiner">Cefalosporiner</a></p></p></td>
	</tr>
 <tr id="i146633" class="body oddelinje">
	<td id="i146634"    valign="top" width="29.4%" class="startKol">

<p class="entrya"><p id="i146635">Ceftazidim</p></p></td>
	<td id="i146636"    valign="top" width="19.7%" class="mellomKol">

<p class="entrya"><p id="i146637">1</p></p></td>
	<td id="i146638"    valign="top" width="50.9%" class="sluttKol">

<p class="entrya"><p id="i146639">Se cefalosporiner  <a id="arowX146605" class="ref" href="../G/G8.htm#i146605" title="Cefalosporiner">Cefalosporiner</a></p></p></td>
	</tr>
 <tr id="i146640" class="body likelinje">
	<td id="i146641"    valign="top" width="29.4%" class="startKol">

<p class="entrya"><p id="i146642">Ceftriakson</p></p></td>
	<td id="i146643"    valign="top" width="19.7%" class="mellomKol">

<p class="entrya"><p id="i146644">2</p></p></td>
	<td id="i146645"    valign="top" width="50.9%" class="sluttKol">

<p class="entrya"><p id="i146646">Se cefalosporiner  <a id="arowX146605" class="ref" href="../G/G8.htm#i146605" title="Cefalosporiner">Cefalosporiner</a></p></p></td>
	</tr>
 <tr id="i146647" class="body oddelinje">
	<td id="i146648"    valign="top" width="29.4%" class="startKol">

<p class="entrya"><p id="i146649">Cefuroksim</p></p></td>
	<td id="i146650"    valign="top" width="19.7%" class="mellomKol">

<p class="entrya"><p id="i146651">2</p></p></td>
	<td id="i146652"    valign="top" width="50.9%" class="sluttKol">

<p class="entrya"><p id="i146653">Se cefalosporiner  <a id="arowX146605" class="ref" href="../G/G8.htm#i146605" title="Cefalosporiner">Cefalosporiner</a></p></p></td>
	</tr>
 <tr id="i146654" class="body likelinje">
	<td id="i146655"    valign="top" width="29.4%" class="startKol">

<p class="entrya"><p id="i146656">Celekoksib</p></p></td>
	<td id="i146657"    valign="top" width="19.7%" class="mellomKol">

<p class="entrya"><p id="i146658">2</p></p></td>
	<td id="i146659"    valign="top" width="50.9%" class="sluttKol">

<p class="entrya"><p id="i146660">Overgang til morsmelk er minimal. Se COX-2-hemmere  <a id="arowX146801" class="ref" href="../G/G8.htm#i146801" title="COX-2-hemmere">COX-2-hemmere</a></p></p></td>
	</tr>
 <tr id="i146661" class="body oddelinje">
	<td id="i146662"    valign="top" width="29.4%" class="startKol">

<p class="entrya"><p id="i146663">Certolizumab</p></p></td>
	<td id="i146664"    valign="top" width="19.7%" class="mellomKol">

<p class="entrya"><p id="i146665">3</p></p></td>
	<td id="i146666"    valign="top" width="50.9%" class="sluttKol">

<p class="entrya"><p id="i146667">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i146668" class="body likelinje">
	<td id="i146669"    valign="top" width="29.4%" class="startKol">

<p class="entrya"><p id="i146670">C1-esterasehemmer</p></p></td>
	<td id="i146671"    valign="top" width="19.7%" class="mellomKol">

<p class="entrya"><p id="i146672">0</p></p></td>
	<td id="i146673"    valign="top" width="50.9%" class="sluttKol">

<p class="entrya"><p id="i146674">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i146675" class="body oddelinje">
	<td id="i146676"    valign="top" width="29.4%" class="startKol">

<p class="entrya"><p id="i146677">Cetirizin</p></p></td>
	<td id="i146678"    valign="top" width="19.7%" class="mellomKol">

<p class="entrya"><p id="i146679">2</p></p></td>
	<td id="i146680"    valign="top" width="50.9%" class="sluttKol">

<p class="entrya"><p id="i146681">Opplysninger om overgang til morsmelk mangler. Se antihistaminer  <a id="arowX145840" class="ref" href="../G/G8.htm#i145840" title="Antihistaminer (H1-antagonister)">Antihistaminer (H1-antagonister)</a></p></p></td>
	</tr>
 <tr id="i146682" class="body likelinje">
	<td id="i146683"    valign="top" width="29.4%" class="startKol">

<p class="entrya"><p id="i146684">Cetrorelix</p></p></td>
	<td id="i146685"    valign="top" width="19.7%" class="mellomKol">

<p class="entrya"><p id="i146686">0</p></p></td>
	<td id="i146687"    valign="top" width="50.9%" class="sluttKol">

<p class="entrya"><p id="i146688">Se GnRH-analoger  <a id="arowX148458" class="ref" href="../G/G8.htm#i148458" title="GnRH-analoger">GnRH-analoger</a></p></p></td>
	</tr>
 <tr id="i146689" class="body oddelinje">
	<td id="i146690"    valign="top" width="29.4%" class="startKol">

<p class="entrya"><p id="i146691">Cetuximab</p></p></td>
	<td id="i146692"    valign="top" width="19.7%" class="mellomKol">

<p class="entrya"><p id="i146693">3</p></p></td>
	<td id="i146694"    valign="top" width="50.9%" class="sluttKol">

<p class="entrya"><p id="i146695">Opplysninger mangler. Virkningsmekanismen tilsier tilbakeholdenhet</p></p></td>
	</tr>
 <tr id="i146696" class="body likelinje">
	<td id="i146697"    valign="top" width="29.4%" class="startKol">

<p class="entrya"><p id="i146698">Cetylpyridin</p></p></td>
	<td id="i146699"    valign="top" width="19.7%" class="mellomKol">

<p class="entrya"><p id="i146700">2</p></p></td>
	<td id="i146701"    valign="top" width="50.9%" class="sluttKol">

<p class="entrya"><p id="i146702">Lokalbehandling: Kan brukes av ammende</p></p></td>
	</tr>
 <tr id="i146703" class="body oddelinje">
	<td id="i146704"    valign="top" width="29.4%" class="startKol">

<p class="entrya"><p id="i146705">Cidofovir</p></p></td>
	<td id="i146706"    valign="top" width="19.7%" class="mellomKol">

<p class="entrya"><p id="i146707">3</p></p></td>
	<td id="i146708"    valign="top" width="50.9%" class="sluttKol">

<p class="entrya"><p id="i146709">Opplysninger mangler. Se antivirale midler  <a id="arowX145939" class="ref" href="../G/G8.htm#i145939" title="Antivirale midler">Antivirale midler</a></p></p></td>
	</tr>
 <tr id="i146710" class="body likelinje">
	<td id="i146711"    valign="top" width="29.4%" class="startKol">

<p class="entrya"><p id="i146712">Ciklesonid</p></p></td>
	<td id="i146713"    valign="top" width="19.7%" class="mellomKol">

<p class="entrya"><p id="i146714">3</p></p></td>
	<td id="i146715"    valign="top" width="50.9%" class="sluttKol">

<p class="entrya"><p id="i146716">Overgang til morsmelk er ukjent. Andre midler bør fortrinnsvis benyttes av ammende pga. liten klinisk erfaring. Se inhalasjonsglukokortikoider  <a id="arowX148403" class="ref" href="../G/G8.htm#i148403" title="Glukokortikoider">Glukokortikoider</a></p></p></td>
	</tr>
 <tr id="i146717" class="body oddelinje">
	<td id="i146718"    valign="top" width="29.4%" class="startKol">

<p class="entrya"><p id="i146719">Ciklopiroksolamin</p></p></td>
	<td id="i146720"    valign="top" width="19.7%" class="mellomKol">

<p class="entrya"><p id="i146721">0</p></p></td>
	<td id="i146722"    valign="top" width="50.9%" class="sluttKol">

<p class="entrya"><p id="i146723">Kan brukes av ammende</p></p></td>
	</tr>
 <tr id="i146724" class="body likelinje">
	<td id="i146725"    valign="top" width="29.4%" class="startKol">

<p class="entrya"><p id="i146726">Ciklosporin</p></p></td>
	<td id="i146727"    valign="top" width="19.7%" class="mellomKol">

<p class="entrya"><p id="i146728">4</p></p></td>
	<td id="i146729"    valign="top" width="50.9%" class="sluttKol">

<p class="entrya"><p id="i146730">Overgang til morsmelk er minimal. Amming bør likevel unngås pga. ciklosporins immunsuppressive effekt og begrenset klinisk erfaring hos ammende</p></p></td>
	</tr>
 <tr id="i146731" class="body oddelinje">
	<td id="i146732"    valign="top" width="29.4%" class="startKol">

<p class="entrya"><p id="i146733">Cilastatin</p></p></td>
	<td id="i146734"    valign="top" width="19.7%" class="mellomKol">

<p class="entrya"><p id="i146735">3</p></p></td>
	<td id="i146736"    valign="top" width="50.9%" class="sluttKol">

<p class="entrya"><p id="i146737">Opplysninger mangler. Risiko for farmakologiske effekter på barnet ansees som liten</p></p></td>
	</tr>
 <tr id="i146738" class="body likelinje">
	<td id="i146739"    valign="top" width="29.4%" class="startKol">

<p class="entrya"><p id="i146740">Cimetidin</p></p></td>
	<td id="i146741"    valign="top" width="19.7%" class="mellomKol">

<p class="entrya"><p id="i146742">2</p></p></td>
	<td id="i146743"    valign="top" width="50.9%" class="sluttKol">

<p class="entrya"><p id="i146744">Overgang til morsmelk er høy (muligens aktivt opptak). Teoretisk mulighet for hemning av barnets mikrosomale enzymer. Se H<Sub>2</Sub>-antagonister  <a id="arowX148562" class="ref" href="../G/G8.htm#i148562" title="H2-antagonister">H2-antagonister</a></p></p></td>
	</tr>
 <tr id="i146745" class="body oddelinje">
	<td id="i146746"    valign="top" width="29.4%" class="startKol">

<p class="entrya"><p id="i146747">Cinacalcet</p></p></td>
	<td id="i146748"    valign="top" width="19.7%" class="mellomKol">

<p class="entrya"><p id="i146749">3</p></p></td>
	<td id="i146750"    valign="top" width="50.9%" class="sluttKol">

<p class="entrya"><p id="i146751">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i146752" class="body likelinje">
	<td id="i146753"    valign="top" width="29.4%" class="startKol">

<p class="entrya"><p id="i146754">Ciprofloksacin</p></p></td>
	<td id="i146755"    valign="top" width="19.7%" class="mellomKol">

<p class="entrya"><p id="i146756">3</p></p></td>
	<td id="i146757"    valign="top" width="50.9%" class="sluttKol">

<p class="entrya"><p id="i146758">Overgang til morsmelk er liten. Se fluorokinoloner  <a id="arowX148025" class="ref" href="../G/G8.htm#i148025" title="Fluorokinoloner">Fluorokinoloner</a></p></p></td>
	</tr>
 <tr id="i146759" class="body oddelinje">
	<td id="i146760"    valign="top" width="29.4%" class="startKol">

<p class="entrya"><p id="i146761">Cisatrakurium</p></p></td>
	<td id="i146762"    valign="top" width="19.7%" class="mellomKol">

<p class="entrya"><p id="i146763">2</p></p></td>
	<td id="i146764"    valign="top" width="50.9%" class="sluttKol">

<p class="entrya"><p id="i146765">Se nevromuskulære blokkere  <a id="arowX150558" class="ref" href="../G/G8.htm#i150558" title="Nevromuskulære blokkere">Nevromuskulære blokkere</a></p></p></td>
	</tr>
 <tr id="i146766" class="body likelinje">
	<td id="i146767"    valign="top" width="29.4%" class="startKol">

<p class="entrya"><p id="i146768">Cisplatin</p></p></td>
	<td id="i146769"    valign="top" width="19.7%" class="mellomKol">

<p class="entrya"><p id="i146770">5</p></p></td>
	<td id="i146771"    valign="top" width="50.9%" class="sluttKol">

<p class="entrya"><p id="i146772">Overgang til morsmelk er høy. Bruk hos ammende frarådes. Se cytostatika  <a id="arowX146868" class="ref" href="../G/G8.htm#i146868" title="Cytostatika">Cytostatika</a></p></p></td>
	</tr>
 <tr id="i146773" class="body oddelinje">
	<td id="i146774"    valign="top" width="29.4%" class="startKol">

<p class="entrya"><p id="i146775">Citalopram</p></p></td>
	<td id="i146776"    valign="top" width="19.7%" class="mellomKol">

<p class="entrya"><p id="i146777">2</p></p></td>
	<td id="i146778"    valign="top" width="50.9%" class="sluttKol">

<p class="entrya"><p id="i146779">Overgang til morsmelk er liten til moderat. Se SSRI  <a id="arowX151966" class="ref" href="../G/G8.htm#i151966" title="SSRI">SSRI</a></p></p></td>
	</tr>
 <tr id="i146780" class="body likelinje">
	<td id="i146781"    valign="top" width="29.4%" class="startKol">

<p class="entrya"><p id="i146782">Cladribin</p></p></td>
	<td id="i146783"    valign="top" width="19.7%" class="mellomKol">

<p class="entrya"><p id="i146784">5</p></p></td>
	<td id="i146785"    valign="top" width="50.9%" class="sluttKol">

<p class="entrya"><p id="i146786">Se cytostatika  <a id="arowX146868" class="ref" href="../G/G8.htm#i146868" title="Cytostatika">Cytostatika</a></p></p></td>
	</tr>
 <tr id="i146787" class="body oddelinje">
	<td id="i146788"    valign="top" width="29.4%" class="startKol">

<p class="entrya"><p id="i146789">Colistin</p></p></td>
	<td id="i146790"    valign="top" width="19.7%" class="mellomKol">

<p class="entrya"><p id="i146791">3</p></p></td>
	<td id="i146792"    valign="top" width="50.9%" class="sluttKol">

<p class="entrya"><p id="i146793">Overgang til morsmelk er liten. Absorberes i liten grad systemisk. Tilbakeholdenhet anbefales pga. virkestoffets toksiske egenskaper. Se antibakterielle midler  <a id="arowX145756" class="ref" href="../G/G8.htm#i145756" title="Anestesimidler">Anestesimidler</a></p></p></td>
	</tr>
 <tr id="i146794" class="body likelinje">
	<td id="i146795"    valign="top" width="29.4%" class="startKol">

<p class="entrya"><p id="i146796"><em>COMT-hemmere</em></p></p></td>
	<td id="i146797"    valign="top" width="19.7%" class="mellomKol">

<p class="entrya"><p id="i146798">3</p></p></td>
	<td id="i146799"    valign="top" width="50.9%" class="sluttKol">

<p class="entrya"><p id="i146800">Se de enkelte virkestoffene</p></p></td>
	</tr>
 <tr id="i221817" class="body oddelinje">
	<td id="i221818"    valign="top" width="29.4%" class="startKol">

<p class="entrya"><p id="i221819">Conestat alfa </p></p></td>
	<td id="i221820"    valign="top" width="19.7%" class="mellomKol">

<p class="entrya"><p id="i221821">0 </p></p></td>
	<td id="i221822"    valign="top" width="50.9%" class="sluttKol">

<p class="entrya"><p id="i221823">Opplysninger mangler. Liten sannsynlighet for absorpsjon av legemidlet fra barnets mage-tarm-kanal</p></p></td>
	</tr>
 <tr id="i146801" class="body likelinje">
	<td id="i146802"    valign="top" width="29.4%" class="startKol">

<p class="entrya"><p id="i146803"><em>COX-2-hemmere</em></p></p></td>
	<td id="i146804"    valign="top" width="19.7%" class="mellomKol">

<p class="entrya"><p id="i146805">2, 3</p></p></td>
	<td id="i146806"    valign="top" width="50.9%" class="sluttKol">

<p class="entrya"><p id="i146807">Klinisk erfaring hos ammende er begrenset. Se også de enkelte virkestoffene</p></p></td>
	</tr>
 <tr id="i146808" class="body oddelinje">
	<td id="i146809"    valign="top" width="29.4%" class="startKol">

<p class="entrya"><p id="i146810">Crisantaspase</p></p></td>
	<td id="i146811"    valign="top" width="19.7%" class="mellomKol">

<p class="entrya"><p id="i146812"> </p></p></td>
	<td id="i146813"    valign="top" width="50.9%" class="sluttKol">

<p class="entrya"><p id="i146814">Se cytostatika  <a id="arowX146868" class="ref" href="../G/G8.htm#i146868" title="Cytostatika">Cytostatika</a></p></p></td>
	</tr>
 <tr id="i146815" class="body likelinje">
	<td id="i146816"    valign="top" width="29.4%" class="startKol">

<p class="entrya"><p id="i146817">Cyanokobalamin (= vitamin B<Sub>12</Sub>)</p></p></td>
	<td id="i146818"    valign="top" width="19.7%" class="mellomKol">

<p class="entrya"><p id="i146819">1</p></p></td>
	<td id="i146820"    valign="top" width="50.9%" class="sluttKol">

<p class="entrya"><p id="i146821">Se vitaminer  <a id="arowX152903" class="ref" href="../G/G8.htm#i152903" title="Vitaminer">Vitaminer</a></p></p></td>
	</tr>
 <tr id="i146854" class="body oddelinje">
	<td id="i146855"    valign="top" width="29.4%" class="startKol">

<p class="entrya"><p id="i146856">Cyproteron</p></p></td>
	<td id="i146857"    valign="top" width="19.7%" class="mellomKol">

<p class="entrya"><p id="i146858">4</p></p></td>
	<td id="i146859"    valign="top" width="50.9%" class="sluttKol">

<p class="entrya"><p id="i146860">Se antiandrogener  <a id="arowX145798" class="ref" href="../G/G8.htm#i145798" title="Antiandrogener">Antiandrogener</a></p></p></td>
	</tr>
 <tr id="i146861" class="body likelinje">
	<td id="i146862"    valign="top" width="29.4%" class="startKol">

<p class="entrya"><p id="i146863">Cytarabin</p></p></td>
	<td id="i146864"    valign="top" width="19.7%" class="mellomKol">

<p class="entrya"><p id="i146865">5</p></p></td>
	<td id="i146866"    valign="top" width="50.9%" class="sluttKol">

<p class="entrya"><p id="i146867">Se cytostatika  <a id="arowX146868" class="ref" href="../G/G8.htm#i146868" title="Cytostatika">Cytostatika</a></p></p></td>
	</tr>
 <tr id="i146868" class="body oddelinje">
	<td id="i146869"    valign="top" width="29.4%" class="startKol">

<p class="entrya"><p id="i146870"><em>Cytostatika</em></p></p></td>
	<td id="i146871"    valign="top" width="19.7%" class="mellomKol">

<p class="entrya"><p id="i146872">5</p></p></td>
	<td id="i146873"    valign="top" width="50.9%" class="sluttKol">

<p class="entrya"><p id="i146874">Bruk hos ammende frarådes pga. virkestoffenes toksiske virkninger</p></p></td>
	</tr>
 </tbody></table>
 <table id="i146876" width="100%" class="maintable" border="0" cellpadding="5" cellspacing="0">
 <caption> <Uth Id="NUTHid2331322" Type="Halvfet">D</Uth></caption> <thead>
	<tr class = "linjetopp">
	<th id="i146884"  colspan="3"  valign="top"  class="sluttKol">

<p class="entrya"><p id="i146885">Overgang til morsmelk angis som minimal (< 2 %), liten (2&#8211;5 %), moderat (5&#8211;10 %) eller høy (10&#8211;50 %) basert på fraksjon av morens dose/kg kroppsvekt som barnet tilføres. (Barnets relative dose.)&ML;						Over 3&#8211;4 ukers bruk ansees som langtidsbehandling.</p></p></th>
	</tr>
	<tr class = "linjetopp">
	<th id="i146888"    valign="top"  class="startKol">

<p class="entrya"><p id="i146889"><strong>Legemiddel</strong></p></p></th>
	<th id="i146890"    valign="top"  class="mellomKol">

<p class="entrya"><p id="i146891"><strong>MM kategori</strong></p></p></th>
	<th id="i146892"    valign="top"  class="sluttKol">

<p class="entrya"><p id="i146893"><strong>Dokumentasjon vedrørende bruk under amming</strong></p></p></th>
	</tr>
</thead>
<tbody>
<tr id="i146895" class="body likelinje">
	<td id="i146896"    valign="top" width="29.3%" class="startKol">

<p class="entrya"><p id="i146897">Dabigatran</p></p></td>
	<td id="i146898"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i146899">3</p></p></td>
	<td id="i146900"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i146901">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i146902" class="body oddelinje">
	<td id="i146903"    valign="top" width="29.3%" class="startKol">

<p class="entrya"><p id="i146904">Daclizumab</p></p></td>
	<td id="i146905"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i146906">3</p></p></td>
	<td id="i146907"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i146908">Opplysninger mangler. Se monoklonale antistoffer  <a id="arowX150370" class="ref" href="../G/G8.htm#i150370" title="Monoklonale antistoffer">Monoklonale antistoffer</a></p></p></td>
	</tr>
 <tr id="i146909" class="body likelinje">
	<td id="i146910"    valign="top" width="29.3%" class="startKol">

<p class="entrya"><p id="i146911">Dakarbazin</p></p></td>
	<td id="i146912"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i146913">5</p></p></td>
	<td id="i146914"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i146915">Se cytostatika  <a id="arowX146868" class="ref" href="../G/G8.htm#i146868" title="Cytostatika">Cytostatika</a></p></p></td>
	</tr>
 <tr id="i146916" class="body oddelinje">
	<td id="i146917"    valign="top" width="29.3%" class="startKol">

<p class="entrya"><p id="i146918">Daktinomycin</p></p></td>
	<td id="i146919"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i146920">5</p></p></td>
	<td id="i146921"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i146922">Se cytostatika  <a id="arowX146868" class="ref" href="../G/G8.htm#i146868" title="Cytostatika">Cytostatika</a></p></p></td>
	</tr>
 <tr id="i146923" class="body likelinje">
	<td id="i146924"    valign="top" width="29.3%" class="startKol">

<p class="entrya"><p id="i146925">Dalteparin</p></p></td>
	<td id="i146926"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i146927">0</p></p></td>
	<td id="i146928"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i146929">Se hepariner  <a id="arowX148576" class="ref" href="../G/G8.htm#i148576" title="Hepariner">Hepariner</a></p></p></td>
	</tr>
 <tr id="i146930" class="body oddelinje">
	<td id="i146931"    valign="top" width="29.3%" class="startKol">

<p class="entrya"><p id="i146932">Danaparoid</p></p></td>
	<td id="i146933"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i146934">0</p></p></td>
	<td id="i146935"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i146936">Se hepariner  <a id="arowX148576" class="ref" href="../G/G8.htm#i148576" title="Hepariner">Hepariner</a></p></p></td>
	</tr>
 <tr id="i146937" class="body likelinje">
	<td id="i146938"    valign="top" width="29.3%" class="startKol">

<p class="entrya"><p id="i146939">Danazol</p></p></td>
	<td id="i146940"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i146941">4</p></p></td>
	<td id="i146942"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i146943">Unngå bruk hos ammende. Mulig androgen effekt på barnet</p></p></td>
	</tr>
 <tr id="i146944" class="body oddelinje">
	<td id="i146945"    valign="top" width="29.3%" class="startKol">

<p class="entrya"><p id="i146946">Dantrolen</p></p></td>
	<td id="i146947"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i146948">4</p></p></td>
	<td id="i146949"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i146950">Opplysninger mangler. Tilbakeholdenhet anbefales pga. virkestoffets toksisitet</p></p></td>
	</tr>
 <tr id="i146951" class="body likelinje">
	<td id="i146952"    valign="top" width="29.3%" class="startKol">

<p class="entrya"><p id="i146953">Dapson</p></p></td>
	<td id="i146954"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i146955">4</p></p></td>
	<td id="i146956"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i146957">Overgang til morsmelk er høy. Tilbakeholdenhet anbefales pga. risiko for toksiske effekter hos brysternærte barn. Hemolytisk anemi er rapportert</p></p></td>
	</tr>
 <tr id="i146958" class="body oddelinje">
	<td id="i146959"    valign="top" width="29.3%" class="startKol">

<p class="entrya"><p id="i218843">Daptomycin</p></p></td>
	<td id="i146960"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i146961"> </p></p></td>
	<td id="i146962"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i146963">Erfaring med bruk hos ammende mangler. Liten sannsynlighet for absorpsjon av daptomycin fra barnets mage-tarm-kanal. Se antibakterielle midler  <a id="aentryX145806" class="ref" href="../G/G8.htm#i145806" title="Antibakterielle midler">Antibakterielle midler</a></p></p></td>
	</tr>
 <tr id="i146964" class="body likelinje">
	<td id="i146965"    valign="top" width="29.3%" class="startKol">

<p class="entrya"><p id="i146966">Darbepoetin alfa</p></p></td>
	<td id="i146967"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i146968">0</p></p></td>
	<td id="i146969"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i146970">Manglende klinisk erfaring</p></p></td>
	</tr>
 <tr id="i146971" class="body oddelinje">
	<td id="i146972"    valign="top" width="29.3%" class="startKol">

<p class="entrya"><p id="i146973">Darifenacin</p></p></td>
	<td id="i146974"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i146975">3</p></p></td>
	<td id="i146976"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i146977">Opplysninger mangler. Mulig risiko for antikolinerge effekter i brysternærte barn</p></p></td>
	</tr>
 <tr id="i146978" class="body likelinje">
	<td id="i146979"    valign="top" width="29.3%" class="startKol">

<p class="entrya"><p id="i146980">Darunavir</p></p></td>
	<td id="i146981"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i146982">5</p></p></td>
	<td id="i146983"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i146984">Opplysninger mangler. Se antivirale midler  <a id="arowX145939" class="ref" href="../G/G8.htm#i145939" title="Antivirale midler">Antivirale midler</a></p></p></td>
	</tr>
 <tr id="i146985" class="body oddelinje">
	<td id="i146986"    valign="top" width="29.3%" class="startKol">

<p class="entrya"><p id="i146987">Dasatinib</p></p></td>
	<td id="i146988"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i146989">3</p></p></td>
	<td id="i146990"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i146991">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i146992" class="body likelinje">
	<td id="i146993"    valign="top" width="29.3%" class="startKol">

<p class="entrya"><p id="i146994">Daunorubicin</p></p></td>
	<td id="i146995"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i146996">5</p></p></td>
	<td id="i146997"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i146998">Se cytostatika  <a id="arowX146868" class="ref" href="../G/G8.htm#i146868" title="Cytostatika">Cytostatika</a></p></p></td>
	</tr>
 <tr id="i146999" class="body oddelinje">
	<td id="i147000"    valign="top" width="29.3%" class="startKol">

<p class="entrya"><p id="i147001">Deferipron</p></p></td>
	<td id="i147002"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i147003">3</p></p></td>
	<td id="i147004"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i147005">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i147006" class="body likelinje">
	<td id="i147007"    valign="top" width="29.3%" class="startKol">

<p class="entrya"><p id="i147008">Degarelix</p></p></td>
	<td id="i147009"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i147010">&#8211;</p></p></td>
	<td id="i147011"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i147012">Ingen indikasjon for bruk hos kvinner</p></p></td>
	</tr>
 <tr id="i147013" class="body oddelinje">
	<td id="i147014"    valign="top" width="29.3%" class="startKol">

<p class="entrya"><p id="i147015">Deksametason</p></p></td>
	<td id="i147016"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i147017">3</p></p></td>
	<td id="i147018"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i147019">Opplysninger om overgang til morsmelk mangler. Se glukokortikoider  <a id="arowX148403" class="ref" href="../G/G8.htm#i148403" title="Glukokortikoider">Glukokortikoider</a></p></p></td>
	</tr>
 <tr id="i147020" class="body likelinje">
	<td id="i147021"    valign="top" width="29.3%" class="startKol">

<p class="entrya"><p id="i147022">Deksibuprofen</p></p></td>
	<td id="i147023"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i147024">1</p></p></td>
	<td id="i147025"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i147026">Se ibuprofen  <a id="arowX148760" class="ref" href="../G/G8.htm#i148760" title="Ibuprofen">Ibuprofen</a></p></p></td>
	</tr>
 <tr id="i147027" class="body oddelinje">
	<td id="i147028"    valign="top" width="29.3%" class="startKol">

<p class="entrya"><p id="i147029">Deksklorfeniramin</p></p></td>
	<td id="i147030"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i147031">3</p></p></td>
	<td id="i147032"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i147033">Opplysninger om overgang til morsmelk mangler. Se antihistaminer  <a id="arowX145840" class="ref" href="../G/G8.htm#i145840" title="Antihistaminer (H1-antagonister)">Antihistaminer (H1-antagonister)</a></p></p></td>
	</tr>
 <tr id="i147034" class="body likelinje">
	<td id="i147035"    valign="top" width="29.3%" class="startKol">

<p class="entrya"><p id="i147036">Deksrazoksan</p></p></td>
	<td id="i147037"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i147038">5</p></p></td>
	<td id="i147039"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i147040">Brukes som del av cytostatikabehandling hvor amming er kontraindisert</p></p></td>
	</tr>
 <tr id="i147041" class="body oddelinje">
	<td id="i147042"    valign="top" width="29.3%" class="startKol">

<p class="entrya"><p id="i147043"><em>Dekstraner</em></p></p></td>
	<td id="i147044"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i147045">0</p></p></td>
	<td id="i147046"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i147047">Kan brukes av ammende</p></p></td>
	</tr>
 <tr id="i147048" class="body likelinje">
	<td id="i147049"    valign="top" width="29.3%" class="startKol">

<p class="entrya"><p id="i147050">Dekstropropoksyfen</p></p></td>
	<td id="i147051"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i147052">2</p></p></td>
	<td id="i147053"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i147054">Se opioidanalgetika  <a id="arowX150865" class="ref" href="../G/G8.htm#i150865" title="Opioidanalgetika">Opioidanalgetika</a></p></p></td>
	</tr>
 <tr id="i221824" class="body oddelinje">
	<td id="i221825"    valign="top" width="29.3%" class="startKol">

<p class="entrya"><p id="i221826">Denosumab </p></p></td>
	<td id="i221827"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i221828">&#8211; </p></p></td>
	<td id="i221829"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i221830">Ikke aktuell til bruk hos ammende</p></p></td>
	</tr>
 <tr id="i147055" class="body likelinje">
	<td id="i147056"    valign="top" width="29.3%" class="startKol">

<p class="entrya"><p id="i147057">Desfluran</p></p></td>
	<td id="i147058"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i147059">2</p></p></td>
	<td id="i147060"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i147061">Opplysninger om overgang til morsmelk mangler. Se anestesimidler  <a id="arowX145756" class="ref" href="../G/G8.htm#i145756" title="Anestesimidler">Anestesimidler</a></p></p></td>
	</tr>
 <tr id="i147062" class="body oddelinje">
	<td id="i147063"    valign="top" width="29.3%" class="startKol">

<p class="entrya"><p id="i147064">Desloratadin</p></p></td>
	<td id="i147065"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i147066">1</p></p></td>
	<td id="i147067"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i147068">Se loratadin  <a id="arowX149870" class="ref" href="../G/G8.htm#i149870" title="Loratadin">Loratadin</a></p></p></td>
	</tr>
 <tr id="i147069" class="body likelinje">
	<td id="i147070"    valign="top" width="29.3%" class="startKol">

<p class="entrya"><p id="i147071">Desmopressin</p></p></td>
	<td id="i147072"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i147073">0</p></p></td>
	<td id="i147074"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i147075">Kan brukes av ammende</p></p></td>
	</tr>
 <tr id="i147076" class="body oddelinje">
	<td id="i147077"    valign="top" width="29.3%" class="startKol">

<p class="entrya"><p id="i147078">Desogestrel</p></p></td>
	<td id="i147079"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i147080">2</p></p></td>
	<td id="i147081"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i147082">Se gestagener  <a id="arowX148350" class="ref" href="../G/G8.htm#i148350" title="Gestagener">Gestagener</a> og p-piller  <a id="arowX151249" class="ref" href="../G/G8.htm#i151249" title="P-piller">P-piller</a></p></p></td>
	</tr>
 <tr id="i147083" class="body likelinje">
	<td id="i147084"    valign="top" width="29.3%" class="startKol">

<p class="entrya"><p id="i147085">Desoksymetason</p></p></td>
	<td id="i147086"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i147087">2</p></p></td>
	<td id="i147088"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i147089">Se glukokortikoider, lokalbehandling  <a id="arowX148403" class="ref" href="../G/G8.htm#i148403" title="Glukokortikoider">Glukokortikoider</a></p></p></td>
	</tr>
 <tr id="i147090" class="body oddelinje">
	<td id="i147091"    valign="top" width="29.3%" class="startKol">

<p class="entrya"><p id="i147092">Desonid</p></p></td>
	<td id="i147093"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i147094">2</p></p></td>
	<td id="i147095"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i147096">Lokalbehandling: Kan brukes av ammende</p></p></td>
	</tr>
 <tr id="i147097" class="body likelinje">
	<td id="i147098"    valign="top" width="29.3%" class="startKol">

<p class="entrya"><p id="i147099">Diatrizoinsyre</p></p></td>
	<td id="i147100"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i147101">0</p></p></td>
	<td id="i147102"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i147103">Se røntgenkontrastmidler  <a id="arowX151757" class="ref" href="../G/G8.htm#i151757" title="Røntgenkontrastmidler">Røntgenkontrastmidler</a></p></p></td>
	</tr>
 <tr id="i147104" class="body oddelinje">
	<td id="i147105"    valign="top" width="29.3%" class="startKol">

<p class="entrya"><p id="i147106">Diazepam</p></p></td>
	<td id="i147107"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i147108">3 &#x2013;&ML;	enkeltinntak&ML;	4 &#x2013;&ML;	regelmessig bruk</p></p></td>
	<td id="i147112"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i147113">Overgang til morsmelk er moderat. Tilbakeholdenhet anbefales. Letargi og vekttap er blitt rapportert i brysternærte barn. Dagsdose bør ikke overskride 10 mg. Se benzodiazepiner  <a id="arowX146283" class="ref" href="../G/G8.htm#i146283" title="Benzodiazepiner">Benzodiazepiner</a></p></p></td>
	</tr>
 <tr id="i147114" class="body likelinje">
	<td id="i147115"    valign="top" width="29.3%" class="startKol">

<p class="entrya"><p id="i147116">Dibrompropamidin</p></p></td>
	<td id="i147117"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i147118">2</p></p></td>
	<td id="i147119"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i147120">Lokalbehandling: Kan brukes av ammende</p></p></td>
	</tr>
 <tr id="i147121" class="body oddelinje">
	<td id="i147122"    valign="top" width="29.3%" class="startKol">

<p class="entrya"><p id="i147123">Didanosin</p></p></td>
	<td id="i147124"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i147125">5</p></p></td>
	<td id="i147126"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i147127">Se antivirale midler  <a id="arowX145939" class="ref" href="../G/G8.htm#i145939" title="Antivirale midler">Antivirale midler</a></p></p></td>
	</tr>
 <tr id="i147128" class="body likelinje">
	<td id="i147129"    valign="top" width="29.3%" class="startKol">

<p class="entrya"><p id="i147130">Diemal</p></p></td>
	<td id="i147131"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i147132">4</p></p></td>
	<td id="i147133"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i147134">Se barbiturater  <a id="arowX146213" class="ref" href="../G/G8.htm#i146213" title="Barbiturater">Barbiturater</a></p></p></td>
	</tr>
 <tr id="i221831" class="body oddelinje">
	<td id="i221832"    valign="top" width="29.3%" class="startKol">

<p class="entrya"><p id="i221833">Dienogest </p></p></td>
	<td id="i221834"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i221835">3 </p></p></td>
	<td id="i221836"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i221837">Opplysninger om overgang til morsmelk mangler. Se gestagener  <a id="arowX148350" class="ref" href="../G/G8.htm#i148350" title="Gestagener">Gestagener</a></p></p></td>
	</tr>
 <tr id="i147135" class="body likelinje">
	<td id="i147136"    valign="top" width="29.3%" class="startKol">

<p class="entrya"><p id="i147137">Digitoksin</p></p></td>
	<td id="i147138"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i147139">2</p></p></td>
	<td id="i147140"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i147141">Opplysninger om overgang til morsmelk mangler. Klinisk erfaring tilsier at digitoksin kan brukes av ammende</p></p></td>
	</tr>
 <tr id="i147142" class="body oddelinje">
	<td id="i147143"    valign="top" width="29.3%" class="startKol">

<p class="entrya"><p id="i147144">Digoksin</p></p></td>
	<td id="i147145"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i147146">2</p></p></td>
	<td id="i147147"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i147148">Overgang til morsmelk er liten. Kan brukes av ammende</p></p></td>
	</tr>
 <tr id="i147149" class="body likelinje">
	<td id="i147150"    valign="top" width="29.3%" class="startKol">

<p class="entrya"><p id="i147151">Dihydralazin</p></p></td>
	<td id="i147152"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i147153">2</p></p></td>
	<td id="i147154"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i147155">Se hydralazin  <a id="arowX148645" class="ref" href="../G/G8.htm#i148645" title="Hydralazin">Hydralazin</a> og antihypertensiva  <a id="arowX145848" class="ref" href="../G/G8.htm#i145848" title="Antihypertensiva">Antihypertensiva</a></p></p></td>
	</tr>
 <tr id="i320168" class="body oddelinje">
	<td id="i320169"    valign="top" width="29.3%" class="startKol">

<p class="entrya"><p id="i320170">Dihydroartemisinin</p></p></td>
	<td id="i320171"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i320172">3</p></p></td>
	<td id="i320173"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i320174">Opplysninger om overgang til morsmelk mangler. Alternative antimalariamidler b&#x00F8;r brukes av ammende pga. manglende klinisk erfaring</p></p></td>
	</tr>
 <tr id="i147156" class="body likelinje">
	<td id="i147157"    valign="top" width="29.3%" class="startKol">

<p class="entrya"><p id="i147158">Diklofenak</p></p></td>
	<td id="i147159"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i147160">2</p></p></td>
	<td id="i147161"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i147162">Overgang til morsmelk er minimal. Se NSAID  <a id="arowX150698" class="ref" href="../G/G8.htm#i150698" title="NSAID">NSAID</a></p></p></td>
	</tr>
 <tr id="i147163" class="body oddelinje">
	<td id="i147164"    valign="top" width="29.3%" class="startKol">

<p class="entrya"><p id="i147165">Dikloksacillin</p></p></td>
	<td id="i147166"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i147167">1</p></p></td>
	<td id="i147168"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i147169">Kan brukes av ammende. Se også antibakterielle midler  <a id="arowX145756" class="ref" href="../G/G8.htm#i145756" title="Anestesimidler">Anestesimidler</a></p></p></td>
	</tr>
 <tr id="i147170" class="body likelinje">
	<td id="i147171"    valign="top" width="29.3%" class="startKol">

<p class="entrya"><p id="i147172">Dikumarol</p></p></td>
	<td id="i147173"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i147174">2</p></p></td>
	<td id="i147175"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i147176">Se antikoagulantia, perorale  <a id="arowX145862" class="ref" href="../G/G8.htm#i145862" title="Antikoagulantia, perorale">Antikoagulantia, perorale</a></p></p></td>
	</tr>
 <tr id="i147177" class="body oddelinje">
	<td id="i147178"    valign="top" width="29.3%" class="startKol">

<p class="entrya"><p id="i147179">Diloxanid</p></p></td>
	<td id="i147180"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i147181">3</p></p></td>
	<td id="i147182"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i147183">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i147184" class="body likelinje">
	<td id="i147185"    valign="top" width="29.3%" class="startKol">

<p class="entrya"><p id="i147186">Diltiazem</p></p></td>
	<td id="i147187"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i147188">3</p></p></td>
	<td id="i147189"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i147190">Data fra én ammende tyder på at overgang til morsmelk er minimal. Se kalsiumantagonister  <a id="arowX149110" class="ref" href="../G/G8.htm#i149110" title="Kalsiumantagonister">Kalsiumantagonister</a></p></p></td>
	</tr>
 <tr id="i147191" class="body oddelinje">
	<td id="i147192"    valign="top" width="29.3%" class="startKol">

<p class="entrya"><p id="i147193">Dinatriumgadoteksinsyre</p></p></td>
	<td id="i147194"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i147195">3</p></p></td>
	<td id="i147196"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i147197">Kvinnen kan amme etter 24 timer</p></p></td>
	</tr>
 <tr id="i147198" class="body likelinje">
	<td id="i147199"    valign="top" width="29.3%" class="startKol">

<p class="entrya"><p id="i147200">Dinitrogenoksid</p></p></td>
	<td id="i147201"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i147202">3</p></p></td>
	<td id="i147203"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i147204">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i147205" class="body oddelinje">
	<td id="i147206"    valign="top" width="29.3%" class="startKol">

<p class="entrya"><p id="i147207">Dinoproston</p></p></td>
	<td id="i147208"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i147209">3</p></p></td>
	<td id="i147210"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i147211">Kan muligens påvirke melkeutskillelsen. Kort plasmahalveringstid og liten systemisk absorpsjon hos mor tilsier at overgang til morsmelk er minimal</p></p></td>
	</tr>
 <tr id="i147212" class="body likelinje">
	<td id="i147213"    valign="top" width="29.3%" class="startKol">

<p class="entrya"><p id="i147214">Dipivefrin</p></p></td>
	<td id="i147215"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i147216">2</p></p></td>
	<td id="i147217"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i147218">Øyedråper: Opplysninger om overgang til morsmelk mangler. Risiko for farmakologiske effekter på barnet ansees som liten</p></p></td>
	</tr>
 <tr id="i147219" class="body oddelinje">
	<td id="i147220"    valign="top" width="29.3%" class="startKol">

<p class="entrya"><p id="i147221">Dipyridamol</p></p></td>
	<td id="i147222"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i147223">3</p></p></td>
	<td id="i147224"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i147225">Opplysninger om overgang til morsmelk mangler</p></p></td>
	</tr>
 <tr id="i147226" class="body likelinje">
	<td id="i147227"    valign="top" width="29.3%" class="startKol">

<p class="entrya"><p id="i147228">Disopyramid</p></p></td>
	<td id="i147229"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i147230">2</p></p></td>
	<td id="i147231"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i147232">Overgang til morsmelk er liten&#8211;moderat. Observer barnet for antikolinerge effekter</p></p></td>
	</tr>
 <tr id="i147233" class="body oddelinje">
	<td id="i147234"    valign="top" width="29.3%" class="startKol">

<p class="entrya"><p id="i147235">Disulfiram</p></p></td>
	<td id="i147236"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i147237">3</p></p></td>
	<td id="i147238"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i147239">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i147240" class="body likelinje">
	<td id="i147241"    valign="top" width="29.3%" class="startKol">

<p class="entrya"><p id="i147242">Ditranol</p></p></td>
	<td id="i147243"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i147244">2</p></p></td>
	<td id="i147245"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i147246">Klinisk erfaring tilsier at ammende kan bruke ditranol som lokalbehandling</p></p></td>
	</tr>
 <tr id="i147247" class="body oddelinje">
	<td id="i147248"    valign="top" width="29.3%" class="startKol">

<p class="entrya"><p id="i147249"><em>Diuretika</em></p></p></td>
	<td id="i147250"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i147251">2, 3</p></p></td>
	<td id="i147252"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i147253">Bruk av høye doser i lengre tid frarådes. Tiazid- og slyngediuretika kan hemme melkeproduksjonen. For alle diuretika foreligger det en mulighet for reduksjon av melkevolumet. Sannsynligheten for diuretisk effekt hos barnet ansees som liten</p></p></td>
	</tr>
 <tr id="i147254" class="body likelinje">
	<td id="i147255"    valign="top" width="29.3%" class="startKol">

<p class="entrya"><p id="i147256">Dixantogen</p></p></td>
	<td id="i147257"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i147258">2</p></p></td>
	<td id="i147259"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i147260">Lokalbehandling: Kan brukes av ammende</p></p></td>
	</tr>
 <tr id="i147261" class="body oddelinje">
	<td id="i147262"    valign="top" width="29.3%" class="startKol">

<p class="entrya"><p id="i147263">Dobutamin</p></p></td>
	<td id="i147264"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i147265">3</p></p></td>
	<td id="i147266"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i147267">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i147268" class="body likelinje">
	<td id="i147269"    valign="top" width="29.3%" class="startKol">

<p class="entrya"><p id="i147270">Docetaxel</p></p></td>
	<td id="i147271"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i147272">5</p></p></td>
	<td id="i147273"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i147274">Se cytostatika  <a id="arowX146868" class="ref" href="../G/G8.htm#i146868" title="Cytostatika">Cytostatika</a></p></p></td>
	</tr>
 <tr id="i147275" class="body oddelinje">
	<td id="i147276"    valign="top" width="29.3%" class="startKol">

<p class="entrya"><p id="i147277">Doksorubicin</p></p></td>
	<td id="i147278"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i147279">5</p></p></td>
	<td id="i147280"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i147281">Se cytostatika  <a id="arowX146868" class="ref" href="../G/G8.htm#i146868" title="Cytostatika">Cytostatika</a></p></p></td>
	</tr>
 <tr id="i147282" class="body likelinje">
	<td id="i147283"    valign="top" width="29.3%" class="startKol">

<p class="entrya"><p id="i147284">Doksysyklin</p></p></td>
	<td id="i147285"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i147286">3</p></p></td>
	<td id="i147287"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i147288">Overgang til morsmelk er liten. Se tetrasykliner  <a id="arowX152325" class="ref" href="../G/G8.htm#i152325" title="Tetrasykliner">Tetrasykliner</a></p></p></td>
	</tr>
 <tr id="i147289" class="body oddelinje">
	<td id="i147290"    valign="top" width="29.3%" class="startKol">

<p class="entrya"><p id="i147291">Donepezil</p></p></td>
	<td id="i147292"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i147293">3</p></p></td>
	<td id="i147294"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i147295">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i147296" class="body likelinje">
	<td id="i147297"    valign="top" width="29.3%" class="startKol">

<p class="entrya"><p id="i147298">Dopamin</p></p></td>
	<td id="i147299"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i147300">3</p></p></td>
	<td id="i147301"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i147302">Opplysninger mangler. Teoretisk risiko for at melkeproduksjonen hemmes</p></p></td>
	</tr>
 <tr id="i147303" class="body oddelinje">
	<td id="i147304"    valign="top" width="29.3%" class="startKol">

<p class="entrya"><p id="i147305"><em>Dopaminagonister</em></p></p></td>
	<td id="i147306"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i147307">4</p></p></td>
	<td id="i147308"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i147309">Alle dopaminerge legemidler kan hemme prolaktinsekresjon og dermed melkeproduksjonen</p></p></td>
	</tr>
 <tr id="i147310" class="body likelinje">
	<td id="i147311"    valign="top" width="29.3%" class="startKol">

<p class="entrya"><p id="i147312">Doripenem</p></p></td>
	<td id="i147313"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i147314">3</p></p></td>
	<td id="i147315"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i147316">Opplysninger om overgang til morsmelk mangler. Se antibakterielle midler  <a id="arowX145805" class="ref" href="../G/G8.htm#i145805" title="Antibakterielle midler">Antibakterielle midler</a></p></p></td>
	</tr>
 <tr id="i147317" class="body oddelinje">
	<td id="i147318"    valign="top" width="29.3%" class="startKol">

<p class="entrya"><p id="i147319">Dornase alfa</p></p></td>
	<td id="i147320"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i147321">0</p></p></td>
	<td id="i147322"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i147323">Klinisk erfaring mangler</p></p></td>
	</tr>
 <tr id="i147324" class="body likelinje">
	<td id="i147325"    valign="top" width="29.3%" class="startKol">

<p class="entrya"><p id="i147326">Dorzolamid</p></p></td>
	<td id="i147327"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i147328">3</p></p></td>
	<td id="i147329"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i147330">Øyedråper: Opplysninger om overgang til morsmelk mangler. Forsiktighet anbefales</p></p></td>
	</tr>
 <tr id="i147331" class="body oddelinje">
	<td id="i147332"    valign="top" width="29.3%" class="startKol">

<p class="entrya"><p id="i147333">Doxazosin</p></p></td>
	<td id="i147334"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i147335">4</p></p></td>
	<td id="i147336"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i147337">Opplysninger om overgang til morsmelk mangler. Andre antihypertensiva bør fortrinnsvis brukes av ammende. Se antihypertensiva  <a id="arowX145848" class="ref" href="../G/G8.htm#i145848" title="Antihypertensiva">Antihypertensiva</a></p></p></td>
	</tr>
 <tr id="i147338" class="body likelinje">
	<td id="i147339"    valign="top" width="29.3%" class="startKol">

<p class="entrya"><p id="i147340">Doksepin</p></p></td>
	<td id="i147341"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i147342">5</p></p></td>
	<td id="i147343"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i147344">Akkumulering av aktiv metabolitt kan forårsake sedasjon og respirasjonshemning. Alternative antidepressiva bør brukes. Se trisykliske antidepressiva  <a id="arowX152619" class="ref" href="../G/G8.htm#i152619" title="Trisykliske antidepressiva (TCA)">Trisykliske antidepressiva (TCA)</a></p></p></td>
	</tr>
 <tr id="i147345" class="body oddelinje">
	<td id="i147346"    valign="top" width="29.3%" class="startKol">

<p class="entrya"><p id="i147347">Dronedaron</p></p></td>
	<td id="i147348"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i147349">3</p></p></td>
	<td id="i147350"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i147351">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i147352" class="body likelinje">
	<td id="i147353"    valign="top" width="29.3%" class="startKol">

<p class="entrya"><p id="i218844">Droperidol</p></p></td>
	<td id="i147354"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i147355">3</p></p></td>
	<td id="i147356"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i147357">Opplysninger mangler. Kan teoretisk øke melkeproduksjonen ved å blokkere dopaminreseptorer og øke prolaktinnivået</p></p></td>
	</tr>
 <tr id="i147358" class="body oddelinje">
	<td id="i147359"    valign="top" width="29.3%" class="startKol">

<p class="entrya"><p id="i147360">Drospirenon</p></p></td>
	<td id="i147361"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i147362">3</p></p></td>
	<td id="i147363"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i147364">Begrenset klinisk erfaring. Se gestagener  <a id="arowX148350" class="ref" href="../G/G8.htm#i148350" title="Gestagener">Gestagener</a> og p-piller  <a id="arowX151249" class="ref" href="../G/G8.htm#i151249" title="P-piller">P-piller</a></p></p></td>
	</tr>
 <tr id="i147365" class="body likelinje">
	<td id="i147366"    valign="top" width="29.3%" class="startKol">

<p class="entrya"><p id="i147367">Drotrecogin alfa</p></p></td>
	<td id="i147368"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i147369">3</p></p></td>
	<td id="i147370"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i147371">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i147372" class="body oddelinje">
	<td id="i147373"    valign="top" width="29.3%" class="startKol">

<p class="entrya"><p id="i147374">Duloksetin</p></p></td>
	<td id="i147375"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i147376">3</p></p></td>
	<td id="i147377"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i147378">Opplysninger om overgang til morsmelk mangler. Se antidepressiva  <a id="arowX145812" class="ref" href="../G/G8.htm#i145812" title="Antidepressiva">Antidepressiva</a></p></p></td>
	</tr>
 <tr id="i147379" class="body likelinje">
	<td id="i147380"    valign="top" width="29.3%" class="startKol">

<p class="entrya"><p id="i147381">Dutasterid</p></p></td>
	<td id="i147382"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i147383">4</p></p></td>
	<td id="i147384"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i147385">Opplysninger mangler. Se antiandrogener  <a id="arowX145798" class="ref" href="../G/G8.htm#i145798" title="Antiandrogener">Antiandrogener</a></p></p></td>
	</tr>
 <tr id="i147386" class="body oddelinje">
	<td id="i147387"    valign="top" width="29.3%" class="startKol">

<p class="entrya"><p id="i147388">Dydrogesteron</p></p></td>
	<td id="i147389"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i147390">3</p></p></td>
	<td id="i147391"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i147392">Opplysninger om overgang til morsmelk mangler. Se gestagener  <a id="arowX148350" class="ref" href="../G/G8.htm#i148350" title="Gestagener">Gestagener</a></p></p></td>
	</tr>
 </tbody></table>
 <table id="i147394" width="100%" class="maintable" border="0" cellpadding="5" cellspacing="0">
 <caption> <Uth Id="NUTHid2331476" Type="Halvfet">E</Uth></caption> <thead>
	<tr class = "linjetopp">
	<th id="i147402"  colspan="3"  valign="top"  class="sluttKol">

<p class="entrya"><p id="i147403">Overgang til morsmelk angis som minimal (< 2 %), liten (2&#8211;5 %), moderat (5&#8211;10 %) eller høy (10&#8211;50 %) basert på fraksjon av morens dose/kg kroppsvekt som barnet tilføres. (Barnets relative dose.)&ML;						Over 3&#8211;4 ukers bruk ansees som langtidsbehandling.</p></p></th>
	</tr>
	<tr class = "linjetopp">
	<th id="i147406"    valign="top"  class="startKol">

<p class="entrya"><p id="i147407"><strong>Legemiddel</strong></p></p></th>
	<th id="i147408"    valign="top"  class="mellomKol">

<p class="entrya"><p id="i147409"><strong>MM kategori</strong></p></p></th>
	<th id="i147410"    valign="top"  class="sluttKol">

<p class="entrya"><p id="i147411"><strong>Dokumentasjon vedrørende bruk under amming</strong></p></p></th>
	</tr>
</thead>
<tbody>
<tr id="i147413" class="body likelinje">
	<td id="i147414"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i147415">Ebastin</p></p></td>
	<td id="i147416"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i147417">3</p></p></td>
	<td id="i147418"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i147419">Opplysninger om overgang til morsmelk mangler. Se antihistaminer  <a id="arowX145840" class="ref" href="../G/G8.htm#i145840" title="Antihistaminer (H1-antagonister)">Antihistaminer (H1-antagonister)</a></p></p></td>
	</tr>
 <tr id="i147420" class="body oddelinje">
	<td id="i147421"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i147422">Edrofonium</p></p></td>
	<td id="i147423"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i147424">3</p></p></td>
	<td id="i147425"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i147426">Virkestoffet er ionisert ved fysiologisk pH. Derfor antas overgang til morsmelk å være minimal</p></p></td>
	</tr>
 <tr id="i147427" class="body likelinje">
	<td id="i147428"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i147429">Efavirenz</p></p></td>
	<td id="i147430"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i147431">5</p></p></td>
	<td id="i147432"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i147433">Se antivirale midler  <a id="arowX145939" class="ref" href="../G/G8.htm#i145939" title="Antivirale midler">Antivirale midler</a></p></p></td>
	</tr>
 <tr id="i147434" class="body oddelinje">
	<td id="i147435"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i147436">Efedrin</p></p></td>
	<td id="i147437"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i147438">2</p></p></td>
	<td id="i147439"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i147440">Opplysninger om overgang til morsmelk mangler. Sporadisk bruk ansees som forenlig med amming</p></p></td>
	</tr>
 <tr id="i147448" class="body likelinje">
	<td id="i147449"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i147450">Ekonazol</p></p></td>
	<td id="i147451"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i147452">1</p></p></td>
	<td id="i147453"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i147454">Se fungicider til lokal bruk  <a id="arowX148164" class="ref" href="../G/G8.htm#i148164" title="Fungicider til lokal bruk">Fungicider til lokal bruk</a></p></p></td>
	</tr>
 <tr id="i147455" class="body oddelinje">
	<td id="i147456"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i147457">Eksemestan</p></p></td>
	<td id="i147458"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i147459">5</p></p></td>
	<td id="i147460"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i147461">Se cytostatika  <a id="arowX146868" class="ref" href="../G/G8.htm#i146868" title="Cytostatika">Cytostatika</a></p></p></td>
	</tr>
 <tr id="i147462" class="body likelinje">
	<td id="i147463"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i147464">Eletriptan</p></p></td>
	<td id="i147465"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i147466">3</p></p></td>
	<td id="i147467"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i147468">Overgang til morsmelk er minimal. Manglende klinisk erfaring. Se triptaner  <a id="arowX152605" class="ref" href="../G/G8.htm#i152605" title="Triptaner">Triptaner</a></p></p></td>
	</tr>
 <tr id="i221838" class="body oddelinje">
	<td id="i221839"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i221840">Eltrombopag </p></p></td>
	<td id="i221841"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i221842">3 </p></p></td>
	<td id="i221843"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i221844">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i147469" class="body likelinje">
	<td id="i147470"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i147471">Emedastin</p></p></td>
	<td id="i147472"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i147473">3</p></p></td>
	<td id="i147474"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i147475">Opplysninger om overgang til morsmelk mangler. Se antihistaminer  <a id="arowX145840" class="ref" href="../G/G8.htm#i145840" title="Antihistaminer (H1-antagonister)">Antihistaminer (H1-antagonister)</a></p></p></td>
	</tr>
 <tr id="i147476" class="body oddelinje">
	<td id="i147477"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i147478">Emepron</p></p></td>
	<td id="i147479"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i147480">3</p></p></td>
	<td id="i147481"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i147482">Opplysninger mangler. Se antikolinergika  <a id="arowX145869" class="ref" href="../G/G8.htm#i145869" title="Antikolinergika">Antikolinergika</a></p></p></td>
	</tr>
 <tr id="i147483" class="body likelinje">
	<td id="i147484"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i147485">Emtricitabin</p></p></td>
	<td id="i147486"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i147487">5</p></p></td>
	<td id="i147488"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i147489">Se antivirale midler  <a id="arowX145939" class="ref" href="../G/G8.htm#i145939" title="Antivirale midler">Antivirale midler</a></p></p></td>
	</tr>
 <tr id="i147490" class="body oddelinje">
	<td id="i147491"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i147492">Enalapril</p></p></td>
	<td id="i147493"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i147494">2</p></p></td>
	<td id="i147495"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i147496">Overgang til morsmelk er minimal. Kan brukes av ammende</p></p></td>
	</tr>
 <tr id="i147497" class="body likelinje">
	<td id="i147498"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i147499">Enfuvirtide</p></p></td>
	<td id="i147500"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i147501">5</p></p></td>
	<td id="i147502"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i147503">Amming er kontraindisert ved HIV-infeksjon hos mor</p></p></td>
	</tr>
 <tr id="i147504" class="body oddelinje">
	<td id="i147505"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i147506">Enoksaparin</p></p></td>
	<td id="i147507"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i147508">0</p></p></td>
	<td id="i147509"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i147510">Se hepariner  <a id="arowX148576" class="ref" href="../G/G8.htm#i148576" title="Hepariner">Hepariner</a></p></p></td>
	</tr>
 <tr id="i147511" class="body likelinje">
	<td id="i147512"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i147513">Entakapon</p></p></td>
	<td id="i147514"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i147515">3</p></p></td>
	<td id="i147516"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i147517">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i147518" class="body oddelinje">
	<td id="i147519"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i147520">Entekavir</p></p></td>
	<td id="i147521"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i147522">3</p></p></td>
	<td id="i147523"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i147524">Opplysninger mangler. Se antivirale midler  <a id="arowX145939" class="ref" href="../G/G8.htm#i145939" title="Antivirale midler">Antivirale midler</a></p></p></td>
	</tr>
 <tr id="i147525" class="body likelinje">
	<td id="i147526"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i147527">Epirubicin</p></p></td>
	<td id="i147528"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i147529">5</p></p></td>
	<td id="i147530"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i147531">Se cytostatika  <a id="arowX146868" class="ref" href="../G/G8.htm#i146868" title="Cytostatika">Cytostatika</a></p></p></td>
	</tr>
 <tr id="i147532" class="body oddelinje">
	<td id="i147533"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i147534">Eplerenon</p></p></td>
	<td id="i147535"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i147536">3</p></p></td>
	<td id="i147537"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i147538">Opplysninger mangler. Se diuretika  <a id="arowX147247" class="ref" href="../G/G8.htm#i147247" title="Diuretika">Diuretika</a></p></p></td>
	</tr>
 <tr id="i147539" class="body likelinje">
	<td id="i147540"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i147541">Epoetin (= erytropoietin)</p></p></td>
	<td id="i147542"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i147543">0</p></p></td>
	<td id="i147544"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i147545">Kan brukes av ammende</p></p></td>
	</tr>
 <tr id="i147546" class="body oddelinje">
	<td id="i147547"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i147548">Epoprostenol</p></p></td>
	<td id="i147549"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i147550">3</p></p></td>
	<td id="i147551"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i147552">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i147553" class="body likelinje">
	<td id="i147554"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i147555">Eprosartan</p></p></td>
	<td id="i147556"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i147557">3</p></p></td>
	<td id="i147558"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i147559">Se angiotensin II-reseptorantagonister  <a id="arowX145763" class="ref" href="../G/G8.htm#i145763" title="Angiotensin II-reseptorantagonister">Angiotensin II-reseptorantagonister</a></p></p></td>
	</tr>
 <tr id="i147560" class="body oddelinje">
	<td id="i147561"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i147562">Eptacog alfa (= faktor VIIa)</p></p></td>
	<td id="i147563"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i147564">3</p></p></td>
	<td id="i147565"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i147566">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i147567" class="body likelinje">
	<td id="i147568"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i147569">Eptifibatid</p></p></td>
	<td id="i147570"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i147571">3</p></p></td>
	<td id="i147572"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i147573">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i147574" class="body oddelinje">
	<td id="i147575"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i147576">Ergokalsiferol</p></p></td>
	<td id="i147577"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i147578">2</p></p></td>
	<td id="i147579"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i147580">Se vitamin D  <a id="arowX152882" class="ref" href="../G/G8.htm#i152882" title="Vitamin D og vitamin D-analoger">Vitamin D og vitamin D-analoger</a></p></p></td>
	</tr>
 <tr id="i147581" class="body likelinje">
	<td id="i147582"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i147583">Ergotamin</p></p></td>
	<td id="i147584"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i147585">5</p></p></td>
	<td id="i147586"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i147587">Bruk hos ammende frarådes pga. risiko for toksiske effekter (ergotisme) hos barnet, samt mulig hemning av melkeproduksjonen</p></p></td>
	</tr>
 <tr id="i320063" class="body oddelinje">
	<td id="i320064"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i320065">Eribulin</p></p></td>
	<td id="i320066"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i320067">3</p></p></td>
	<td id="i320068"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i320069">Se cytostatika <a id="aentryX146869" class="ref" href="../G/G8.htm#i146869" title="Cytostatika">Cytostatika</a> </p></p></td>
	</tr>
 <tr id="i147588" class="body likelinje">
	<td id="i147589"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i147590">Erlotinib</p></p></td>
	<td id="i147591"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i147592">5</p></p></td>
	<td id="i147593"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i147594">Virkningsmekanismen tilsier at det ikke bør brukes av ammende</p></p></td>
	</tr>
 <tr id="i147595" class="body oddelinje">
	<td id="i147596"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i147597">Ertapenem</p></p></td>
	<td id="i147598"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i147599">2</p></p></td>
	<td id="i147600"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i147601">Overgang til morsmelk er minimal. Se antibakterielle midler  <a id="arowX145756" class="ref" href="../G/G8.htm#i145756" title="Anestesimidler">Anestesimidler</a></p></p></td>
	</tr>
 <tr id="i147602" class="body likelinje">
	<td id="i147603"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i147604">Erytromycin</p></p></td>
	<td id="i147605"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i147606">1</p></p></td>
	<td id="i147607"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i147608">Kan brukes av ammende. Se antibakterielle midler  <a id="arowX145756" class="ref" href="../G/G8.htm#i145756" title="Anestesimidler">Anestesimidler</a></p></p></td>
	</tr>
 <tr id="i147609" class="body oddelinje">
	<td id="i147610"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i147611">Erytropoietin</p></p></td>
	<td id="i147612"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i147613">0</p></p></td>
	<td id="i147614"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i147615">Se epoetin  <a id="arowX147539" class="ref" href="../G/G8.htm#i147539" title="Epoetin (= erytropoietin)">Epoetin (= erytropoietin)</a></p></p></td>
	</tr>
 <tr id="i147616" class="body likelinje">
	<td id="i147617"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i147618">Escitalopram</p></p></td>
	<td id="i147619"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i147620">2</p></p></td>
	<td id="i147621"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i147622">Se citalopram  <a id="arowX146773" class="ref" href="../G/G8.htm#i146773" title="Citalopram">Citalopram</a> og SSRI  <a id="arowX151966" class="ref" href="../G/G8.htm#i151966" title="SSRI">SSRI</a></p></p></td>
	</tr>
 <tr id="i147623" class="body oddelinje">
	<td id="i147624"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i147625">Eslikarbazepin</p></p></td>
	<td id="i147626"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i147627">3</p></p></td>
	<td id="i147628"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i147629">Opplysninger om overgang til morsmelk mangler. Se antiepileptika  <a id="arowX145833" class="ref" href="../G/G8.htm#i145833" title="Antiepileptika">Antiepileptika</a></p></p></td>
	</tr>
 <tr id="i147630" class="body likelinje">
	<td id="i147631"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i147632">Esmolol</p></p></td>
	<td id="i147633"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i147634">3</p></p></td>
	<td id="i147635"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i147636">Opplysninger om overgang til morsmelk mangler. Etter en time er esmolol metabolisert, og amming kan gjenopptas. Se betareseptorantagonister, adrenerge  <a id="arowX146361" class="ref" href="../G/G8.htm#i146361" title="Betareseptorantagonister, adrenerge">Betareseptorantagonister, adrenerge</a></p></p></td>
	</tr>
 <tr id="i147637" class="body oddelinje">
	<td id="i147638"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i147639">Esomeprazol</p></p></td>
	<td id="i147640"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i147641">2</p></p></td>
	<td id="i147642"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i147643">Opplysninger om overgang til morsmelk mangler. Se protonpumpehemmere  <a id="arowX151433" class="ref" href="../G/G8.htm#i151433" title="Protonpumpehemmere">Protonpumpehemmere</a></p></p></td>
	</tr>
 <tr id="i147644" class="body likelinje">
	<td id="i147645"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i147646">Estramustin</p></p></td>
	<td id="i147647"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i147648">5</p></p></td>
	<td id="i147649"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i147650">Se cytostatika  <a id="arowX146868" class="ref" href="../G/G8.htm#i146868" title="Cytostatika">Cytostatika</a></p></p></td>
	</tr>
 <tr id="i147651" class="body oddelinje">
	<td id="i147652"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i147653">Etambutol</p></p></td>
	<td id="i147654"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i147655">2</p></p></td>
	<td id="i147656"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i147657">Overgang til morsmelk er minimal. Klinisk erfaring tilsier at etambutol kan brukes av ammende</p></p></td>
	</tr>
 <tr id="i147658" class="body likelinje">
	<td id="i147659"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i147660">Etanercept</p></p></td>
	<td id="i147661"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i147662">0</p></p></td>
	<td id="i147663"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i147664">Opplysninger mangler. Se immunsuppresive midler  <a id="arowX148847" class="ref" href="../G/G8.htm#i148847" title="Immunsuppressive midler">Immunsuppressive midler</a></p></p></td>
	</tr>
 <tr id="i147665" class="body oddelinje">
	<td id="i147666"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i147667">Etanol</p></p></td>
	<td id="i147668"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i147669">3</p></p></td>
	<td id="i147670"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i147671">Overgang til morsmelk er høy. Kan påvirke smaken på morsmelken. Sporadisk konsum er forenlig med amming. En alkoholenhet per dag er sannsynligvis trygt. Forsinket motorisk utvikling hos barnet er påvist ved bruk av to enheter daglig hos ammende. Risiko for nedsatt melkesekresjon</p></p></td>
	</tr>
 <tr id="i147672" class="body likelinje">
	<td id="i147673"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i147674">Etidronat</p></p></td>
	<td id="i147675"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i147676">0</p></p></td>
	<td id="i147677"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i147678">Se bisfosfonater  <a id="arowX146417" class="ref" href="../G/G8.htm#i146417" title="Bisfosfonater">Bisfosfonater</a></p></p></td>
	</tr>
 <tr id="i147679" class="body oddelinje">
	<td id="i147680"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i147681">Etilefrin</p></p></td>
	<td id="i147682"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i147683">3</p></p></td>
	<td id="i147684"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i147685">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i147686" class="body likelinje">
	<td id="i147687"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i147688">Etinyløstradiol</p></p></td>
	<td id="i147689"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i147690">3</p></p></td>
	<td id="i147691"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i147692">Overgang til morsmelk er minimal. Kan redusere melkeproduksjonen. Se p-piller  <a id="arowX151249" class="ref" href="../G/G8.htm#i151249" title="P-piller">P-piller</a></p></p></td>
	</tr>
 <tr id="i147693" class="body oddelinje">
	<td id="i147694"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i147695">Etonogestrel</p></p></td>
	<td id="i147696"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i147697">3</p></p></td>
	<td id="i147698"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i147699">Manglende klinisk erfaring med implantat. Se p-piller  <a id="arowX151249" class="ref" href="../G/G8.htm#i151249" title="P-piller">P-piller</a></p></p></td>
	</tr>
 <tr id="i147700" class="body likelinje">
	<td id="i147701"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i147702">Etoposid</p></p></td>
	<td id="i147703"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i147704">5</p></p></td>
	<td id="i147705"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i147706">Se cytostatika  <a id="arowX146868" class="ref" href="../G/G8.htm#i146868" title="Cytostatika">Cytostatika</a></p></p></td>
	</tr>
 <tr id="i147707" class="body oddelinje">
	<td id="i147708"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i147709">Etorikoksib</p></p></td>
	<td id="i147710"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i147711">3</p></p></td>
	<td id="i147712"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i147713">Opplysninger om overgang til morsmelk mangler. Se COX-2-hemmere  <a id="arowX146801" class="ref" href="../G/G8.htm#i146801" title="COX-2-hemmere">COX-2-hemmere</a></p></p></td>
	</tr>
 <tr id="i147714" class="body likelinje">
	<td id="i147715"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i147716">Etosuksimid</p></p></td>
	<td id="i147717"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i147718">4</p></p></td>
	<td id="i147719"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i147720">Overgang til morsmelk er høy. Sedativ effekt hos brysternærte barn er rapportert. Se antiepileptika  <a id="arowX145833" class="ref" href="../G/G8.htm#i145833" title="Antiepileptika">Antiepileptika</a></p></p></td>
	</tr>
 <tr id="i147721" class="body oddelinje">
	<td id="i147722"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i147723">Etravirin</p></p></td>
	<td id="i147724"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i147725">5</p></p></td>
	<td id="i147726"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i147727">Opplysninger om overgang til morsmelk mangler. Se antivirale midler  <a id="arowX145939" class="ref" href="../G/G8.htm#i145939" title="Antivirale midler">Antivirale midler</a></p></p></td>
	</tr>
 <tr id="i147728" class="body likelinje">
	<td id="i147729"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i147730">Etylmorfin</p></p></td>
	<td id="i147731"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i147732">3</p></p></td>
	<td id="i147733"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i147734">Opplysninger om overgang til morsmelk mangler. Potensiell risiko for sedasjon hos brysternærte barn ved langtidsbruk. Se opioidanalgetika  <a id="arowX150865" class="ref" href="../G/G8.htm#i150865" title="Opioidanalgetika">Opioidanalgetika</a></p></p></td>
	</tr>
 <tr id="i147735" class="body oddelinje">
	<td id="i147736"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i147737">Everolimus</p></p></td>
	<td id="i147738"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i147739">4</p></p></td>
	<td id="i147740"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i147741">Opplysninger mangler. Se immunsuppressive midler  <a id="arowX148847" class="ref" href="../G/G8.htm#i148847" title="Immunsuppressive midler">Immunsuppressive midler</a></p></p></td>
	</tr>
 <tr id="i147742" class="body likelinje">
	<td id="i147743"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i147744">Exenatid</p></p></td>
	<td id="i147745"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i147746">3</p></p></td>
	<td id="i147747"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i218845">Se antidiabetika, perorale  <a id="arowX145819" class="ref" href="../G/G8.htm#i145819" title="Antidiabetika, perorale">Antidiabetika, perorale</a>&ML;						Opplysninger om overgang til morsmelk mangler</p></p></td>
	</tr>
 <tr id="i147749" class="body oddelinje">
	<td id="i147750"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i147751">Ezetimib</p></p></td>
	<td id="i147752"    valign="top" width="19.3%" class="mellomKol">

<p class="entrya"><p id="i147753">3</p></p></td>
	<td id="i147754"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i147755">Opplysninger mangler</p></p></td>
	</tr>
 </tbody></table>
 <table id="i147757" width="100%" class="maintable" border="0" cellpadding="5" cellspacing="0">
 <caption> <Uth Id="NUTHid2330504" Type="Halvfet">F</Uth></caption> <thead>
	<tr class = "linjetopp">
	<th id="i147765"  colspan="3"  valign="top"  class="sluttKol">

<p class="entrya"><p id="i147766">Overgang til morsmelk angis som minimal (< 2 %), liten (2&#8211;5 %), moderat (5&#8211;10 %) eller høy (10&#8211;50 %) basert på fraksjon av morens dose/kg kroppsvekt som barnet tilføres. (Barnets relative dose.)&ML;						Over 3&#8211;4 ukers bruk ansees som langtidsbehandling.</p></p></th>
	</tr>
	<tr class = "linjetopp">
	<th id="i147769"    valign="top"  class="startKol">

<p class="entrya"><p id="i147770"><strong>Legemiddel</strong></p></p></th>
	<th id="i147771"    valign="top"  class="mellomKol">

<p class="entrya"><p id="i147772"><strong>MM kategori</strong></p></p></th>
	<th id="i147773"    valign="top"  class="sluttKol">

<p class="entrya"><p id="i147774"><strong>Dokumentasjon vedrørende bruk under amming</strong></p></p></th>
	</tr>
</thead>
<tbody>
<tr id="i147776" class="body likelinje">
	<td id="i147777"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i147778">Faktor VIII inhibitor bypass</p></p></td>
	<td id="i147779"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i147780">0</p></p></td>
	<td id="i147781"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i147782">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i221845" class="body oddelinje">
	<td id="i221846"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i221847">Famciklovir </p></p></td>
	<td id="i221848"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i221849">2 </p></p></td>
	<td id="i221850"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i221851">Se antivirale midler, herpesinfeksjoner  <a id="arowX145939" class="ref" href="../G/G8.htm#i145939" title="Antivirale midler">Antivirale midler</a></p></p></td>
	</tr>
 <tr id="i147783" class="body likelinje">
	<td id="i147784"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i147785">Famotidin</p></p></td>
	<td id="i147786"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i147787">1</p></p></td>
	<td id="i147788"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i147789">Overgang til morsmelk er liten. Se H<Sub>2</Sub>-antagonister  <a id="arowX148562" class="ref" href="../G/G8.htm#i148562" title="H2-antagonister">H2-antagonister</a></p></p></td>
	</tr>
 <tr id="i320070" class="body oddelinje">
	<td id="i320071"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i320072">Fampridin</p></p></td>
	<td id="i320073"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i320074">3</p></p></td>
	<td id="i320075"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i320076">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i147790" class="body likelinje">
	<td id="i147791"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i218846">Febuksostat</p></p></td>
	<td id="i147792"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i147793">3</p></p></td>
	<td id="i147794"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i147795">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i147796" class="body oddelinje">
	<td id="i147797"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i147798">Felbamat</p></p></td>
	<td id="i147799"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i147800">4</p></p></td>
	<td id="i147801"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i147802">Opplysninger om overgang til morsmelk mangler. Bør unngås til erfaring hos ammende foreligger. Se antiepileptika  <a id="arowX145833" class="ref" href="../G/G8.htm#i145833" title="Antiepileptika">Antiepileptika</a></p></p></td>
	</tr>
 <tr id="i147803" class="body likelinje">
	<td id="i147804"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i147805">Felodipin</p></p></td>
	<td id="i147806"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i147807">3</p></p></td>
	<td id="i147808"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i147809">Opplysninger om overgang til morsmelk mangler. Se kalsiumantagonister  <a id="arowX149110" class="ref" href="../G/G8.htm#i149110" title="Kalsiumantagonister">Kalsiumantagonister</a></p></p></td>
	</tr>
 <tr id="i147810" class="body oddelinje">
	<td id="i147811"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i147812">Fenazon</p></p></td>
	<td id="i147813"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i147814">2</p></p></td>
	<td id="i147815"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i147816">Overgang til morsmelk er moderat. Kan brukes av ammende ved sporadisk bruk i terapeutiske doser</p></p></td>
	</tr>
 <tr id="i147817" class="body likelinje">
	<td id="i147818"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i147819">Fenelzin</p></p></td>
	<td id="i147820"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i147821">3</p></p></td>
	<td id="i147822"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i147823">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i147824" class="body oddelinje">
	<td id="i147825"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i147826">Fenobarbital</p></p></td>
	<td id="i147827"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i147828">4</p></p></td>
	<td id="i147829"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i147830">Overgang til morsmelk er høy. Barnet bør observeres for døsighet, dårlig sugeevne og lav vektøkning, spesielt hvis barnet også har vært eksponert under svangerskapet. Se barbiturater  <a id="arowX146213" class="ref" href="../G/G8.htm#i146213" title="Barbiturater">Barbiturater</a></p></p></td>
	</tr>
 <tr id="i147831" class="body likelinje">
	<td id="i147832"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i147833">Fenofibrat</p></p></td>
	<td id="i147834"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i147835">3</p></p></td>
	<td id="i147836"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i147837">Opplysninger om overgang til morsmelk mangler. Tilbakeholdenhet med bruk hos ammende anbefales fordi produkter fra kolesterolbiosyntesen er viktig for neonatal utvikling</p></p></td>
	</tr>
 <tr id="i147838" class="body oddelinje">
	<td id="i147839"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i147840">Fenoksymetylpenicillin</p></p></td>
	<td id="i147841"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i147842">1</p></p></td>
	<td id="i147843"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i147844">Se penicilliner  <a id="arowX151075" class="ref" href="../G/G8.htm#i151075" title="Penicilliner">Penicilliner</a></p></p></td>
	</tr>
 <tr id="i147845" class="body likelinje">
	<td id="i147846"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i147847">Fenoterol</p></p></td>
	<td id="i147848"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i147849">3</p></p></td>
	<td id="i147850"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i147851">Opplysninger om overgang til morsmelk mangler. Se beta-2-reseptoragonister, adrenerge  <a id="arowX146354" class="ref" href="../G/G8.htm#i146354" title="Beta-2-reseptoragonister, adrenerge">Beta-2-reseptoragonister, adrenerge</a></p></p></td>
	</tr>
 <tr id="i147852" class="body oddelinje">
	<td id="i147853"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i147854">Fentanyl</p></p></td>
	<td id="i147855"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i147856">2</p></p>
<p class="entrya"><p id="i271510"> </p></p>
<p class="entrya"><p id="i271511"> </p></p>
<p class="entrya"><p id="i271512"> </p></p>
<p class="entrya"><p id="i271509">3</p></p></td>
	<td id="i147857"    valign="top" width="51.7%" class="sluttKol">
	<UL type="circle">
		<LI id="i271502"><p id="i271503"><em>Parenteral tilførsel:</em> Overgang til morsmelk er liten. Kan brukes av ammende ved engangsdosering eller dosering over kort tid. Noen anbefaler likevel at amming utsettes til 6 timer etter eksponering</p><br>		</LI>
		<LI id="i271504"><p id="i271505">Depotplaster: Overgang til morsmelk er moderat. Observer barnet for farmakologiske effekter</p><br>		</LI>
	</UL>

<p class="entrya"><p id="i271508">Se opioidanalgetika  <a id="arowX150865" class="ref" href="../G/G8.htm#i150865" title="Opioidanalgetika">Opioidanalgetika</a></p></p></td>
	</tr>
 <tr id="i147871" class="body likelinje">
	<td id="i147872"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i147873">Fenylefrin</p></p></td>
	<td id="i147874"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i147875">2</p></p></td>
	<td id="i147876"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i147877">Øyedråper: Kan brukes av ammende</p></p></td>
	</tr>
 <tr id="i147878" class="body oddelinje">
	<td id="i147879"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i147880">Fenylindandion</p></p></td>
	<td id="i147881"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i147882">3</p></p></td>
	<td id="i147883"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i147884">Opplysninger mangler. Se antikoagulantia, perorale  <a id="arowX145862" class="ref" href="../G/G8.htm#i145862" title="Antikoagulantia, perorale">Antikoagulantia, perorale</a></p></p></td>
	</tr>
 <tr id="i147885" class="body likelinje">
	<td id="i147886"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i147887">Fenylpropanolamin</p></p></td>
	<td id="i147888"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i147889">2</p></p></td>
	<td id="i147890"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i147891">Opplysninger om overgang til morsmelk mangler. Risiko for farmakologiske effekter på barnet ansees som minimal ved terapeutiske doser</p></p></td>
	</tr>
 <tr id="i147892" class="body oddelinje">
	<td id="i147893"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i147894">Fenytoin</p></p></td>
	<td id="i147895"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i147896">2</p></p></td>
	<td id="i147897"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i147898">Kan brukes av ammende. Se antiepileptika  <a id="arowX145833" class="ref" href="../G/G8.htm#i145833" title="Antiepileptika">Antiepileptika</a></p></p></td>
	</tr>
 <tr id="i147899" class="body likelinje">
	<td id="i147900"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i147901">Fesoterodin</p></p></td>
	<td id="i147902"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i147903">3</p></p></td>
	<td id="i147904"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i147905">Opplysninger mangler. Mulig risiko for antikolinerge effekter i brysternærte barn</p></p></td>
	</tr>
 <tr id="i147906" class="body oddelinje">
	<td id="i147907"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i147908">Fexofenadin</p></p></td>
	<td id="i147909"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i147910">2</p></p></td>
	<td id="i147911"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i147912">Overgang til morsmelk er minimal. Se antihistaminer  <a id="arowX145840" class="ref" href="../G/G8.htm#i145840" title="Antihistaminer (H1-antagonister)">Antihistaminer (H1-antagonister)</a></p></p></td>
	</tr>
 <tr id="i221852" class="body likelinje">
	<td id="i221853"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i221854">Fibrinogen </p></p></td>
	<td id="i221855"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i221856">0 </p></p></td>
	<td id="i221857"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i221858">Opplysninger mangler. Liten sannsynlighet for absorpsjon av legemidlet fra barnets mage-tarm-kanal</p></p></td>
	</tr>
 <tr id="i320147" class="body oddelinje">
	<td id="i320148"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i320149">Fidaksomicin</p></p></td>
	<td id="i320150"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i320151">3</p></p></td>
	<td id="i320152"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i320153">Lav peroral biotilgjengelighet tilsier minimal eksponering av diebarn. Erfaring med bruk hos ammende mangler. Se også antibakterielle midler <a id="aentryX145806" class="ref" href="../G/G8.htm#i145806" title="Antibakterielle midler">Antibakterielle midler</a> </p></p></td>
	</tr>
 <tr id="i147913" class="body likelinje">
	<td id="i147914"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i147915">Filgrastim</p></p></td>
	<td id="i147916"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i147917">0</p></p></td>
	<td id="i147918"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i147919">Erfaring med bruk hos ammende mangler. Ingen absorpsjon fra barnets mage-tarm-kanal</p></p></td>
	</tr>
 <tr id="i147920" class="body oddelinje">
	<td id="i147921"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i147922">Finasterid</p></p></td>
	<td id="i147923"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i147924">4</p></p></td>
	<td id="i147925"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i147926">Opplysninger mangler. Se antiandrogener  <a id="arowX145798" class="ref" href="../G/G8.htm#i145798" title="Antiandrogener">Antiandrogener</a></p></p></td>
	</tr>
 <tr id="i320077" class="body likelinje">
	<td id="i320078"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i320079">Fingolimod</p></p></td>
	<td id="i320080"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i320081">4</p></p></td>
	<td id="i320082"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i320083">Opplysninger mangler. Se immunsuppresive midler <a id="aentryX148848" class="ref" href="../G/G8.htm#i148848" title="Immunsuppressive midler">Immunsuppressive midler</a> </p></p></td>
	</tr>
 <tr id="i147927" class="body oddelinje">
	<td id="i147928"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i147929">Flekainid</p></p></td>
	<td id="i147930"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i147931">2</p></p></td>
	<td id="i147932"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i147933">Overgang til morsmelk er moderat. Kan brukes av ammende</p></p></td>
	</tr>
 <tr id="i147934" class="body likelinje">
	<td id="i147935"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i147936">Flucytosin</p></p></td>
	<td id="i147937"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i147938">3</p></p></td>
	<td id="i147939"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i147940">Opplysninger mangler. Tilbakeholdenhet anbefales til mer erfaring foreligger</p></p></td>
	</tr>
 <tr id="i147941" class="body oddelinje">
	<td id="i147942"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i147943">Fludarabin</p></p></td>
	<td id="i147944"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i147945">5</p></p></td>
	<td id="i147946"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i147947">Se cytostatika  <a id="arowX146868" class="ref" href="../G/G8.htm#i146868" title="Cytostatika">Cytostatika</a></p></p></td>
	</tr>
 <tr id="i147948" class="body likelinje">
	<td id="i147949"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i147950">Fludrokortison</p></p></td>
	<td id="i147951"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i147952">3</p></p></td>
	<td id="i147953"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i147954">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i147955" class="body oddelinje">
	<td id="i147956"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i147957">Flufenazin</p></p></td>
	<td id="i147958"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i147959">3</p></p></td>
	<td id="i147960"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i147961">Opplysninger om overgang til morsmelk mangler. Se antipsykotika  <a id="arowX145918" class="ref" href="../G/G8.htm#i145918" title="Antipsykotika">Antipsykotika</a></p></p></td>
	</tr>
 <tr id="i147962" class="body likelinje">
	<td id="i147963"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i147964">Flukonazol</p></p></td>
	<td id="i147965"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i147966">2</p></p></td>
	<td id="i147967"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i147968">Overgang til morsmelk er høy. Kan brukes av ammende ved korttidsbehandling (2 uker)</p></p></td>
	</tr>
 <tr id="i147969" class="body oddelinje">
	<td id="i147970"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i147971">Flumazenil</p></p></td>
	<td id="i147972"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i147973">3</p></p></td>
	<td id="i147974"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i147975">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i147976" class="body likelinje">
	<td id="i147977"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i147978">Flumetason</p></p></td>
	<td id="i147979"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i147980">2</p></p></td>
	<td id="i147981"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i147982">Se glukokortikoider, lokalbehandling  <a id="arowX148403" class="ref" href="../G/G8.htm#i148403" title="Glukokortikoider">Glukokortikoider</a></p></p></td>
	</tr>
 <tr id="i147983" class="body oddelinje">
	<td id="i147984"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i147985">Flunitrazepam</p></p></td>
	<td id="i147986"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i147987">3</p></p></td>
	<td id="i147988"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i147989">Opplysninger om overgang til morsmelk mangler. Se benzodiazepiner  <a id="arowX146283" class="ref" href="../G/G8.htm#i146283" title="Benzodiazepiner">Benzodiazepiner</a></p></p></td>
	</tr>
 <tr id="i147990" class="body likelinje">
	<td id="i147991"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i147992">Fluocinolon</p></p></td>
	<td id="i147993"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i147994">2</p></p></td>
	<td id="i147995"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i147996">Se glukokortikoider, lokalbehandling  <a id="arowX148403" class="ref" href="../G/G8.htm#i148403" title="Glukokortikoider">Glukokortikoider</a></p></p></td>
	</tr>
 <tr id="i147997" class="body oddelinje">
	<td id="i147998"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i147999">Fluocinonid</p></p></td>
	<td id="i148000"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i148001">2</p></p></td>
	<td id="i148002"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i148003">Se glukokortikoider, lokalbehandling  <a id="arowX148403" class="ref" href="../G/G8.htm#i148403" title="Glukokortikoider">Glukokortikoider</a></p></p></td>
	</tr>
 <tr id="i148004" class="body likelinje">
	<td id="i148005"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i148006">Fluoksetin</p></p></td>
	<td id="i148007"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i148008">3</p></p></td>
	<td id="i148009"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i148010">Overgang til morsmelk er moderat. Mulighet for akkumulering av aktiv metabolitt med lang plasmahalveringstid. Alternativt SSRI bør foretrekkes. Se SSRI  <a id="arowX151966" class="ref" href="../G/G8.htm#i151966" title="SSRI">SSRI</a></p></p></td>
	</tr>
 <tr id="i148011" class="body oddelinje">
	<td id="i148012"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i148013">Fluorescein</p></p></td>
	<td id="i148014"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i148015">3</p></p></td>
	<td id="i148016"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i148017">Overgang til morsmelk er minimal. Teoretisk risiko for fototoksistet hos diebarn som får lysterapi</p></p></td>
	</tr>
 <tr id="i148018" class="body likelinje">
	<td id="i148019"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i148020">Fluorid/fluor</p></p></td>
	<td id="i148021"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i148022">1</p></p></td>
	<td id="i148023"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i148024">Overgang til morsmelk er liten. Lokal fluorprofylakse anbefales til ammende.</p></p></td>
	</tr>
 <tr id="i148025" class="body oddelinje">
	<td id="i148026"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i148027"><em>Fluorokinoloner</em></p></p></td>
	<td id="i148028"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i148029">2, 3</p></p></td>
	<td id="i148030"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i148031">Bør kun brukes i kortere perioder pga. potensiell risiko for påvirkning av barnets tarmflora. Se antibakterielle midler  <a id="arowX145756" class="ref" href="../G/G8.htm#i145756" title="Anestesimidler">Anestesimidler</a></p></p></td>
	</tr>
 <tr id="i148032" class="body likelinje">
	<td id="i148033"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i148034">Fluorouracil</p></p></td>
	<td id="i148035"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i148036">5</p></p></td>
	<td id="i148037"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i148038">Se cytostatika  <a id="arowX146868" class="ref" href="../G/G8.htm#i146868" title="Cytostatika">Cytostatika</a></p></p></td>
	</tr>
 <tr id="i148039" class="body oddelinje">
	<td id="i148040"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i148041">Flupentixol</p></p></td>
	<td id="i148042"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i148043">3</p></p></td>
	<td id="i148044"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i148045">Overgang til morsmelk er minimal. Se antipsykotika  <a id="arowX145918" class="ref" href="../G/G8.htm#i145918" title="Antipsykotika">Antipsykotika</a></p></p></td>
	</tr>
 <tr id="i148046" class="body likelinje">
	<td id="i148047"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i148048">Flutamid</p></p></td>
	<td id="i148049"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i148050">&#8211;</p></p></td>
	<td id="i148051"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i148052">Ikke aktuelt til bruk hos ammende. Se antiandrogener  <a id="arowX145798" class="ref" href="../G/G8.htm#i145798" title="Antiandrogener">Antiandrogener</a></p></p></td>
	</tr>
 <tr id="i148053" class="body oddelinje">
	<td id="i148054"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i148055">Flutikason</p></p></td>
	<td id="i148056"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i148057">2</p></p></td>
	<td id="i148058"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i148059">Farmakokinetiske egenskaper tilsier minimal eksponering av brysternærte barn. Se glukokortikoider, lokalbehandling  <a id="arowX148403" class="ref" href="../G/G8.htm#i148403" title="Glukokortikoider">Glukokortikoider</a></p></p></td>
	</tr>
 <tr id="i148060" class="body likelinje">
	<td id="i148061"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i148062">Fluvastatin</p></p></td>
	<td id="i148063"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i148064">3</p></p></td>
	<td id="i148065"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i148066">Se statiner  <a id="arowX151973" class="ref" href="../G/G8.htm#i151973" title="Statiner">Statiner</a></p></p></td>
	</tr>
 <tr id="i148067" class="body oddelinje">
	<td id="i148068"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i148069">Fluvoksamin</p></p></td>
	<td id="i148070"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i148071">2</p></p></td>
	<td id="i148072"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i148073">Overgang til morsmelk er liten. Se SSRI  <a id="arowX151966" class="ref" href="../G/G8.htm#i151966" title="SSRI">SSRI</a></p></p></td>
	</tr>
 <tr id="i148074" class="body likelinje">
	<td id="i148075"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i148076">Folat</p></p></td>
	<td id="i148077"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i148078">1</p></p></td>
	<td id="i148079"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i148080">Se folsyre  <a id="arowX148095" class="ref" href="../G/G8.htm#i148095" title="Folsyre/folat">Folsyre/folat</a></p></p></td>
	</tr>
 <tr id="i148081" class="body oddelinje">
	<td id="i148082"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i148083">Folinat</p></p></td>
	<td id="i148084"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i148085">1</p></p></td>
	<td id="i148086"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i148087">Kan brukes av ammende</p></p></td>
	</tr>
 <tr id="i148088" class="body likelinje">
	<td id="i148089"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i148090">Follitropin</p></p></td>
	<td id="i148091"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i148092">0</p></p></td>
	<td id="i148093"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i148094">Se gonadotropiner  <a id="arowX148472" class="ref" href="../G/G8.htm#i148472" title="Gonadotropiner">Gonadotropiner</a></p></p></td>
	</tr>
 <tr id="i148095" class="body oddelinje">
	<td id="i148096"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i148097">Folsyre/folat</p></p></td>
	<td id="i148098"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i148099">1</p></p></td>
	<td id="i148100"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i148101">Kan brukes av ammende. Se vitaminer  <a id="arowX152903" class="ref" href="../G/G8.htm#i152903" title="Vitaminer">Vitaminer</a></p></p></td>
	</tr>
 <tr id="i148102" class="body likelinje">
	<td id="i148103"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i148104">Fomepizol</p></p></td>
	<td id="i148105"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i148106">3</p></p></td>
	<td id="i148107"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i148108">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i148109" class="body oddelinje">
	<td id="i148110"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i148111">Fondaparinuks</p></p></td>
	<td id="i148112"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i148113">0</p></p></td>
	<td id="i148114"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i148115">Manglende klinisk erfaring</p></p></td>
	</tr>
 <tr id="i148116" class="body likelinje">
	<td id="i148117"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i148118">Formoterol</p></p></td>
	<td id="i148119"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i148120">3</p></p></td>
	<td id="i148121"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i148122">Opplysninger mangler. Se beta-2-reseptoragonister, adrenerge  <a id="arowX146354" class="ref" href="../G/G8.htm#i146354" title="Beta-2-reseptoragonister, adrenerge">Beta-2-reseptoragonister, adrenerge</a></p></p></td>
	</tr>
 <tr id="i148123" class="body oddelinje">
	<td id="i148124"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i148125">Fosamprenavir</p></p></td>
	<td id="i148126"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i148127">5</p></p></td>
	<td id="i148128"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i148129">Se antivirale midler  <a id="arowX145939" class="ref" href="../G/G8.htm#i145939" title="Antivirale midler">Antivirale midler</a></p></p></td>
	</tr>
 <tr id="i148130" class="body likelinje">
	<td id="i148131"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i148132">Fosaprepitant</p></p></td>
	<td id="i148133"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i148134">3</p></p></td>
	<td id="i148135"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i148136">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i148137" class="body oddelinje">
	<td id="i148138"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i148139">Foscarnet</p></p></td>
	<td id="i148140"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i148141">5</p></p></td>
	<td id="i148142"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i148143">Se antivirale midler  <a id="arowX145939" class="ref" href="../G/G8.htm#i145939" title="Antivirale midler">Antivirale midler</a></p></p></td>
	</tr>
 <tr id="i148144" class="body likelinje">
	<td id="i148145"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i148146">Framycetin (hud)</p></p></td>
	<td id="i148147"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i148148">2</p></p></td>
	<td id="i148149"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i148150">Lokalbehandling: Kan brukes av ammende</p></p></td>
	</tr>
 <tr id="i148151" class="body oddelinje">
	<td id="i148152"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i218847">Frovatriptan</p></p></td>
	<td id="i148153"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i148154">3</p></p></td>
	<td id="i148155"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i148156">Opplysning om overgang til morsmelk mangler. Se triptaner  <a id="arowX152605" class="ref" href="../G/G8.htm#i152605" title="Triptaner">Triptaner</a></p></p></td>
	</tr>
 <tr id="i148157" class="body likelinje">
	<td id="i148158"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i148159">Fulvestrant</p></p></td>
	<td id="i148160"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i148161">&#8211;</p></p></td>
	<td id="i148162"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i148163">Ikke aktuelt til bruk hos ammende</p></p></td>
	</tr>
 <tr id="i148164" class="body oddelinje">
	<td id="i148165"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i148166"><em>Fungicider til lokal bruk</em></p></p></td>
	<td id="i148167"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i148168">0, 1, 2</p></p></td>
	<td id="i148169"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i148170">Liten systemisk absorpsjon hos mor tilsier minimal overgang til morsmelk. Liten sannsynlighet for absorpsjon av legemidlet fra barnets mage-tarm-kanal&ML;						Overgang til morsmelk av dermatologiske soppdrepende preparater applisert rundt brystknoppen er ikke studert. Se også de enkelte virkestoffene</p></p></td>
	</tr>
 <tr id="i148172" class="body likelinje">
	<td id="i148173"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i148174">Furosemid</p></p></td>
	<td id="i148175"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i148176">3</p></p></td>
	<td id="i148177"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i148178">Overgang til morsmelk er minimal. Se diuretika  <a id="arowX147247" class="ref" href="../G/G8.htm#i147247" title="Diuretika">Diuretika</a></p></p></td>
	</tr>
 <tr id="i148179" class="body oddelinje">
	<td id="i148180"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i148181">Fusidin</p></p></td>
	<td id="i148182"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i148183">2</p></p>
<p class="entrya"><p id="i271519"> </p></p>
<p class="entrya"><p id="i271520">2</p></p>
<p class="entrya"><p id="i271515"> </p></p></td>
	<td id="i148184"    valign="top" width="51.7%" class="sluttKol">
	<UL type="circle">
		<LI id="i271524"><p id="i271525"><em>Systemisk bruk:</em> Overgang til morsmelk er minimal. Risiko for påvirkning av barnet er liten ved bruk av terapeutiske doser. Se antibakterielle midler  <a id="arowX145756" class="ref" href="../G/G8.htm#i145756" title="Anestesimidler">Anestesimidler</a></p><br>		</LI>
		<LI id="i271526"><p id="i271527">Lokal bruk: Kan brukes av ammende</p><br>		</LI>
	</UL>
</td>
	</tr>
 <tr id="i148197" class="body likelinje">
	<td id="i148198"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i148199">Fysostigmin</p></p></td>
	<td id="i148200"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i148201">3</p></p></td>
	<td id="i148202"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i148203">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i148204" class="body oddelinje">
	<td id="i148205"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i148206">Fytomenadion (= vitamin K1)</p></p></td>
	<td id="i148207"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i148208">2</p></p></td>
	<td id="i148209"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i148210">Kan brukes av ammende. Se vitaminer  <a id="arowX152903" class="ref" href="../G/G8.htm#i152903" title="Vitaminer">Vitaminer</a></p></p></td>
	</tr>
 </tbody></table>
 <table id="i148212" width="100%" class="maintable" border="0" cellpadding="5" cellspacing="0">
 <caption> <Uth Id="NUTHid2330232" Type="Halvfet">G</Uth></caption> <thead>
	<tr class = "linjetopp">
	<th id="i148220"  colspan="3"  valign="top"  class="sluttKol">

<p class="entrya"><p id="i148221">Overgang til morsmelk angis som minimal (< 2 %), liten (2&#8211;5 %), moderat (5&#8211;10 %) eller høy (10&#8211;50 %) basert på fraksjon av morens dose/kg kroppsvekt som barnet tilføres. (Barnets relative dose.)&ML;						Over 3&#8211;4 ukers bruk ansees som langtidsbehandling.</p></p></th>
	</tr>
	<tr class = "linjetopp">
	<th id="i148224"    valign="top"  class="startKol">

<p class="entrya"><p id="i148225"><strong>Legemiddel</strong></p></p></th>
	<th id="i148226"    valign="top"  class="mellomKol">

<p class="entrya"><p id="i148227"><strong>MM kategori</strong></p></p></th>
	<th id="i148228"    valign="top"  class="sluttKol">

<p class="entrya"><p id="i148229"><strong>Dokumentasjon vedrørende bruk under amming</strong></p></p></th>
	</tr>
</thead>
<tbody>
<tr id="i148231" class="body likelinje">
	<td id="i148232"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i148233">Gabapentin</p></p></td>
	<td id="i148234"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i148235">3</p></p></td>
	<td id="i148236"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i148237">Overgang til morsmelk er moderat. Se antiepileptika  <a id="arowX145833" class="ref" href="../G/G8.htm#i145833" title="Antiepileptika">Antiepileptika</a></p></p></td>
	</tr>
 <tr id="i148238" class="body oddelinje">
	<td id="i148239"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i148240">Gadobensyre</p></p></td>
	<td id="i148241"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i148242">3</p></p></td>
	<td id="i148243"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i148244">Kvinnen kan amme etter 24 timer</p></p></td>
	</tr>
 <tr id="i148245" class="body likelinje">
	<td id="i148246"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i148247">Gadodiamid</p></p></td>
	<td id="i148248"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i148249">3</p></p></td>
	<td id="i148250"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i148251">Kvinnen kan amme etter 24 timer</p></p></td>
	</tr>
 <tr id="i148259" class="body oddelinje">
	<td id="i148260"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i148261">Gadopentetat</p></p></td>
	<td id="i148262"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i148263">2</p></p></td>
	<td id="i148264"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i148265">Overgang til morsmelk er minimal. Kvinnen kan amme etter 12 timer</p></p></td>
	</tr>
 <tr id="i148266" class="body likelinje">
	<td id="i148267"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i148268">Gadoteridol</p></p></td>
	<td id="i148269"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i148270">3</p></p></td>
	<td id="i148271"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i148272">Kvinnen kan amme etter 24 timer</p></p></td>
	</tr>
 <tr id="i148273" class="body oddelinje">
	<td id="i148274"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i148275">Gadotersyre</p></p></td>
	<td id="i148276"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i148277">2</p></p></td>
	<td id="i148278"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i148279">Kan brukes av ammende ved terapeutiske doser</p></p></td>
	</tr>
 <tr id="i148280" class="body likelinje">
	<td id="i148281"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i148282">Gadoversetamid</p></p></td>
	<td id="i148283"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i148284">2</p></p></td>
	<td id="i148285"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i148286">Kan brukes av ammende</p></p></td>
	</tr>
 <tr id="i148287" class="body oddelinje">
	<td id="i148288"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i148289">Galaktoseagglomerater</p></p></td>
	<td id="i148290"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i148291">0</p></p></td>
	<td id="i148292"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i148293">Opplysninger om overgang til morsmelk mangler, men den er trolig ubetydelig</p></p></td>
	</tr>
 <tr id="i148294" class="body likelinje">
	<td id="i148295"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i148296">Galantamin</p></p></td>
	<td id="i148297"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i148298">3</p></p></td>
	<td id="i148299"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i148300">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i148301" class="body oddelinje">
	<td id="i148302"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i148303">Ganciklovir</p></p></td>
	<td id="i148304"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i148305">3</p></p></td>
	<td id="i148306"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i148307">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i148308" class="body likelinje">
	<td id="i148309"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i148310">Ganirelix</p></p></td>
	<td id="i148311"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i148312">0</p></p></td>
	<td id="i148313"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i148314">Se GnRH-analoger  <a id="arowX148458" class="ref" href="../G/G8.htm#i148458" title="GnRH-analoger">GnRH-analoger</a></p></p></td>
	</tr>
 <tr id="i148315" class="body oddelinje">
	<td id="i148316"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i148317">Gefitinib</p></p></td>
	<td id="i148318"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i148319">3</p></p></td>
	<td id="i148320"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i148321">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i148322" class="body likelinje">
	<td id="i148323"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i148324">Gemcitabin</p></p></td>
	<td id="i148325"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i148326">5</p></p></td>
	<td id="i148327"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i148328">Se cytostatika  <a id="arowX146868" class="ref" href="../G/G8.htm#i146868" title="Cytostatika">Cytostatika</a></p></p></td>
	</tr>
 <tr id="i148329" class="body oddelinje">
	<td id="i148330"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i148331">Gemeprost</p></p></td>
	<td id="i148332"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i148333">3</p></p></td>
	<td id="i148334"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i148335">Kan muligens påvirke melkeutskillelsen</p></p></td>
	</tr>
 <tr id="i148336" class="body likelinje">
	<td id="i148337"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i148338">Gemfibrozil</p></p></td>
	<td id="i148339"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i148340">3</p></p></td>
	<td id="i148341"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i148342">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i148343" class="body oddelinje">
	<td id="i148344"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i148345">Gentamicin</p></p></td>
	<td id="i148346"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i148347">2</p></p></td>
	<td id="i148348"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i148349">Overgang til morsmelk er minimal. Se aminoglykosider  <a id="arowX145643" class="ref" href="../G/G8.htm#i145643" title="Aminoglykosider">Aminoglykosider</a></p></p></td>
	</tr>
 <tr id="i148350" class="body likelinje">
	<td id="i148351"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i148352"><em>Gestagener</em></p></p></td>
	<td id="i148353"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i148354">2, 3, 4</p></p>
<p class="entrya"><p id="i271581"> </p></p>
<p class="entrya"><p id="i271582">1</p></p></td>
	<td id="i148355"    valign="top" width="51.7%" class="sluttKol">
	<UL type="circle">
		<LI id="i148357"><p id="i148358"><em>Systemisk bruk:</em> Se p-piller  <a id="arowX151249" class="ref" href="../G/G8.htm#i151249" title="P-piller">P-piller</a>. Tilbakeholdenhet ved høydosebehandling av kreft</p><br>		</LI>
		<LI id="i271583"><p id="i271584">Lokal bruk: Kan brukes av ammende. Lang klinisk erfaring</p><br>		</LI>
	</UL>
</td>
	</tr>
 <tr id="i320084" class="body oddelinje">
	<td id="i320085"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i320086">Gimeracil</p></p></td>
	<td id="i320087"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i320088">5</p></p></td>
	<td id="i320089"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i320090">Se cytostatika <a id="aentryX146869" class="ref" href="../G/G8.htm#i146869" title="Cytostatika">Cytostatika</a> </p></p></td>
	</tr>
 <tr id="i148368" class="body likelinje">
	<td id="i148369"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i148370">Glatirameracetat</p></p></td>
	<td id="i148371"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i148372">3</p></p></td>
	<td id="i148373"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i148374">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i148375" class="body oddelinje">
	<td id="i148376"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i148377">Glibenklamid</p></p></td>
	<td id="i148378"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i148379">3</p></p></td>
	<td id="i148380"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i148381">Se antidiabetika, perorale  <a id="arowX145819" class="ref" href="../G/G8.htm#i145819" title="Antidiabetika, perorale">Antidiabetika, perorale</a></p></p></td>
	</tr>
 <tr id="i148382" class="body likelinje">
	<td id="i148383"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i148384">Glimepirid</p></p></td>
	<td id="i148385"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i148386">3</p></p></td>
	<td id="i148387"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i148388">Se antidiabetika, perorale  <a id="arowX145819" class="ref" href="../G/G8.htm#i145819" title="Antidiabetika, perorale">Antidiabetika, perorale</a></p></p></td>
	</tr>
 <tr id="i148389" class="body oddelinje">
	<td id="i148390"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i148391">Glipizid</p></p></td>
	<td id="i148392"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i148393">3</p></p></td>
	<td id="i148394"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i148395">Se antidiabetika, perorale  <a id="arowX145819" class="ref" href="../G/G8.htm#i145819" title="Antidiabetika, perorale">Antidiabetika, perorale</a></p></p></td>
	</tr>
 <tr id="i148396" class="body likelinje">
	<td id="i148397"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i148398">Glukagon</p></p></td>
	<td id="i148399"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i148400">0</p></p></td>
	<td id="i148401"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i148402">Kan brukes av ammende</p></p></td>
	</tr>
 <tr id="i148403" class="body oddelinje">
	<td id="i148404"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i148405"><em>Glukokortikoider</em></p></p></td>
	<td id="i148406"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i148407">2, 3</p></p>
<p class="entrya"><p id="i271639"> </p></p>
<p class="entrya"><p id="i271640">2,3</p></p>
<p class="entrya"><p id="i271641"> </p></p>
<p class="entrya"><p id="i271642">2</p></p></td>
	<td id="i148408"    valign="top" width="51.7%" class="sluttKol">
	<UL type="circle">
		<LI id="i148410"><p id="i148411"><em>Systemisk bruk:</em> Ved lengre tids bruk av høye doser glukokortikoider bør barnet observeres med tanke på binyrebarksuppresjon</p><br>		</LI>
		<LI id="i271643"><p id="i271644">Inhalasjonsglukokortikoider: Kan brukes av ammende i anbefalte terapeutiske doser. Midler hvor det foreligger lengre klinisk erfaring bør fortrinnsvis benyttes</p><br>		</LI>
		<LI id="i271645"><p id="i271646">Annen lokalbehandling: Kan brukes av ammende. Bruk av glukokortikoid hudpreparater på brystene bør brukes med forsiktighet av ammende</p><br>		</LI>
	</UL>
</td>
	</tr>
 <tr id="i148430" class="body likelinje">
	<td id="i148431"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i148432">Glukosamin</p></p></td>
	<td id="i148433"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i148434">0</p></p></td>
	<td id="i148435"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i148436">Kan brukes av ammende</p></p></td>
	</tr>
 <tr id="i148437" class="body oddelinje">
	<td id="i148438"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i148439">Glykopyrron</p></p></td>
	<td id="i148440"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i148441">3</p></p></td>
	<td id="i148442"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i148443">Se antikolinergika, kvartære ammoniumforbindelser  <a id="arowX145869" class="ref" href="../G/G8.htm#i145869" title="Antikolinergika">Antikolinergika</a></p></p></td>
	</tr>
 <tr id="i148444" class="body likelinje">
	<td id="i148445"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i148446">Glyseroltrinitrat</p></p></td>
	<td id="i148447"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i148448">3</p></p></td>
	<td id="i148449"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i148450">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i148451" class="body oddelinje">
	<td id="i148452"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i148453">Glysin (= aminoeddiksyre)</p></p></td>
	<td id="i148454"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i148455">3</p></p></td>
	<td id="i148456"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i148457">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i148458" class="body likelinje">
	<td id="i148459"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i148460"><em>GnRH-analoger</em></p></p></td>
	<td id="i148461"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i148462">0</p></p></td>
	<td id="i148463"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i148464">Overgang til morsmelk er minimal pga. høy molekylvekt. Liten sannsynlighet for absorpsjon av intakt peptid fra barnets mage-tarm-kanal. Manglende klinisk erfaring</p></p></td>
	</tr>
 <tr id="i148465" class="body oddelinje">
	<td id="i148466"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i148467">Golimumab</p></p></td>
	<td id="i148468"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i148469">3</p></p></td>
	<td id="i148470"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i148471">Opplysninger om overgang til morsmelk mangler Se monoklonale antistoffer  <a id="arowX150370" class="ref" href="../G/G8.htm#i150370" title="Monoklonale antistoffer">Monoklonale antistoffer</a></p></p></td>
	</tr>
 <tr id="i148472" class="body likelinje">
	<td id="i148473"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i148474"><em>Gonadotropiner</em></p></p></td>
	<td id="i148475"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i148476">0</p></p></td>
	<td id="i148477"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i148478">Farmakokinetiske egenskaper tilsier minimal overgang til morsmelk. Liten sannsynlighet for absorpsjon av intakt peptid fra barnets mage-tarm-kanal. Klinisk erfaring med bruk hos ammende er svært begrenset</p></p></td>
	</tr>
 <tr id="i148479" class="body oddelinje">
	<td id="i148480"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i148481">Goserelin</p></p></td>
	<td id="i148482"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i148483">&#8211;</p></p></td>
	<td id="i148484"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i148485">Ikke aktuell til bruk hos ammende</p></p></td>
	</tr>
 <tr id="i148486" class="body likelinje">
	<td id="i148487"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i148488">Gramicidin</p></p></td>
	<td id="i148489"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i148490">2</p></p></td>
	<td id="i148491"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i148492">Lokal bruk: Kan brukes av ammende</p></p></td>
	</tr>
 <tr id="i148493" class="body oddelinje">
	<td id="i148494"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i148495">Granisetron</p></p></td>
	<td id="i148496"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i148497">3</p></p></td>
	<td id="i148498"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i148499">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i148500" class="body likelinje">
	<td id="i148501"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i148502">Gresspollerallergen</p></p></td>
	<td id="i148503"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i148504">2</p></p></td>
	<td id="i148505"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i148506">Ansees forenlig med amming</p></p></td>
	</tr>
 <tr id="i148507" class="body oddelinje">
	<td id="i148508"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i148509">Guaifenesin</p></p></td>
	<td id="i148510"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i148511">2</p></p></td>
	<td id="i148512"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i148513">Klinisk erfaring tyder på at midlet kan brukes av ammende</p></p></td>
	</tr>
 <tr id="i148514" class="body likelinje">
	<td id="i148515"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i148516">Guanetidin</p></p></td>
	<td id="i148517"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i148518">3</p></p></td>
	<td id="i148519"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i148520">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i148521" class="body oddelinje">
	<td id="i148522"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i148523"><em>Gullforbindelser</em></p></p></td>
	<td id="i148524"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i148525">5</p></p></td>
	<td id="i148526"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i148527">Begrensede data tilsier at overgang til morsmelk kan være høy. Kontraindisert hos ammende pga. risiko for akkumulering og toksisitet hos barnet</p></p></td>
	</tr>
 </tbody></table>
 <table id="i148529" width="100%" class="maintable" border="0" cellpadding="5" cellspacing="0">
 <caption> <Uth Id="NUTHid2331885" Type="Halvfet">H</Uth></caption> <thead>
	<tr class = "linjetopp">
	<th id="i148537"  colspan="3"  valign="top"  class="sluttKol">

<p class="entrya"><p id="i148538">Overgang til morsmelk angis som minimal (< 2 %), liten (2&#8211;5 %), moderat (5&#8211;10 %) eller høy (10&#8211;50 %) basert på fraksjon av morens dose/kg kroppsvekt som barnet tilføres. (Barnets relative dose.)&ML;						Over 3&#8211;4 ukers bruk ansees som langtidsbehandling.</p></p></th>
	</tr>
	<tr class = "linjetopp">
	<th id="i148541"    valign="top"  class="startKol">

<p class="entrya"><p id="i148542"><strong>Legemiddel</strong></p></p></th>
	<th id="i148543"    valign="top"  class="mellomKol">

<p class="entrya"><p id="i148544"><strong>MM kategori</strong></p></p></th>
	<th id="i148545"    valign="top"  class="sluttKol">

<p class="entrya"><p id="i148546"><strong>Dokumentasjon vedrørende bruk under amming</strong></p></p></th>
	</tr>
</thead>
<tbody>
<tr id="i148548" class="body likelinje">
	<td id="i148549"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i148550">Haloperidol</p></p></td>
	<td id="i148551"    valign="top" width="18.9%" class="mellomKol">

<p class="entrya"><p id="i148552">3</p></p></td>
	<td id="i148553"    valign="top" width="51.9%" class="sluttKol">

<p class="entrya"><p id="i148554">Overgang til morsmelk er liten. Se antipsykotika  <a id="arowX145918" class="ref" href="../G/G8.htm#i145918" title="Antipsykotika">Antipsykotika</a></p></p></td>
	</tr>
 <tr id="i148555" class="body oddelinje">
	<td id="i148556"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i148557"><em>H<Sub>1</Sub>-antagonister</em></p></p></td>
	<td id="i148558"    valign="top" width="18.9%" class="mellomKol">

<p class="entrya"><p id="i148559">1, 2, 3</p></p></td>
	<td id="i148560"    valign="top" width="51.9%" class="sluttKol">

<p class="entrya"><p id="i148561">Se antihistaminer  <a id="arowX145840" class="ref" href="../G/G8.htm#i145840" title="Antihistaminer (H1-antagonister)">Antihistaminer (H1-antagonister)</a></p></p></td>
	</tr>
 <tr id="i148562" class="body likelinje">
	<td id="i148563"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i148564"><em>H<Sub>2</Sub>-antagonister</em></p></p></td>
	<td id="i148565"    valign="top" width="18.9%" class="mellomKol">

<p class="entrya"><p id="i148566">2</p></p></td>
	<td id="i148567"    valign="top" width="51.9%" class="sluttKol">

<p class="entrya"><p id="i148568">Famotidin foretrekkes til ammende pga. lengst klinisk erfaring. Risiko for farmakologiske effekter på barnet er liten ved sporadisk bruk av terapeutiske doser. Se også de enkelte virkestoffene</p></p></td>
	</tr>
 <tr id="i148569" class="body oddelinje">
	<td id="i148570"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i148571">Hemearginat</p></p></td>
	<td id="i148572"    valign="top" width="18.9%" class="mellomKol">

<p class="entrya"><p id="i148573">3</p></p></td>
	<td id="i148574"    valign="top" width="51.9%" class="sluttKol">

<p class="entrya"><p id="i148575">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i148576" class="body likelinje">
	<td id="i148577"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i148578"><em>Hepariner</em></p></p></td>
	<td id="i148579"    valign="top" width="18.9%" class="mellomKol">

<p class="entrya"><p id="i148580">0</p></p></td>
	<td id="i148581"    valign="top" width="51.9%" class="sluttKol">

<p class="entrya"><p id="i148582">Høy molekylvekt hindrer overgang av både heparin og lavmolekylære hepariner til morsmelk. Kan brukes av ammende</p></p></td>
	</tr>
 <tr id="i148583" class="body oddelinje">
	<td id="i148584"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i148585">Hetastivelse</p></p></td>
	<td id="i148586"    valign="top" width="18.9%" class="mellomKol">

<p class="entrya"><p id="i148587">0</p></p></td>
	<td id="i148588"    valign="top" width="51.9%" class="sluttKol">

<p class="entrya"><p id="i148589">Kan brukes av ammende</p></p></td>
	</tr>
 <tr id="i148590" class="body likelinje">
	<td id="i148591"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i148592">Hexametylmelamin (= altretamin)</p></p></td>
	<td id="i148593"    valign="top" width="18.9%" class="mellomKol">

<p class="entrya"><p id="i148594">5</p></p></td>
	<td id="i148595"    valign="top" width="51.9%" class="sluttKol">

<p class="entrya"><p id="i148596">Se cytostatika  <a id="arowX146868" class="ref" href="../G/G8.htm#i146868" title="Cytostatika">Cytostatika</a></p></p></td>
	</tr>
 <tr id="i148597" class="body oddelinje">
	<td id="i148598"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i148599">Hexaminolevulinat</p></p></td>
	<td id="i148600"    valign="top" width="18.9%" class="mellomKol">

<p class="entrya"><p id="i148601">0</p></p></td>
	<td id="i148602"    valign="top" width="51.9%" class="sluttKol">

<p class="entrya"><p id="i148603">Manglende klinisk erfaring</p></p></td>
	</tr>
 <tr id="i148604" class="body likelinje">
	<td id="i148605"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i218848">Histamin</p></p></td>
	<td id="i148606"    valign="top" width="18.9%" class="mellomKol">

<p class="entrya"><p id="i148607">3</p></p></td>
	<td id="i148608"    valign="top" width="51.9%" class="sluttKol">

<p class="entrya"><p id="i148609">I kombinasjon med interleukin-2 i kreftterapi: Amming frarådes</p></p></td>
	</tr>
 <tr id="i221859" class="body oddelinje">
	<td id="i221860"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i221861">Histrelin </p></p></td>
	<td id="i221862"    valign="top" width="18.9%" class="mellomKol">

<p class="entrya"><p id="i221863">0 </p></p></td>
	<td id="i221864"    valign="top" width="51.9%" class="sluttKol">

<p class="entrya"><p id="i221865">Se gonadotropiner  <a id="arowX148472" class="ref" href="../G/G8.htm#i148472" title="Gonadotropiner">Gonadotropiner</a></p></p></td>
	</tr>
 <tr id="i148610" class="body likelinje">
	<td id="i148611"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i148612">HMG-CoA-reduktase</p></p></td>
	<td id="i148613"    valign="top" width="18.9%" class="mellomKol">

<p class="entrya"><p id="i148614">3</p></p></td>
	<td id="i148615"    valign="top" width="51.9%" class="sluttKol">

<p class="entrya"><p id="i148616">Se statiner  <a id="arowX151973" class="ref" href="../G/G8.htm#i151973" title="Statiner">Statiner</a></p></p></td>
	</tr>
 <tr id="i148617" class="body oddelinje">
	<td id="i148618"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i148619">Homatropin</p></p></td>
	<td id="i148620"    valign="top" width="18.9%" class="mellomKol">

<p class="entrya"><p id="i148621">2</p></p></td>
	<td id="i148622"    valign="top" width="51.9%" class="sluttKol">

<p class="entrya"><p id="i148623">Øyedråper: Kan brukes av ammende</p></p></td>
	</tr>
 <tr id="i148624" class="body likelinje">
	<td id="i148625"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i148626"><em>5-HT<Sub>1</Sub>-agonister</em></p></p></td>
	<td id="i148627"    valign="top" width="18.9%" class="mellomKol">

<p class="entrya"><p id="i148628">2, 3</p></p></td>
	<td id="i148629"    valign="top" width="51.9%" class="sluttKol">

<p class="entrya"><p id="i148630">Se triptaner  <a id="arowX152605" class="ref" href="../G/G8.htm#i152605" title="Triptaner">Triptaner</a></p></p></td>
	</tr>
 <tr id="i148631" class="body oddelinje">
	<td id="i148632"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i148633"><em>5-HT<Sub>3</Sub>-antagonister</em></p></p></td>
	<td id="i148634"    valign="top" width="18.9%" class="mellomKol">

<p class="entrya"><p id="i148635">3</p></p></td>
	<td id="i148636"    valign="top" width="51.9%" class="sluttKol">

<p class="entrya"><p id="i148637">Se de enkelte virkestoffene</p></p></td>
	</tr>
 <tr id="i148638" class="body likelinje">
	<td id="i148639"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i148640">Humant protein C</p></p></td>
	<td id="i148641"    valign="top" width="18.9%" class="mellomKol">

<p class="entrya"><p id="i148642">0</p></p></td>
	<td id="i148643"    valign="top" width="51.9%" class="sluttKol">

<p class="entrya"><p id="i148644">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i148645" class="body oddelinje">
	<td id="i148646"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i148647">Hydralazin</p></p></td>
	<td id="i148648"    valign="top" width="18.9%" class="mellomKol">

<p class="entrya"><p id="i148649">2</p></p></td>
	<td id="i148650"    valign="top" width="51.9%" class="sluttKol">

<p class="entrya"><p id="i148651">Overgang til morsmelk er minimal. Kan brukes av ammende. Se antihypertensiva  <a id="arowX145848" class="ref" href="../G/G8.htm#i145848" title="Antihypertensiva">Antihypertensiva</a></p></p></td>
	</tr>
 <tr id="i148652" class="body likelinje">
	<td id="i148653"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i148654">Hydrogenperoksid</p></p></td>
	<td id="i148655"    valign="top" width="18.9%" class="mellomKol">

<p class="entrya"><p id="i148656">2</p></p></td>
	<td id="i148657"    valign="top" width="51.9%" class="sluttKol">

<p class="entrya"><p id="i148658">Lokalbehandling: Kan brukes av ammende</p></p></td>
	</tr>
 <tr id="i148659" class="body oddelinje">
	<td id="i148660"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i148661">Hydroklortiazid</p></p></td>
	<td id="i148662"    valign="top" width="18.9%" class="mellomKol">

<p class="entrya"><p id="i148663">2</p></p></td>
	<td id="i148664"    valign="top" width="51.9%" class="sluttKol">

<p class="entrya"><p id="i148665">Overgang til morsmelk er liten. Se diuretika  <a id="arowX147247" class="ref" href="../G/G8.htm#i147247" title="Diuretika">Diuretika</a></p></p></td>
	</tr>
 <tr id="i148666" class="body likelinje">
	<td id="i148667"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i148668">Hydrokodon</p></p></td>
	<td id="i148669"    valign="top" width="18.9%" class="mellomKol">

<p class="entrya"><p id="i148670">3</p></p></td>
	<td id="i148671"    valign="top" width="51.9%" class="sluttKol">

<p class="entrya"><p id="i148672">Opplysninger om overgang til morsmelk mangler. Risiko for farmakologiske effekter på barnet ansees som liten ved sporadisk bruk i terapeutiske doser. Se opioidanalgetika  <a id="arowX150865" class="ref" href="../G/G8.htm#i150865" title="Opioidanalgetika">Opioidanalgetika</a></p></p></td>
	</tr>
 <tr id="i148673" class="body oddelinje">
	<td id="i148674"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i148675">Hydrokortison</p></p></td>
	<td id="i148676"    valign="top" width="18.9%" class="mellomKol">

<p class="entrya"><p id="i148677">2</p></p></td>
	<td id="i148678"    valign="top" width="51.9%" class="sluttKol">

<p class="entrya"><p id="i148679">Lokalbehandling: Kan brukes av ammende. Se glukokortikoider  <a id="arowX148403" class="ref" href="../G/G8.htm#i148403" title="Glukokortikoider">Glukokortikoider</a></p></p></td>
	</tr>
 <tr id="i271678" class="body likelinje">
	<td id="i271679"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i271680">Hydroksyklorokin</p></p></td>
	<td id="i271681"    valign="top" width="18.9%" class="mellomKol">

<p class="entrya"><p id="i271682"> </p></p>
<p class="entrya"><p id="i271686">2</p></p>
<p class="entrya"><p id="i271694"> </p></p>
<p class="entrya"><p id="i271696"> </p></p>
<p class="entrya"><p id="i271697"> </p></p>
<p class="entrya"><p id="i271692">3</p></p></td>
	<td id="i271683"    valign="top" width="51.9%" class="sluttKol">

<p class="entrya"><p id="i271684">Overgang til morsmelk er liten</p></p>	<UL type="circle">
		<LI id="i271689"><p id="i271691"><em>Ved malariaprofylakse:</em> Risiko for farmakologiske effekter på barnet ansees som liten ved terapeutiske doser gitt én gang ukentlig. Amming mens mor bruker hydroksyklorokin, gir ikke barnet adekvat malariaprofylakse. Se også antimalariamidler  <a id="arowX145897" class="ref" href="../G/G8.htm#i145897" title="Antimalariamidler">Antimalariamidler</a></p><br><p id="i271690"><em>Ved revmatiske lidelser:</em> Forsiktighet må utvises ved daglig bruk av hydroksyklorokin pga. risiko for akkumulering og toksiske effekter i barnet</p><br>		</LI>
	</UL>
</td>
	</tr>
 <tr id="i148705" class="body oddelinje">
	<td id="i148706"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i148707">Hydroksyurea</p></p></td>
	<td id="i148708"    valign="top" width="18.9%" class="mellomKol">

<p class="entrya"><p id="i148709">5</p></p></td>
	<td id="i148710"    valign="top" width="51.9%" class="sluttKol">

<p class="entrya"><p id="i148711">Se cytostatika  <a id="arowX146868" class="ref" href="../G/G8.htm#i146868" title="Cytostatika">Cytostatika</a></p></p></td>
	</tr>
 <tr id="i148712" class="body likelinje">
	<td id="i148713"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i148714">Hydroksyzin</p></p></td>
	<td id="i148715"    valign="top" width="18.9%" class="mellomKol">

<p class="entrya"><p id="i148716">2</p></p></td>
	<td id="i148717"    valign="top" width="51.9%" class="sluttKol">

<p class="entrya"><p id="i148718">Opplysninger om overgang til morsmelk mangler. Se antihistaminer  <a id="arowX145840" class="ref" href="../G/G8.htm#i145840" title="Antihistaminer (H1-antagonister)">Antihistaminer (H1-antagonister)</a></p></p></td>
	</tr>
 <tr id="i148719" class="body oddelinje">
	<td id="i148720"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i148721">Hydromorfon</p></p></td>
	<td id="i148722"    valign="top" width="18.9%" class="mellomKol">

<p class="entrya"><p id="i148723">3</p></p></td>
	<td id="i148724"    valign="top" width="51.9%" class="sluttKol">

<p class="entrya"><p id="i148725">Overgang til morsmelk er minimal. Se opioidanalgetika  <a id="arowX150865" class="ref" href="../G/G8.htm#i150865" title="Opioidanalgetika">Opioidanalgetika</a></p></p></td>
	</tr>
 <tr id="i148726" class="body likelinje">
	<td id="i148727"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i148728">Hyoscyamin</p></p></td>
	<td id="i148729"    valign="top" width="18.9%" class="mellomKol">

<p class="entrya"><p id="i148730">2</p></p></td>
	<td id="i148731"    valign="top" width="51.9%" class="sluttKol">

<p class="entrya"><p id="i148732">Se atropin  <a id="arowX146095" class="ref" href="../G/G8.htm#i146095" title="Atropin">Atropin</a></p></p></td>
	</tr>
 </tbody></table>
 <table id="i148734" width="100%" class="maintable" border="0" cellpadding="5" cellspacing="0">
 <caption> <Uth Id="NUTHid2330504" Type="Halvfet">I</Uth></caption> <thead>
	<tr class = "linjetopp">
	<th id="i148742"  colspan="3"  valign="top"  class="sluttKol">

<p class="entrya"><p id="i148743">Overgang til morsmelk angis som minimal (< 2 %), liten (2&#8211;5 %), moderat (5&#8211;10 %) eller høy (10&#8211;50 %) basert på fraksjon av morens dose/kg kroppsvekt som barnet tilføres. (Barnets relative dose.)&ML;						Over 3&#8211;4 ukers bruk ansees som langtidsbehandling.</p></p></th>
	</tr>
	<tr class = "linjetopp">
	<th id="i148746"    valign="top"  class="startKol">

<p class="entrya"><p id="i148747"><strong>Legemiddel</strong></p></p></th>
	<th id="i148748"    valign="top"  class="mellomKol">

<p class="entrya"><p id="i148749"><strong>MM kategori</strong></p></p></th>
	<th id="i148750"    valign="top"  class="sluttKol">

<p class="entrya"><p id="i148751"><strong>Dokumentasjon vedrørende bruk under amming</strong></p></p></th>
	</tr>
</thead>
<tbody>
<tr id="i148753" class="body likelinje">
	<td id="i148754"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i148755">Ibandronat</p></p></td>
	<td id="i148756"    valign="top" width="18.8%" class="mellomKol">

<p class="entrya"><p id="i148757">0</p></p></td>
	<td id="i148758"    valign="top" width="52%" class="sluttKol">

<p class="entrya"><p id="i148759">Se bisfosfonater  <a id="arowX146417" class="ref" href="../G/G8.htm#i146417" title="Bisfosfonater">Bisfosfonater</a></p></p></td>
	</tr>
 <tr id="i148760" class="body oddelinje">
	<td id="i148761"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i148762">Ibuprofen</p></p></td>
	<td id="i148763"    valign="top" width="18.8%" class="mellomKol">

<p class="entrya"><p id="i148764">1</p></p></td>
	<td id="i148765"    valign="top" width="52%" class="sluttKol">

<p class="entrya"><p id="i148766">Overgang til morsmelk er minimal. Se NSAID  <a id="arowX150698" class="ref" href="../G/G8.htm#i150698" title="NSAID">NSAID</a></p></p></td>
	</tr>
 <tr id="i148767" class="body likelinje">
	<td id="i148768"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i148769">Ibutilid</p></p></td>
	<td id="i148770"    valign="top" width="18.8%" class="mellomKol">

<p class="entrya"><p id="i148771">3</p></p></td>
	<td id="i148772"    valign="top" width="52%" class="sluttKol">

<p class="entrya"><p id="i148773">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i148774" class="body oddelinje">
	<td id="i148775"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i218849">Icatibant</p></p></td>
	<td id="i148776"    valign="top" width="18.8%" class="mellomKol">

<p class="entrya"><p id="i148777">3</p></p></td>
	<td id="i148778"    valign="top" width="52%" class="sluttKol">

<p class="entrya"><p id="i148779">Opplysninger om overgang til morsmelk mangler. Lav biotilgjengelighet tilsier liten systemisk absorpsjon via barnets mage-tarm-kanal</p></p></td>
	</tr>
 <tr id="i148780" class="body likelinje">
	<td id="i148781"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i148782">Idarubicin</p></p></td>
	<td id="i148783"    valign="top" width="18.8%" class="mellomKol">

<p class="entrya"><p id="i148784">5</p></p></td>
	<td id="i148785"    valign="top" width="52%" class="sluttKol">

<p class="entrya"><p id="i148786">Se cytostatika  <a id="arowX146868" class="ref" href="../G/G8.htm#i146868" title="Cytostatika">Cytostatika</a></p></p></td>
	</tr>
 <tr id="i148787" class="body oddelinje">
	<td id="i148788"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i148789">Ifosfamid</p></p></td>
	<td id="i148790"    valign="top" width="18.8%" class="mellomKol">

<p class="entrya"><p id="i148791">5</p></p></td>
	<td id="i148792"    valign="top" width="52%" class="sluttKol">

<p class="entrya"><p id="i148793">Se cytostatika  <a id="arowX146868" class="ref" href="../G/G8.htm#i146868" title="Cytostatika">Cytostatika</a></p></p></td>
	</tr>
 <tr id="i148794" class="body likelinje">
	<td id="i148795"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i148796"><em>Ikke-steroide antiinflammatoriske midler</em></p></p></td>
	<td id="i148797"    valign="top" width="18.8%" class="mellomKol">

<p class="entrya"><p id="i148798">1, 2, 3</p></p></td>
	<td id="i148799"    valign="top" width="52%" class="sluttKol">

<p class="entrya"><p id="i148800">Se NSAID  <a id="arowX150698" class="ref" href="../G/G8.htm#i150698" title="NSAID">NSAID</a></p></p></td>
	</tr>
 <tr id="i148801" class="body oddelinje">
	<td id="i148802"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i148803">Iloprost</p></p></td>
	<td id="i148804"    valign="top" width="18.8%" class="mellomKol">

<p class="entrya"><p id="i148805">3</p></p></td>
	<td id="i148806"    valign="top" width="52%" class="sluttKol">

<p class="entrya"><p id="i148807">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i148808" class="body likelinje">
	<td id="i148809"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i148810">Imatinib</p></p></td>
	<td id="i148811"    valign="top" width="18.8%" class="mellomKol">

<p class="entrya"><p id="i148812">3</p></p></td>
	<td id="i148813"    valign="top" width="52%" class="sluttKol">

<p class="entrya"><p id="i148814">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i148815" class="body oddelinje">
	<td id="i148816"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i148817">Imipenem</p></p></td>
	<td id="i148818"    valign="top" width="18.8%" class="mellomKol">

<p class="entrya"><p id="i148819">2</p></p></td>
	<td id="i148820"    valign="top" width="52%" class="sluttKol">

<p class="entrya"><p id="i148821">Opplysninger om overgang til morsmelk mangler, men er trolig minimal. Se antibakterielle midler  <a id="arowX145756" class="ref" href="../G/G8.htm#i145756" title="Anestesimidler">Anestesimidler</a></p></p></td>
	</tr>
 <tr id="i148822" class="body likelinje">
	<td id="i148823"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i148824">Imiquimod</p></p></td>
	<td id="i148825"    valign="top" width="18.8%" class="mellomKol">

<p class="entrya"><p id="i148826">0</p></p></td>
	<td id="i148827"    valign="top" width="52%" class="sluttKol">

<p class="entrya"><p id="i148828">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i148829" class="body oddelinje">
	<td id="i148830"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i148831"><em>Immunglobuliner</em></p></p></td>
	<td id="i148832"    valign="top" width="18.8%" class="mellomKol">

<p class="entrya"><p id="i148833">2</p></p>
<p class="entrya"><p id="i271711"> </p></p>
<p class="entrya"><p id="i271709">2</p></p></td>
	<td id="i148834"    valign="top" width="52%" class="sluttKol">
	<UL type="circle">
		<LI id="i148836"><p id="i148837"><em>Intravenøst:</em> Kan overføres til morsmelken og øke nivåer av immunoglobuliner (som kan virke beskyttende på barnet)</p><br>		</LI>
		<LI id="i271706"><p id="i271707">Intramuskulært./subkutant: Passerer over i morsmelk, men i mengder som trolig ikke påvirker barnet</p><br>		</LI>
	</UL>
</td>
	</tr>
 <tr id="i148847" class="body likelinje">
	<td id="i148848"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i148849"><em>Immunsuppressive midler</em></p></p></td>
	<td id="i148850"    valign="top" width="18.8%" class="mellomKol">

<p class="entrya"><p id="i148851">0, 3, 4</p></p></td>
	<td id="i148852"    valign="top" width="52%" class="sluttKol">

<p class="entrya"><p id="i148853">Immunsuppressive egenskaper tilsier at disse midlene ikke skal brukes under amming</p></p></td>
	</tr>
 <tr id="i148854" class="body oddelinje">
	<td id="i148855"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i148856">Indakaterol</p></p></td>
	<td id="i148857"    valign="top" width="18.8%" class="mellomKol">

<p class="entrya"><p id="i148858">3</p></p></td>
	<td id="i148859"    valign="top" width="52%" class="sluttKol">

<p class="entrya"><p id="i148860">Opplysninger mangler. Se beta-2-reseptoragonister, adrenerge  <a id="arowX146354" class="ref" href="../G/G8.htm#i146354" title="Beta-2-reseptoragonister, adrenerge">Beta-2-reseptoragonister, adrenerge</a></p></p></td>
	</tr>
 <tr id="i148861" class="body likelinje">
	<td id="i148862"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i148863">Indinavir</p></p></td>
	<td id="i148864"    valign="top" width="18.8%" class="mellomKol">

<p class="entrya"><p id="i148865">5</p></p></td>
	<td id="i148866"    valign="top" width="52%" class="sluttKol">

<p class="entrya"><p id="i148867">Se antivirale midler  <a id="arowX145939" class="ref" href="../G/G8.htm#i145939" title="Antivirale midler">Antivirale midler</a></p></p></td>
	</tr>
 <tr id="i148868" class="body oddelinje">
	<td id="i148869"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i148870">Indometacin</p></p></td>
	<td id="i148871"    valign="top" width="18.8%" class="mellomKol">

<p class="entrya"><p id="i148872">2</p></p></td>
	<td id="i148873"    valign="top" width="52%" class="sluttKol">

<p class="entrya"><p id="i148874">Overgang til morsmelk er minimal. Se NSAID  <a id="arowX150698" class="ref" href="../G/G8.htm#i150698" title="NSAID">NSAID</a></p></p></td>
	</tr>
 <tr id="i148875" class="body likelinje">
	<td id="i148876"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i148877">Infliksimab</p></p></td>
	<td id="i148878"    valign="top" width="18.8%" class="mellomKol">

<p class="entrya"><p id="i148879">0</p></p></td>
	<td id="i148880"    valign="top" width="52%" class="sluttKol">

<p class="entrya"><p id="i148881">Opplysninger mangler. Se monoklonale antistoffer  <a id="arowX150370" class="ref" href="../G/G8.htm#i150370" title="Monoklonale antistoffer">Monoklonale antistoffer</a></p></p></td>
	</tr>
 <tr id="i148882" class="body oddelinje">
	<td id="i148883"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i148884">Insulin</p></p></td>
	<td id="i148885"    valign="top" width="18.8%" class="mellomKol">

<p class="entrya"><p id="i148886">0</p></p></td>
	<td id="i148887"    valign="top" width="52%" class="sluttKol">

<p class="entrya"><p id="i148888">Kan brukes av ammende</p></p></td>
	</tr>
 <tr id="i148889" class="body likelinje">
	<td id="i148890"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i148891"><em>Interferoner</em> (alfa, beta, gamma)</p></p></td>
	<td id="i148892"    valign="top" width="18.8%" class="mellomKol">

<p class="entrya"><p id="i148893">0</p></p></td>
	<td id="i148894"    valign="top" width="52%" class="sluttKol">

<p class="entrya"><p id="i148895">Manglende erfaring tilsier forsiktighet med bruk hos ammende</p></p></td>
	</tr>
 <tr id="i148896" class="body oddelinje">
	<td id="i148897"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i148898">Iobitridol</p></p></td>
	<td id="i148899"    valign="top" width="18.8%" class="mellomKol">

<p class="entrya"><p id="i148900">3</p></p></td>
	<td id="i148901"    valign="top" width="52%" class="sluttKol">

<p class="entrya"><p id="i148902">Opplysninger mangler. Se røntgenkontrastmidler  <a id="arowX151757" class="ref" href="../G/G8.htm#i151757" title="Røntgenkontrastmidler">Røntgenkontrastmidler</a></p></p></td>
	</tr>
 <tr id="i148903" class="body likelinje">
	<td id="i148904"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i148905">Iodixanol</p></p></td>
	<td id="i148906"    valign="top" width="18.8%" class="mellomKol">

<p class="entrya"><p id="i148907">3</p></p></td>
	<td id="i148908"    valign="top" width="52%" class="sluttKol">

<p class="entrya"><p id="i148909">Opplysninger mangler. Se røntgenkontrastmidler  <a id="arowX151757" class="ref" href="../G/G8.htm#i151757" title="Røntgenkontrastmidler">Røntgenkontrastmidler</a></p></p></td>
	</tr>
 <tr id="i148910" class="body oddelinje">
	<td id="i148911"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i148912">Iomeprol</p></p></td>
	<td id="i148913"    valign="top" width="18.8%" class="mellomKol">

<p class="entrya"><p id="i148914">3</p></p></td>
	<td id="i148915"    valign="top" width="52%" class="sluttKol">

<p class="entrya"><p id="i148916">Opplysninger mangler. Se røntgenkontrastmidler  <a id="arowX151757" class="ref" href="../G/G8.htm#i151757" title="Røntgenkontrastmidler">Røntgenkontrastmidler</a></p></p></td>
	</tr>
 <tr id="i320098" class="body likelinje">
	<td id="i320099"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i320100">Ipilimumab</p></p></td>
	<td id="i320101"    valign="top" width="18.8%" class="mellomKol">

<p class="entrya"><p id="i320102">3</p></p></td>
	<td id="i320103"    valign="top" width="52%" class="sluttKol">

<p class="entrya"><p id="i320104">Opplysninger om overgang til morsmelk mangler.&ML;						Immunglobuliner (IgG) utskilles i morsmelk. Tilbakeholdenhet anbefales pga. en mulig effekt p&#x00E5; immunsystemet</p></p></td>
	</tr>
 <tr id="i148917" class="body oddelinje">
	<td id="i148918"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i148919">Ipratropium</p></p></td>
	<td id="i148920"    valign="top" width="18.8%" class="mellomKol">

<p class="entrya"><p id="i148921">3</p></p></td>
	<td id="i148922"    valign="top" width="52%" class="sluttKol">

<p class="entrya"><p id="i148923">Til inhalasjon: Farmakokinetiske egenskaper tilsier at ipratropium kan brukes av ammende</p></p></td>
	</tr>
 <tr id="i148924" class="body likelinje">
	<td id="i148925"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i148926">Irbesartan</p></p></td>
	<td id="i148927"    valign="top" width="18.8%" class="mellomKol">

<p class="entrya"><p id="i148928">3</p></p></td>
	<td id="i148929"    valign="top" width="52%" class="sluttKol">

<p class="entrya"><p id="i148930">Se angiotensin II-reseptorantagonister  <a id="arowX145763" class="ref" href="../G/G8.htm#i145763" title="Angiotensin II-reseptorantagonister">Angiotensin II-reseptorantagonister</a></p></p></td>
	</tr>
 <tr id="i148931" class="body oddelinje">
	<td id="i148932"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i148933">Irinotekan</p></p></td>
	<td id="i148934"    valign="top" width="18.8%" class="mellomKol">

<p class="entrya"><p id="i148935">5</p></p></td>
	<td id="i148936"    valign="top" width="52%" class="sluttKol">

<p class="entrya"><p id="i148937">Se cytostatika  <a id="arowX146868" class="ref" href="../G/G8.htm#i146868" title="Cytostatika">Cytostatika</a></p></p></td>
	</tr>
 <tr id="i148938" class="body likelinje">
	<td id="i148939"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i148940">Isofluran</p></p></td>
	<td id="i148941"    valign="top" width="18.8%" class="mellomKol">

<p class="entrya"><p id="i148942">2</p></p></td>
	<td id="i148943"    valign="top" width="52%" class="sluttKol">

<p class="entrya"><p id="i148944">Opplysninger mangler. Se anestesimidler  <a id="arowX145756" class="ref" href="../G/G8.htm#i145756" title="Anestesimidler">Anestesimidler</a></p></p></td>
	</tr>
 <tr id="i148945" class="body oddelinje">
	<td id="i148946"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i148947">Isoniazid</p></p></td>
	<td id="i148948"    valign="top" width="18.8%" class="mellomKol">

<p class="entrya"><p id="i148949">3</p></p></td>
	<td id="i148950"    valign="top" width="52%" class="sluttKol">

<p class="entrya"><p id="i148951">Overgang til morsmelk er moderat&#8211;høy. Observer barnet for slapphet, anoreksi og oppkast ved brysternæring. Pyridoksintilskudd til barnet kan vurderes</p></p></td>
	</tr>
 <tr id="i148952" class="body likelinje">
	<td id="i148953"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i148954">Isoprenalin</p></p></td>
	<td id="i148955"    valign="top" width="18.8%" class="mellomKol">

<p class="entrya"><p id="i148956">3</p></p></td>
	<td id="i148957"    valign="top" width="52%" class="sluttKol">

<p class="entrya"><p id="i148958">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i148959" class="body oddelinje">
	<td id="i148960"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i148961">Isosorbiddinitrat</p></p></td>
	<td id="i148962"    valign="top" width="18.8%" class="mellomKol">

<p class="entrya"><p id="i148963">3</p></p></td>
	<td id="i148964"    valign="top" width="52%" class="sluttKol">

<p class="entrya"><p id="i148965">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i148966" class="body likelinje">
	<td id="i148967"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i148968">Isosorbidmononitrat</p></p></td>
	<td id="i148969"    valign="top" width="18.8%" class="mellomKol">

<p class="entrya"><p id="i148970">3</p></p></td>
	<td id="i148971"    valign="top" width="52%" class="sluttKol">

<p class="entrya"><p id="i148972">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i148973" class="body oddelinje">
	<td id="i148974"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i148975">Isotretionin</p></p></td>
	<td id="i148976"    valign="top" width="18.8%" class="mellomKol">

<p class="entrya"><p id="i148977">4</p></p></td>
	<td id="i148978"    valign="top" width="52%" class="sluttKol">

<p class="entrya"><p id="i148979">Se retinoider  <a id="arowX151587" class="ref" href="../G/G8.htm#i151587" title="Retinoider">Retinoider</a></p></p></td>
	</tr>
 <tr id="i148980" class="body likelinje">
	<td id="i148981"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i148982">Isradipin</p></p></td>
	<td id="i148983"    valign="top" width="18.8%" class="mellomKol">

<p class="entrya"><p id="i148984">3</p></p></td>
	<td id="i148985"    valign="top" width="52%" class="sluttKol">

<p class="entrya"><p id="i148986">Opplysninger mangler. Se kalsiumantagonister  <a id="arowX149110" class="ref" href="../G/G8.htm#i149110" title="Kalsiumantagonister">Kalsiumantagonister</a></p></p></td>
	</tr>
 <tr id="i148987" class="body oddelinje">
	<td id="i148988"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i148989">Itrakonazol</p></p></td>
	<td id="i148990"    valign="top" width="18.8%" class="mellomKol">

<p class="entrya"><p id="i148991">0</p></p></td>
	<td id="i148992"    valign="top" width="52%" class="sluttKol">

<p class="entrya"><p id="i148993">Kan brukes av ammende</p></p></td>
	</tr>
 <tr id="i148994" class="body likelinje">
	<td id="i148995"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i218850">Ivermectin</p></p></td>
	<td id="i148996"    valign="top" width="18.8%" class="mellomKol">

<p class="entrya"><p id="i148997">3</p></p></td>
	<td id="i148998"    valign="top" width="52%" class="sluttKol">

<p class="entrya"><p id="i148999">Overgang til morsmelk er minimal. Begrenset erfaring tilsier at bruk er forenlig med amming</p></p></td>
	</tr>
 </tbody></table>
 <table id="i149001" width="100%" class="maintable" border="0" cellpadding="5" cellspacing="0">
 <caption> <Uth Id="NUTHid2338410" Type="Halvfet">J</Uth></caption> <thead>
	<tr class = "linjetopp">
	<th id="i149009"  colspan="3"  valign="top"  class="sluttKol">

<p class="entrya"><p id="i149010">Overgang til morsmelk angis som minimal (< 2 %), liten (2&#8211;5 %), moderat (5&#8211;10 %) eller høy (10&#8211;50 %) basert på fraksjon av morens dose/kg kroppsvekt som barnet tilføres. (Barnets relative dose.)&ML;						Over 3&#8211;4 ukers bruk ansees som langtidsbehandling.</p></p></th>
	</tr>
	<tr class = "linjetopp">
	<th id="i149013"    valign="top"  class="startKol">

<p class="entrya"><p id="i149014"><strong>Legemiddel</strong></p></p></th>
	<th id="i149015"    valign="top"  class="mellomKol">

<p class="entrya"><p id="i149016"><strong>MM kategori</strong></p></p></th>
	<th id="i149017"    valign="top"  class="sluttKol">

<p class="entrya"><p id="i149018"><strong>Dokumentasjon vedrørende bruk under amming</strong></p></p></th>
	</tr>
</thead>
<tbody>
<tr id="i149020" class="body likelinje">
	<td id="i149021"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149022"><em>Jern</em></p></p></td>
	<td id="i149023"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i149024">1</p></p></td>
	<td id="i149025"    valign="top" width="51.6%" class="sluttKol">

<p class="entrya"><p id="i149026">Jerninnholdet i morsmelk synes upåvirket av mors kosthold eller jerntilskudd. Det ansees som lite sannsynlig at jerntilskudd hos mor kan føre til toksisitet, rette opp jernmangel hos brysternærte barn eller påvirke sammensetningen av morsmelk. Kan brukes av ammende</p></p></td>
	</tr>
 <tr id="i149027" class="body oddelinje">
	<td id="i149028"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149029">Jern(III)hydroksid sukrosekompleks</p></p></td>
	<td id="i149030"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i149031">3</p></p></td>
	<td id="i149032"    valign="top" width="51.6%" class="sluttKol">

<p class="entrya"><p id="i149033">Se jern  <a id="arowX149020" class="ref" href="../G/G8.htm#i149020" title="Jern">Jern</a></p></p></td>
	</tr>
 <tr id="i149034" class="body likelinje">
	<td id="i149035"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149036">Jod/jodofor</p></p></td>
	<td id="i149037"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i149038">3</p></p></td>
	<td id="i149039"    valign="top" width="51.6%" class="sluttKol">

<p class="entrya"><p id="i149040">Lokalbehandling: Bør sannsynligvis brukes med forsiktighet rundt brystknoppene pga. høyt opptak av jod i melken</p></p></td>
	</tr>
 <tr id="i149041" class="body oddelinje">
	<td id="i149042"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149043">Joheksol</p></p></td>
	<td id="i149044"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i149045">2</p></p></td>
	<td id="i149046"    valign="top" width="51.6%" class="sluttKol">

<p class="entrya"><p id="i149047">Overgang til morsmelk er minimal. Se røntgenkontrastmidler  <a id="arowX151757" class="ref" href="../G/G8.htm#i151757" title="Røntgenkontrastmidler">Røntgenkontrastmidler</a></p></p></td>
	</tr>
 <tr id="i149048" class="body likelinje">
	<td id="i149049"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149050">Jopromid</p></p></td>
	<td id="i149051"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i149052">3</p></p></td>
	<td id="i149053"    valign="top" width="51.6%" class="sluttKol">

<p class="entrya"><p id="i149054">Opplysninger mangler. Se røntgenkontrastmidler  <a id="arowX151757" class="ref" href="../G/G8.htm#i151757" title="Røntgenkontrastmidler">Røntgenkontrastmidler</a></p></p></td>
	</tr>
 <tr id="i149055" class="body oddelinje">
	<td id="i149056"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149057">Joxaglinsyre</p></p></td>
	<td id="i149058"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i149059">3</p></p></td>
	<td id="i149060"    valign="top" width="51.6%" class="sluttKol">

<p class="entrya"><p id="i149061">Opplysninger mangler. Se røntgenkontrastmidler  <a id="arowX151757" class="ref" href="../G/G8.htm#i151757" title="Røntgenkontrastmidler">Røntgenkontrastmidler</a></p></p></td>
	</tr>
 </tbody></table>
 <table id="i149063" width="100%" class="maintable" border="0" cellpadding="5" cellspacing="0">
 <caption> <Uth Id="NUTHid2330232" Type="Halvfet">K</Uth></caption> <thead>
	<tr class = "linjetopp">
	<th id="i149071"  colspan="3"  valign="top"  class="sluttKol">

<p class="entrya"><p id="i149072">Overgang til morsmelk angis som minimal (< 2 %), liten (2&#8211;5 %), moderat (5&#8211;10 %) eller høy (10&#8211;50 %) basert på fraksjon av morens dose/kg kroppsvekt som barnet tilføres. (Barnets relative dose.)&ML;						Over 3&#8211;4 ukers bruk ansees som langtidsbehandling.</p></p></th>
	</tr>
	<tr class = "linjetopp">
	<th id="i149075"    valign="top"  class="startKol">

<p class="entrya"><p id="i149076"><strong>Legemiddel</strong></p></p></th>
	<th id="i149077"    valign="top"  class="mellomKol">

<p class="entrya"><p id="i149078"><strong>MM kategori</strong></p></p></th>
	<th id="i149079"    valign="top"  class="sluttKol">

<p class="entrya"><p id="i149080"><strong>Dokumentasjon vedrørende bruk under amming</strong></p></p></th>
	</tr>
</thead>
<tbody>
<tr id="i149082" class="body likelinje">
	<td id="i149083"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149084">Kabergolin</p></p></td>
	<td id="i149085"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149086">5</p></p></td>
	<td id="i149087"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149088">Hemmer prolaktinsekresjon og dermed melkeproduksjonen. Effekt oppnås etter 3 timer og varer i flere uker</p></p></td>
	</tr>
 <tr id="i149089" class="body oddelinje">
	<td id="i149090"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149091">Kalsipotriol</p></p></td>
	<td id="i149092"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149093">3</p></p></td>
	<td id="i149094"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149095">Opplysninger mangler. (Dette er til bruk på huden.)</p></p></td>
	</tr>
 <tr id="i149096" class="body likelinje">
	<td id="i149097"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149098">Kalsitonin</p></p></td>
	<td id="i149099"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149100">0</p></p></td>
	<td id="i149101"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149102">Har virket laktasjonshemmende i dyrestudier</p></p></td>
	</tr>
 <tr id="i149103" class="body oddelinje">
	<td id="i149104"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149105">Kalsitriol</p></p></td>
	<td id="i149106"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149107">3</p></p></td>
	<td id="i149108"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149109">Se vitamin D  <a id="arowX152882" class="ref" href="../G/G8.htm#i152882" title="Vitamin D og vitamin D-analoger">Vitamin D og vitamin D-analoger</a></p></p></td>
	</tr>
 <tr id="i149110" class="body likelinje">
	<td id="i149111"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149112"><em>Kalsiumantagonister</em></p></p></td>
	<td id="i149113"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149114">2, 3</p></p></td>
	<td id="i149115"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149116">Begrenset klinisk erfaring tilsier forsiktighet ved bruk til ammende kvinner</p></p>	<UL type="circle">
		<LI id="i149118"><p id="i149119">For kalsiumantagonister med primær vaskulær virkning: Mest data foreligger for nifedipin. Observer barnet for hypotensjon ved langtidsbruk. Se også de enkelte virkestoffene</p><br>		</LI>
		<LI id="i149120"><p id="i149121">For kalsiumantagonister med direkte effekt på hjertet: Observer barnet for bradykardi og hypotensjon ved langtidsbruk. Se også de enkelte virkestoffene</p><br>		</LI>
	</UL>
</td>
	</tr>
 <tr id="i149122" class="body oddelinje">
	<td id="i149123"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149124">Kandesartan</p></p></td>
	<td id="i149125"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149126">3</p></p></td>
	<td id="i149127"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149128">Se angiotensin II-reseptorantagonister  <a id="arowX145763" class="ref" href="../G/G8.htm#i145763" title="Angiotensin II-reseptorantagonister">Angiotensin II-reseptorantagonister</a></p></p></td>
	</tr>
 <tr id="i149129" class="body likelinje">
	<td id="i149130"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149131">Kanrenoat</p></p></td>
	<td id="i149132"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149133">3</p></p></td>
	<td id="i149134"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149135">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i149136" class="body oddelinje">
	<td id="i149137"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149138">Kapecitabin</p></p></td>
	<td id="i149139"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149140">5</p></p></td>
	<td id="i149141"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149142">Se cytostatika  <a id="arowX146868" class="ref" href="../G/G8.htm#i146868" title="Cytostatika">Cytostatika</a></p></p></td>
	</tr>
 <tr id="i149143" class="body likelinje">
	<td id="i149144"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149145">Kapsaicin</p></p></td>
	<td id="i149146"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149147">3</p></p></td>
	<td id="i149148"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149149">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i149150" class="body oddelinje">
	<td id="i149151"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149152">Kaptopril</p></p></td>
	<td id="i149153"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149154">2</p></p></td>
	<td id="i149155"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149156">Overgang til morsmelk er minimal. Kan brukes av ammende</p></p></td>
	</tr>
 <tr id="i149157" class="body likelinje">
	<td id="i149158"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149159">Karbakolin</p></p></td>
	<td id="i149160"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149161">3</p></p></td>
	<td id="i149162"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149163">Opplysninger mangler. Øyedråper: Kan brukes av ammende</p></p></td>
	</tr>
 <tr id="i149164" class="body oddelinje">
	<td id="i149165"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149166">Karbamazepin</p></p></td>
	<td id="i149167"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149168">2</p></p></td>
	<td id="i149169"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149170">Kan brukes av ammende. Se antiepileptika  <a id="arowX145833" class="ref" href="../G/G8.htm#i145833" title="Antiepileptika">Antiepileptika</a></p></p></td>
	</tr>
 <tr id="i149171" class="body likelinje">
	<td id="i149172"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149173">Karbetocin</p></p></td>
	<td id="i149174"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149175">3</p></p></td>
	<td id="i149176"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149177">Opplysninger mangler. Kan teoretisk stimulere melkeutdrivelsen</p></p></td>
	</tr>
 <tr id="i149178" class="body oddelinje">
	<td id="i149179"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149180">Karbidopa</p></p></td>
	<td id="i149181"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149182">3</p></p></td>
	<td id="i149183"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149184">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i149185" class="body likelinje">
	<td id="i149186"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149187">Karbimazol</p></p></td>
	<td id="i149188"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149189">3</p></p></td>
	<td id="i149190"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149191">Overgang til morsmelk er liten. Monitorer barnets thyreoideastatus (T<Sub>3</Sub> og T<Sub>4</Sub>). Propyltiouracil foretrekkes pga. lengre klinisk erfaring</p></p></td>
	</tr>
 <tr id="i149192" class="body oddelinje">
	<td id="i149193"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149194">Karboplatin</p></p></td>
	<td id="i149195"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149196">5</p></p></td>
	<td id="i149197"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149198">Se cytostatika  <a id="arowX146868" class="ref" href="../G/G8.htm#i146868" title="Cytostatika">Cytostatika</a></p></p></td>
	</tr>
 <tr id="i149199" class="body likelinje">
	<td id="i149200"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149201">Karisoprodol</p></p></td>
	<td id="i149202"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149203">4</p></p></td>
	<td id="i149204"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149205">Begrensede data kan tyde på at overgang til morsmelk er høy. Observer barnet for sedasjon</p></p></td>
	</tr>
 <tr id="i149206" class="body oddelinje">
	<td id="i149207"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149208">Karvedilol</p></p></td>
	<td id="i149209"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149210">3</p></p></td>
	<td id="i149211"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149212">Opplysninger om overgang til morsmelk mangler. Se betareseptorantagonister, adrenerge  <a id="arowX146361" class="ref" href="../G/G8.htm#i146361" title="Betareseptorantagonister, adrenerge">Betareseptorantagonister, adrenerge</a></p></p></td>
	</tr>
 <tr id="i149213" class="body likelinje">
	<td id="i149214"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149215">Ketamin</p></p></td>
	<td id="i149216"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149217">2</p></p></td>
	<td id="i149218"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149219">Se anestesimidler  <a id="arowX145756" class="ref" href="../G/G8.htm#i145756" title="Anestesimidler">Anestesimidler</a></p></p></td>
	</tr>
 <tr id="i149220" class="body oddelinje">
	<td id="i149221"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149222">Ketobemidon</p></p></td>
	<td id="i149223"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149224">3</p></p></td>
	<td id="i149225"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149226">Overgang til morsmelk er liten. Se opioidanalgetika  <a id="arowX150865" class="ref" href="../G/G8.htm#i150865" title="Opioidanalgetika">Opioidanalgetika</a></p></p></td>
	</tr>
 <tr id="i149227" class="body likelinje">
	<td id="i149228"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149229">Ketokonazol</p></p></td>
	<td id="i149230"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149231">2</p></p>
<p class="entrya"><p id="i271790"> </p></p>
<p class="entrya"><p id="i271785">1</p></p></td>
	<td id="i149232"    valign="top" width="51.7%" class="sluttKol">
	<UL type="circle">
		<LI id="i149234"><p id="i149235"><em>Systemisk bruk:</em> Overgang til morsmelk er liten. Kan brukes av ammende ved korttidsbehandling (< 14 dager)</p><br>		</LI>
		<LI id="i271786"><p id="i271788"><em>Lokal bruk:</em> Se fungicider til lokal bruk  <a id="arowX148164" class="ref" href="../G/G8.htm#i148164" title="Fungicider til lokal bruk">Fungicider til lokal bruk</a></p><br>		</LI>
	</UL>
</td>
	</tr>
 <tr id="i149245" class="body oddelinje">
	<td id="i149246"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149247">Ketoprofen</p></p></td>
	<td id="i149248"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149249">3</p></p></td>
	<td id="i149250"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149251">Opplysninger om overgang til morsmelk mangler. Se NSAID  <a id="arowX150698" class="ref" href="../G/G8.htm#i150698" title="NSAID">NSAID</a></p></p></td>
	</tr>
 <tr id="i149252" class="body likelinje">
	<td id="i149253"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149254">Ketorolac</p></p></td>
	<td id="i149255"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149256">2</p></p></td>
	<td id="i149257"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149258">Overgang til morsmelk er minimal. Se NSAID  <a id="arowX150698" class="ref" href="../G/G8.htm#i150698" title="NSAID">NSAID</a></p></p></td>
	</tr>
 <tr id="i149259" class="body oddelinje">
	<td id="i149260"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149261">Ketotifen</p></p></td>
	<td id="i149262"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149263">2</p></p></td>
	<td id="i149264"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149265">Øyedråper: Kan brukes av ammende</p></p></td>
	</tr>
 <tr id="i149266" class="body likelinje">
	<td id="i149267"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149268">Kinin</p></p></td>
	<td id="i149269"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149270">2</p></p></td>
	<td id="i149271"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149272">Overgang til morsmelk er moderat. Kan brukes av ammende. Se antimalariamidler  <a id="arowX145897" class="ref" href="../G/G8.htm#i145897" title="Antimalariamidler">Antimalariamidler</a></p></p></td>
	</tr>
 <tr id="i149273" class="body oddelinje">
	<td id="i149274"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149275">Klaritromycin</p></p></td>
	<td id="i149276"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149277">2</p></p></td>
	<td id="i149278"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149279">Opplysninger om overgang til morsmelk mangler. Se antibakterielle midler  <a id="arowX145756" class="ref" href="../G/G8.htm#i145756" title="Anestesimidler">Anestesimidler</a></p></p></td>
	</tr>
 <tr id="i149280" class="body likelinje">
	<td id="i149281"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149282">Klindamycin</p></p></td>
	<td id="i149283"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149284">3</p></p>
<p class="entrya"><p id="i271801"> </p></p>
<p class="entrya"><p id="i271803">2</p></p></td>
	<td id="i149285"    valign="top" width="51.7%" class="sluttKol">
	<UL type="circle">
		<LI id="i149287"><p id="i149288"><em>Systemisk bruk:</em> Overgang til morsmelk er liten. Alternativt antibakterielt middel anbefales til ammende. Se antibakterielle midler  <a id="arowX145756" class="ref" href="../G/G8.htm#i145756" title="Anestesimidler">Anestesimidler</a></p><br>		</LI>
		<LI id="i271804"><p id="i271805">Lokal bruk: Kan brukes av ammende</p><br>		</LI>
	</UL>
</td>
	</tr>
 <tr id="i149298" class="body oddelinje">
	<td id="i149299"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149300">Klobazam</p></p></td>
	<td id="i149301"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149302">3</p></p></td>
	<td id="i149303"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149304">Opplysninger om overgang til morsmelk mangler. Se benzodiazepiner  <a id="arowX146283" class="ref" href="../G/G8.htm#i146283" title="Benzodiazepiner">Benzodiazepiner</a></p></p></td>
	</tr>
 <tr id="i149305" class="body likelinje">
	<td id="i149306"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149307">Klobetasol</p></p></td>
	<td id="i149308"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149309">2</p></p></td>
	<td id="i149310"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149311">Opplysninger om overgang til morsmelk mangler. Se glukokortikoider, lokalbehandling  <a id="arowX148403" class="ref" href="../G/G8.htm#i148403" title="Glukokortikoider">Glukokortikoider</a></p></p></td>
	</tr>
 <tr id="i149312" class="body oddelinje">
	<td id="i149313"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149314">Klodronat</p></p></td>
	<td id="i149315"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149316">0</p></p></td>
	<td id="i149317"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149318">Se bisfosfonater  <a id="arowX146417" class="ref" href="../G/G8.htm#i146417" title="Bisfosfonater">Bisfosfonater</a></p></p></td>
	</tr>
 <tr id="i149319" class="body likelinje">
	<td id="i149320"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149321">Klofarabin</p></p></td>
	<td id="i149322"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149323">5</p></p></td>
	<td id="i149324"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149325">Se cytostatika  <a id="arowX146868" class="ref" href="../G/G8.htm#i146868" title="Cytostatika">Cytostatika</a></p></p></td>
	</tr>
 <tr id="i149326" class="body oddelinje">
	<td id="i149327"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149328">Kloksacillin</p></p></td>
	<td id="i149329"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149330">1</p></p></td>
	<td id="i149331"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149332">Kan brukes av ammende. Se også antibakterielle midler  <a id="arowX145756" class="ref" href="../G/G8.htm#i145756" title="Anestesimidler">Anestesimidler</a></p></p></td>
	</tr>
 <tr id="i149333" class="body likelinje">
	<td id="i149334"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149335">Klometiazol</p></p></td>
	<td id="i149336"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149337">3</p></p></td>
	<td id="i149338"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149339">Overgang til morsmelk er minimal. Bør bare brukes over kortere tidsperioder</p></p></td>
	</tr>
 <tr id="i149340" class="body oddelinje">
	<td id="i149341"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149342">Klomifen</p></p></td>
	<td id="i149343"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149344">0</p></p></td>
	<td id="i149345"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149346">Bør unngås under oppstart av amming pga. mulig hemning av melkeproduksjonen</p></p></td>
	</tr>
 <tr id="i149347" class="body likelinje">
	<td id="i149348"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149349">Klomipramin</p></p></td>
	<td id="i149350"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149351">2</p></p></td>
	<td id="i149352"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149353">Overgang til morsmelk er liten. Se trisykliske antidepressiva  <a id="arowX152619" class="ref" href="../G/G8.htm#i152619" title="Trisykliske antidepressiva (TCA)">Trisykliske antidepressiva (TCA)</a></p></p></td>
	</tr>
 <tr id="i149354" class="body oddelinje">
	<td id="i149355"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149356">Klonazepam</p></p></td>
	<td id="i149357"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149358">3</p></p></td>
	<td id="i149359"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149360">Overgang til morsmelk er liten. Observer barnet for sedasjon. Se antiepileptika  <a id="arowX145833" class="ref" href="../G/G8.htm#i145833" title="Antiepileptika">Antiepileptika</a></p></p></td>
	</tr>
 <tr id="i149361" class="body likelinje">
	<td id="i149362"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149363">Klonidin</p></p></td>
	<td id="i149364"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149365">3</p></p>
<p class="entrya"><p id="i271809"> </p></p>
<p class="entrya"><p id="i271810"> </p></p>
<p class="entrya"><p id="i271811">3</p></p></td>
	<td id="i149366"    valign="top" width="51.7%" class="sluttKol">
	<UL type="circle">
		<LI id="i149368"><p id="i149369"><em>Migreneprofylakse:</em> Risiko for påvirkning av barnet er liten ved sporadisk bruk i terapeutiske doser. Barnet bør observeres for hypotensjon</p><br>		</LI>
		<LI id="i271812"><p id="i271813">Hypertensjon: Overgang til morsmelk er moderat. Tilbakeholdenhet med bruk hos ammende. Kan redusere melkeproduksjonen</p><br>		</LI>
	</UL>
</td>
	</tr>
 <tr id="i149379" class="body oddelinje">
	<td id="i149380"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149381">Klopidogrel</p></p></td>
	<td id="i149382"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149383">3</p></p></td>
	<td id="i149384"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149385">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i149386" class="body likelinje">
	<td id="i149387"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149388">Klorambucil</p></p></td>
	<td id="i149389"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149390">5</p></p></td>
	<td id="i149391"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149392">Se cytostatika  <a id="arowX146868" class="ref" href="../G/G8.htm#i146868" title="Cytostatika">Cytostatika</a></p></p></td>
	</tr>
 <tr id="i149393" class="body oddelinje">
	<td id="i149394"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149395">Kloramfenikol</p></p></td>
	<td id="i149396"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149397">5</p></p>
<p class="entrya"><p id="i271817"> </p></p>
<p class="entrya"><p id="i271818"> </p></p>
<p class="entrya"><p id="i271819">2</p></p></td>
	<td id="i149398"    valign="top" width="51.7%" class="sluttKol">
	<UL type="circle">
		<LI id="i149400"><p id="i149401"><em>Peroralt:</em> Bruk hos ammende frarådes ved systemisk behandling pga. virkestoffets toksisitet. Premature barn og spedbarn yngre enn en måned, er spesielt utsatte pga. redusert glukuronideringsevne</p><br>		</LI>
		<LI id="i271820"><p id="i271821">Øyedråper: Kan brukes av ammende</p><br>		</LI>
	</UL>
</td>
	</tr>
 <tr id="i149411" class="body likelinje">
	<td id="i149412"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149413">Klorsyklizin</p></p></td>
	<td id="i149414"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149415">3</p></p></td>
	<td id="i149416"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149417">Opplysninger om overgang til morsmelk mangler. Bivirkninger hos brysternærte barn er rapportert. Bruk bør begrenses til det minimale ved amming. Se antihistaminer  <a id="arowX145840" class="ref" href="../G/G8.htm#i145840" title="Antihistaminer (H1-antagonister)">Antihistaminer (H1-antagonister)</a></p></p></td>
	</tr>
 <tr id="i149418" class="body oddelinje">
	<td id="i149419"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149420">Klorheksidin</p></p></td>
	<td id="i149421"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149422">1</p></p></td>
	<td id="i149423"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149424">Kan brukes av ammende</p></p></td>
	</tr>
 <tr id="i149425" class="body likelinje">
	<td id="i149426"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149427">Klorokin</p></p></td>
	<td id="i149428"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149429">3</p></p></td>
	<td id="i149430"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149431">Overgang til morsmelk er moderat. Se antimalariamidler  <a id="arowX145897" class="ref" href="../G/G8.htm#i145897" title="Antimalariamidler">Antimalariamidler</a></p></p></td>
	</tr>
 <tr id="i149432" class="body oddelinje">
	<td id="i149433"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149434">Klorpromazin</p></p></td>
	<td id="i149435"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149436">3</p></p></td>
	<td id="i149437"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149438">Overgang til morsmelk er minimal. Observer barnet for sløvhet og døsighet. Økt melkeproduksjon har vært observert hos mor. Se antipsykotika  <a id="arowX145918" class="ref" href="../G/G8.htm#i145918" title="Antipsykotika">Antipsykotika</a></p></p></td>
	</tr>
 <tr id="i149439" class="body likelinje">
	<td id="i149440"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149441">Klorprotiksen</p></p></td>
	<td id="i149442"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149443">3</p></p></td>
	<td id="i149444"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149445">Overgang til morsmelk er minimal. Se antipsykotika  <a id="arowX145918" class="ref" href="../G/G8.htm#i145918" title="Antipsykotika">Antipsykotika</a></p></p></td>
	</tr>
 <tr id="i149446" class="body oddelinje">
	<td id="i149447"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149448">Klortetrasyklin</p></p></td>
	<td id="i149449"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149450">2</p></p></td>
	<td id="i149451"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149452">Lokalbehandling: Kan brukes av ammende</p></p></td>
	</tr>
 <tr id="i149453" class="body likelinje">
	<td id="i149454"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149455">Klotrimazol (hud- og gynekologisk bruk)</p></p></td>
	<td id="i149456"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149457">1</p></p></td>
	<td id="i149458"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149459">Lokalbehandling: Passerer ikke over i morsmelk. Se også fungicider til lokal bruk  <a id="arowX148164" class="ref" href="../G/G8.htm#i148164" title="Fungicider til lokal bruk">Fungicider til lokal bruk</a></p></p></td>
	</tr>
 <tr id="i149460" class="body oddelinje">
	<td id="i149461"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149462">Klozapin</p></p></td>
	<td id="i149463"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149464">3</p></p></td>
	<td id="i149465"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149466">Overgang til morsmelk er minimal. Tilbakeholdenhet med bruk hos ammende pga. virkestoffets toksisitet. Se antipsykotika  <a id="arowX145918" class="ref" href="../G/G8.htm#i145918" title="Antipsykotika">Antipsykotika</a></p></p></td>
	</tr>
 <tr id="i149467" class="body likelinje">
	<td id="i149468"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149469">Kodein</p></p></td>
	<td id="i149470"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149471">3&#8211;4&ML;						avhengig av dosering og varighet for bruk</p></p></td>
	<td id="i149473"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149474">Ammende bør ikke bruke kodeinholdige preparater sammenhengende utover et par dager. Diebarn bør observeres med tanke på slapphet og sedasjon. Kvinner med ultrarask genotype av CYP2D6 vil i høy grad kunne omdanne kodein til morfin. Høye doser av morfin vil kunne gjenfinnes i morsmelken etter sammenhengende bruk utover to uker. Bruk av kodeinholdige preparater hos slike kvinner anbefales ikke</p></p></td>
	</tr>
 <tr id="i149475" class="body oddelinje">
	<td id="i149476"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149477">Koffein</p></p></td>
	<td id="i149478"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149479">3</p></p></td>
	<td id="i149480"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149481">Overgang til morsmelk er moderat. Koffein har lang plasmahalveringstid i spedbarn. 3&#x2013;5 kopper kaffe daglig ansees som forenlig med amming. En liter coladrikk inneholder koffein tilsvarende ca. én kopp kaffe. Risiko for irritabilitet hos barnet ved høye doser</p></p></td>
	</tr>
 <tr id="i149482" class="body likelinje">
	<td id="i149483"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149484">Kolesevelam</p></p></td>
	<td id="i149485"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149486">0</p></p></td>
	<td id="i149487"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149488">Kan brukes av ammende</p></p></td>
	</tr>
 <tr id="i149489" class="body oddelinje">
	<td id="i149490"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149491">Kolestipol</p></p></td>
	<td id="i149492"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149493">0</p></p></td>
	<td id="i149494"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149495">Kan brukes av ammende</p></p></td>
	</tr>
 <tr id="i149496" class="body likelinje">
	<td id="i149497"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149498">Kolestyramin</p></p></td>
	<td id="i149499"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149500">0</p></p></td>
	<td id="i149501"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149502">Kan brukes av ammende</p></p></td>
	</tr>
 <tr id="i149503" class="body oddelinje">
	<td id="i149504"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149505">Kolfoskeril</p></p></td>
	<td id="i149506"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149507">3</p></p></td>
	<td id="i149508"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149509">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i149510" class="body likelinje">
	<td id="i149511"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149512">Kolinteofyllinat</p></p></td>
	<td id="i149513"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149514">3</p></p></td>
	<td id="i149515"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149516">Overgang til morsmelk er liten. Se teofyllin  <a id="arowX152258" class="ref" href="../G/G8.htm#i152258" title="Teofyllin">Teofyllin</a></p></p></td>
	</tr>
 <tr id="i149517" class="body oddelinje">
	<td id="i149518"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149519">Kolkisin</p></p></td>
	<td id="i149520"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149521">3</p></p></td>
	<td id="i149522"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149523">Overgang til morsmelk er liten. Begrenset klinisk erfaring og toksiske egenskaper tilsier tilbakeholdenhet ved amming</p></p></td>
	</tr>
 <tr id="i320105" class="body likelinje">
	<td id="i320106"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i320107">Kollagenase</p></p></td>
	<td id="i320108"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i320109">0</p></p></td>
	<td id="i320110"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i320111">Farmakokinetiske egenskaper tilsier minimal eksponering av brystern&#x00E6;rte barn. Kan brukes av ammende</p></p></td>
	</tr>
 <tr id="i149524" class="body oddelinje">
	<td id="i149525"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149526">Korifollitropin alfa</p></p></td>
	<td id="i149527"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149528">0</p></p></td>
	<td id="i149529"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149530">Se gonadotropiner  <a id="arowX148472" class="ref" href="../G/G8.htm#i148472" title="Gonadotropiner">Gonadotropiner</a></p></p></td>
	</tr>
 <tr id="i149531" class="body likelinje">
	<td id="i149532"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149533">Koriongonadotropin</p></p></td>
	<td id="i149534"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149535">0</p></p></td>
	<td id="i149536"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149537">Se gonadotropiner  <a id="arowX148472" class="ref" href="../G/G8.htm#i148472" title="Gonadotropiner">Gonadotropiner</a></p></p></td>
	</tr>
 <tr id="i149538" class="body oddelinje">
	<td id="i149539"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149540">Kortison</p></p></td>
	<td id="i149541"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149542">3</p></p></td>
	<td id="i149543"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149544">Overgang til morsmelk er moderat. Se glukokortikoider  <a id="arowX148403" class="ref" href="../G/G8.htm#i148403" title="Glukokortikoider">Glukokortikoider</a></p></p></td>
	</tr>
 <tr id="i149545" class="body likelinje">
	<td id="i149546"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149547">Kromoglikat</p></p></td>
	<td id="i149548"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149549">1</p></p></td>
	<td id="i149550"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149551">Overgang til morsmelk er minimal</p></p></td>
	</tr>
 <tr id="i149552" class="body oddelinje">
	<td id="i149553"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149554">Krotamiton</p></p></td>
	<td id="i149555"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149556">0</p></p></td>
	<td id="i149557"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149558">Lokal bruk: Kan brukes av ammende</p></p></td>
	</tr>
 <tr id="i149559" class="body likelinje">
	<td id="i149560"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149561">Kvetiapin</p></p></td>
	<td id="i149562"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149563">3</p></p></td>
	<td id="i149564"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149565">Overgang til morsmelk er minimal. Se også antipsykotika  <a id="arowX145918" class="ref" href="../G/G8.htm#i145918" title="Antipsykotika">Antipsykotika</a></p></p></td>
	</tr>
 <tr id="i149566" class="body oddelinje">
	<td id="i149567"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149568">Kvinagolid</p></p></td>
	<td id="i149569"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149570">5</p></p></td>
	<td id="i149571"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149572">Hemmer prolaktinproduksjonen og dermed melkeproduksjonen</p></p></td>
	</tr>
 </tbody></table>
 <table id="i149574" width="100%" class="maintable" border="0" cellpadding="5" cellspacing="0">
 <caption> <Uth Id="NUTHid2331469" Type="Halvfet">L</Uth></caption> <thead>
	<tr class = "linjetopp">
	<th id="i149582"  colspan="3"  valign="top"  class="sluttKol">

<p class="entrya"><p id="i149583">Overgang til morsmelk angis som minimal (< 2 %), liten (2&#8211;5 %), moderat (5&#8211;10 %) eller høy (10&#8211;50 %) basert på fraksjon av morens dose/kg kroppsvekt som barnet tilføres. (Barnets relative dose.)&ML;						Over 3&#8211;4 ukers bruk ansees som langtidsbehandling.</p></p></th>
	</tr>
	<tr class = "linjetopp">
	<th id="i149586"    valign="top"  class="startKol">

<p class="entrya"><p id="i149587"><strong>Legemiddel</strong></p></p></th>
	<th id="i149588"    valign="top"  class="mellomKol">

<p class="entrya"><p id="i149589"><strong>MM kategori</strong></p></p></th>
	<th id="i149590"    valign="top"  class="sluttKol">

<p class="entrya"><p id="i149591"><strong>Dokumentasjon vedrørende bruk under amming</strong></p></p></th>
	</tr>
</thead>
<tbody>
<tr id="i149593" class="body likelinje">
	<td id="i149594"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149595">Labetalol</p></p></td>
	<td id="i149596"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149597">2</p></p></td>
	<td id="i149598"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149599">Overgang til morsmelk er minimal. Se betareseptorantagonister, adrenerge  <a id="arowX146361" class="ref" href="../G/G8.htm#i146361" title="Betareseptorantagonister, adrenerge">Betareseptorantagonister, adrenerge</a></p></p></td>
	</tr>
 <tr id="i149600" class="body oddelinje">
	<td id="i149601"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i218851">Lakosamid</p></p></td>
	<td id="i149602"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149603">3</p></p></td>
	<td id="i149604"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149605">Opplysninger om overgang til morsmelk mangler. Se antiepileptika  <a id="arowX145833" class="ref" href="../G/G8.htm#i145833" title="Antiepileptika">Antiepileptika</a></p></p></td>
	</tr>
 <tr id="i149606" class="body likelinje">
	<td id="i149607"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149608"><em>Laksantia</em></p></p></td>
	<td id="i149609"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149610">0</p></p></td>
	<td id="i149611"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149612">Kan brukes av ammende</p></p></td>
	</tr>
 <tr id="i149613" class="body oddelinje">
	<td id="i149614"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149615">Laktitol</p></p></td>
	<td id="i149616"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149617">0</p></p></td>
	<td id="i149618"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149619">Se laksantia  <a id="arowX149606" class="ref" href="../G/G8.htm#i149606" title="Laksantia">Laksantia</a></p></p></td>
	</tr>
 <tr id="i149620" class="body likelinje">
	<td id="i149621"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149622">Laktulose</p></p></td>
	<td id="i149623"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149624">0</p></p></td>
	<td id="i149625"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149626">Se laksantia  <a id="arowX149606" class="ref" href="../G/G8.htm#i149606" title="Laksantia">Laksantia</a></p></p></td>
	</tr>
 <tr id="i149627" class="body oddelinje">
	<td id="i149628"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149629">Lamivudin</p></p></td>
	<td id="i149630"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149631">5</p></p></td>
	<td id="i149632"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149633">Overgang til morsmelk er moderat. Se antivirale midler <a id="arowX145939" class="ref" href="../G/G8.htm#i145939" title="Antivirale midler">Antivirale midler</a></p></p></td>
	</tr>
 <tr id="i149634" class="body likelinje">
	<td id="i149635"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149636">Lamotrigin</p></p></td>
	<td id="i149637"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149638">3</p></p></td>
	<td id="i149639"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149640">Overgang til morsmelk er høy. Tilbakeholdenhet anbefales pga. risiko for farmakologiske effekter hos barnet og liten erfaring med bruk hos ammende. Se antiepileptika  <a id="arowX145833" class="ref" href="../G/G8.htm#i145833" title="Antiepileptika">Antiepileptika</a></p></p></td>
	</tr>
 <tr id="i149641" class="body oddelinje">
	<td id="i149642"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149643">Lanreotid</p></p></td>
	<td id="i149644"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149645">0</p></p></td>
	<td id="i149646"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149647">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i149648" class="body likelinje">
	<td id="i149649"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149650">Lansoprazol</p></p></td>
	<td id="i149651"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149652">2</p></p></td>
	<td id="i149653"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149654">Opplysninger mangler. Se protonpumpehemmere  <a id="arowX151433" class="ref" href="../G/G8.htm#i151433" title="Protonpumpehemmere">Protonpumpehemmere</a></p></p></td>
	</tr>
 <tr id="i149655" class="body oddelinje">
	<td id="i149656"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149657">Lantankarbonathydrat</p></p></td>
	<td id="i149658"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149659">0</p></p></td>
	<td id="i149660"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149661">Kan brukes av ammende</p></p></td>
	</tr>
 <tr id="i149662" class="body likelinje">
	<td id="i149663"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149664">Lapatinib</p></p></td>
	<td id="i149665"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149666">5</p></p></td>
	<td id="i149667"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149668">Virkningmekanismen tilsier at det ikke bør brukes av ammende</p></p></td>
	</tr>
 <tr id="i149669" class="body oddelinje">
	<td id="i149670"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149671">Laropiprant</p></p></td>
	<td id="i149672"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149673">3</p></p></td>
	<td id="i149674"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149675">Overgangen av laropiprant til morsmelk er ukjent</p></p></td>
	</tr>
 <tr id="i149676" class="body likelinje">
	<td id="i149677"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149678">Latanoprost</p></p></td>
	<td id="i149679"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149680">3</p></p></td>
	<td id="i149681"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149682">Øyedråper: Lav systemisk dose og kort halveringstid tilsier at latanoprost kan brukes av ammende</p></p></td>
	</tr>
 <tr id="i149683" class="body oddelinje">
	<td id="i149684"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149685">Latanoprost/timolol</p></p></td>
	<td id="i149686"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149687">2</p></p></td>
	<td id="i149688"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149689">Se de enkelte virkestoffene</p></p></td>
	</tr>
 <tr id="i149690" class="body likelinje">
	<td id="i149691"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149692">Leflunomid</p></p></td>
	<td id="i149693"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149694">4</p></p></td>
	<td id="i149695"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149696">Opplysninger mangler. Se immunsuppressive midler  <a id="arowX148847" class="ref" href="../G/G8.htm#i148847" title="Immunsuppressive midler">Immunsuppressive midler</a></p></p></td>
	</tr>
 <tr id="i149697" class="body oddelinje">
	<td id="i149698"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149699">Lenalidomid</p></p></td>
	<td id="i149700"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149701">4</p></p></td>
	<td id="i149702"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149703">Opplysninger mangler, men virkestoffets toksisitet tilsier at ammende ikke bør bruke lenalidomid</p></p></td>
	</tr>
 <tr id="i149704" class="body likelinje">
	<td id="i149705"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149706">Lepirudin</p></p></td>
	<td id="i149707"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149708">3</p></p></td>
	<td id="i149709"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149710">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i149711" class="body oddelinje">
	<td id="i149712"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149713">Lerkanidipin</p></p></td>
	<td id="i149714"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149715">3</p></p></td>
	<td id="i149716"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149717">Opplysninger mangler. Se kalsiumantagonister  <a id="arowX149110" class="ref" href="../G/G8.htm#i149110" title="Kalsiumantagonister">Kalsiumantagonister</a></p></p></td>
	</tr>
 <tr id="i149718" class="body likelinje">
	<td id="i149719"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149720">Letrozol</p></p></td>
	<td id="i149721"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149722">4</p></p></td>
	<td id="i149723"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149724">Opplysninger mangler. Letrozols virkningsmekanisme tilsier at amming bør frarådes</p></p></td>
	</tr>
 <tr id="i149725" class="body oddelinje">
	<td id="i149726"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149727">Leuprorelin</p></p></td>
	<td id="i149728"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149729">0</p></p></td>
	<td id="i149730"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149731">Ikke aktuell til bruk hos ammende</p></p></td>
	</tr>
 <tr id="i149732" class="body likelinje">
	<td id="i149733"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149734">Levetiracetam</p></p></td>
	<td id="i149735"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149736">3</p></p></td>
	<td id="i149737"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149738">Overgang til morsmelk er moderat. Se antiepileptika  <a id="arowX145833" class="ref" href="../G/G8.htm#i145833" title="Antiepileptika">Antiepileptika</a></p></p></td>
	</tr>
 <tr id="i149739" class="body oddelinje">
	<td id="i149740"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149741">Levocetirizin</p></p></td>
	<td id="i149742"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149743">3</p></p></td>
	<td id="i149744"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149745">Opplysninger om overgang til morsmelk mangler. Se antihistaminer  <a id="arowX145840" class="ref" href="../G/G8.htm#i145840" title="Antihistaminer (H1-antagonister)">Antihistaminer (H1-antagonister)</a></p></p></td>
	</tr>
 <tr id="i149746" class="body likelinje">
	<td id="i149747"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149748">Levodopa</p></p></td>
	<td id="i149749"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149750">4</p></p></td>
	<td id="i149751"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149752">Opplysninger mangler. Alle dopaminerge legemidler kan hemme melkeproduksjonen</p></p></td>
	</tr>
 <tr id="i320154" class="body oddelinje">
	<td id="i320155"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i320156">Levofloksacin</p></p></td>
	<td id="i320157"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i320158">3</p></p></td>
	<td id="i320159"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i320160">Se fluorokinoloner <a id="aentryX148026" class="ref" href="../G/G8.htm#i148026" title="Fluorokinoloner">Fluorokinoloner</a> </p></p></td>
	</tr>
 <tr id="i149753" class="body likelinje">
	<td id="i149754"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149755">Levokabastin</p></p></td>
	<td id="i149756"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149757">3</p></p>
<p class="entrya"><p id="i271853"> </p></p>
<p class="entrya"><p id="i271843">2</p></p></td>
	<td id="i149758"    valign="top" width="51.7%" class="sluttKol">
	<UL type="circle">
		<LI id="i149760"><p id="i149761"><em>Nesespray:</em> Overgang til morsmelk er høy. Kan brukes av ammende ved sporadisk bruk</p><br>		</LI>
		<LI id="i271844"><p id="i271845">Øyedråper: Overgang til morsmelk er liten. Kan brukes av ammende</p><br>		</LI>
	</UL>

<p class="entrya"><p id="i271846">Se antihistaminer  <a id="arowX145840" class="ref" href="../G/G8.htm#i145840" title="Antihistaminer (H1-antagonister)">Antihistaminer (H1-antagonister)</a></p></p></td>
	</tr>
 <tr id="i149772" class="body oddelinje">
	<td id="i149773"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149774">Levomepromazin</p></p></td>
	<td id="i149775"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149776">3</p></p></td>
	<td id="i149777"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149778">Opplysninger om overgang til morsmelk mangler. Se antipsykotika  <a id="arowX145918" class="ref" href="../G/G8.htm#i145918" title="Antipsykotika">Antipsykotika</a></p></p></td>
	</tr>
 <tr id="i149779" class="body likelinje">
	<td id="i149780"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149781">Levonorgestrel</p></p></td>
	<td id="i149782"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149783">1</p></p></td>
	<td id="i149784"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149785">Overgang til morsmelk er liten. Kan brukes av ammende. Se p-piller  <a id="arowX151249" class="ref" href="../G/G8.htm#i151249" title="P-piller">P-piller</a></p></p></td>
	</tr>
 <tr id="i149786" class="body oddelinje">
	<td id="i149787"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149788">Levosimendan</p></p></td>
	<td id="i149789"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149790">3</p></p></td>
	<td id="i149791"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149792">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i149793" class="body likelinje">
	<td id="i149794"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149795">Levotyroksin (T<Sub>4</Sub>=tyroksin)</p></p></td>
	<td id="i149796"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149797">2</p></p></td>
	<td id="i149798"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149799">Se thyreoideahormoner  <a id="arowX152339" class="ref" href="../G/G8.htm#i152339" title="Thyreoideahormoner">Thyreoideahormoner</a></p></p></td>
	</tr>
 <tr id="i149800" class="body oddelinje">
	<td id="i149801"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149802">Lidokain</p></p></td>
	<td id="i149803"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149804">2</p></p></td>
	<td id="i149805"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149806">Overgang til morsmelk er minimal. Se lokalanestetika  <a id="arowX149842" class="ref" href="../G/G8.htm#i149842" title="Lokalanestetika">Lokalanestetika</a></p></p></td>
	</tr>
 <tr id="i320112" class="body likelinje">
	<td id="i320113"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i320114">Linagliptin</p></p></td>
	<td id="i320115"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i320116">3</p></p></td>
	<td id="i320117"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i320118">Opplysninger om overgang til morsmelk mangler. Se antidiabetika, perorale <a id="aentryX145820" class="ref" href="../G/G8.htm#i145820" title="Antidiabetika, perorale">Antidiabetika, perorale</a> </p></p></td>
	</tr>
 <tr id="i149807" class="body oddelinje">
	<td id="i149808"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149809">Linezolid</p></p></td>
	<td id="i149810"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149811">5</p></p></td>
	<td id="i149812"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149813">Opplysninger om overgang til morsmelk mangler. Skal ikke brukes av ammende pga. mulige bivirkninger. Se antibakterielle midler  <a id="arowX145756" class="ref" href="../G/G8.htm#i145756" title="Anestesimidler">Anestesimidler</a></p></p></td>
	</tr>
 <tr id="i149814" class="body likelinje">
	<td id="i149815"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149816">Liotyronin (T<Sub>3</Sub>=trijodtyronin)</p></p></td>
	<td id="i149817"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149818">2</p></p></td>
	<td id="i149819"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149820">Se thyreoideahormoner  <a id="arowX152339" class="ref" href="../G/G8.htm#i152339" title="Thyreoideahormoner">Thyreoideahormoner</a></p></p></td>
	</tr>
 <tr id="i149821" class="body oddelinje">
	<td id="i149822"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149823">Liraglutid</p></p></td>
	<td id="i149824"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149825">3</p></p></td>
	<td id="i149826"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149827">Opplysninger om overgang til morsmelk mangler, men den er trolig minimal. Erfaring med bruk hos ammende er minimal</p></p></td>
	</tr>
 <tr id="i149828" class="body likelinje">
	<td id="i149829"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149830">Lisinopril</p></p></td>
	<td id="i149831"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149832">3</p></p></td>
	<td id="i149833"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149834">Opplysninger om overgang til morsmelk mangler. Se ACE-hemmere  <a id="arowX145374" class="ref" href="../G/G8.htm#i145374" title="ACE-hemmere">ACE-hemmere</a></p></p></td>
	</tr>
 <tr id="i149835" class="body oddelinje">
	<td id="i149836"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149837">Litium</p></p></td>
	<td id="i149838"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149839">5</p></p></td>
	<td id="i149840"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149841">Overgang til morsmelk er høy. Amming kan unntaksvis tillates når gode muligheter til å monitorere barnet er til stede</p></p></td>
	</tr>
 <tr id="i149842" class="body likelinje">
	<td id="i149843"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149844"><em>Lokalanestetika</em></p></p></td>
	<td id="i149845"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149846">2</p></p></td>
	<td id="i149847"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149848">Kan brukes av ammende</p></p></td>
	</tr>
 <tr id="i149849" class="body oddelinje">
	<td id="i149850"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149851">Lomustin</p></p></td>
	<td id="i149852"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149853">5</p></p></td>
	<td id="i149854"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149855">Se cytostatika  <a id="arowX146868" class="ref" href="../G/G8.htm#i146868" title="Cytostatika">Cytostatika</a></p></p></td>
	</tr>
 <tr id="i149856" class="body likelinje">
	<td id="i149857"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149858">Loperamid</p></p></td>
	<td id="i149859"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149860">2</p></p></td>
	<td id="i149861"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149862">Overgang til morsmelk er minimal. Kan brukes av ammende</p></p></td>
	</tr>
 <tr id="i149863" class="body oddelinje">
	<td id="i149864"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149865">Lopinavir/ritonavir</p></p></td>
	<td id="i149866"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149867">5</p></p></td>
	<td id="i149868"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149869">Se antivirale midler  <a id="arowX145939" class="ref" href="../G/G8.htm#i145939" title="Antivirale midler">Antivirale midler</a></p></p></td>
	</tr>
 <tr id="i149870" class="body likelinje">
	<td id="i149871"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149872">Loratadin</p></p></td>
	<td id="i149873"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149874">1</p></p></td>
	<td id="i149875"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149876">Overgang til morsmelk er minimal. Kan brukes av ammende. Se antihistaminer  <a id="arowX145840" class="ref" href="../G/G8.htm#i145840" title="Antihistaminer (H1-antagonister)">Antihistaminer (H1-antagonister)</a></p></p></td>
	</tr>
 <tr id="i149877" class="body oddelinje">
	<td id="i149878"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149879">Lorazepam</p></p></td>
	<td id="i149880"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149881">3</p></p></td>
	<td id="i149882"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149883">Overgang til morsmelk er liten. Se benzodiazepiner  <a id="arowX146283" class="ref" href="../G/G8.htm#i146283" title="Benzodiazepiner">Benzodiazepiner</a></p></p></td>
	</tr>
 <tr id="i149884" class="body likelinje">
	<td id="i149885"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149886">Losartan</p></p></td>
	<td id="i149887"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149888">3</p></p></td>
	<td id="i149889"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149890">Se angiotensin II-reseptorantagonister  <a id="arowX145763" class="ref" href="../G/G8.htm#i145763" title="Angiotensin II-reseptorantagonister">Angiotensin II-reseptorantagonister</a></p></p></td>
	</tr>
 <tr id="i149891" class="body oddelinje">
	<td id="i149892"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149893">Lovastatin</p></p></td>
	<td id="i149894"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149895">3</p></p></td>
	<td id="i149896"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149897">Se statiner  <a id="arowX151973" class="ref" href="../G/G8.htm#i151973" title="Statiner">Statiner</a></p></p></td>
	</tr>
 <tr id="i149898" class="body likelinje">
	<td id="i149899"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149900">Lumefantrin</p></p></td>
	<td id="i149901"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149902">3</p></p></td>
	<td id="i149903"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149904">Opplysninger om overgang til morsmelk mangler. Se antimalariamidler  <a id="arowX145897" class="ref" href="../G/G8.htm#i145897" title="Antimalariamidler">Antimalariamidler</a></p></p></td>
	</tr>
 <tr id="i149905" class="body oddelinje">
	<td id="i149906"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149907">Lutropin alfa</p></p></td>
	<td id="i149908"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149909">0</p></p></td>
	<td id="i149910"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149911">Se gonadotropiner  <a id="arowX148472" class="ref" href="../G/G8.htm#i148472" title="Gonadotropiner">Gonadotropiner</a></p></p></td>
	</tr>
 <tr id="i149912" class="body likelinje">
	<td id="i149913"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149914">Lymesyklin</p></p></td>
	<td id="i149915"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149916">3</p></p></td>
	<td id="i149917"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149918">Opplysninger mangler. Se tetrasykliner  <a id="arowX152325" class="ref" href="../G/G8.htm#i152325" title="Tetrasykliner">Tetrasykliner</a></p></p></td>
	</tr>
 <tr id="i149919" class="body oddelinje">
	<td id="i149920"    valign="top" width="29.2%" class="startKol">

<p class="entrya"><p id="i149921">Lynestrenol</p></p></td>
	<td id="i149922"    valign="top" width="19.1%" class="mellomKol">

<p class="entrya"><p id="i149923">2</p></p></td>
	<td id="i149924"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149925">Overgang til morsmelk er minimal. Se p-piller  <a id="arowX151249" class="ref" href="../G/G8.htm#i151249" title="P-piller">P-piller</a></p></p></td>
	</tr>
 </tbody></table>
 <table id="i149927" width="100%" class="maintable" border="0" cellpadding="5" cellspacing="0">
 <caption> <Uth Id="NUTHid2330647" Type="Halvfet">M</Uth></caption> <thead>
	<tr class = "linjetopp">
	<th id="i149935"  colspan="3"  valign="top"  class="sluttKol">

<p class="entrya"><p id="i149936">Overgang til morsmelk angis som minimal (< 2 %), liten (2&#8211;5 %), moderat (5&#8211;10 %) eller høy (10&#8211;50 %) basert på fraksjon av morens dose/kg kroppsvekt som barnet tilføres. (Barnets relative dose.)&ML;						Over 3&#8211;4 ukers bruk ansees som langtidsbehandling.</p></p></th>
	</tr>
	<tr class = "linjetopp">
	<th id="i149939"    valign="top"  class="startKol">

<p class="entrya"><p id="i149940"><strong>Legemiddel</strong></p></p></th>
	<th id="i149941"    valign="top"  class="mellomKol">

<p class="entrya"><p id="i149942"><strong>MM kategori</strong></p></p></th>
	<th id="i149943"    valign="top"  class="sluttKol">

<p class="entrya"><p id="i149944"><strong>Dokumentasjon vedrørende bruk under amming</strong></p></p></th>
	</tr>
</thead>
<tbody>
<tr id="i149946" class="body likelinje">
	<td id="i149947"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i149948">Malation (hud)</p></p></td>
	<td id="i149949"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i149950">3</p></p></td>
	<td id="i149951"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149952">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i149953" class="body oddelinje">
	<td id="i149954"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i149955">Mannitol</p></p></td>
	<td id="i149956"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i149957">3</p></p></td>
	<td id="i149958"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149959">Kan brukes av ammende</p></p></td>
	</tr>
 <tr id="i149960" class="body likelinje">
	<td id="i149961"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i149962">Maraviroc</p></p></td>
	<td id="i149963"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i149964">5</p></p></td>
	<td id="i149965"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149966">Se antivirale midler  <a id="arowX145939" class="ref" href="../G/G8.htm#i145939" title="Antivirale midler">Antivirale midler</a></p></p></td>
	</tr>
 <tr id="i149967" class="body oddelinje">
	<td id="i149968"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i149969">Mebendazol</p></p></td>
	<td id="i149970"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i149971">0</p></p></td>
	<td id="i149972"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149973">Kan brukes av ammende. En rapport om laktasjonshemning</p></p></td>
	</tr>
 <tr id="i149974" class="body likelinje">
	<td id="i149975"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i149976">Mecasermin</p></p></td>
	<td id="i149977"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i149978">&#8211;</p></p></td>
	<td id="i149979"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149980">Ikke aktuelt til bruk hos ammende</p></p></td>
	</tr>
 <tr id="i149981" class="body oddelinje">
	<td id="i149982"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i149983">Mecillinam</p></p></td>
	<td id="i149984"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i149985">1</p></p></td>
	<td id="i149986"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149987">Se penicilliner  <a id="arowX151075" class="ref" href="../G/G8.htm#i151075" title="Penicilliner">Penicilliner</a></p></p></td>
	</tr>
 <tr id="i149988" class="body likelinje">
	<td id="i149989"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i149990">Medroksyprogesteron</p></p></td>
	<td id="i149991"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i149992"> </p></p>
<p class="entrya"><p id="i271905"> </p></p>
<p class="entrya"><p id="i271906">2</p></p>
<p class="entrya"><p id="i271911"> </p></p>
<p class="entrya"><p id="i271908">4</p></p></td>
	<td id="i149993"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i149994">Begrenset klinisk erfaring. I noen tilfeller kan melkeproduksjonen øke</p></p>	<UL type="circle">
		<LI id="i271903"><p id="i271904">Depotinjeksjoner med medroksyprogesteron gir lave konsentrasjoner i morsmelk og kan brukes i ammeperioden. Se p-piller  <a id="arowX151249" class="ref" href="../G/G8.htm#i151249" title="P-piller">P-piller</a></p><br>		</LI>
		<LI id="i271909"><p id="i271910">Ved høydosebehandling av kreft tilrådes tilbakeholdenhet med amming</p><br>		</LI>
	</UL>
</td>
	</tr>
 <tr id="i150013" class="body oddelinje">
	<td id="i150014"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150015">Meflokin</p></p></td>
	<td id="i150016"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i150017">3</p></p></td>
	<td id="i150018"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i150019">Overgang til morsmelk er moderat. Se antimalariamidler  <a id="arowX145897" class="ref" href="../G/G8.htm#i145897" title="Antimalariamidler">Antimalariamidler</a></p></p></td>
	</tr>
 <tr id="i150020" class="body likelinje">
	<td id="i150021"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150022">Megestrol</p></p></td>
	<td id="i150023"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i150024">4</p></p></td>
	<td id="i150025"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i150026">Ved høydosebehandling av kreft anbefales tilbakeholdenhet med amming</p></p></td>
	</tr>
 <tr id="i150027" class="body oddelinje">
	<td id="i150028"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150029">Meklozin</p></p></td>
	<td id="i150030"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i150031">3</p></p></td>
	<td id="i150032"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i150033">Opplysninger om overgang til morsmelk mangler. Bivirkninger hos brysternærte barn er rapportert. Bruk bør begrenses til det minimale ved amming. Se antihistaminer  <a id="arowX145840" class="ref" href="../G/G8.htm#i145840" title="Antihistaminer (H1-antagonister)">Antihistaminer (H1-antagonister)</a></p></p></td>
	</tr>
 <tr id="i150034" class="body likelinje">
	<td id="i150035"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150036">Meksiletin</p></p></td>
	<td id="i150037"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i150038">3</p></p></td>
	<td id="i150039"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i150040">Overgang til morsmelk er liten. Manglende klinisk erfaring</p></p></td>
	</tr>
 <tr id="i150041" class="body oddelinje">
	<td id="i150042"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150043">Melatonin</p></p></td>
	<td id="i150044"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i150045">3</p></p></td>
	<td id="i150046"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i150047">Opplysninger mangler. Endogen substans som finnes naturlig i melk</p></p></td>
	</tr>
 <tr id="i150048" class="body likelinje">
	<td id="i150049"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150050">Melfalan</p></p></td>
	<td id="i150051"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i150052">5</p></p></td>
	<td id="i150053"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i150054">Se cytostatika  <a id="arowX146868" class="ref" href="../G/G8.htm#i146868" title="Cytostatika">Cytostatika</a></p></p></td>
	</tr>
 <tr id="i150055" class="body oddelinje">
	<td id="i150056"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150057">Meloksikam</p></p></td>
	<td id="i150058"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i150059">3</p></p></td>
	<td id="i150060"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i150061">Opplysninger om overgang til morsmelk mangler. Se NSAID  <a id="arowX150698" class="ref" href="../G/G8.htm#i150698" title="NSAID">NSAID</a></p></p></td>
	</tr>
 <tr id="i150062" class="body likelinje">
	<td id="i150063"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150064">Memantin</p></p></td>
	<td id="i150065"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i150066">3</p></p></td>
	<td id="i150067"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i150068">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i150069" class="body oddelinje">
	<td id="i150070"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150071">Mepivakain</p></p></td>
	<td id="i150072"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i150073">2</p></p></td>
	<td id="i150074"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i150075">Til ammende foretrekkes bupivakain fremfor mepivakain. Se lokalanestetika  <a id="arowX149842" class="ref" href="../G/G8.htm#i149842" title="Lokalanestetika">Lokalanestetika</a></p></p></td>
	</tr>
 <tr id="i150076" class="body likelinje">
	<td id="i150077"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150078">Merkaptopurin</p></p></td>
	<td id="i150079"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i150080">3</p></p></td>
	<td id="i150081"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i150082">Se cytostatika  <a id="arowX146868" class="ref" href="../G/G8.htm#i146868" title="Cytostatika">Cytostatika</a></p></p></td>
	</tr>
 <tr id="i150083" class="body oddelinje">
	<td id="i150084"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150085">Meropenem</p></p></td>
	<td id="i150086"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i150087">3</p></p></td>
	<td id="i150088"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i150089">Opplysninger om overgang til morsmelk mangler. Se antibakterielle midler  <a id="arowX145756" class="ref" href="../G/G8.htm#i145756" title="Anestesimidler">Anestesimidler</a></p></p></td>
	</tr>
 <tr id="i150090" class="body likelinje">
	<td id="i150091"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150092">Mesalazin (= 5-ASA)</p></p></td>
	<td id="i150093"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i150094">3</p></p></td>
	<td id="i150095"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i150096">Se 5-ASA-preparater  <a id="arowX146032" class="ref" href="../G/G8.htm#i146032" title="5-ASA-preparater">5-ASA-preparater</a></p></p></td>
	</tr>
 <tr id="i150097" class="body oddelinje">
	<td id="i150098"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150099">Mesna</p></p></td>
	<td id="i150100"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i150101">3</p></p></td>
	<td id="i150102"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i150103">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i150104" class="body likelinje">
	<td id="i150105"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150106">Metadon</p></p></td>
	<td id="i150107"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i150108">3</p></p></td>
	<td id="i150109"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i150110">Overgang til morsmelk er liten. Dosen bør holdes lavest mulig. Barnet bør observeres for døsighet, pustevansker, irritabilitet, dårlig sugeevne og lav vektøkning, spesielt hvis barnet også er blitt eksponert under svangerskapet. Se opioidanalgetika  <a id="arowX150865" class="ref" href="../G/G8.htm#i150865" title="Opioidanalgetika">Opioidanalgetika</a></p></p></td>
	</tr>
 <tr id="i150111" class="body oddelinje">
	<td id="i150112"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150113">Metenamin</p></p></td>
	<td id="i150114"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i150115">2</p></p></td>
	<td id="i150116"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i150117">Passerer over i morsmelk, men det er ikke rapportert skadelig effekt i barnet</p></p></td>
	</tr>
 <tr id="i150118" class="body likelinje">
	<td id="i150119"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150120">Metformin</p></p></td>
	<td id="i150121"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i150122">1</p></p></td>
	<td id="i150123"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i150124">Overgang til morsmelk er minimal. Se antidiabetika, perorale  <a id="arowX145819" class="ref" href="../G/G8.htm#i145819" title="Antidiabetika, perorale">Antidiabetika, perorale</a></p></p></td>
	</tr>
 <tr id="i150125" class="body oddelinje">
	<td id="i150126"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150127">Metoklopramid</p></p></td>
	<td id="i150128"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i150129">2</p></p></td>
	<td id="i150130"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i150131">Overgang til morsmelk er liten. Sporadisk bruk under 45 mg/dag ansees som trygt. Kan øke melkeproduksjonen</p></p></td>
	</tr>
 <tr id="i150132" class="body likelinje">
	<td id="i150133"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150134">Metoksalen</p></p></td>
	<td id="i150135"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i150136">3</p></p></td>
	<td id="i150137"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i150138">Tilbakeholdenhet med PUVA-behandling til ammende mødre. Amming kan gjenopptas 24 timer etter avsluttet behandling</p></p></td>
	</tr>
 <tr id="i150139" class="body oddelinje">
	<td id="i150140"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150141">MetoksyPEG epoietin beta</p></p></td>
	<td id="i150142"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i150143">0</p></p></td>
	<td id="i150144"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i150145">Manglende klinisk erfaring</p></p></td>
	</tr>
 <tr id="i150146" class="body likelinje">
	<td id="i150147"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150148">Metoprolol</p></p></td>
	<td id="i150149"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i150150">3</p></p></td>
	<td id="i150151"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i150152">Overgang til morsmelk er minimal. Se betareseptorantagonister, adrenerge  <a id="arowX146361" class="ref" href="../G/G8.htm#i146361" title="Betareseptorantagonister, adrenerge">Betareseptorantagonister, adrenerge</a></p></p></td>
	</tr>
 <tr id="i150153" class="body oddelinje">
	<td id="i150154"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150155">Metotreksat</p></p></td>
	<td id="i150156"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i150157"> </p></p>
<p class="entrya"><p id="i271917">5</p></p>
<p class="entrya"><p id="i271919">3</p></p></td>
	<td id="i150158"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i150159">Overgang til morsmelk er minimal</p></p>	<UL type="circle">
		<LI id="i271915"><p id="i271916"><em>Som cytostatikum:</em> Bruk hos ammende frarådes pga. virkestoffets toksisitet</p><br>		</LI>
		<LI id="i271920"><p id="i271921">Immunsuppressiv behandling: Ved antirevmatisk behandling er amming ikke strengt kontraindisert, men amming bør utsettes en dag etter legemiddelinntak</p><br>		</LI>
	</UL>
</td>
	</tr>
 <tr id="i150178" class="body likelinje">
	<td id="i150179"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150180">Metronidazol </p></p></td>
	<td id="i150181"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i150182">3</p></p>
<p class="entrya"><p id="i271926"> </p></p>
<p class="entrya"><p id="i271927"> </p></p>
<p class="entrya"><p id="i271928"> </p></p>
<p class="entrya"><p id="i271932"> </p></p>
<p class="entrya"><p id="i271933"> </p></p>
<p class="entrya"><p id="i271929">2</p></p></td>
	<td id="i150183"    valign="top" width="51.7%" class="sluttKol">
	<UL type="circle">
		<LI id="i150185"><p id="i150186"><em>Systemisk bruk:</em> Overgang til morsmelk er moderat til høy. Kan brukes hos ammende i perorale doser på under 1,2 g daglig i kortere perioder (2 uker). Ved intravenøst bruk av metronidazol 500 mg x 3 daglig vil et opphold i ammingen på 2&#8211;3 timer etter administrasjon være tilstrekkelig. Se også antibakterielle midler  <a id="arowX145756" class="ref" href="../G/G8.htm#i145756" title="Anestesimidler">Anestesimidler</a>. Andre midler bør fortrinnsvis benyttes av ammende hvis det fins alternativer</p><br>		</LI>
		<LI id="i271930"><p id="i271931">Lokal bruk: Systemisk opptak er lavt. Kan brukes av ammende</p><br>		</LI>
	</UL>
</td>
	</tr>
 <tr id="i150196" class="body oddelinje">
	<td id="i150197"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150198">Metylaminolevulinat</p></p></td>
	<td id="i150199"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i150200">3</p></p></td>
	<td id="i150201"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i150202">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i150203" class="body likelinje">
	<td id="i150204"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150205">Metyldopa</p></p></td>
	<td id="i150206"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i150207">2</p></p></td>
	<td id="i150208"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i150209">Overgang til morsmelk er minimal. Se antihypertensiva  <a id="arowX145848" class="ref" href="../G/G8.htm#i145848" title="Antihypertensiva">Antihypertensiva</a></p></p></td>
	</tr>
 <tr id="i150210" class="body oddelinje">
	<td id="i150211"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150212">Metylfenidat</p></p></td>
	<td id="i150213"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i150214">4</p></p></td>
	<td id="i150215"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i150216">Opplysninger om overgang til morsmelk mangler. Risiko for påvirkning av brysternærte barn er til stede. Se amfetamin  <a id="arowX145615" class="ref" href="../G/G8.htm#i145615" title="Amfetamin">Amfetamin</a></p></p></td>
	</tr>
 <tr id="i150217" class="body likelinje">
	<td id="i150218"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i218852">Metylnaltrekson</p></p></td>
	<td id="i150219"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i150220">3</p></p></td>
	<td id="i150221"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i150222">Opplysninger mangler. Se naltrekson  <a id="arowX150460" class="ref" href="../G/G8.htm#i150460" title="Naltrekson">Naltrekson</a></p></p></td>
	</tr>
 <tr id="i150223" class="body oddelinje">
	<td id="i150224"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150225">Metylprednisolon</p></p></td>
	<td id="i150226"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i150227">3</p></p></td>
	<td id="i150228"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i150229">Opplysninger om overgang til morsmelk mangler. Se glukokortikoider  <a id="arowX148403" class="ref" href="../G/G8.htm#i148403" title="Glukokortikoider">Glukokortikoider</a></p></p></td>
	</tr>
 <tr id="i150230" class="body likelinje">
	<td id="i150231"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150232">Metylrosanilin</p></p></td>
	<td id="i150233"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i150234">0</p></p></td>
	<td id="i150235"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i150236">Lokalbehandling: Kan brukes av ammende. Alternativt preparat bør velges ved applikasjon på bryst hos ammende mødre pga. risiko for irritasjon i slimhinner hos spedbarnet</p></p></td>
	</tr>
 <tr id="i150237" class="body oddelinje">
	<td id="i150238"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150239">Mianserin</p></p></td>
	<td id="i150240"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i150241">3</p></p></td>
	<td id="i150242"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i150243">Overgang til morsmelk er liten. Pga. manglende erfaring hos ammende bør barnet observeres for legemiddeleffekter. Se antidepressiva  <a id="arowX145812" class="ref" href="../G/G8.htm#i145812" title="Antidepressiva">Antidepressiva</a></p></p></td>
	</tr>
 <tr id="i150244" class="body likelinje">
	<td id="i150245"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150246">Micafungin</p></p></td>
	<td id="i150247"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i150248">3</p></p></td>
	<td id="i150249"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i150250">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i150251" class="body oddelinje">
	<td id="i150252"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150253">Midazolam</p></p></td>
	<td id="i150254"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i150255">3</p></p></td>
	<td id="i150256"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i150257">Overgang til morsmelk er minimal. Morsmelken er fri for midazolam 4 timer etter inntak. Se benzodiazepiner  <a id="arowX146283" class="ref" href="../G/G8.htm#i146283" title="Benzodiazepiner">Benzodiazepiner</a></p></p></td>
	</tr>
 <tr id="i150258" class="body likelinje">
	<td id="i150259"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150260">Mifepriston</p></p></td>
	<td id="i150261"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i150262">3</p></p></td>
	<td id="i150263"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i150264">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i150265" class="body oddelinje">
	<td id="i150266"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150267">Miglitol</p></p></td>
	<td id="i150268"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i150269">3</p></p></td>
	<td id="i150270"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i150271">Opplysninger om overgang til morsmelk mangler. Se antidiabetika, perorale  <a id="arowX145819" class="ref" href="../G/G8.htm#i145819" title="Antidiabetika, perorale">Antidiabetika, perorale</a></p></p></td>
	</tr>
 <tr id="i150272" class="body likelinje">
	<td id="i150273"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150274">Mikonazol</p></p></td>
	<td id="i150275"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i150276">0</p></p></td>
	<td id="i150277"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i150278">Se fungicider til lokal bruk  <a id="arowX148164" class="ref" href="../G/G8.htm#i148164" title="Fungicider til lokal bruk">Fungicider til lokal bruk</a></p></p></td>
	</tr>
 <tr id="i150279" class="body oddelinje">
	<td id="i150280"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150281">Minoksidil (hud)</p></p></td>
	<td id="i150282"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i150283">0</p></p></td>
	<td id="i150284"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i150285">Lokalbehandling: Kan brukes av ammende ved bruk av terapeutiske doser</p></p></td>
	</tr>
 <tr id="i150286" class="body likelinje">
	<td id="i150287"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150288">Mirtazapin</p></p></td>
	<td id="i150289"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i150290">3</p></p></td>
	<td id="i150291"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i150292">Opplysninger om overgang til morsmelk mangler. Se antidepressiva  <a id="arowX145812" class="ref" href="../G/G8.htm#i145812" title="Antidepressiva">Antidepressiva</a></p></p></td>
	</tr>
 <tr id="i150293" class="body oddelinje">
	<td id="i150294"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150295">Misoprostol</p></p></td>
	<td id="i150296"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i150297">3</p></p></td>
	<td id="i150298"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i150299">Bruk bør begrenses til det minimale ved amming. Observer brysternærte barn for diaré og magesmerter. Kan muligens lette melkeutdrivelsen</p></p></td>
	</tr>
 <tr id="i150300" class="body likelinje">
	<td id="i150301"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150302">Mitoksantron</p></p></td>
	<td id="i150303"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i150304">5</p></p></td>
	<td id="i150305"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i150306">Se cytostatika  <a id="arowX146868" class="ref" href="../G/G8.htm#i146868" title="Cytostatika">Cytostatika</a></p></p></td>
	</tr>
 <tr id="i150307" class="body oddelinje">
	<td id="i150308"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150309">Mitomycin</p></p></td>
	<td id="i150310"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i150311">5</p></p></td>
	<td id="i150312"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i150313">Se cytostatika  <a id="arowX146868" class="ref" href="../G/G8.htm#i146868" title="Cytostatika">Cytostatika</a></p></p></td>
	</tr>
 <tr id="i150314" class="body likelinje">
	<td id="i150315"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150316">Mitotan</p></p></td>
	<td id="i150317"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i150318">3</p></p></td>
	<td id="i150319"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i150320">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i150328" class="body oddelinje">
	<td id="i150329"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150330">Mivakurium</p></p></td>
	<td id="i150331"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i150332">2</p></p></td>
	<td id="i150333"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i150334">Se nevromuskulære blokkere  <a id="arowX150558" class="ref" href="../G/G8.htm#i150558" title="Nevromuskulære blokkere">Nevromuskulære blokkere</a></p></p></td>
	</tr>
 <tr id="i150335" class="body likelinje">
	<td id="i150336"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150337">Modafinil</p></p></td>
	<td id="i150338"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i150339">3</p></p></td>
	<td id="i150340"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i150341">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i150342" class="body oddelinje">
	<td id="i150343"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150344">Moklobemid</p></p></td>
	<td id="i150345"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i150346">3</p></p></td>
	<td id="i150347"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i150348">Overgang til morsmelk er liten. Pga. manglende erfaring hos ammende bør barnet observeres for legemiddeleffekter. Se antidepressiva  <a id="arowX145812" class="ref" href="../G/G8.htm#i145812" title="Antidepressiva">Antidepressiva</a></p></p></td>
	</tr>
 <tr id="i150349" class="body likelinje">
	<td id="i150350"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150351">Moksonidin</p></p></td>
	<td id="i150352"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i150353">3</p></p></td>
	<td id="i150354"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i150355">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i150356" class="body oddelinje">
	<td id="i150357"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150358">Molgramostim</p></p></td>
	<td id="i150359"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i150360">0</p></p></td>
	<td id="i150361"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i150362">Erfaring med bruk hos ammende mangler. Ingen absorpsjon fra barnets mage-tarm-kanal</p></p></td>
	</tr>
 <tr id="i150363" class="body likelinje">
	<td id="i150364"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150365">Mometason</p></p></td>
	<td id="i150366"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i150367">2</p></p></td>
	<td id="i150368"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i150369">Opplysninger mangler. Se glukokortikoider, lokalbehandling  <a id="arowX148403" class="ref" href="../G/G8.htm#i148403" title="Glukokortikoider">Glukokortikoider</a></p></p></td>
	</tr>
 <tr id="i150370" class="body oddelinje">
	<td id="i150371"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150372"><em>Monoklonale antistoffer</em></p></p></td>
	<td id="i150373"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i150374">0, 3</p></p></td>
	<td id="i150375"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i150376">Immunglobuliner (IgG) utskilles i morsmelk, vesentlig de første dagene etter fødselen. Tilbakeholdenhet anbefales pga. mulig effekt på immunsystemet hos barnet</p></p></td>
	</tr>
 <tr id="i150377" class="body likelinje">
	<td id="i150378"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150379">Montelukast</p></p></td>
	<td id="i150380"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i150381">3</p></p></td>
	<td id="i150382"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i150383">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i150384" class="body oddelinje">
	<td id="i150385"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150386">Morfin</p></p></td>
	<td id="i150387"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i150388">2&#8211;3 avhengig av dosering og varighet for bruk</p></p></td>
	<td id="i150389"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i150390">Overgang til morsmelk er høy. Se opioidanalgetika  <a id="arowX150865" class="ref" href="../G/G8.htm#i150865" title="Opioidanalgetika">Opioidanalgetika</a></p></p></td>
	</tr>
 <tr id="i150391" class="body likelinje">
	<td id="i150392"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150393">Moroktokog alfa</p></p></td>
	<td id="i150394"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i150395">0</p></p></td>
	<td id="i150396"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i150397">Ingen klinisk erfaring</p></p></td>
	</tr>
 <tr id="i150398" class="body oddelinje">
	<td id="i150399"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150400">Muromonab-CD3</p></p></td>
	<td id="i150401"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i150402">0</p></p></td>
	<td id="i150403"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i150404">Opplysninger mangler. Se monoklonale antistoffer  <a id="arowX150370" class="ref" href="../G/G8.htm#i150370" title="Monoklonale antistoffer">Monoklonale antistoffer</a></p></p></td>
	</tr>
 <tr id="i150405" class="body likelinje">
	<td id="i150406"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150407"><em>Muskelrelakserende midler, perifert virkende</em></p></p></td>
	<td id="i150408"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i150409">2</p></p></td>
	<td id="i150410"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i150411">Se nevromuskulære blokkere  <a id="arowX150558" class="ref" href="../G/G8.htm#i150558" title="Nevromuskulære blokkere">Nevromuskulære blokkere</a></p></p></td>
	</tr>
 <tr id="i150412" class="body oddelinje">
	<td id="i150413"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150414">Mykofenolat</p></p></td>
	<td id="i150415"    valign="top" width="19.2%" class="mellomKol">

<p class="entrya"><p id="i150416">4</p></p></td>
	<td id="i150417"    valign="top" width="51.7%" class="sluttKol">

<p class="entrya"><p id="i150418">Opplysninger mangler. Se immunsuppressive midler  <a id="arowX148847" class="ref" href="../G/G8.htm#i148847" title="Immunsuppressive midler">Immunsuppressive midler</a></p></p></td>
	</tr>
 </tbody></table>
 <table id="i150420" width="100%" class="maintable" border="0" cellpadding="5" cellspacing="0">
 <caption> <Uth Id="NUTHid2330647" Type="Halvfet">N</Uth></caption> <thead>
	<tr class = "linjetopp">
	<th id="i150428"  colspan="3"  valign="top"  class="sluttKol">

<p class="entrya"><p id="i150429">Overgang til morsmelk angis som minimal (< 2 %), liten (2&#8211;5 %), moderat (5&#8211;10 %) eller høy (10&#8211;50 %) basert på fraksjon av morens dose/kg kroppsvekt som barnet tilføres. (Barnets relative dose.)&ML;						Over 3&#8211;4 ukers bruk ansees som langtidsbehandling.</p></p></th>
	</tr>
	<tr class = "linjetopp">
	<th id="i150432"    valign="top"  class="startKol">

<p class="entrya"><p id="i150433"><strong>Legemiddel</strong></p></p></th>
	<th id="i150434"    valign="top"  class="mellomKol">

<p class="entrya"><p id="i150435"><strong>MM kategori</strong></p></p></th>
	<th id="i150436"    valign="top"  class="sluttKol">

<p class="entrya"><p id="i150437"><strong>Dokumentasjon vedrørende bruk under amming</strong></p></p></th>
	</tr>
</thead>
<tbody>
<tr id="i150439" class="body likelinje">
	<td id="i150440"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150441">Nabumeton</p></p></td>
	<td id="i150442"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i150443">3</p></p></td>
	<td id="i150444"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i150445">Opplysninger om overgang til morsmelk mangler. Se NSAID  <a id="arowX150698" class="ref" href="../G/G8.htm#i150698" title="NSAID">NSAID</a></p></p></td>
	</tr>
 <tr id="i150446" class="body oddelinje">
	<td id="i150447"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150448">Nafarelin</p></p></td>
	<td id="i150449"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i150450">0</p></p></td>
	<td id="i150451"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i150452">Se GnRH-analoger  <a id="arowX148458" class="ref" href="../G/G8.htm#i148458" title="GnRH-analoger">GnRH-analoger</a></p></p></td>
	</tr>
 <tr id="i150453" class="body likelinje">
	<td id="i150454"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150455">Nalokson</p></p></td>
	<td id="i150456"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i150457">3</p></p></td>
	<td id="i150458"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i150459">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i150460" class="body oddelinje">
	<td id="i150461"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150462">Naltrekson</p></p></td>
	<td id="i150463"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i150464">2</p></p></td>
	<td id="i150465"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i150466">Overgang til morsmelk er minimal. Teoretisk mulighet for påvirkning av melkeutdrivelsen</p></p></td>
	</tr>
 <tr id="i150467" class="body likelinje">
	<td id="i150468"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150469">Nandrolon</p></p></td>
	<td id="i150470"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i150471">5</p></p></td>
	<td id="i150472"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i150473">Bruk hos ammende frarådes pga. mulig anabol effekt på barnet</p></p></td>
	</tr>
 <tr id="i150474" class="body oddelinje">
	<td id="i150475"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150476">Naproksen</p></p></td>
	<td id="i150477"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i150478">2</p></p></td>
	<td id="i150479"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i150480">Overgang til morsmelk er minimal. Unngå langtidsbruk. Se NSAID  <a id="arowX150698" class="ref" href="../G/G8.htm#i150698" title="NSAID">NSAID</a></p></p></td>
	</tr>
 <tr id="i150481" class="body likelinje">
	<td id="i150482"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150483">Naratriptan</p></p></td>
	<td id="i150484"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i150485">3</p></p></td>
	<td id="i150486"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i150487">Opplysninger om overgang til morsmelk mangler. Se triptaner  <a id="arowX152605" class="ref" href="../G/G8.htm#i152605" title="Triptaner">Triptaner</a></p></p></td>
	</tr>
 <tr id="i150488" class="body oddelinje">
	<td id="i150489"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150490">Natalizumab</p></p></td>
	<td id="i150491"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i150492"> </p></p></td>
	<td id="i150493"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i150494">Opplysninger om overgang til morsmelk mangler. Se immunsuppressive midler  <a id="arowX148847" class="ref" href="../G/G8.htm#i148847" title="Immunsuppressive midler">Immunsuppressive midler</a></p></p></td>
	</tr>
 <tr id="i150495" class="body likelinje">
	<td id="i150496"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150497">Nateglinid</p></p></td>
	<td id="i150498"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i150499">3</p></p></td>
	<td id="i150500"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i150501">Opplysninger om overgang til morsmelk mangler. Se antidiabetika, perorale  <a id="arowX145819" class="ref" href="../G/G8.htm#i145819" title="Antidiabetika, perorale">Antidiabetika, perorale</a></p></p></td>
	</tr>
 <tr id="i150502" class="body oddelinje">
	<td id="i150503"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150504">Natriumoksybat</p></p></td>
	<td id="i150505"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i150506">4</p></p></td>
	<td id="i150507"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i150508">Bør ikke brukes av ammende pga. mulig respirasjonhemmende effekt hos diebarnet</p></p></td>
	</tr>
 <tr id="i150509" class="body likelinje">
	<td id="i150510"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150511">Nedokromil</p></p></td>
	<td id="i150512"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i150513">2</p></p></td>
	<td id="i150514"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i150515">Øyedråper: Kan brukes av ammende</p></p></td>
	</tr>
 <tr id="i150523" class="body oddelinje">
	<td id="i150524"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150525">Nelarabin</p></p></td>
	<td id="i150526"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i150527">5</p></p></td>
	<td id="i150528"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i150529">Se cytostatika  <a id="arowX146868" class="ref" href="../G/G8.htm#i146868" title="Cytostatika">Cytostatika</a></p></p></td>
	</tr>
 <tr id="i150530" class="body likelinje">
	<td id="i150531"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150532">Neomycin</p></p></td>
	<td id="i150533"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i150534">0</p></p></td>
	<td id="i150535"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i150536">Lokalbehandling: Kan brukes av ammende</p></p></td>
	</tr>
 <tr id="i150537" class="body oddelinje">
	<td id="i150538"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150539">Neostigmin</p></p></td>
	<td id="i150540"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i150541">0</p></p></td>
	<td id="i150542"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i150543">Klinisk erfaring mangler</p></p></td>
	</tr>
 <tr id="i150544" class="body likelinje">
	<td id="i150545"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150546">Nevirapin</p></p></td>
	<td id="i150547"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i150548">5</p></p></td>
	<td id="i150549"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i150550">Se antivirale midler  <a id="arowX145939" class="ref" href="../G/G8.htm#i145939" title="Antivirale midler">Antivirale midler</a></p></p></td>
	</tr>
 <tr id="i150551" class="body oddelinje">
	<td id="i150552"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150553"><em>Nevroleptika</em></p></p></td>
	<td id="i150554"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i150555">3, 4</p></p></td>
	<td id="i150556"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i150557">Se antipsykotika  <a id="arowX145918" class="ref" href="../G/G8.htm#i145918" title="Antipsykotika">Antipsykotika</a></p></p></td>
	</tr>
 <tr id="i150558" class="body likelinje">
	<td id="i150559"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150560"><em>Nevromuskulære blokkere</em></p></p></td>
	<td id="i150561"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i150562">2</p></p></td>
	<td id="i150563"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i150564">Opplysninger om overgang til morsmelk mangler, men forventes å være liten. Tidspunkt for amming etter inngrepet bør reguleres etter hvilket middel (plasmahalveringstid) som er blitt brukt. Som regel kan amming gjenopptas når det er praktisk mulig etter et kirurgisk inngrep</p></p></td>
	</tr>
 <tr id="i150565" class="body oddelinje">
	<td id="i150566"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150567">Nifedipin</p></p></td>
	<td id="i150568"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i150569">2</p></p></td>
	<td id="i150570"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i150571">Overgang til morsmelk er minimal. Se kalsiumantagonister  <a id="arowX149110" class="ref" href="../G/G8.htm#i149110" title="Kalsiumantagonister">Kalsiumantagonister</a></p></p></td>
	</tr>
 <tr id="i150572" class="body likelinje">
	<td id="i150573"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150574">Niklosamid</p></p></td>
	<td id="i150575"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i150576">3</p></p></td>
	<td id="i150577"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i150578">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i150579" class="body oddelinje">
	<td id="i150580"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150581">Nikotin</p></p></td>
	<td id="i150582"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i150583">2</p></p></td>
	<td id="i150584"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i150585">Overgang til morsmelk er moderat. Amming frarådes ikke hos moderate røykere. Kan nedsette melkeproduksjonen. Økt forekomst av kolikk. Andre substanser i tobakk går også over i morsmelken. Derfor kan nikotinplaster og -tyggegummi ansees som tryggere enn sigaretter. Disse preparatene gir også lavere nikotinnivå i morsmelken</p></p></td>
	</tr>
 <tr id="i150586" class="body likelinje">
	<td id="i150587"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150588">Nikotinsyre</p></p></td>
	<td id="i150589"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i150590">3</p></p></td>
	<td id="i150591"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i150592">Nikotinsyre er rapportert å forekomme i morsmelk. Ammende bør ikke overskride doser på 20 mg daglig. Brukt i lipidsenkende doser er det risiko for bivirkninger hos barnet ved amming</p></p></td>
	</tr>
 <tr id="i150593" class="body oddelinje">
	<td id="i150594"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150595">Nilotinib</p></p></td>
	<td id="i150596"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i150597">3</p></p></td>
	<td id="i150598"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i150599">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i150607" class="body likelinje">
	<td id="i150608"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150609">Nimodipin</p></p></td>
	<td id="i150610"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i150611">2</p></p></td>
	<td id="i150612"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i150613">Overgang til morsmelk er minimal. Se kalsiumantagonister  <a id="arowX149110" class="ref" href="../G/G8.htm#i149110" title="Kalsiumantagonister">Kalsiumantagonister</a></p></p></td>
	</tr>
 <tr id="i150621" class="body oddelinje">
	<td id="i150622"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150623">Nitazoxanid</p></p></td>
	<td id="i150624"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i150625">3</p></p></td>
	<td id="i150626"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i150627">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i150628" class="body likelinje">
	<td id="i150629"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150630">Nitrazepam</p></p></td>
	<td id="i150631"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i150632">3</p></p></td>
	<td id="i150633"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i150634">Overgang til morsmelk er liten, også ved gjentatte doser. Se benzodiazepiner  <a id="arowX146283" class="ref" href="../G/G8.htm#i146283" title="Benzodiazepiner">Benzodiazepiner</a></p></p></td>
	</tr>
 <tr id="i150635" class="body oddelinje">
	<td id="i150636"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150637">Nitrofurantoin</p></p></td>
	<td id="i150638"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i150639">2</p></p></td>
	<td id="i150640"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i150641">Overgang til morsmelk er minimal. Kan brukes av ammende</p></p></td>
	</tr>
 <tr id="i150642" class="body likelinje">
	<td id="i150643"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150644">Nitroprussid</p></p></td>
	<td id="i150645"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i150646">3</p></p></td>
	<td id="i150647"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i150648">Opplysninger mangler. Bruk bør unngås hos ammende pga. virkestoffets toksisitet</p></p></td>
	</tr>
 <tr id="i320119" class="body oddelinje">
	<td id="i320120"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i320121">Nomegestrol</p></p></td>
	<td id="i320122"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i320123">3</p></p></td>
	<td id="i320124"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i320125">Manglende klinisk erfaring. Se p-piller, østrogenholdige preparater <a id="aentryX151250" class="ref" href="../G/G8.htm#i151250" title="P-piller">P-piller</a> </p></p></td>
	</tr>
 <tr id="i150656" class="body likelinje">
	<td id="i150657"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150658">Noradrenalin</p></p></td>
	<td id="i150659"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i150660">3</p></p></td>
	<td id="i150661"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i150662">Se adrenalin  <a id="arowX145461" class="ref" href="../G/G8.htm#i145461" title="Adrenalin">Adrenalin</a></p></p></td>
	</tr>
 <tr id="i150663" class="body oddelinje">
	<td id="i150664"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150665">Norelgestromin</p></p></td>
	<td id="i150666"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i150667">3</p></p></td>
	<td id="i150668"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i150669">Begrenset klinisk erfaring. Se p-piller  <a id="arowX151249" class="ref" href="../G/G8.htm#i151249" title="P-piller">P-piller</a></p></p></td>
	</tr>
 <tr id="i150670" class="body likelinje">
	<td id="i150671"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150672">Noretisteron</p></p></td>
	<td id="i150673"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i150674">2</p></p></td>
	<td id="i150675"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i150676">Overgang til morsmelk er minimal. Se p-piller  <a id="arowX151249" class="ref" href="../G/G8.htm#i151249" title="P-piller">P-piller</a></p></p></td>
	</tr>
 <tr id="i150677" class="body oddelinje">
	<td id="i150678"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150679">Norgestrel</p></p></td>
	<td id="i150680"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i150681">2</p></p></td>
	<td id="i150682"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i150683">Overgang til morsmelk er liten. Se p-piller  <a id="arowX151249" class="ref" href="../G/G8.htm#i151249" title="P-piller">P-piller</a></p></p></td>
	</tr>
 <tr id="i150684" class="body likelinje">
	<td id="i150685"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150686">Nortriptylin</p></p></td>
	<td id="i150687"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i150688">2</p></p></td>
	<td id="i150689"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i150690">Overgang til morsmelk er minimal. Doser < 150 mg kan brukes i 2&#8211;3 uker. Se trisykliske antidepressiva  <a id="arowX152619" class="ref" href="../G/G8.htm#i152619" title="Trisykliske antidepressiva (TCA)">Trisykliske antidepressiva (TCA)</a></p></p></td>
	</tr>
 <tr id="i150691" class="body oddelinje">
	<td id="i150692"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150693">Noskapin</p></p></td>
	<td id="i150694"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i150695">2</p></p></td>
	<td id="i150696"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i150697">Opplysninger om overgang til morsmelk mangler. Lang erfaring tilsier at noskapin kan brukes sporadisk av ammende</p></p></td>
	</tr>
 <tr id="i150698" class="body likelinje">
	<td id="i150699"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150700"><em>NSAID</em></p></p></td>
	<td id="i150701"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i150702">1, 2, 3</p></p></td>
	<td id="i150703"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i150704">Ingen av de vanligste ikke-steroide antiinflammatoriske midlene synes å overføres i mengder som gir farmakologiske effekter hos det brysternærte barnet ved bruk av høye enkeltdoser eller middelshøye doser som vedlikeholdsbehandling. Ved valget mellom flere NSAID er kort plasmahalveringstid og lav toksisitet av størst betydning. Ibuprofen og diklofenak er førstevalg</p></p></td>
	</tr>
 <tr id="i150705" class="body oddelinje">
	<td id="i150706"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150707">Nystatin</p></p></td>
	<td id="i150708"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i150709">0</p></p></td>
	<td id="i150710"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i150711">Kan brukes av ammende</p></p></td>
	</tr>
 </tbody></table>
 <table id="i150713" width="100%" class="maintable" border="0" cellpadding="5" cellspacing="0">
 <caption> <Uth Id="NUTHid2331357" Type="Halvfet">O</Uth></caption> <thead>
	<tr class = "linjetopp">
	<th id="i150721"  colspan="3"  valign="top"  class="sluttKol">

<p class="entrya"><p id="i150722">Overgang til morsmelk angis som minimal (< 2 %), liten (2&#8211;5 %), moderat (5&#8211;10 %) eller høy (10&#8211;50 %) basert på fraksjon av morens dose/kg kroppsvekt som barnet tilføres. (Barnets relative dose.)&ML;						Over 3&#8211;4 ukers bruk ansees som langtidsbehandling.</p></p></th>
	</tr>
	<tr class = "linjetopp">
	<th id="i150725"    valign="top"  class="startKol">

<p class="entrya"><p id="i150726"><strong>Legemiddel</strong></p></p></th>
	<th id="i150727"    valign="top"  class="mellomKol">

<p class="entrya"><p id="i150728"><strong>MM kategori</strong></p></p></th>
	<th id="i150729"    valign="top"  class="sluttKol">

<p class="entrya"><p id="i150730"><strong>Dokumentasjon vedrørende bruk under amming</strong></p></p></th>
	</tr>
</thead>
<tbody>
<tr id="i150732" class="body likelinje">
	<td id="i150733"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150734">Ofatumumab</p></p></td>
	<td id="i150735"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i150736">3</p></p></td>
	<td id="i150737"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i150738">Opplysninger om overgang til morsmelk mangler. Immunglobuliner utskilles i morsmelk. Tilbakeholdenhet anbefales pga. en mulig effekt på immunsystemet</p></p></td>
	</tr>
 <tr id="i221866" class="body oddelinje">
	<td id="i221867"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i221868">Ofloksacin </p></p></td>
	<td id="i221869"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i221870">2 </p></p></td>
	<td id="i221871"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i221872">Overgang til morsmelk er liten. Se fluorokinoloner  <a id="arowX148025" class="ref" href="../G/G8.htm#i148025" title="Fluorokinoloner">Fluorokinoloner</a></p></p></td>
	</tr>
 <tr id="i150739" class="body likelinje">
	<td id="i150740"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150741">Oksaliplatin</p></p></td>
	<td id="i150742"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i150743">5</p></p></td>
	<td id="i150744"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i150745">Se cytostatika  <a id="arowX146868" class="ref" href="../G/G8.htm#i146868" title="Cytostatika">Cytostatika</a></p></p></td>
	</tr>
 <tr id="i150746" class="body oddelinje">
	<td id="i150747"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150748">Oksazepam</p></p></td>
	<td id="i150749"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i150750">3</p></p></td>
	<td id="i150751"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i150752">Overgang til morsmelk er minimal. Se benzodiazepiner  <a id="arowX146283" class="ref" href="../G/G8.htm#i146283" title="Benzodiazepiner">Benzodiazepiner</a></p></p></td>
	</tr>
 <tr id="i150753" class="body likelinje">
	<td id="i150754"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150755">Okskarbazepin</p></p></td>
	<td id="i150756"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i150757">3</p></p></td>
	<td id="i150758"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i150759">Se antiepileptika  <a id="arowX145833" class="ref" href="../G/G8.htm#i145833" title="Antiepileptika">Antiepileptika</a></p></p></td>
	</tr>
 <tr id="i150760" class="body oddelinje">
	<td id="i150761"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150762">Oksybuprokain</p></p></td>
	<td id="i150763"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i150764">2</p></p></td>
	<td id="i150765"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i150766">Øyedråper: Kan brukes av ammende</p></p></td>
	</tr>
 <tr id="i150767" class="body likelinje">
	<td id="i150768"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150769">Oksybutynin</p></p></td>
	<td id="i150770"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i150771">3</p></p></td>
	<td id="i150772"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i150773">Opplysninger mangler. Mulig risiko for antikolinerge effekter hos brysternærte barn</p></p></td>
	</tr>
 <tr id="i150774" class="body oddelinje">
	<td id="i150775"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150776">Oksykodon</p></p></td>
	<td id="i150777"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i150778">3</p></p></td>
	<td id="i150779"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i150780">Overgang til morsmelk er liten. Observer for sedasjon. Liten klinisk erfaring</p></p></td>
	</tr>
 <tr id="i150781" class="body likelinje">
	<td id="i150782"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150783">Oksymetazolin</p></p></td>
	<td id="i150784"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i150785">2</p></p></td>
	<td id="i150786"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i150787">Nesespray: Kan brukes av ammende</p></p></td>
	</tr>
 <tr id="i150788" class="body oddelinje">
	<td id="i150789"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150790">Oksytetrasyklin</p></p></td>
	<td id="i150791"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i150792">3</p></p></td>
	<td id="i150793"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i150794">Se tetrasykliner  <a id="arowX152325" class="ref" href="../G/G8.htm#i152325" title="Tetrasykliner">Tetrasykliner</a></p></p></td>
	</tr>
 <tr id="i150795" class="body likelinje">
	<td id="i150796"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150797">Oksytocin</p></p></td>
	<td id="i150798"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i150799">2</p></p></td>
	<td id="i150800"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i150801">Stimulerer tømmingen av brystet. Brukes ved ammeproblemer pga. dårlig utdrivningsrefleks, tilstoppede melkeganger, såre brystknopper og som hjelpemiddel ved tømming med pumpe. Bør ikke brukes ved normal amming</p></p></td>
	</tr>
 <tr id="i221982" class="body oddelinje">
	<td id="i221983"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i221984">Oktokog alfa (rekombinant koagulasjonsfaktor VIII) </p></p></td>
	<td id="i221985"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i221986">0 </p></p></td>
	<td id="i221987"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i221988">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i150802" class="body likelinje">
	<td id="i150803"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150804">Oktreotid</p></p></td>
	<td id="i150805"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i150806">0</p></p></td>
	<td id="i150807"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i150808">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i150809" class="body oddelinje">
	<td id="i150810"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150811">Olanzapin</p></p></td>
	<td id="i150812"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i150813">3</p></p></td>
	<td id="i150814"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i150815">Overgang til morsmelk er minimal. Se antipsykotika  <a id="arowX145918" class="ref" href="../G/G8.htm#i145918" title="Antipsykotika">Antipsykotika</a></p></p></td>
	</tr>
 <tr id="i150816" class="body likelinje">
	<td id="i150817"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150818">Olmesartan</p></p></td>
	<td id="i150819"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i150820">3</p></p></td>
	<td id="i150821"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i150822">Se angiotensin II-reseptorantagonister  <a id="arowX145763" class="ref" href="../G/G8.htm#i145763" title="Angiotensin II-reseptorantagonister">Angiotensin II-reseptorantagonister</a></p></p></td>
	</tr>
 <tr id="i150823" class="body oddelinje">
	<td id="i150824"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150825">Olopatadin</p></p></td>
	<td id="i150826"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i150827">3</p></p></td>
	<td id="i150828"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i150829">Øyedråper: Farmakokinetiske egenskaper tilsier minimal eksponering av diebarnet. Klinisk erfaring mangler</p></p></td>
	</tr>
 <tr id="i150830" class="body likelinje">
	<td id="i150831"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150832">Olsalazin</p></p></td>
	<td id="i150833"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i150834">3</p></p></td>
	<td id="i150835"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i150836">Se 5-ASA-preparater  <a id="arowX146032" class="ref" href="../G/G8.htm#i146032" title="5-ASA-preparater">5-ASA-preparater</a></p></p></td>
	</tr>
 <tr id="i150837" class="body oddelinje">
	<td id="i150838"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150839">Omalizumab</p></p></td>
	<td id="i150840"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i150841">3</p></p></td>
	<td id="i150842"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i150843">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i150844" class="body likelinje">
	<td id="i150845"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150846">Omega-3-fettsyreestere</p></p></td>
	<td id="i150847"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i150848">1</p></p></td>
	<td id="i150849"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i150850">Kan brukes av ammende</p></p></td>
	</tr>
 <tr id="i150851" class="body oddelinje">
	<td id="i150852"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150853">Omeprazol</p></p></td>
	<td id="i150854"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i150855">2</p></p></td>
	<td id="i150856"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i150857">Se protonpumpehemmere  <a id="arowX151433" class="ref" href="../G/G8.htm#i151433" title="Protonpumpehemmere">Protonpumpehemmere</a></p></p></td>
	</tr>
 <tr id="i150858" class="body likelinje">
	<td id="i150859"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150860">Ondansetron</p></p></td>
	<td id="i150861"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i150862">3</p></p></td>
	<td id="i150863"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i150864">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i150865" class="body oddelinje">
	<td id="i150866"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150867"><em>Opioidanalgetika</em></p></p></td>
	<td id="i150868"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i150869">2 &#x2013;&ML;	enkeltdose&ML;	3 &#x2013;&ML;	gjentatte doser</p></p></td>
	<td id="i150873"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i150874">Ved bruk av gjentatte doser opioidanalgetika er det risiko for legemiddeleffekter på det brysternærte barnet. Dette gjelder spesielt hvis barnet i tillegg er blitt eksponert i tredje trimester eller er < 2 måneder gammelt. Ved langtidsbruk bør barnet observeres for døsighet, dårlig sugeevne og hypotoni. Apné, cyanose og bradykardi er blitt rapportert hos brysternærte barn. Langtidseffekter på kognitiv og psykomotorisk utvikling kan ikke utelukkes</p></p></td>
	</tr>
 <tr id="i150875" class="body likelinje">
	<td id="i150876"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150877">Orfenadrin</p></p></td>
	<td id="i150878"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i150879">3</p></p></td>
	<td id="i150880"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i150881">Opplysninger mangler. Se atropin  <a id="arowX146095" class="ref" href="../G/G8.htm#i146095" title="Atropin">Atropin</a></p></p></td>
	</tr>
 <tr id="i150882" class="body oddelinje">
	<td id="i150883"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150884">Organo-heparinoid</p></p></td>
	<td id="i150885"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i150886">2</p></p></td>
	<td id="i150887"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i150888">Lokalbehandling: Kan brukes av ammende</p></p></td>
	</tr>
 <tr id="i150889" class="body likelinje">
	<td id="i150890"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150891">Orlistat</p></p></td>
	<td id="i150892"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i150893">0</p></p></td>
	<td id="i150894"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i150895">Kan brukes av ammende</p></p></td>
	</tr>
 <tr id="i150896" class="body oddelinje">
	<td id="i150897"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150898">Oseltamivir</p></p></td>
	<td id="i150899"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i150900">3</p></p></td>
	<td id="i150901"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i150902">Klinisk erfaring og opplysninger om overgang til morsmelk mangler</p></p></td>
	</tr>
 <tr id="i320091" class="body likelinje">
	<td id="i320092"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i320093">Oteracil</p></p></td>
	<td id="i320094"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i320095">5</p></p></td>
	<td id="i320096"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i320097">Se cytostatika <a id="aentryX146869" class="ref" href="../G/G8.htm#i146869" title="Cytostatika">Cytostatika</a> </p></p></td>
	</tr>
 </tbody></table>
 <table id="i150904" width="100%" class="maintable" border="0" cellpadding="5" cellspacing="0">
 <caption> <Uth Id="NUTHid2332149O150905" Type="Halvfet">P</Uth></caption> <thead>
	<tr class = "linjetopp">
	<th id="i150912"  colspan="3"  valign="top"  class="sluttKol">

<p class="entrya"><p id="i150913">Overgang til morsmelk angis som minimal (< 2 %), liten (2&#x2013;5 %), moderat (5&#x2013;10 %) eller høy (10&#x2013;50 %) basert på fraksjon av morens dose/kg kroppsvekt som barnet tilføres. (Barnets relative dose.)&ML;						Over 3&#x2013;4 ukers bruk ansees som langtidsbehandling.</p></p></th>
	</tr>
	<tr class = "linjetopp">
	<th id="i150916"    valign="top"  class="startKol">

<p class="entrya"><p id="i150917"><strong>Legemiddel</strong></p></p></th>
	<th id="i150918"    valign="top"  class="mellomKol">

<p class="entrya"><p id="i150919"><strong>MM kategori</strong></p></p></th>
	<th id="i150920"    valign="top"  class="sluttKol">

<p class="entrya"><p id="i150921"><strong>Dokumentasjon vedrørende bruk under amming</strong></p></p></th>
	</tr>
</thead>
<tbody>
<tr id="i150923" class="body likelinje">
	<td id="i150924"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150925">Paklitaxel</p></p></td>
	<td id="i150926"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i150927">5</p></p></td>
	<td id="i150928"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i150929">Se cytostatika  <a id="arowX146868" class="ref" href="../G/G8.htm#i146868" title="Cytostatika">Cytostatika</a></p></p></td>
	</tr>
 <tr id="i150930" class="body oddelinje">
	<td id="i150931"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150932">Palifermin</p></p></td>
	<td id="i150933"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i150934">3</p></p></td>
	<td id="i150935"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i150936">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i150937" class="body likelinje">
	<td id="i150938"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150939">Paliperidon</p></p></td>
	<td id="i150940"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i150941">3</p></p></td>
	<td id="i150942"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i150943">Opplysninger mangler. Se antipsykotika  <a id="arowX145918" class="ref" href="../G/G8.htm#i145918" title="Antipsykotika">Antipsykotika</a></p></p></td>
	</tr>
 <tr id="i150944" class="body oddelinje">
	<td id="i150945"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150946">Palivizumab</p></p></td>
	<td id="i150947"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i150948">3</p></p></td>
	<td id="i150949"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i150950">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i150951" class="body likelinje">
	<td id="i150952"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150953">Palonosetron</p></p></td>
	<td id="i150954"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i150955">3</p></p></td>
	<td id="i150956"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i150957">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i150958" class="body oddelinje">
	<td id="i150959"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150960">Pamidronat</p></p></td>
	<td id="i150961"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i150962">0</p></p></td>
	<td id="i150963"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i150964">Ingen overgang til morsmelk etter intravenøs injeksjon av pamidronat hos en ammende. Se bisfosfonater  <a id="arowX146417" class="ref" href="../G/G8.htm#i146417" title="Bisfosfonater">Bisfosfonater</a></p></p></td>
	</tr>
 <tr id="i223563" class="body likelinje">
	<td id="i223564"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i223565">Panitumumab </p></p></td>
	<td id="i223566"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i223567">3 </p></p></td>
	<td id="i223568"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i223569">Opplysninger om overgang til morsmelk mangler. Immunglobuliner utskilles i morsmelk. Tilbakeholdenhet anbefales pga. virkningsmekanismen</p></p></td>
	</tr>
 <tr id="i150965" class="body oddelinje">
	<td id="i150966"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150967"><em>Pankreasenzymer</em></p></p></td>
	<td id="i150968"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i150969">0</p></p></td>
	<td id="i150970"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i150971">Kan brukes av ammende</p></p></td>
	</tr>
 <tr id="i150972" class="body likelinje">
	<td id="i150973"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150974">Pankuron</p></p></td>
	<td id="i150975"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i150976">2</p></p></td>
	<td id="i150977"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i150978">Se nevromuskulære blokkere  <a id="arowX150558" class="ref" href="../G/G8.htm#i150558" title="Nevromuskulære blokkere">Nevromuskulære blokkere</a></p></p></td>
	</tr>
 <tr id="i150979" class="body oddelinje">
	<td id="i150980"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150981">Pantoprazol</p></p></td>
	<td id="i150982"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i150983">2</p></p></td>
	<td id="i150984"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i150985">Overgang til morsmelk er minimal. Se protonpumpehemmere  <a id="arowX151433" class="ref" href="../G/G8.htm#i151433" title="Protonpumpehemmere">Protonpumpehemmere</a></p></p></td>
	</tr>
 <tr id="i150986" class="body likelinje">
	<td id="i150987"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150988">Papillomavirusvaksine, human</p></p></td>
	<td id="i150989"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i150990">2</p></p></td>
	<td id="i150991"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i218853">Begrenset klinisk erfaring hos ammende</p></p></td>
	</tr>
 <tr id="i150992" class="body oddelinje">
	<td id="i150993"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i150994">Paracetamol</p></p></td>
	<td id="i150995"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i150996">1</p></p></td>
	<td id="i150997"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i150998">Overgang til morsmelk er liten til moderat. Førstehåndsvalg blant smertestillende midler til ammende</p></p></td>
	</tr>
 <tr id="i150999" class="body likelinje">
	<td id="i151000"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i151001">Parafin, flytende</p></p></td>
	<td id="i151002"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i151003">0</p></p></td>
	<td id="i151004"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i151005">Se laksantia  <a id="arowX149606" class="ref" href="../G/G8.htm#i149606" title="Laksantia">Laksantia</a></p></p></td>
	</tr>
 <tr id="i151006" class="body oddelinje">
	<td id="i151007"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i151008">Parathyreoideahormon</p></p></td>
	<td id="i151009"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i218854">&#x2013;</p></p></td>
	<td id="i151010"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i151011">Ikke relevant til bruk hos ammende</p></p></td>
	</tr>
 <tr id="i151012" class="body likelinje">
	<td id="i151013"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i151014">Parekoksib</p></p></td>
	<td id="i151015"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i151016">3</p></p></td>
	<td id="i151017"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i151018">Opplysninger om overgang til morsmelk mangler. Se COX-2-hemmere  <a id="arowX146801" class="ref" href="../G/G8.htm#i146801" title="COX-2-hemmere">COX-2-hemmere</a></p></p></td>
	</tr>
 <tr id="i151019" class="body oddelinje">
	<td id="i151020"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i151021">Paricalcitol</p></p></td>
	<td id="i151022"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i151023">3</p></p></td>
	<td id="i151024"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i151025">Opplysninger om overgang til morsmelk mangler. Se vitamin D-analoger  <a id="arowX152882" class="ref" href="../G/G8.htm#i152882" title="Vitamin D og vitamin D-analoger">Vitamin D og vitamin D-analoger</a></p></p></td>
	</tr>
 <tr id="i151026" class="body likelinje">
	<td id="i151027"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i151028">Paroksetin</p></p></td>
	<td id="i151029"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i151030">2</p></p></td>
	<td id="i151031"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i151032">Overgang til morsmelk er liten. Se SSRI  <a id="arowX151966" class="ref" href="../G/G8.htm#i151966" title="SSRI">SSRI</a></p></p></td>
	</tr>
 <tr id="i221873" class="body oddelinje">
	<td id="i221874"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i221875">Pazopanib </p></p></td>
	<td id="i221876"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i221877">3 </p></p></td>
	<td id="i221878"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i221879">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i151033" class="body likelinje">
	<td id="i151034"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i151035">Pegaptanib</p></p></td>
	<td id="i151036"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i151037">3</p></p></td>
	<td id="i151038"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i151039">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i151040" class="body oddelinje">
	<td id="i151041"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i151042">Pegfilgrastim</p></p></td>
	<td id="i151043"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i151044">0</p></p></td>
	<td id="i151045"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i151046">Erfaring med bruk hos ammende mangler. Ingen absorpsjon fra barnets mage-tarm-kanal</p></p></td>
	</tr>
 <tr id="i151047" class="body likelinje">
	<td id="i151048"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i151049">Pegvisomant</p></p></td>
	<td id="i151050"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i151051">3</p></p></td>
	<td id="i151052"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i151053">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i151054" class="body oddelinje">
	<td id="i151055"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i151056">Pemetreksed</p></p></td>
	<td id="i151057"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i151058">5</p></p></td>
	<td id="i151059"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i151060">Se cytostatika  <a id="arowX146868" class="ref" href="../G/G8.htm#i146868" title="Cytostatika">Cytostatika</a></p></p></td>
	</tr>
 <tr id="i151061" class="body likelinje">
	<td id="i151062"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i151063">Penciklovir</p></p></td>
	<td id="i151064"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i151065">0</p></p></td>
	<td id="i151066"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i151067">Lokalbehandling. Se antivirale midler, herpesinfeksjoner  <a id="arowX145939" class="ref" href="../G/G8.htm#i145939" title="Antivirale midler">Antivirale midler</a></p></p></td>
	</tr>
 <tr id="i151068" class="body oddelinje">
	<td id="i151069"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i151070">Penicillamin</p></p></td>
	<td id="i151071"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i151072">4</p></p></td>
	<td id="i151073"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i151074">Bruk hos ammende frarådes pga. mulige toksiske effekter i barnet</p></p></td>
	</tr>
 <tr id="i151075" class="body likelinje">
	<td id="i151076"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i151077"><em>Penicilliner</em></p></p></td>
	<td id="i151078"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i151079">1, 2</p></p></td>
	<td id="i151080"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i151081">Overgang til morsmelk er minimal. Kan brukes av ammende. Se også antibakterielle midler  <a id="arowX145756" class="ref" href="../G/G8.htm#i145756" title="Anestesimidler">Anestesimidler</a></p></p></td>
	</tr>
 <tr id="i151082" class="body oddelinje">
	<td id="i151083"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i151084">Pentamidin</p></p></td>
	<td id="i151085"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i151086">3</p></p></td>
	<td id="i151087"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i151088">Opplysninger om overgang til morsmelk mangler. Amming er kontraindisert ved HIV-infeksjon hos mor</p></p></td>
	</tr>
 <tr id="i151089" class="body likelinje">
	<td id="i151090"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i151091">Pentoksyfyllin</p></p></td>
	<td id="i151092"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i151093">2</p></p></td>
	<td id="i151094"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i151095">Overgang til morsmelk er minimal. Kan brukes av ammende</p></p></td>
	</tr>
 <tr id="i151096" class="body oddelinje">
	<td id="i151097"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i151098">Perfenazin</p></p></td>
	<td id="i151099"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i151100">3</p></p></td>
	<td id="i151101"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i151102">Overgang til morsmelk er minimal. Se antipsykotika  <a id="arowX145918" class="ref" href="../G/G8.htm#i145918" title="Antipsykotika">Antipsykotika</a></p></p></td>
	</tr>
 <tr id="i151103" class="body likelinje">
	<td id="i151104"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i151105">Perindopril</p></p></td>
	<td id="i151106"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i151107">3</p></p></td>
	<td id="i151108"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i151109">Opplysninger om overgang til morsmelk mangler. Se ACE-hemmere</p></p></td>
	</tr>
 <tr id="i151110" class="body oddelinje">
	<td id="i151111"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i151112">Permetrin</p></p></td>
	<td id="i151113"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i151114">2</p></p></td>
	<td id="i151115"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i151116">Lokalbehandling: Kan brukes av ammende</p></p></td>
	</tr>
 <tr id="i151117" class="body likelinje">
	<td id="i151118"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i151119">Petidin</p></p></td>
	<td id="i151120"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i151121">3</p></p></td>
	<td id="i151122"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i151123">Overgang til morsmelk er liten. Ved bruk av petidin som smertestillende før og under fødselen er det blitt observert svekket søke- og sugeatferd, forsinket amming, redusert våkenhetsgrad og respirasjonsdepresjon hos nyfødte. Unngå gjentatt bruk. Langtidseffekter av petidineksponering på atferd og psykomotorisk utvikling er ukjent. Se også opioidanalgetika  <a id="arowX150865" class="ref" href="../G/G8.htm#i150865" title="Opioidanalgetika">Opioidanalgetika</a></p></p></td>
	</tr>
 <tr id="i151124" class="body oddelinje">
	<td id="i151125"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i151126">Pilokarpin</p></p></td>
	<td id="i151127"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i151128">2</p></p></td>
	<td id="i151129"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i151130">Øyedråper: Kan brukes av ammende</p></p></td>
	</tr>
 <tr id="i151131" class="body likelinje">
	<td id="i151132"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i151133">Pimecrolimus</p></p></td>
	<td id="i151134"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i151135">0</p></p></td>
	<td id="i151136"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i151137">Lokalbehandling: Kan brukes av ammende. Manglende klinisk erfaring tilsier at ammende bør unngå påsmøring på brystene</p></p></td>
	</tr>
 <tr id="i151138" class="body oddelinje">
	<td id="i151139"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i151140">Pimozid</p></p></td>
	<td id="i151141"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i151142">4</p></p></td>
	<td id="i151143"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i151144">Opplysninger om overgang til morsmelk mangler. Teoretisk høy risiko for bivirkninger hos diebarn. Se også antipsykotika  <a id="arowX145918" class="ref" href="../G/G8.htm#i145918" title="Antipsykotika">Antipsykotika</a></p></p></td>
	</tr>
 <tr id="i151145" class="body likelinje">
	<td id="i151146"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i151147">Pioglitazon</p></p></td>
	<td id="i151148"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i151149">3</p></p></td>
	<td id="i151150"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i151151">Opplysninger mangler. Se antidiabetika, perorale  <a id="arowX145819" class="ref" href="../G/G8.htm#i145819" title="Antidiabetika, perorale">Antidiabetika, perorale</a></p></p></td>
	</tr>
 <tr id="i151152" class="body oddelinje">
	<td id="i151153"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i151154">Piperacillin</p></p></td>
	<td id="i151155"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i151156">2</p></p></td>
	<td id="i151157"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i151158">Se penicilliner  <a id="arowX151075" class="ref" href="../G/G8.htm#i151075" title="Penicilliner">Penicilliner</a></p></p></td>
	</tr>
 <tr id="i320161" class="body likelinje">
	<td id="i320162"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i320163">Piperakin</p></p></td>
	<td id="i320164"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i320165">3</p></p></td>
	<td id="i320166"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i320167">Opplysninger om overgang til morsmelk mangler. Alternative antimalariamidler b&#x00F8;r brukes av ammende pga. manglende klinisk erfaring</p></p></td>
	</tr>
 <tr id="i151159" class="body oddelinje">
	<td id="i151160"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i151161">Piracetam</p></p></td>
	<td id="i151162"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i151163">3</p></p></td>
	<td id="i151164"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i151165">Opplysninger mangler. Tilbakeholdenhet anbefales pga. virkestoffets egenskaper og manglende erfaring med bruk hos ammende</p></p></td>
	</tr>
 <tr id="i320126" class="body likelinje">
	<td id="i320127"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i320128">Pirfenidon</p></p></td>
	<td id="i320129"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i320130">3</p></p></td>
	<td id="i320131"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i320132">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i151166" class="body oddelinje">
	<td id="i151167"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i151168">Piroksikam</p></p></td>
	<td id="i151169"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i151170">2</p></p></td>
	<td id="i151171"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i151172">Overgang til morsmelk er liten. Se NSAID  <a id="arowX150698" class="ref" href="../G/G8.htm#i150698" title="NSAID">NSAID</a></p></p></td>
	</tr>
 <tr id="i221880" class="body likelinje">
	<td id="i221881"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i221882">Pitavastatin </p></p></td>
	<td id="i221883"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i221884">3 </p></p></td>
	<td id="i221885"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i221886">Opplysninger om overgang til morsmelk mangler. Se statiner  <a id="arowX151973" class="ref" href="../G/G8.htm#i151973" title="Statiner">Statiner</a></p></p></td>
	</tr>
 <tr id="i151173" class="body oddelinje">
	<td id="i151174"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i151175">Pivmecillinam</p></p></td>
	<td id="i151176"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i151177">1</p></p></td>
	<td id="i151178"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i151179">Se penicilliner  <a id="arowX151075" class="ref" href="../G/G8.htm#i151075" title="Penicilliner">Penicilliner</a></p></p></td>
	</tr>
 <tr id="i151180" class="body likelinje">
	<td id="i151181"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i218855">Plerixafor</p></p></td>
	<td id="i151182"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i151183">3</p></p></td>
	<td id="i151184"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i151185">Opplysninger om overgang til morsmelk mangler, men den er trolig minimal. Bruk hos ammende anbefales ikke pga. virkningsmekanismen og manglende erfaring</p></p></td>
	</tr>
 <tr id="i151193" class="body oddelinje">
	<td id="i151194"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i151195">Podofyllin/podofyllotoksin</p></p></td>
	<td id="i151196"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i151197">0</p></p></td>
	<td id="i151198"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i151199">Overgang til morsmelk er høy. Lokalbehandling. Kan brukes av ammende</p></p></td>
	</tr>
 <tr id="i151200" class="body likelinje">
	<td id="i151201"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i151202">Polygelin</p></p></td>
	<td id="i151203"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i151204">0</p></p></td>
	<td id="i151205"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i151206">Kan brukes av ammende</p></p></td>
	</tr>
 <tr id="i151207" class="body oddelinje">
	<td id="i151208"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i151209">Polymyksin (hud, øye)</p></p></td>
	<td id="i151210"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i151211">0</p></p></td>
	<td id="i151212"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i151213">Lokal bruk: Kan brukes av ammende</p></p></td>
	</tr>
 <tr id="i151214" class="body likelinje">
	<td id="i151215"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i151216">Polystyrensulfonat</p></p></td>
	<td id="i151217"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i151218">3</p></p></td>
	<td id="i151219"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i151220">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i151221" class="body oddelinje">
	<td id="i151222"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i151223">Polyøstradiol</p></p></td>
	<td id="i151224"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i151225">3</p></p></td>
	<td id="i151226"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i151227">Se østrogener  <a id="arowX153095" class="ref" href="../G/G8.htm#i153095" title="Østrogener">Østrogener</a></p></p></td>
	</tr>
 <tr id="i151228" class="body likelinje">
	<td id="i151229"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i151230">Porfimernatrium</p></p></td>
	<td id="i151231"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i151232">3</p></p></td>
	<td id="i151233"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i151234">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i151235" class="body oddelinje">
	<td id="i151236"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i151237">Posakonazol</p></p></td>
	<td id="i151238"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i151239">3</p></p></td>
	<td id="i151240"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i151241">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i151242" class="body likelinje">
	<td id="i151243"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i151244">Povidon</p></p></td>
	<td id="i151245"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i151246">2</p></p></td>
	<td id="i151247"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i151248">Øyedråper: Kan brukes av ammende</p></p></td>
	</tr>
 <tr id="i151249" class="body oddelinje">
	<td id="i151250"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i151251"><em>P-piller</em></p></p></td>
	<td id="i151252"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i151253">3 &#x2013;&ML;						østrogenholdige preparater</p></p>
<p class="entrya"><p id="i317122"> </p></p>
<p class="entrya"><p id="i317131"> </p></p>
<p class="entrya"><p id="i317123">1 &#x2013;&ML;						østrogenfrie preparater</p></p></td>
	<td id="i151255"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i151256">Overgangen av perorale antikonsepsjonsmidler til morsmelk er liten. Østrogener og gestagener i større mengder kan hemme melkeproduksjon. Selv om mengden østrogen i kombinasjonsantikonseptiva er lav, kan melkeproduksjonen reduseres initialt</p></p>
<p class="entrya"><p id="i317124">Minipillen som bare inneholder gestagen, anbefales fremfor kombinasjonspillen i ammeperioden. Full amming i seg selv hindrer graviditet i 97&#x2013;98 % av tilfellene i opptil 6 måneder etter fødsel, hvis mor ikke har fått igjen menstruasjonen, og hvis barnet ammes også om natten</p></p></td>
	</tr>
 <tr id="i151265" class="body likelinje">
	<td id="i151266"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i151267">Pramipeksol</p></p></td>
	<td id="i151268"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i151269">5</p></p></td>
	<td id="i151270"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i151271">Opplysninger om overgang til morsmelk mangler. Alle dopaminerge legemidler kan hemme prolaktinsekresjon og dermed melkeproduksjonen</p></p></td>
	</tr>
 <tr id="i151272" class="body oddelinje">
	<td id="i151273"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i218856">Prasugrel</p></p></td>
	<td id="i151274"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i151275">3</p></p></td>
	<td id="i151276"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i151277">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i151278" class="body likelinje">
	<td id="i151279"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i151280">Pravastatin</p></p></td>
	<td id="i151281"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i151282">3</p></p></td>
	<td id="i151283"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i151284">Se statiner  <a id="arowX151973" class="ref" href="../G/G8.htm#i151973" title="Statiner">Statiner</a></p></p></td>
	</tr>
 <tr id="i151285" class="body oddelinje">
	<td id="i151286"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i151287">Praziquantel</p></p></td>
	<td id="i151288"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i151289">0</p></p></td>
	<td id="i151290"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i151291">Risiko for farmakologiske effekter hos brysternærte barn ansees som liten</p></p></td>
	</tr>
 <tr id="i151292" class="body likelinje">
	<td id="i151293"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i151294">Prednisolon</p></p></td>
	<td id="i151295"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i151296">2</p></p></td>
	<td id="i151297"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i151298">Overgang til morsmelk er minimal. Se glukokortikoider  <a id="arowX148403" class="ref" href="../G/G8.htm#i148403" title="Glukokortikoider">Glukokortikoider</a></p></p></td>
	</tr>
 <tr id="i151299" class="body oddelinje">
	<td id="i151300"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i151301">Pregabalin</p></p></td>
	<td id="i151302"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i151303">4</p></p></td>
	<td id="i151304"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i151305">Opplysinger om overgang til morsmelk mangler. Tilbakeholdenhet anbefales pga. risiko for farmakologiske effekter hos barnet og manglende erfaring med bruk hos ammende. Se antiepileptika  <a id="arowX145833" class="ref" href="../G/G8.htm#i145833" title="Antiepileptika">Antiepileptika</a></p></p></td>
	</tr>
 <tr id="i151306" class="body likelinje">
	<td id="i151307"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i151308">Prilokain</p></p></td>
	<td id="i151309"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i151310">2</p></p></td>
	<td id="i151311"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i151312">Passerer over i morsmelk. Kan brukes av ammende. Se lokalanestetika  <a id="arowX149842" class="ref" href="../G/G8.htm#i149842" title="Lokalanestetika">Lokalanestetika</a></p></p></td>
	</tr>
 <tr id="i151313" class="body oddelinje">
	<td id="i151314"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i151315">Primakin</p></p></td>
	<td id="i151316"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i151317">3</p></p></td>
	<td id="i151318"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i151319">Opplysninger mangler. Se antimalariamidler  <a id="arowX145897" class="ref" href="../G/G8.htm#i145897" title="Antimalariamidler">Antimalariamidler</a></p></p></td>
	</tr>
 <tr id="i151320" class="body likelinje">
	<td id="i151321"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i151322">Primidon</p></p></td>
	<td id="i151323"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i151324">5</p></p></td>
	<td id="i151325"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i151326">Overgang til morsmelk er høy. Se barbiturater  <a id="arowX146213" class="ref" href="../G/G8.htm#i146213" title="Barbiturater">Barbiturater</a></p></p></td>
	</tr>
 <tr id="i151327" class="body oddelinje">
	<td id="i151328"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i151329">Probenecid</p></p></td>
	<td id="i151330"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i151331">3</p></p></td>
	<td id="i151332"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i151333">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i151334" class="body likelinje">
	<td id="i151335"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i151336">Progesteron</p></p></td>
	<td id="i151337"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i151338">2</p></p></td>
	<td id="i151339"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i151340">Se gestagener, lokal bruk  <a id="arowX148350" class="ref" href="../G/G8.htm#i148350" title="Gestagener">Gestagener</a></p></p></td>
	</tr>
 <tr id="i151341" class="body oddelinje">
	<td id="i151342"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i151343"><em>Progesteroner</em></p></p></td>
	<td id="i151344"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i151345">2, 3</p></p></td>
	<td id="i151346"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i151347">Se gestagener  <a id="arowX148350" class="ref" href="../G/G8.htm#i148350" title="Gestagener">Gestagener</a></p></p></td>
	</tr>
 <tr id="i151348" class="body likelinje">
	<td id="i151349"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i151350">Proguanil</p></p></td>
	<td id="i151351"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i151352">2</p></p></td>
	<td id="i151353"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i151354">Opplysninger om overgang til morsmelk mangler. Risiko for farmakologiske effekter på barnet ansees som liten ved profylaktiske doser. Se antimalariamidler  <a id="arowX145897" class="ref" href="../G/G8.htm#i145897" title="Antimalariamidler">Antimalariamidler</a></p></p></td>
	</tr>
 <tr id="i151355" class="body oddelinje">
	<td id="i151356"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i151357">Proklorperazin</p></p></td>
	<td id="i151358"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i151359">3</p></p></td>
	<td id="i151360"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i151361">Opplysninger om overgang til morsmelk mangler. Se antipsykotika  <a id="arowX145918" class="ref" href="../G/G8.htm#i145918" title="Antipsykotika">Antipsykotika</a></p></p></td>
	</tr>
 <tr id="i151362" class="body likelinje">
	<td id="i151363"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i151364">Proksymetakain</p></p></td>
	<td id="i151365"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i151366">2</p></p></td>
	<td id="i151367"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i151368">Øyedråper: Kan brukes av ammende</p></p></td>
	</tr>
 <tr id="i151369" class="body oddelinje">
	<td id="i151370"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i151371">Prometazin</p></p></td>
	<td id="i151372"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i151373">2</p></p></td>
	<td id="i151374"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i151375">Overgang til morsmelk er minimal. Se antihistaminer  <a id="arowX145840" class="ref" href="../G/G8.htm#i145840" title="Antihistaminer (H1-antagonister)">Antihistaminer (H1-antagonister)</a></p></p></td>
	</tr>
 <tr id="i151383" class="body likelinje">
	<td id="i151384"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i151385">Propofol</p></p></td>
	<td id="i151386"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i151387">2</p></p></td>
	<td id="i151388"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i151389">Overgang til morsmelk er liten. Kan brukes av ammende</p></p></td>
	</tr>
 <tr id="i151390" class="body oddelinje">
	<td id="i151391"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i151392">Propranolol</p></p></td>
	<td id="i151393"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i151394">2</p></p></td>
	<td id="i151395"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i151396">Overgang til morsmelk er minimal. Se betareseptorantagonister, adrenerge  <a id="arowX146361" class="ref" href="../G/G8.htm#i146361" title="Betareseptorantagonister, adrenerge">Betareseptorantagonister, adrenerge</a></p></p></td>
	</tr>
 <tr id="i151397" class="body likelinje">
	<td id="i151398"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i151399">Propyltiouracil</p></p></td>
	<td id="i151400"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i151401">2</p></p></td>
	<td id="i151402"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i151403">Overgang til morsmelk er minimal. Kan brukes av ammende. Monitorer barnets thyreoideastatus (T<Sub>3</Sub> og T<Sub>4</Sub>)</p></p></td>
	</tr>
 <tr id="i151404" class="body oddelinje">
	<td id="i151405"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i151406"><em>Prostaglandiner</em></p></p></td>
	<td id="i151407"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i272050"> </p></p></td>
	<td id="i151408"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i151409">Kan påvirke melkeutskillelsen</p></p></td>
	</tr>
 <tr id="i151410" class="body likelinje">
	<td id="i151411"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i151412"> </p></p></td>
	<td id="i151413"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i151414">3</p></p></td>
	<td id="i151415"    valign="top" width="51.5%" class="sluttKol">
	<UL type="circle">
		<LI id="i151417"><p id="i151418"><em>Øyedråper:</em> Lav systemisk dose og kort halveringstid tilsier at prostaglandinanaloger kan brukes av ammende</p><br>		</LI>
	</UL>
</td>
	</tr>
 <tr id="i151419" class="body oddelinje">
	<td id="i151420"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i151421">Protamin</p></p></td>
	<td id="i151422"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i151423">3</p></p></td>
	<td id="i151424"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i151425">Opplysninger mangler. Se antidoter  <a id="arowX145826" class="ref" href="../G/G8.htm#i145826" title="Antidoter">Antidoter</a></p></p></td>
	</tr>
 <tr id="i151426" class="body likelinje">
	<td id="i151427"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i151428">Protein C</p></p></td>
	<td id="i151429"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i151430">3</p></p></td>
	<td id="i151431"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i151432">Erfaring med bruk hos ammende mangler</p></p></td>
	</tr>
 <tr id="i151433" class="body oddelinje">
	<td id="i151434"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i151435"><em>Protonpumpehemmere</em></p></p></td>
	<td id="i151436"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i151437">2, 3</p></p></td>
	<td id="i151438"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i151439">Virkestoffenes syrelabilitet tilsier liten sannsynlighet for systemisk opptak gjennom mage-tarm-kanalen hos brysternærte barn</p></p></td>
	</tr>
 <tr id="i151440" class="body likelinje">
	<td id="i151441"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i151442">Pyrazinamid</p></p></td>
	<td id="i151443"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i151444">2</p></p></td>
	<td id="i151445"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i151446">Overgang til morsmelk er minimal. Kan brukes av ammende</p></p></td>
	</tr>
 <tr id="i151447" class="body oddelinje">
	<td id="i151448"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i151449">Pyridostigmin</p></p></td>
	<td id="i151450"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i151451">2</p></p></td>
	<td id="i151452"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i151453">Overgang til morsmelk er minimal. Kan brukes av ammende</p></p></td>
	</tr>
 <tr id="i151454" class="body likelinje">
	<td id="i151455"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i151456">Pyrimetamin</p></p></td>
	<td id="i151457"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i151458">4</p></p></td>
	<td id="i151459"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i151460">Overgang til morsmelk er høy. Unngå samtidig bruk av annen folatantagonist under amming. Se antimalariamidler  <a id="arowX145897" class="ref" href="../G/G8.htm#i145897" title="Antimalariamidler">Antimalariamidler</a></p></p></td>
	</tr>
 <tr id="i151461" class="body oddelinje">
	<td id="i151462"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i151463">Pyrvin</p></p></td>
	<td id="i151464"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i151465">0</p></p></td>
	<td id="i151466"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i151467">Kan brukes av ammende</p></p></td>
	</tr>
 </tbody></table>
 <table id="i151469" width="100%" class="maintable" border="0" cellpadding="5" cellspacing="0">
 <caption> <Uth Id="NUTHid2330232" Type="Halvfet">R</Uth></caption> <thead>
	<tr class = "linjetopp">
	<th id="i151477"  colspan="3"  valign="top"  class="sluttKol">

<p class="entrya"><p id="i151478">Overgang til morsmelk angis som minimal (< 2 %), liten (2&#8211;5 %), moderat (5&#8211;10 %) eller høy (10&#8211;50 %) basert på fraksjon av morens dose/kg kroppsvekt som barnet tilføres. (Barnets relative dose.)&ML;						Over 3&#8211;4 ukers bruk ansees som langtidsbehandling.</p></p></th>
	</tr>
	<tr class = "linjetopp">
	<th id="i151481"    valign="top"  class="startKol">

<p class="entrya"><p id="i151482"><strong>Legemiddel</strong></p></p></th>
	<th id="i151483"    valign="top"  class="mellomKol">

<p class="entrya"><p id="i151484"><strong>MM kategori</strong></p></p></th>
	<th id="i151485"    valign="top"  class="sluttKol">

<p class="entrya"><p id="i151486"><strong>Dokumentasjon vedrørende bruk under amming</strong></p></p></th>
	</tr>
</thead>
<tbody>
<tr id="i151488" class="body likelinje">
	<td id="i151489"    valign="top" width="29%" class="startKol">

<p class="entrya"><p id="i151490"><em>Radiofarmaka</em></p></p></td>
	<td id="i151491"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i151492">3</p></p></td>
	<td id="i151493"    valign="top" width="51.6%" class="sluttKol">

<p class="entrya"><p id="i151494">Pga. strålebelastning anbefales tilbakeholdenhet</p></p></td>
	</tr>
 <tr id="i151495" class="body oddelinje">
	<td id="i151496"    valign="top" width="29%" class="startKol">

<p class="entrya"><p id="i151497">Raloksifen</p></p></td>
	<td id="i151498"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i151499">3</p></p></td>
	<td id="i151500"    valign="top" width="51.6%" class="sluttKol">

<p class="entrya"><p id="i151501">Opplysninger mangler. (Postmenopausal behandling)</p></p></td>
	</tr>
 <tr id="i151502" class="body likelinje">
	<td id="i151503"    valign="top" width="29%" class="startKol">

<p class="entrya"><p id="i151504">Raltegravir</p></p></td>
	<td id="i151505"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i151506">5</p></p></td>
	<td id="i151507"    valign="top" width="51.6%" class="sluttKol">

<p class="entrya"><p id="i151508">Se antivirale midler  <a id="arowX145939" class="ref" href="../G/G8.htm#i145939" title="Antivirale midler">Antivirale midler</a></p></p></td>
	</tr>
 <tr id="i151509" class="body oddelinje">
	<td id="i151510"    valign="top" width="29%" class="startKol">

<p class="entrya"><p id="i151511">Raltitrexed</p></p></td>
	<td id="i151512"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i151513">5</p></p></td>
	<td id="i151514"    valign="top" width="51.6%" class="sluttKol">

<p class="entrya"><p id="i151515">Se cytostatika  <a id="arowX146868" class="ref" href="../G/G8.htm#i146868" title="Cytostatika">Cytostatika</a></p></p></td>
	</tr>
 <tr id="i151516" class="body likelinje">
	<td id="i151517"    valign="top" width="29%" class="startKol">

<p class="entrya"><p id="i151518">Ramipril</p></p></td>
	<td id="i151519"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i151520">3</p></p></td>
	<td id="i151521"    valign="top" width="51.6%" class="sluttKol">

<p class="entrya"><p id="i151522">Opplysninger om overgang til morsmelk mangler. Se ACE-hemmere</p></p></td>
	</tr>
 <tr id="i151523" class="body oddelinje">
	<td id="i151524"    valign="top" width="29%" class="startKol">

<p class="entrya"><p id="i151525">Ranitidin</p></p></td>
	<td id="i151526"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i151527">2</p></p></td>
	<td id="i151528"    valign="top" width="51.6%" class="sluttKol">

<p class="entrya"><p id="i151529">Overgang til morsmelk er moderat. Se H<Sub>2</Sub>-antagonister  <a id="arowX148562" class="ref" href="../G/G8.htm#i148562" title="H2-antagonister">H2-antagonister</a></p></p></td>
	</tr>
 <tr id="i151530" class="body likelinje">
	<td id="i151531"    valign="top" width="29%" class="startKol">

<p class="entrya"><p id="i151532">Rasagilin</p></p></td>
	<td id="i151533"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i151534">4</p></p></td>
	<td id="i151535"    valign="top" width="51.6%" class="sluttKol">

<p class="entrya"><p id="i151536">Opplysninger om overgang til morsmelk mangler. Kan hemme prolaktinsekresjon og dermed melkeproduksjonen</p></p></td>
	</tr>
 <tr id="i151537" class="body oddelinje">
	<td id="i151538"    valign="top" width="29%" class="startKol">

<p class="entrya"><p id="i151539">Rasburikase</p></p></td>
	<td id="i151540"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i151541">3</p></p></td>
	<td id="i151542"    valign="top" width="51.6%" class="sluttKol">

<p class="entrya"><p id="i151543">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i151544" class="body likelinje">
	<td id="i151545"    valign="top" width="29%" class="startKol">

<p class="entrya"><p id="i151546">Reboksetin</p></p></td>
	<td id="i151547"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i151548">3</p></p></td>
	<td id="i151549"    valign="top" width="51.6%" class="sluttKol">

<p class="entrya"><p id="i151550">Opplysninger om overgang til morsmelk mangler. Se antidepressiva  <a id="arowX145812" class="ref" href="../G/G8.htm#i145812" title="Antidepressiva">Antidepressiva</a></p></p></td>
	</tr>
 <tr id="i221887" class="body oddelinje">
	<td id="i221888"    valign="top" width="29%" class="startKol">

<p class="entrya"><p id="i221889">Regadenoson </p></p></td>
	<td id="i221890"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i221891">3 </p></p></td>
	<td id="i221892"    valign="top" width="51.6%" class="sluttKol">

<p class="entrya"><p id="i221893">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i151551" class="body likelinje">
	<td id="i151552"    valign="top" width="29%" class="startKol">

<p class="entrya"><p id="i151553">Remifentanil</p></p></td>
	<td id="i151554"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i151555">2</p></p></td>
	<td id="i151556"    valign="top" width="51.6%" class="sluttKol">

<p class="entrya"><p id="i151557">Se anestesimidler  <a id="arowX145756" class="ref" href="../G/G8.htm#i145756" title="Anestesimidler">Anestesimidler</a></p></p></td>
	</tr>
 <tr id="i151558" class="body oddelinje">
	<td id="i151559"    valign="top" width="29%" class="startKol">

<p class="entrya"><p id="i151560">Repaglinid</p></p></td>
	<td id="i151561"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i151562">3</p></p></td>
	<td id="i151563"    valign="top" width="51.6%" class="sluttKol">

<p class="entrya"><p id="i151564">Se antidiabetika, perorale  <a id="arowX145819" class="ref" href="../G/G8.htm#i145819" title="Antidiabetika, perorale">Antidiabetika, perorale</a></p></p></td>
	</tr>
 <tr id="i151565" class="body likelinje">
	<td id="i151566"    valign="top" width="29%" class="startKol">

<p class="entrya"><p id="i151567"><em>Resiner</em></p></p></td>
	<td id="i151568"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i151569">0</p></p></td>
	<td id="i151570"    valign="top" width="51.6%" class="sluttKol">

<p class="entrya"><p id="i151571">Kan brukes av ammende</p></p></td>
	</tr>
 <tr id="i151572" class="body oddelinje">
	<td id="i151573"    valign="top" width="29%" class="startKol">

<p class="entrya"><p id="i151574">Retapamulin</p></p></td>
	<td id="i151575"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i151576">Lokal behandling&ML;						0</p></p></td>
	<td id="i151578"    valign="top" width="51.6%" class="sluttKol">

<p class="entrya"><p id="i151579">Kan brukes av ammende</p></p></td>
	</tr>
 <tr id="i151580" class="body likelinje">
	<td id="i151581"    valign="top" width="29%" class="startKol">

<p class="entrya"><p id="i151582">Reteplase</p></p></td>
	<td id="i151583"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i151584">0</p></p></td>
	<td id="i151585"    valign="top" width="51.6%" class="sluttKol">

<p class="entrya"><p id="i151586">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i320133" class="body oddelinje">
	<td id="i320134"    valign="top" width="29%" class="startKol">

<p class="entrya"><p id="i320135">Retigabin</p></p></td>
	<td id="i320136"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i320137">3</p></p></td>
	<td id="i320138"    valign="top" width="51.6%" class="sluttKol">

<p class="entrya"><p id="i320139">Opplysninger om overgang til morsmelk mangler</p></p></td>
	</tr>
 <tr id="i151587" class="body likelinje">
	<td id="i151588"    valign="top" width="29%" class="startKol">

<p class="entrya"><p id="i151589"><em>Retinoider</em></p></p></td>
	<td id="i151590"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i151591">5</p></p>
<p class="entrya"><p id="i272072"> </p></p>
<p class="entrya"><p id="i272073">3</p></p></td>
	<td id="i151592"    valign="top" width="51.6%" class="sluttKol">
	<UL type="circle">
		<LI id="i151594"><p id="i151595"><em>Peroral bruk:</em> Bruk av retinoider frarådes hos ammende pga. virkestoffenes toksisitet</p><br>		</LI>
		<LI id="i272074"><p id="i272075">Lokal bruk: Selv om systemisk absorpsjon av tretinoin og adapalen er liten, anbefales tilbakeholdenhet under ammeperioden pga. virkestoffenes toksisitet</p><br>		</LI>
	</UL>
</td>
	</tr>
 <tr id="i151605" class="body oddelinje">
	<td id="i151606"    valign="top" width="29%" class="startKol">

<p class="entrya"><p id="i151607">Ribavirin</p></p></td>
	<td id="i151608"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i151609">4</p></p></td>
	<td id="i151610"    valign="top" width="51.6%" class="sluttKol">

<p class="entrya"><p id="i151611">Opplysninger mangler, men virkestoffets toksisitet tilsier tilbakeholdenhet med amming ved langtidsbruk</p></p></td>
	</tr>
 <tr id="i151612" class="body likelinje">
	<td id="i151613"    valign="top" width="29%" class="startKol">

<p class="entrya"><p id="i151614">Rifampicin</p></p></td>
	<td id="i151615"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i151616">2</p></p></td>
	<td id="i151617"    valign="top" width="51.6%" class="sluttKol">

<p class="entrya"><p id="i151618">Overgang til morsmelk er minimal. Kan brukes av ammende</p></p></td>
	</tr>
 <tr id="i320175" class="body oddelinje">
	<td id="i320176"    valign="top" width="29%" class="startKol">

<p class="entrya"><p id="i320177">Rilpivirin</p></p></td>
	<td id="i320178"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i320179">5</p></p></td>
	<td id="i320180"    valign="top" width="51.6%" class="sluttKol">

<p class="entrya"><p id="i320181">Se antivirale midler <a id="aentryX145940" class="ref" href="../G/G8.htm#i145940" title="Antivirale midler">Antivirale midler</a> </p></p></td>
	</tr>
 <tr id="i151619" class="body likelinje">
	<td id="i151620"    valign="top" width="29%" class="startKol">

<p class="entrya"><p id="i151621">Riluzol</p></p></td>
	<td id="i151622"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i151623">3</p></p></td>
	<td id="i151624"    valign="top" width="51.6%" class="sluttKol">

<p class="entrya"><p id="i151625">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i151626" class="body oddelinje">
	<td id="i151627"    valign="top" width="29%" class="startKol">

<p class="entrya"><p id="i151628">Rimeksolon</p></p></td>
	<td id="i151629"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i151630">2</p></p></td>
	<td id="i151631"    valign="top" width="51.6%" class="sluttKol">

<p class="entrya"><p id="i151632">Se glukokortikoider, lokalbehandling  <a id="arowX148403" class="ref" href="../G/G8.htm#i148403" title="Glukokortikoider">Glukokortikoider</a></p></p></td>
	</tr>
 <tr id="i151633" class="body likelinje">
	<td id="i151634"    valign="top" width="29%" class="startKol">

<p class="entrya"><p id="i218857">Rimonabant</p></p></td>
	<td id="i151635"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i151636">3</p></p></td>
	<td id="i151637"    valign="top" width="51.6%" class="sluttKol">

<p class="entrya"><p id="i218858">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i151638" class="body oddelinje">
	<td id="i151639"    valign="top" width="29%" class="startKol">

<p class="entrya"><p id="i151640">Risedronat</p></p></td>
	<td id="i151641"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i151642">0</p></p></td>
	<td id="i151643"    valign="top" width="51.6%" class="sluttKol">

<p class="entrya"><p id="i151644">Se bisfosfonater  <a id="arowX146417" class="ref" href="../G/G8.htm#i146417" title="Bisfosfonater">Bisfosfonater</a></p></p></td>
	</tr>
 <tr id="i151645" class="body likelinje">
	<td id="i151646"    valign="top" width="29%" class="startKol">

<p class="entrya"><p id="i151647">Risperidon</p></p></td>
	<td id="i151648"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i151649">3</p></p></td>
	<td id="i151650"    valign="top" width="51.6%" class="sluttKol">

<p class="entrya"><p id="i151651">Overgang til morsmelk er liten. Galaktorré er rapportert. Se antipsykotika  <a id="arowX145918" class="ref" href="../G/G8.htm#i145918" title="Antipsykotika">Antipsykotika</a></p></p></td>
	</tr>
 <tr id="i151652" class="body oddelinje">
	<td id="i151653"    valign="top" width="29%" class="startKol">

<p class="entrya"><p id="i151654">Ritonavir</p></p></td>
	<td id="i151655"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i151656">5</p></p></td>
	<td id="i151657"    valign="top" width="51.6%" class="sluttKol">

<p class="entrya"><p id="i151658">Se antivirale midler  <a id="arowX145939" class="ref" href="../G/G8.htm#i145939" title="Antivirale midler">Antivirale midler</a></p></p></td>
	</tr>
 <tr id="i151659" class="body likelinje">
	<td id="i151660"    valign="top" width="29%" class="startKol">

<p class="entrya"><p id="i151661">Rituximab</p></p></td>
	<td id="i151662"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i151663">0</p></p></td>
	<td id="i151664"    valign="top" width="51.6%" class="sluttKol">

<p class="entrya"><p id="i151665">Opplysninger mangler. Se monoklonale antistoffer  <a id="arowX150370" class="ref" href="../G/G8.htm#i150370" title="Monoklonale antistoffer">Monoklonale antistoffer</a></p></p></td>
	</tr>
 <tr id="i151666" class="body oddelinje">
	<td id="i151667"    valign="top" width="29%" class="startKol">

<p class="entrya"><p id="i151668">Rivaroksaban</p></p></td>
	<td id="i151669"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i151670">3</p></p></td>
	<td id="i151671"    valign="top" width="51.6%" class="sluttKol">

<p class="entrya"><p id="i151672">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i151673" class="body likelinje">
	<td id="i151674"    valign="top" width="29%" class="startKol">

<p class="entrya"><p id="i151675">Rivastigmin</p></p></td>
	<td id="i151676"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i151677">3</p></p></td>
	<td id="i151678"    valign="top" width="51.6%" class="sluttKol">

<p class="entrya"><p id="i151679">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i151680" class="body oddelinje">
	<td id="i151681"    valign="top" width="29%" class="startKol">

<p class="entrya"><p id="i151682">Rizatriptan</p></p></td>
	<td id="i151683"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i151684">3</p></p></td>
	<td id="i151685"    valign="top" width="51.6%" class="sluttKol">

<p class="entrya"><p id="i151686">Opplysninger om overgang til morsmelk mangler. Se triptaner  <a id="arowX152605" class="ref" href="../G/G8.htm#i152605" title="Triptaner">Triptaner</a></p></p></td>
	</tr>
 <tr id="i221894" class="body likelinje">
	<td id="i221895"    valign="top" width="29%" class="startKol">

<p class="entrya"><p id="i221896">Roflumilast </p></p></td>
	<td id="i221897"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i221898">3</p></p></td>
	<td id="i221899"    valign="top" width="51.6%" class="sluttKol">

<p class="entrya"><p id="i221900">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i151694" class="body oddelinje">
	<td id="i151695"    valign="top" width="29%" class="startKol">

<p class="entrya"><p id="i151696">Rokuron</p></p></td>
	<td id="i151697"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i151698">2</p></p></td>
	<td id="i151699"    valign="top" width="51.6%" class="sluttKol">

<p class="entrya"><p id="i151700">Se nevromuskulære blokkere  <a id="arowX150558" class="ref" href="../G/G8.htm#i150558" title="Nevromuskulære blokkere">Nevromuskulære blokkere</a></p></p></td>
	</tr>
 <tr id="i151701" class="body likelinje">
	<td id="i151702"    valign="top" width="29%" class="startKol">

<p class="entrya"><p id="i151703">Romiplostim</p></p></td>
	<td id="i151704"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i151705">3</p></p></td>
	<td id="i151706"    valign="top" width="51.6%" class="sluttKol">

<p class="entrya"><p id="i151707">Opplysninger om overgang til morsmelk mangler, men den er trolig minimal. Erfaring med bruk hos ammende mangler</p></p></td>
	</tr>
 <tr id="i151708" class="body oddelinje">
	<td id="i151709"    valign="top" width="29%" class="startKol">

<p class="entrya"><p id="i151710">Ropinirol</p></p></td>
	<td id="i151711"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i151712">3</p></p></td>
	<td id="i151713"    valign="top" width="51.6%" class="sluttKol">

<p class="entrya"><p id="i151714">Opplysninger om overgang til morsmelk mangler. Alle dopaminerge legemidler kan hemme prolaktinsekresjon og dermed melkeproduksjone</p></p></td>
	</tr>
 <tr id="i151715" class="body likelinje">
	<td id="i151716"    valign="top" width="29%" class="startKol">

<p class="entrya"><p id="i151717">Ropivakain</p></p></td>
	<td id="i151718"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i151719">2</p></p></td>
	<td id="i151720"    valign="top" width="51.6%" class="sluttKol">

<p class="entrya"><p id="i151721">Opplysninger mangler. Se lokalanestetika  <a id="arowX149842" class="ref" href="../G/G8.htm#i149842" title="Lokalanestetika">Lokalanestetika</a></p></p></td>
	</tr>
 <tr id="i151722" class="body oddelinje">
	<td id="i151723"    valign="top" width="29%" class="startKol">

<p class="entrya"><p id="i151724">Rosiglitazon</p></p></td>
	<td id="i151725"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i151726">3</p></p></td>
	<td id="i151727"    valign="top" width="51.6%" class="sluttKol">

<p class="entrya"><p id="i151728">Se antidiabetika, perorale  <a id="arowX145819" class="ref" href="../G/G8.htm#i145819" title="Antidiabetika, perorale">Antidiabetika, perorale</a></p></p></td>
	</tr>
 <tr id="i151729" class="body likelinje">
	<td id="i151730"    valign="top" width="29%" class="startKol">

<p class="entrya"><p id="i151731">Rosuvastatin</p></p></td>
	<td id="i151732"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i151733">3</p></p></td>
	<td id="i151734"    valign="top" width="51.6%" class="sluttKol">

<p class="entrya"><p id="i151735">Opplysninger om overgang til morsmelk mangler. Se statiner  <a id="arowX151973" class="ref" href="../G/G8.htm#i151973" title="Statiner">Statiner</a></p></p></td>
	</tr>
 <tr id="i151736" class="body oddelinje">
	<td id="i151737"    valign="top" width="29%" class="startKol">

<p class="entrya"><p id="i151738">Rotigotin</p></p></td>
	<td id="i151739"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i151740">4</p></p></td>
	<td id="i151741"    valign="top" width="51.6%" class="sluttKol">

<p class="entrya"><p id="i151742">Opplysninger om overgang til morsmelk mangler. Alle dopaminerge legemidler kan hemme prolaktinsekresjonen og dermed melkeproduksjonen</p></p></td>
	</tr>
 <tr id="i151743" class="body likelinje">
	<td id="i151744"    valign="top" width="29%" class="startKol">

<p class="entrya"><p id="i151745">Rubidomycin (= daunorubicin)</p></p></td>
	<td id="i151746"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i151747">5</p></p></td>
	<td id="i151748"    valign="top" width="51.6%" class="sluttKol">

<p class="entrya"><p id="i151749">Se cytostatika  <a id="arowX146868" class="ref" href="../G/G8.htm#i146868" title="Cytostatika">Cytostatika</a></p></p></td>
	</tr>
 <tr id="i151750" class="body oddelinje">
	<td id="i151751"    valign="top" width="29%" class="startKol">

<p class="entrya"><p id="i151752">Rufinamid</p></p></td>
	<td id="i151753"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i151754">3</p></p></td>
	<td id="i151755"    valign="top" width="51.6%" class="sluttKol">

<p class="entrya"><p id="i151756">Opplysninger om overgang til morsmelk mangler. Se også antiepileptika  <a id="arowX145833" class="ref" href="../G/G8.htm#i145833" title="Antiepileptika">Antiepileptika</a></p></p></td>
	</tr>
 <tr id="i151757" class="body likelinje">
	<td id="i151758"    valign="top" width="29%" class="startKol">

<p class="entrya"><p id="i151759"><em>Røntgenkontrastmidler</em></p></p></td>
	<td id="i151760"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i151761">0, 2, 3</p></p></td>
	<td id="i151762"    valign="top" width="51.6%" class="sluttKol">

<p class="entrya"><p id="i151763">De røntgenkontrastmidler som er undersøkt, går over i morsmelk i minimale mengder</p></p></td>
	</tr>
 </tbody></table>
 <table id="i151765" width="100%" class="maintable" border="0" cellpadding="5" cellspacing="0">
 <caption> <Uth Id="NUTHid2331376O151766" Type="Halvfet">S</Uth></caption> <thead>
	<tr class = "linjetopp">
	<th id="i151773"  colspan="3"  valign="top"  class="sluttKol">

<p class="entrya"><p id="i151774">Overgang til morsmelk angis som minimal (< 2 %), liten (2&#x2013;5 %), moderat (5&#x2013;10 %) eller høy (10&#x2013;50 %) basert på fraksjon av morens dose/kg kroppsvekt som barnet tilføres. (Barnets relative dose.)&ML;						Over 3&#x2013;4 ukers bruk ansees som langtidsbehandling.</p></p></th>
	</tr>
	<tr class = "linjetopp">
	<th id="i151777"    valign="top"  class="startKol">

<p class="entrya"><p id="i151778"><strong>Legemiddel</strong></p></p></th>
	<th id="i151779"    valign="top"  class="mellomKol">

<p class="entrya"><p id="i151780"><strong>MM kategori</strong></p></p></th>
	<th id="i151781"    valign="top"  class="sluttKol">

<p class="entrya"><p id="i151782"><strong>Dokumentasjon vedrørende bruk under amming</strong></p></p></th>
	</tr>
</thead>
<tbody>
<tr id="i151784" class="body likelinje">
	<td id="i151785"    valign="top" width="28.9%" class="startKol">

<p class="entrya"><p id="i151786">Sakinavir</p></p></td>
	<td id="i151787"    valign="top" width="19.7%" class="mellomKol">

<p class="entrya"><p id="i151788">5</p></p></td>
	<td id="i151789"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i151790">Se antivirale midler  <a id="arowX145939" class="ref" href="../G/G8.htm#i145939" title="Antivirale midler">Antivirale midler</a></p></p></td>
	</tr>
 <tr id="i151791" class="body oddelinje">
	<td id="i151792"    valign="top" width="28.9%" class="startKol">

<p class="entrya"><p id="i151793">Saksagliptin</p></p></td>
	<td id="i151794"    valign="top" width="19.7%" class="mellomKol">

<p class="entrya"><p id="i151795">3</p></p></td>
	<td id="i151796"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i151797">Opplysninger om overgang til morsmelk mangler. Se antidiabetika, perorale  <a id="arowX145819" class="ref" href="../G/G8.htm#i145819" title="Antidiabetika, perorale">Antidiabetika, perorale</a></p></p></td>
	</tr>
 <tr id="i151798" class="body likelinje">
	<td id="i151799"    valign="top" width="28.9%" class="startKol">

<p class="entrya"><p id="i151800">Salbutamol</p></p></td>
	<td id="i151801"    valign="top" width="19.7%" class="mellomKol">

<p class="entrya"><p id="i151802">2</p></p></td>
	<td id="i151803"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i151804">Overgang til morsmelk er minimal. Se beta-2-reseptoragonister, adrenerge  <a id="arowX146354" class="ref" href="../G/G8.htm#i146354" title="Beta-2-reseptoragonister, adrenerge">Beta-2-reseptoragonister, adrenerge</a></p></p></td>
	</tr>
 <tr id="i151805" class="body oddelinje">
	<td id="i151806"    valign="top" width="28.9%" class="startKol">

<p class="entrya"><p id="i151807">Salmeterol</p></p></td>
	<td id="i151808"    valign="top" width="19.7%" class="mellomKol">

<p class="entrya"><p id="i151809">2</p></p></td>
	<td id="i151810"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i151811">Overgang til morsmelk er minimal. Se beta-2-reseptoragonister, adrenerge  <a id="arowX146354" class="ref" href="../G/G8.htm#i146354" title="Beta-2-reseptoragonister, adrenerge">Beta-2-reseptoragonister, adrenerge</a></p></p></td>
	</tr>
 <tr id="i151812" class="body likelinje">
	<td id="i151813"    valign="top" width="28.9%" class="startKol">

<p class="entrya"><p id="i151814">Selegilin</p></p></td>
	<td id="i151815"    valign="top" width="19.7%" class="mellomKol">

<p class="entrya"><p id="i151816">4</p></p></td>
	<td id="i151817"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i151818">Opplysninger om overgang til morsmelk mangler. Alle dopaminerge legemidler kan hemme prolaktinsekresjonen og dermed melkeproduksjonen</p></p></td>
	</tr>
 <tr id="i151819" class="body oddelinje">
	<td id="i151820"    valign="top" width="28.9%" class="startKol">

<p class="entrya"><p id="i151821"><em>Selektive serotoninreopptakshemmere</em></p></p></td>
	<td id="i151822"    valign="top" width="19.7%" class="mellomKol">

<p class="entrya"><p id="i151823">2, 3</p></p></td>
	<td id="i151824"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i151825">Se SSRI  <a id="arowX151966" class="ref" href="../G/G8.htm#i151966" title="SSRI">SSRI</a></p></p></td>
	</tr>
 <tr id="i151826" class="body likelinje">
	<td id="i151827"    valign="top" width="28.9%" class="startKol">

<p class="entrya"><p id="i151828"><em>Sennaglykosider</em></p></p></td>
	<td id="i151829"    valign="top" width="19.7%" class="mellomKol">

<p class="entrya"><p id="i151830">0</p></p></td>
	<td id="i151831"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i151832">Se laksantia  <a id="arowX149606" class="ref" href="../G/G8.htm#i149606" title="Laksantia">Laksantia</a></p></p></td>
	</tr>
 <tr id="i151833" class="body oddelinje">
	<td id="i151834"    valign="top" width="28.9%" class="startKol">

<p class="entrya"><p id="i151835">Sermorelin</p></p></td>
	<td id="i151836"    valign="top" width="19.7%" class="mellomKol">

<p class="entrya"><p id="i151837">0</p></p></td>
	<td id="i151838"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i151839">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i151840" class="body likelinje">
	<td id="i151841"    valign="top" width="28.9%" class="startKol">

<p class="entrya"><p id="i151842">Sertindol</p></p></td>
	<td id="i151843"    valign="top" width="19.7%" class="mellomKol">

<p class="entrya"><p id="i151844">3</p></p></td>
	<td id="i151845"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i151846">Opplysninger om overgang til morsmelk mangler. Se antipsykotika  <a id="arowX145918" class="ref" href="../G/G8.htm#i145918" title="Antipsykotika">Antipsykotika</a></p></p></td>
	</tr>
 <tr id="i151847" class="body oddelinje">
	<td id="i151848"    valign="top" width="28.9%" class="startKol">

<p class="entrya"><p id="i151849">Sertralin</p></p></td>
	<td id="i151850"    valign="top" width="19.7%" class="mellomKol">

<p class="entrya"><p id="i151851">2</p></p></td>
	<td id="i151852"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i151853">Overgang til morsmelk er liten. Se SSRI  <a id="arowX151966" class="ref" href="../G/G8.htm#i151966" title="SSRI">SSRI</a></p></p></td>
	</tr>
 <tr id="i151854" class="body likelinje">
	<td id="i151855"    valign="top" width="28.9%" class="startKol">

<p class="entrya"><p id="i151856">Sevelamer</p></p></td>
	<td id="i151857"    valign="top" width="19.7%" class="mellomKol">

<p class="entrya"><p id="i151858">0</p></p></td>
	<td id="i151859"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i151860">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i151861" class="body oddelinje">
	<td id="i151862"    valign="top" width="28.9%" class="startKol">

<p class="entrya"><p id="i151863">Sevofluran</p></p></td>
	<td id="i151864"    valign="top" width="19.7%" class="mellomKol">

<p class="entrya"><p id="i151865">2</p></p></td>
	<td id="i151866"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i151867">Opplysninger mangler. Se anestesimidler  <a id="arowX145756" class="ref" href="../G/G8.htm#i145756" title="Anestesimidler">Anestesimidler</a></p></p></td>
	</tr>
 <tr id="i151868" class="body likelinje">
	<td id="i151869"    valign="top" width="28.9%" class="startKol">

<p class="entrya"><p id="i151870">Sibutramin</p></p></td>
	<td id="i151871"    valign="top" width="19.7%" class="mellomKol">

<p class="entrya"><p id="i151872">3</p></p></td>
	<td id="i151873"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i151874">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i151875" class="body oddelinje">
	<td id="i151876"    valign="top" width="28.9%" class="startKol">

<p class="entrya"><p id="i151877">Sildenafil</p></p></td>
	<td id="i151878"    valign="top" width="19.7%" class="mellomKol">

<p class="entrya"><p id="i151879">&#x2013;</p></p></td>
	<td id="i151880"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i151881">Ikke aktuell til bruk hos ammende</p></p></td>
	</tr>
 <tr id="i151882" class="body likelinje">
	<td id="i151883"    valign="top" width="28.9%" class="startKol">

<p class="entrya"><p id="i151884">Simvastatin</p></p></td>
	<td id="i151885"    valign="top" width="19.7%" class="mellomKol">

<p class="entrya"><p id="i151886">3</p></p></td>
	<td id="i151887"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i151888">Se statiner  <a id="arowX151973" class="ref" href="../G/G8.htm#i151973" title="Statiner">Statiner</a></p></p></td>
	</tr>
 <tr id="i151889" class="body oddelinje">
	<td id="i151890"    valign="top" width="28.9%" class="startKol">

<p class="entrya"><p id="i151891">Sirolimus</p></p></td>
	<td id="i151892"    valign="top" width="19.7%" class="mellomKol">

<p class="entrya"><p id="i151893">4</p></p></td>
	<td id="i151894"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i151895">Opplysninger mangler. Amming bør unngås pga. sirolimus&#39; immunsuppressive effekt</p></p></td>
	</tr>
 <tr id="i151896" class="body likelinje">
	<td id="i151897"    valign="top" width="28.9%" class="startKol">

<p class="entrya"><p id="i151898">Sitagliptin</p></p></td>
	<td id="i151899"    valign="top" width="19.7%" class="mellomKol">

<p class="entrya"><p id="i151900">3</p></p></td>
	<td id="i151901"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i151902">Opplysninger mangler. Se antidiabetika, perorale  <a id="arowX145819" class="ref" href="../G/G8.htm#i145819" title="Antidiabetika, perorale">Antidiabetika, perorale</a></p></p></td>
	</tr>
 <tr id="i151903" class="body oddelinje">
	<td id="i151904"    valign="top" width="28.9%" class="startKol">

<p class="entrya"><p id="i151905">Skopolamin</p></p></td>
	<td id="i151906"    valign="top" width="19.7%" class="mellomKol">

<p class="entrya"><p id="i151907">3</p></p></td>
	<td id="i151908"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i151909">Observer barnet for antikolinerge symptomer som søvnighet og munntørrhet. Se også antikolinergika  <a id="arowX145869" class="ref" href="../G/G8.htm#i145869" title="Antikolinergika">Antikolinergika</a></p></p></td>
	</tr>
 <tr id="i151910" class="body likelinje">
	<td id="i151911"    valign="top" width="28.9%" class="startKol">

<p class="entrya"><p id="i151912"><em>SNRI</em></p></p></td>
	<td id="i151913"    valign="top" width="19.7%" class="mellomKol">

<p class="entrya"><p id="i151914">3</p></p></td>
	<td id="i151915"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i151916">Alle SNRI antidepressiva passerer over til morsmelken i små til moderate mengder. SNRI antidepressiva anses i dag å være forenlig med amming, med forbehold for premature barn. Se også antidepressiva  <a id="aentryX145813" class="ref" href="../G/G8.htm#i145813" title="Antidepressiva">Antidepressiva</a> og de enkelte midlene</p></p></td>
	</tr>
 <tr id="i151917" class="body oddelinje">
	<td id="i151918"    valign="top" width="28.9%" class="startKol">

<p class="entrya"><p id="i151919">Solifenacin</p></p></td>
	<td id="i151920"    valign="top" width="19.7%" class="mellomKol">

<p class="entrya"><p id="i151921">3</p></p></td>
	<td id="i151922"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i151923">Opplysninger mangler. Mulig risiko for antikolinerge effekter i brysternærte barn</p></p></td>
	</tr>
 <tr id="i151924" class="body likelinje">
	<td id="i151925"    valign="top" width="28.9%" class="startKol">

<p class="entrya"><p id="i151926">Somatropin</p></p></td>
	<td id="i151927"    valign="top" width="19.7%" class="mellomKol">

<p class="entrya"><p id="i151928">0</p></p></td>
	<td id="i151929"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i151930">Mulig økning i melkeproduksjonen</p></p></td>
	</tr>
 <tr id="i151931" class="body oddelinje">
	<td id="i151932"    valign="top" width="28.9%" class="startKol">

<p class="entrya"><p id="i151933">Sorafenib</p></p></td>
	<td id="i151934"    valign="top" width="19.7%" class="mellomKol">

<p class="entrya"><p id="i151935">3</p></p></td>
	<td id="i151936"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i151937">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i151938" class="body likelinje">
	<td id="i151939"    valign="top" width="28.9%" class="startKol">

<p class="entrya"><p id="i151940">Sotalol</p></p></td>
	<td id="i151941"    valign="top" width="19.7%" class="mellomKol">

<p class="entrya"><p id="i151942">3</p></p></td>
	<td id="i151943"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i151944">Overgang til morsmelk er høy. Alternativ betablokker bør brukes av ammende. Se betareseptorantagonister, adrenerge  <a id="arowX146361" class="ref" href="../G/G8.htm#i146361" title="Betareseptorantagonister, adrenerge">Betareseptorantagonister, adrenerge</a></p></p></td>
	</tr>
 <tr id="i151945" class="body oddelinje">
	<td id="i151946"    valign="top" width="28.9%" class="startKol">

<p class="entrya"><p id="i151947">Spectinomycin</p></p></td>
	<td id="i151948"    valign="top" width="19.7%" class="mellomKol">

<p class="entrya"><p id="i151949">3</p></p></td>
	<td id="i151950"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i151951">Opplysninger om overgang til morsmelk mangler. Se antibakterielle midler  <a id="arowX145756" class="ref" href="../G/G8.htm#i145756" title="Anestesimidler">Anestesimidler</a></p></p></td>
	</tr>
 <tr id="i151952" class="body likelinje">
	<td id="i151953"    valign="top" width="28.9%" class="startKol">

<p class="entrya"><p id="i151954">Spiramycin</p></p></td>
	<td id="i151955"    valign="top" width="19.7%" class="mellomKol">

<p class="entrya"><p id="i151956">3</p></p></td>
	<td id="i151957"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i151958">Overgang til morsmelk såpass høy at bakteriostatisk effekt hos barnet kan oppnås. Se også antibakterielle midler  <a id="arowX145756" class="ref" href="../G/G8.htm#i145756" title="Anestesimidler">Anestesimidler</a></p></p></td>
	</tr>
 <tr id="i151959" class="body oddelinje">
	<td id="i151960"    valign="top" width="28.9%" class="startKol">

<p class="entrya"><p id="i151961">Spironolakton</p></p></td>
	<td id="i151962"    valign="top" width="19.7%" class="mellomKol">

<p class="entrya"><p id="i151963">2</p></p></td>
	<td id="i151964"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i151965">Overgang til morsmelk er minimal. Se diuretika  <a id="arowX147247" class="ref" href="../G/G8.htm#i147247" title="Diuretika">Diuretika</a></p></p></td>
	</tr>
 <tr id="i151966" class="body likelinje">
	<td id="i151967"    valign="top" width="28.9%" class="startKol">

<p class="entrya"><p id="i151968"><em>SSRI</em></p></p></td>
	<td id="i151969"    valign="top" width="19.7%" class="mellomKol">

<p class="entrya"><p id="i151970">2, 3</p></p></td>
	<td id="i151971"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i151972">Alle antidepressiva passerer over til morsmelken i små mengder. Overgang til morsmelk er minst for sertralin og paroksetin, noe større for citalopram og escitalopram og størst for fluoksetin. Risikoen for påvirkning av barnet er svært liten. Behandling med antidepressiva anses i dag å være forenlig med amming, med forbehold for premature barn. Se også antidepressiva  <a id="arowX145812" class="ref" href="../G/G8.htm#i145812" title="Antidepressiva">Antidepressiva</a> og de enkelte legemidlene.</p></p></td>
	</tr>
 <tr id="i151973" class="body oddelinje">
	<td id="i151974"    valign="top" width="28.9%" class="startKol">

<p class="entrya"><p id="i151975"><em>Statiner</em></p></p></td>
	<td id="i151976"    valign="top" width="19.7%" class="mellomKol">

<p class="entrya"><p id="i151977">3</p></p></td>
	<td id="i151978"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i151979">Opplysning om overgang til morsmelk mangler. Lav biotilgjengelighet tilsier liten systemisk absorpsjon via barnets mage-tarm-kanal. Tilbakeholdenhet med bruk hos ammende anbefales, fordi produkter fra kolesterolbiosyntesen er viktig for neonatal utvikling</p></p></td>
	</tr>
 <tr id="i151980" class="body likelinje">
	<td id="i151981"    valign="top" width="28.9%" class="startKol">

<p class="entrya"><p id="i151982">Stavudin</p></p></td>
	<td id="i151983"    valign="top" width="19.7%" class="mellomKol">

<p class="entrya"><p id="i151984">5</p></p></td>
	<td id="i151985"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i151986">Se antivirale midler  <a id="arowX145939" class="ref" href="../G/G8.htm#i145939" title="Antivirale midler">Antivirale midler</a></p></p></td>
	</tr>
 <tr id="i151987" class="body oddelinje">
	<td id="i151988"    valign="top" width="28.9%" class="startKol">

<p class="entrya"><p id="i151989">Stiripentol</p></p></td>
	<td id="i151990"    valign="top" width="19.7%" class="mellomKol">

<p class="entrya"><p id="i151991">3</p></p></td>
	<td id="i151992"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i151993">Opplysninger om overgang til morsmelk mangler. Se også antiepileptika  <a id="arowX145833" class="ref" href="../G/G8.htm#i145833" title="Antiepileptika">Antiepileptika</a></p></p></td>
	</tr>
 <tr id="i151994" class="body likelinje">
	<td id="i151995"    valign="top" width="28.9%" class="startKol">

<p class="entrya"><p id="i151996">Streptokinase</p></p></td>
	<td id="i151997"    valign="top" width="19.7%" class="mellomKol">

<p class="entrya"><p id="i151998">0</p></p></td>
	<td id="i151999"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i152000">Opplysninger om overgang til morsmelk mangler. Kan brukes av ammende</p></p></td>
	</tr>
 <tr id="i152001" class="body oddelinje">
	<td id="i152002"    valign="top" width="28.9%" class="startKol">

<p class="entrya"><p id="i152003">Streptomycin</p></p></td>
	<td id="i152004"    valign="top" width="19.7%" class="mellomKol">

<p class="entrya"><p id="i152005">2</p></p></td>
	<td id="i152006"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i152007">Overgang til morsmelk er minimal. Se aminoglykosider  <a id="arowX145643" class="ref" href="../G/G8.htm#i145643" title="Aminoglykosider">Aminoglykosider</a></p></p></td>
	</tr>
 <tr id="i152008" class="body likelinje">
	<td id="i152009"    valign="top" width="28.9%" class="startKol">

<p class="entrya"><p id="i152010">Streptozocin</p></p></td>
	<td id="i152011"    valign="top" width="19.7%" class="mellomKol">

<p class="entrya"><p id="i152012">5</p></p></td>
	<td id="i152013"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i152014">Se cytostatika  <a id="arowX146868" class="ref" href="../G/G8.htm#i146868" title="Cytostatika">Cytostatika</a></p></p></td>
	</tr>
 <tr id="i152015" class="body oddelinje">
	<td id="i152016"    valign="top" width="28.9%" class="startKol">

<p class="entrya"><p id="i152017">Sufentanil</p></p></td>
	<td id="i152018"    valign="top" width="19.7%" class="mellomKol">

<p class="entrya"><p id="i152019">2</p></p></td>
	<td id="i152020"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i152021">Se anestesimidler  <a id="arowX145756" class="ref" href="../G/G8.htm#i145756" title="Anestesimidler">Anestesimidler</a></p></p></td>
	</tr>
 <tr id="i152022" class="body likelinje">
	<td id="i152023"    valign="top" width="28.9%" class="startKol">

<p class="entrya"><p id="i152024">Sugammadex</p></p></td>
	<td id="i152025"    valign="top" width="19.7%" class="mellomKol">

<p class="entrya"><p id="i152026">3</p></p></td>
	<td id="i152027"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i152028">Lav peroral biotilgjengelighet tilsier at enkeltdosering med sugammadex kan brukes hos ammende</p></p></td>
	</tr>
 <tr id="i152029" class="body oddelinje">
	<td id="i152030"    valign="top" width="28.9%" class="startKol">

<p class="entrya"><p id="i152031">Sukralfat</p></p></td>
	<td id="i152032"    valign="top" width="19.7%" class="mellomKol">

<p class="entrya"><p id="i152033">0</p></p></td>
	<td id="i152034"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i152035">Kan brukes av ammende</p></p></td>
	</tr>
 <tr id="i152036" class="body likelinje">
	<td id="i152037"    valign="top" width="28.9%" class="startKol">

<p class="entrya"><p id="i152038">Suksameton</p></p></td>
	<td id="i152039"    valign="top" width="19.7%" class="mellomKol">

<p class="entrya"><p id="i152040">2</p></p></td>
	<td id="i152041"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i152042">Se nevromuskulære blokkere  <a id="arowX150558" class="ref" href="../G/G8.htm#i150558" title="Nevromuskulære blokkere">Nevromuskulære blokkere</a></p></p></td>
	</tr>
 <tr id="i152043" class="body oddelinje">
	<td id="i152044"    valign="top" width="28.9%" class="startKol">

<p class="entrya"><p id="i152045">Sulfadoksin</p></p></td>
	<td id="i152046"    valign="top" width="19.7%" class="mellomKol">

<p class="entrya"><p id="i152047">3</p></p></td>
	<td id="i152048"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i152049">Se sulfonamider  <a id="arowX152064" class="ref" href="../G/G8.htm#i152064" title="Sulfonamider">Sulfonamider</a></p></p></td>
	</tr>
 <tr id="i152050" class="body likelinje">
	<td id="i152051"    valign="top" width="28.9%" class="startKol">

<p class="entrya"><p id="i152052">Sulfametoksazol</p></p></td>
	<td id="i152053"    valign="top" width="19.7%" class="mellomKol">

<p class="entrya"><p id="i152054">3</p></p></td>
	<td id="i152055"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i152056">Se sulfonamider  <a id="arowX152064" class="ref" href="../G/G8.htm#i152064" title="Sulfonamider">Sulfonamider</a></p></p></td>
	</tr>
 <tr id="i152057" class="body oddelinje">
	<td id="i152058"    valign="top" width="28.9%" class="startKol">

<p class="entrya"><p id="i152059">Sulfasalazin</p></p></td>
	<td id="i152060"    valign="top" width="19.7%" class="mellomKol">

<p class="entrya"><p id="i152061">3</p></p></td>
	<td id="i152062"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i152063">Overgang til morsmelk er moderat. Observer barnet for diaré. Bør ikke brukes av ammende hvis barnet er prematurt eller under en måned</p></p></td>
	</tr>
 <tr id="i152064" class="body likelinje">
	<td id="i152065"    valign="top" width="28.9%" class="startKol">

<p class="entrya"><p id="i152066"><em>Sulfonamider</em></p></p></td>
	<td id="i152067"    valign="top" width="19.7%" class="mellomKol">

<p class="entrya"><p id="i152068">3</p></p></td>
	<td id="i152069"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i152070">Overgang til morsmelk liten til moderat. Kontraindisert hos premature eller syke barn, eller ved ikterus</p></p></td>
	</tr>
 <tr id="i152071" class="body oddelinje">
	<td id="i152072"    valign="top" width="28.9%" class="startKol">

<p class="entrya"><p id="i152073">Sulindak</p></p></td>
	<td id="i152074"    valign="top" width="19.7%" class="mellomKol">

<p class="entrya"><p id="i152075">3</p></p></td>
	<td id="i152076"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i152077">Opplysninger om overgang til morsmelk mangler. Se NSAID  <a id="arowX150698" class="ref" href="../G/G8.htm#i150698" title="NSAID">NSAID</a></p></p></td>
	</tr>
 <tr id="i152078" class="body likelinje">
	<td id="i152079"    valign="top" width="28.9%" class="startKol">

<p class="entrya"><p id="i152080">Sumatriptan</p></p></td>
	<td id="i152081"    valign="top" width="19.7%" class="mellomKol">

<p class="entrya"><p id="i152082">2</p></p></td>
	<td id="i152083"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i152084">Overgang til morsmelk er liten. Ved å utsette ammingen 6&#x2013;8 timer etter inntak av sumatriptan reduseres mengden i morsmelk til det minimale</p></p></td>
	</tr>
 <tr id="i152085" class="body oddelinje">
	<td id="i152086"    valign="top" width="28.9%" class="startKol">

<p class="entrya"><p id="i152087">Sunitinib</p></p></td>
	<td id="i152088"    valign="top" width="19.7%" class="mellomKol">

<p class="entrya"><p id="i152089">3</p></p></td>
	<td id="i152090"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i152091">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i152092" class="body likelinje">
	<td id="i152093"    valign="top" width="28.9%" class="startKol">

<p class="entrya"><p id="i152094">Superparamagnetisk jernoksid</p></p></td>
	<td id="i152095"    valign="top" width="19.7%" class="mellomKol">

<p class="entrya"><p id="i152096">3</p></p></td>
	<td id="i152097"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i152098">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i152099" class="body oddelinje">
	<td id="i152100"    valign="top" width="28.9%" class="startKol">

<p class="entrya"><p id="i152101">Svovelheksafluorid</p></p></td>
	<td id="i152102"    valign="top" width="19.7%" class="mellomKol">

<p class="entrya"><p id="i152103">3</p></p></td>
	<td id="i152104"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i152105">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i324911" class="body likelinje">
	<td id="i324912"    valign="top" width="28.9%" class="startKol">

<p class="entrya"><p id="i324932">Syklizin</p></p></td>
	<td id="i324914"    valign="top" width="19.7%" class="mellomKol">

<p class="entrya"><p id="i324933">3</p></p></td>
	<td id="i324916"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i324917">Begrensede data tyder på at overgang til morsmelk er moderat. Se antihistaminer  <a id="arowX145840" class="ref" href="../G/G8.htm#i145840" title="Antihistaminer (H1-antagonister)">Antihistaminer (H1-antagonister)</a></p></p></td>
	</tr>
 <tr id="i324918" class="body oddelinje">
	<td id="i324919"    valign="top" width="28.9%" class="startKol">

<p class="entrya"><p id="i324935">Syklofosfamid</p></p></td>
	<td id="i324921"    valign="top" width="19.7%" class="mellomKol">

<p class="entrya"><p id="i324950">5</p></p>
<p class="entrya"><p id="i324951">5</p></p></td>
	<td id="i324923"    valign="top" width="51.4%" class="sluttKol">
	<UL type="circle">
		<LI id="i324953"><p id="i324954"><em>Kreftbehandling:</em> Se cytostatika  <a id="arowX146868" class="ref" href="../G/G8.htm#i146868" title="Cytostatika">Cytostatika</a></p><br>		</LI>
		<LI id="i324955"><p id="i324956">Immunsuppresjon: Amming frarådes pga. syklofosfamids immunsuppressive effekt</p><br>		</LI>
	</UL>
</td>
	</tr>
 <tr id="i324925" class="body likelinje">
	<td id="i324926"    valign="top" width="28.9%" class="startKol">

<p class="entrya"><p id="i324957">Syklopentolat</p></p>
<p class="entrya"><p id="i324927"> </p></p></td>
	<td id="i324928"    valign="top" width="19.7%" class="mellomKol">

<p class="entrya"><p id="i324958">2</p></p>
<p class="entrya"><p id="i324929"> </p></p></td>
	<td id="i324930"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i324959">Øyedråper: Kan brukes av ammende</p></p>
<p class="entrya"><p id="i324931"> </p></p></td>
	</tr>
 <tr id="i152106" class="body oddelinje">
	<td id="i152107"    valign="top" width="28.9%" class="startKol">

<p class="entrya"><p id="i152108">Sølvsulfadiazin (krem)</p></p></td>
	<td id="i152109"    valign="top" width="19.7%" class="mellomKol">

<p class="entrya"><p id="i152110">2</p></p></td>
	<td id="i152111"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i152112">Lokalbehandling: Tilbakeholdenhet anbefales når barnet er prematurt, sykt eller har ikterus</p></p></td>
	</tr>
 </tbody></table>
 <table id="i152114" width="100%" class="maintable" border="0" cellpadding="5" cellspacing="0">
 <caption> <Uth Id="NUTHid2330647" Type="Halvfet">T</Uth></caption> <thead>
	<tr class = "linjetopp">
	<th id="i152122"  colspan="3"  valign="top"  class="sluttKol">

<p class="entrya"><p id="i152123">Overgang til morsmelk angis som minimal (< 2 %), liten (2&#8211;5 %), moderat (5&#8211;10 %) eller høy (10&#8211;50 %) basert på fraksjon av morens dose/kg kroppsvekt som barnet tilføres. (Barnets relative dose.)&ML;						Over 3&#8211;4 ukers bruk ansees som langtidsbehandling.</p></p></th>
	</tr>
	<tr class = "linjetopp">
	<th id="i152126"    valign="top"  class="startKol">

<p class="entrya"><p id="i152127"><strong>Legemiddel</strong></p></p></th>
	<th id="i152128"    valign="top"  class="mellomKol">

<p class="entrya"><p id="i152129"><strong>MM kategori</strong></p></p></th>
	<th id="i152130"    valign="top"  class="sluttKol">

<p class="entrya"><p id="i152131"><strong>Dokumentasjon vedrørende bruk under amming</strong></p></p></th>
	</tr>
</thead>
<tbody>
<tr id="i152133" class="body likelinje">
	<td id="i152134"    valign="top" width="28.7%" class="startKol">

<p class="entrya"><p id="i152135">Tacrolimus</p></p></td>
	<td id="i152136"    valign="top" width="20%" class="mellomKol">

<p class="entrya"><p id="i152137">4</p></p></td>
	<td id="i152138"    valign="top" width="51.3%" class="sluttKol">

<p class="entrya"><p id="i152139">Overgang til morsmelk er minimal. Amming er ikke tilrådelig pga. virkestoffets immunsuppressive egenskaper og manglende klinisk erfaring</p></p></td>
	</tr>
 <tr id="i152140" class="body oddelinje">
	<td id="i152141"    valign="top" width="28.7%" class="startKol">

<p class="entrya"><p id="i152142">Tadalafil</p></p></td>
	<td id="i152143"    valign="top" width="20%" class="mellomKol">

<p class="entrya"><p id="i152144">&#8211;</p></p></td>
	<td id="i152145"    valign="top" width="51.3%" class="sluttKol">

<p class="entrya"><p id="i152146">Ikke aktuelt til bruk hos ammende</p></p></td>
	</tr>
 <tr id="i152147" class="body likelinje">
	<td id="i152148"    valign="top" width="28.7%" class="startKol">

<p class="entrya"><p id="i218859">Tafluprost</p></p></td>
	<td id="i152149"    valign="top" width="20%" class="mellomKol">

<p class="entrya"><p id="i152150">3</p></p></td>
	<td id="i152151"    valign="top" width="51.3%" class="sluttKol">

<p class="entrya"><p id="i152152">Øyedråper: Lav systemisk dose og kort halveringstid tilsier at tafluprost kan brukes av ammende</p></p></td>
	</tr>
 <tr id="i152153" class="body oddelinje">
	<td id="i152154"    valign="top" width="28.7%" class="startKol">

<p class="entrya"><p id="i152155">Talidomid</p></p></td>
	<td id="i152156"    valign="top" width="20%" class="mellomKol">

<p class="entrya"><p id="i152157">4</p></p></td>
	<td id="i152158"    valign="top" width="51.3%" class="sluttKol">

<p class="entrya"><p id="i152159">Opplysninger mangler, men virkestoffets toksisitet tilsier at ammende ikke bør bruke talidomid</p></p></td>
	</tr>
 <tr id="i152160" class="body likelinje">
	<td id="i152161"    valign="top" width="28.7%" class="startKol">

<p class="entrya"><p id="i152162">Tamoksifen</p></p></td>
	<td id="i152163"    valign="top" width="20%" class="mellomKol">

<p class="entrya"><p id="i152164">5</p></p></td>
	<td id="i152165"    valign="top" width="51.3%" class="sluttKol">

<p class="entrya"><p id="i152166">Bruk er kontraindisert hos ammende</p></p></td>
	</tr>
 <tr id="i152167" class="body oddelinje">
	<td id="i152168"    valign="top" width="28.7%" class="startKol">

<p class="entrya"><p id="i152169">Tamsulosin</p></p></td>
	<td id="i152170"    valign="top" width="20%" class="mellomKol">

<p class="entrya"><p id="i152171">3</p></p></td>
	<td id="i152172"    valign="top" width="51.3%" class="sluttKol">

<p class="entrya"><p id="i152173">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i221954" class="body likelinje">
	<td id="i221955"    valign="top" width="28.7%" class="startKol">

<p class="entrya"><p id="i221956">Tapentadol </p></p></td>
	<td id="i221957"    valign="top" width="20%" class="mellomKol">

<p class="entrya"><p id="i221958">3 </p></p></td>
	<td id="i221959"    valign="top" width="51.3%" class="sluttKol">

<p class="entrya"><p id="i221960">Opplysning om overgang til morsmelk mangler. Se opioidanalgetika  <a id="arowX150865" class="ref" href="../G/G8.htm#i150865" title="Opioidanalgetika">Opioidanalgetika</a></p></p></td>
	</tr>
 <tr id="i152174" class="body oddelinje">
	<td id="i152175"    valign="top" width="28.7%" class="startKol">

<p class="entrya"><p id="i152176">Tazobaktam</p></p></td>
	<td id="i152177"    valign="top" width="20%" class="mellomKol">

<p class="entrya"><p id="i152178">3</p></p></td>
	<td id="i152179"    valign="top" width="51.3%" class="sluttKol">

<p class="entrya"><p id="i152180">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i152181" class="body likelinje">
	<td id="i152182"    valign="top" width="28.7%" class="startKol">

<p class="entrya"><p id="i152183"><em>TCA</em></p></p></td>
	<td id="i152184"    valign="top" width="20%" class="mellomKol">

<p class="entrya"><p id="i152185">2, 3</p></p></td>
	<td id="i152186"    valign="top" width="51.3%" class="sluttKol">

<p class="entrya"><p id="i152187">Se trisykliske antidepressiva  <a id="arowX152619" class="ref" href="../G/G8.htm#i152619" title="Trisykliske antidepressiva (TCA)">Trisykliske antidepressiva (TCA)</a></p></p></td>
	</tr>
 <tr id="i152188" class="body oddelinje">
	<td id="i152189"    valign="top" width="28.7%" class="startKol">

<p class="entrya"><p id="i152190">Tegafur</p></p></td>
	<td id="i152191"    valign="top" width="20%" class="mellomKol">

<p class="entrya"><p id="i152192">5</p></p></td>
	<td id="i152193"    valign="top" width="51.3%" class="sluttKol">

<p class="entrya"><p id="i152194">Se cytostatika  <a id="arowX146868" class="ref" href="../G/G8.htm#i146868" title="Cytostatika">Cytostatika</a></p></p></td>
	</tr>
 <tr id="i152195" class="body likelinje">
	<td id="i152196"    valign="top" width="28.7%" class="startKol">

<p class="entrya"><p id="i152197">Teikoplanin</p></p></td>
	<td id="i152198"    valign="top" width="20%" class="mellomKol">

<p class="entrya"><p id="i152199">3</p></p></td>
	<td id="i152200"    valign="top" width="51.3%" class="sluttKol">

<p class="entrya"><p id="i152201">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i320140" class="body oddelinje">
	<td id="i320141"    valign="top" width="28.7%" class="startKol">

<p class="entrya"><p id="i320142">Telaprevir</p></p></td>
	<td id="i320143"    valign="top" width="20%" class="mellomKol">

<p class="entrya"><p id="i320144">3</p></p></td>
	<td id="i320145"    valign="top" width="51.3%" class="sluttKol">

<p class="entrya"><p id="i320146">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i152202" class="body likelinje">
	<td id="i152203"    valign="top" width="28.7%" class="startKol">

<p class="entrya"><p id="i152204">Telbivudin</p></p></td>
	<td id="i152205"    valign="top" width="20%" class="mellomKol">

<p class="entrya"><p id="i152206">3</p></p></td>
	<td id="i152207"    valign="top" width="51.3%" class="sluttKol">

<p class="entrya"><p id="i152208">Opplysninger mangler. Se antivirale midler  <a id="arowX145939" class="ref" href="../G/G8.htm#i145939" title="Antivirale midler">Antivirale midler</a></p></p></td>
	</tr>
 <tr id="i152216" class="body oddelinje">
	<td id="i152217"    valign="top" width="28.7%" class="startKol">

<p class="entrya"><p id="i152218">Telmisartan</p></p></td>
	<td id="i152219"    valign="top" width="20%" class="mellomKol">

<p class="entrya"><p id="i152220">3</p></p></td>
	<td id="i152221"    valign="top" width="51.3%" class="sluttKol">

<p class="entrya"><p id="i152222">Se angiotensin II-reseptorantagonister  <a id="arowX145763" class="ref" href="../G/G8.htm#i145763" title="Angiotensin II-reseptorantagonister">Angiotensin II-reseptorantagonister</a></p></p></td>
	</tr>
 <tr id="i152223" class="body likelinje">
	<td id="i152224"    valign="top" width="28.7%" class="startKol">

<p class="entrya"><p id="i152225">Temoporfin</p></p></td>
	<td id="i152226"    valign="top" width="20%" class="mellomKol">

<p class="entrya"><p id="i152227">3</p></p></td>
	<td id="i152228"    valign="top" width="51.3%" class="sluttKol">

<p class="entrya"><p id="i152229">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i152230" class="body oddelinje">
	<td id="i152231"    valign="top" width="28.7%" class="startKol">

<p class="entrya"><p id="i152232">Temozolomid</p></p></td>
	<td id="i152233"    valign="top" width="20%" class="mellomKol">

<p class="entrya"><p id="i152234">5</p></p></td>
	<td id="i152235"    valign="top" width="51.3%" class="sluttKol">

<p class="entrya"><p id="i152236">Se cytostatika  <a id="arowX146868" class="ref" href="../G/G8.htm#i146868" title="Cytostatika">Cytostatika</a></p></p></td>
	</tr>
 <tr id="i152237" class="body likelinje">
	<td id="i152238"    valign="top" width="28.7%" class="startKol">

<p class="entrya"><p id="i152239">Tenekteplase</p></p></td>
	<td id="i152240"    valign="top" width="20%" class="mellomKol">

<p class="entrya"><p id="i152241">0</p></p></td>
	<td id="i152242"    valign="top" width="51.3%" class="sluttKol">

<p class="entrya"><p id="i152243">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i152244" class="body oddelinje">
	<td id="i152245"    valign="top" width="28.7%" class="startKol">

<p class="entrya"><p id="i152246">Teniposid</p></p></td>
	<td id="i152247"    valign="top" width="20%" class="mellomKol">

<p class="entrya"><p id="i152248">5</p></p></td>
	<td id="i152249"    valign="top" width="51.3%" class="sluttKol">

<p class="entrya"><p id="i152250">Se cytostatika  <a id="arowX146868" class="ref" href="../G/G8.htm#i146868" title="Cytostatika">Cytostatika</a></p></p></td>
	</tr>
 <tr id="i152251" class="body likelinje">
	<td id="i152252"    valign="top" width="28.7%" class="startKol">

<p class="entrya"><p id="i152253">Tenofovir</p></p></td>
	<td id="i152254"    valign="top" width="20%" class="mellomKol">

<p class="entrya"><p id="i152255">5</p></p></td>
	<td id="i152256"    valign="top" width="51.3%" class="sluttKol">

<p class="entrya"><p id="i152257">Se antivirale midler  <a id="arowX145939" class="ref" href="../G/G8.htm#i145939" title="Antivirale midler">Antivirale midler</a></p></p></td>
	</tr>
 <tr id="i152258" class="body oddelinje">
	<td id="i152259"    valign="top" width="28.7%" class="startKol">

<p class="entrya"><p id="i152260">Teofyllin</p></p></td>
	<td id="i152261"    valign="top" width="20%" class="mellomKol">

<p class="entrya"><p id="i152262">3</p></p></td>
	<td id="i152263"    valign="top" width="51.3%" class="sluttKol">

<p class="entrya"><p id="i152264">Overgang til morsmelk er moderat. Risiko for akkumulering av metabolitt er til stede. Uro og søvnløshet kan oppstå. Irritabilitet er rapportert hos brysternærte barn</p></p></td>
	</tr>
 <tr id="i152265" class="body likelinje">
	<td id="i152266"    valign="top" width="28.7%" class="startKol">

<p class="entrya"><p id="i152267">Teofyllinetylendiamin</p></p></td>
	<td id="i152268"    valign="top" width="20%" class="mellomKol">

<p class="entrya"><p id="i152269">3</p></p></td>
	<td id="i152270"    valign="top" width="51.3%" class="sluttKol">

<p class="entrya"><p id="i152271">Overgang til morsmelk er liten. Se teofyllin  <a id="arowX152258" class="ref" href="../G/G8.htm#i152258" title="Teofyllin">Teofyllin</a></p></p></td>
	</tr>
 <tr id="i152272" class="body oddelinje">
	<td id="i152273"    valign="top" width="28.7%" class="startKol">

<p class="entrya"><p id="i152274">Terazosin</p></p></td>
	<td id="i152275"    valign="top" width="20%" class="mellomKol">

<p class="entrya"><p id="i152276">3</p></p></td>
	<td id="i152277"    valign="top" width="51.3%" class="sluttKol">

<p class="entrya"><p id="i152278">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i152279" class="body likelinje">
	<td id="i152280"    valign="top" width="28.7%" class="startKol">

<p class="entrya"><p id="i152281">Terbinafin</p></p></td>
	<td id="i152282"    valign="top" width="20%" class="mellomKol">

<p class="entrya"><p id="i152283">2</p></p>
<p class="entrya"><p id="i272087"> </p></p>
<p class="entrya"><p id="i272082">2</p></p></td>
	<td id="i152284"    valign="top" width="51.3%" class="sluttKol">
	<UL type="circle">
		<LI id="i152286"><p id="i152287"><em>Systemisk bruk:</em> Overgang til morsmelk er minimal. Kan brukes med forsiktighet av ammende</p><br>		</LI>
		<LI id="i272083"><p id="i272084">Lokal bruk: Kan brukes av ammende</p><br>		</LI>
	</UL>
</td>
	</tr>
 <tr id="i152297" class="body oddelinje">
	<td id="i152298"    valign="top" width="28.7%" class="startKol">

<p class="entrya"><p id="i152299">Terbutalin</p></p></td>
	<td id="i152300"    valign="top" width="20%" class="mellomKol">

<p class="entrya"><p id="i152301">2</p></p></td>
	<td id="i152302"    valign="top" width="51.3%" class="sluttKol">

<p class="entrya"><p id="i152303">Overgang til morsmelk er minimal. Se beta-2-reseptoragonister, adrenerge  <a id="arowX146354" class="ref" href="../G/G8.htm#i146354" title="Beta-2-reseptoragonister, adrenerge">Beta-2-reseptoragonister, adrenerge</a></p></p></td>
	</tr>
 <tr id="i152304" class="body likelinje">
	<td id="i152305"    valign="top" width="28.7%" class="startKol">

<p class="entrya"><p id="i152306">Teriparatide</p></p></td>
	<td id="i152307"    valign="top" width="20%" class="mellomKol">

<p class="entrya"><p id="i152308">&#8211;</p></p></td>
	<td id="i152309"    valign="top" width="51.3%" class="sluttKol">

<p class="entrya"><p id="i152310">Ikke aktuell til bruk hos ammende</p></p></td>
	</tr>
 <tr id="i152311" class="body oddelinje">
	<td id="i152312"    valign="top" width="28.7%" class="startKol">

<p class="entrya"><p id="i152313">Terlipressin</p></p></td>
	<td id="i152314"    valign="top" width="20%" class="mellomKol">

<p class="entrya"><p id="i152315">3</p></p></td>
	<td id="i152316"    valign="top" width="51.3%" class="sluttKol">

<p class="entrya"><p id="i152317">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i152318" class="body likelinje">
	<td id="i152319"    valign="top" width="28.7%" class="startKol">

<p class="entrya"><p id="i152320">Testosteron</p></p></td>
	<td id="i152321"    valign="top" width="20%" class="mellomKol">

<p class="entrya"><p id="i152322">4</p></p></td>
	<td id="i152323"    valign="top" width="51.3%" class="sluttKol">

<p class="entrya"><p id="i152324">Se androgener  <a id="arowX145749" class="ref" href="../G/G8.htm#i145749" title="Androgener">Androgener</a></p></p></td>
	</tr>
 <tr id="i152325" class="body oddelinje">
	<td id="i152326"    valign="top" width="28.7%" class="startKol">

<p class="entrya"><p id="i152327"><em>Tetrasykliner</em></p></p></td>
	<td id="i152328"    valign="top" width="20%" class="mellomKol">

<p class="entrya"><p id="i152329">2, 3</p></p></td>
	<td id="i152330"    valign="top" width="51.3%" class="sluttKol">

<p class="entrya"><p id="i152331">Overgang til morsmelk er minimal. Syv dagers kurer er forenlig med amming. Kelatdannelse med kalsiumioner i morsmelken hindrer sannsynligvis absorpsjon hos barnet. Langvarig bruk av tetrasykliner er kontraindisert i ammeperioden pga. teoretisk risiko for misfarging av barnets tenner. Se antibakterielle midler  <a id="arowX145756" class="ref" href="../G/G8.htm#i145756" title="Anestesimidler">Anestesimidler</a></p></p></td>
	</tr>
 <tr id="i152332" class="body likelinje">
	<td id="i152333"    valign="top" width="28.7%" class="startKol">

<p class="entrya"><p id="i152334">Tetrakain</p></p></td>
	<td id="i152335"    valign="top" width="20%" class="mellomKol">

<p class="entrya"><p id="i152336">2</p></p></td>
	<td id="i152337"    valign="top" width="51.3%" class="sluttKol">

<p class="entrya"><p id="i152338">Øyedråper: Kan brukes av ammende</p></p></td>
	</tr>
 <tr id="i152339" class="body oddelinje">
	<td id="i152340"    valign="top" width="28.7%" class="startKol">

<p class="entrya"><p id="i152341"><em>Thyreoideahormoner</em></p></p></td>
	<td id="i152342"    valign="top" width="20%" class="mellomKol">

<p class="entrya"><p id="i152343">2</p></p></td>
	<td id="i152344"    valign="top" width="51.3%" class="sluttKol">

<p class="entrya"><p id="i152345">Overgang til morsmelk er minimal. Kan brukes av ammende</p></p></td>
	</tr>
 <tr id="i152346" class="body likelinje">
	<td id="i152347"    valign="top" width="28.7%" class="startKol">

<p class="entrya"><p id="i152348">Tiaprid</p></p></td>
	<td id="i152349"    valign="top" width="20%" class="mellomKol">

<p class="entrya"><p id="i152350">3</p></p></td>
	<td id="i152351"    valign="top" width="51.3%" class="sluttKol">

<p class="entrya"><p id="i152352">Opplysninger om overgang til morsmelk mangler. Se antipsykotika  <a id="arowX145918" class="ref" href="../G/G8.htm#i145918" title="Antipsykotika">Antipsykotika</a></p></p></td>
	</tr>
 <tr id="i152353" class="body oddelinje">
	<td id="i152354"    valign="top" width="28.7%" class="startKol">

<p class="entrya"><p id="i152355"><em>Tiaziddiuretika</em></p></p></td>
	<td id="i152356"    valign="top" width="20%" class="mellomKol">

<p class="entrya"><p id="i152357">2, 3</p></p></td>
	<td id="i152358"    valign="top" width="51.3%" class="sluttKol">

<p class="entrya"><p id="i152359">Overgang til morsmelk er liten til moderat. Kan virke laktasjonshemmende ved høye doser. Tilbakeholdenhet anbefales ved langtidsbehandling og ved høye doser</p></p></td>
	</tr>
 <tr id="i152360" class="body likelinje">
	<td id="i152361"    valign="top" width="28.7%" class="startKol">

<p class="entrya"><p id="i152362">Tibolon</p></p></td>
	<td id="i152363"    valign="top" width="20%" class="mellomKol">

<p class="entrya"><p id="i152364">4</p></p></td>
	<td id="i152365"    valign="top" width="51.3%" class="sluttKol">

<p class="entrya"><p id="i152366">Opplysninger om morsmelk mangler. Tilbakeholdenhet med bruk hos ammende pga. mulig androgen effekt på barnet</p></p></td>
	</tr>
 <tr id="i221961" class="body oddelinje">
	<td id="i221962"    valign="top" width="28.7%" class="startKol">

<p class="entrya"><p id="i221963">Ticagrelor </p></p></td>
	<td id="i221964"    valign="top" width="20%" class="mellomKol">

<p class="entrya"><p id="i221965">3 </p></p></td>
	<td id="i221966"    valign="top" width="51.3%" class="sluttKol">

<p class="entrya"><p id="i221967">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i152367" class="body likelinje">
	<td id="i152368"    valign="top" width="28.7%" class="startKol">

<p class="entrya"><p id="i152369">Tigecyklin</p></p></td>
	<td id="i152370"    valign="top" width="20%" class="mellomKol">

<p class="entrya"><p id="i152371">3</p></p></td>
	<td id="i152372"    valign="top" width="51.3%" class="sluttKol">

<p class="entrya"><p id="i152373">Opplysninger mangler. Se tetrasykliner  <a id="arowX152325" class="ref" href="../G/G8.htm#i152325" title="Tetrasykliner">Tetrasykliner</a></p></p></td>
	</tr>
 <tr id="i152374" class="body oddelinje">
	<td id="i152375"    valign="top" width="28.7%" class="startKol">

<p class="entrya"><p id="i152376">Tiklopidin</p></p></td>
	<td id="i152377"    valign="top" width="20%" class="mellomKol">

<p class="entrya"><p id="i152378">4</p></p></td>
	<td id="i152379"    valign="top" width="51.3%" class="sluttKol">

<p class="entrya"><p id="i152380">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i152381" class="body likelinje">
	<td id="i152382"    valign="top" width="28.7%" class="startKol">

<p class="entrya"><p id="i152383">Timolol</p></p></td>
	<td id="i152384"    valign="top" width="20%" class="mellomKol">

<p class="entrya"><p id="i152385">2</p></p></td>
	<td id="i152386"    valign="top" width="51.3%" class="sluttKol">

<p class="entrya"><p id="i152387">Overgang til morsmelk er minimal. Se betareseptorantagonister, adrenerge  <a id="arowX146361" class="ref" href="../G/G8.htm#i146361" title="Betareseptorantagonister, adrenerge">Betareseptorantagonister, adrenerge</a> Øyedråper: Kan brukes av ammende</p></p></td>
	</tr>
 <tr id="i152388" class="body oddelinje">
	<td id="i152389"    valign="top" width="28.7%" class="startKol">

<p class="entrya"><p id="i152390">Tioguanin</p></p></td>
	<td id="i152391"    valign="top" width="20%" class="mellomKol">

<p class="entrya"><p id="i152392">5</p></p></td>
	<td id="i152393"    valign="top" width="51.3%" class="sluttKol">

<p class="entrya"><p id="i152394">Se cytostatika  <a id="arowX146868" class="ref" href="../G/G8.htm#i146868" title="Cytostatika">Cytostatika</a></p></p></td>
	</tr>
 <tr id="i152395" class="body likelinje">
	<td id="i152396"    valign="top" width="28.7%" class="startKol">

<p class="entrya"><p id="i152397">Tiopental</p></p></td>
	<td id="i152398"    valign="top" width="20%" class="mellomKol">

<p class="entrya"><p id="i152399">2</p></p></td>
	<td id="i152400"    valign="top" width="51.3%" class="sluttKol">

<p class="entrya"><p id="i152401">Se anestesimidler  <a id="arowX145756" class="ref" href="../G/G8.htm#i145756" title="Anestesimidler">Anestesimidler</a></p></p></td>
	</tr>
 <tr id="i221968" class="body oddelinje">
	<td id="i221969"    valign="top" width="28.7%" class="startKol">

<p class="entrya"><p id="i221970">Tiotepa </p></p></td>
	<td id="i221971"    valign="top" width="20%" class="mellomKol">

<p class="entrya"><p id="i221972">5 </p></p></td>
	<td id="i221973"    valign="top" width="51.3%" class="sluttKol">

<p class="entrya"><p id="i221974">Se cytostatika  <a id="arowX146868" class="ref" href="../G/G8.htm#i146868" title="Cytostatika">Cytostatika</a></p></p></td>
	</tr>
 <tr id="i152402" class="body likelinje">
	<td id="i152403"    valign="top" width="28.7%" class="startKol">

<p class="entrya"><p id="i152404">Tiotropium</p></p></td>
	<td id="i152405"    valign="top" width="20%" class="mellomKol">

<p class="entrya"><p id="i152406">3</p></p></td>
	<td id="i152407"    valign="top" width="51.3%" class="sluttKol">

<p class="entrya"><p id="i152408">Farmakokinetiske egenskaper tilsier minimal eksponering av brysternærte barn</p></p></td>
	</tr>
 <tr id="i152409" class="body oddelinje">
	<td id="i152410"    valign="top" width="28.7%" class="startKol">

<p class="entrya"><p id="i152411">Tipranavir</p></p></td>
	<td id="i152412"    valign="top" width="20%" class="mellomKol">

<p class="entrya"><p id="i152413">5</p></p></td>
	<td id="i152414"    valign="top" width="51.3%" class="sluttKol">

<p class="entrya"><p id="i152415">Se antivirale midler  <a id="arowX145939" class="ref" href="../G/G8.htm#i145939" title="Antivirale midler">Antivirale midler</a></p></p></td>
	</tr>
 <tr id="i152416" class="body likelinje">
	<td id="i152417"    valign="top" width="28.7%" class="startKol">

<p class="entrya"><p id="i152418">Tirofiban</p></p></td>
	<td id="i152419"    valign="top" width="20%" class="mellomKol">

<p class="entrya"><p id="i152420">3</p></p></td>
	<td id="i152421"    valign="top" width="51.3%" class="sluttKol">

<p class="entrya"><p id="i152422">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i152423" class="body oddelinje">
	<td id="i152424"    valign="top" width="28.7%" class="startKol">

<p class="entrya"><p id="i152425">Tobramycin</p></p></td>
	<td id="i152426"    valign="top" width="20%" class="mellomKol">

<p class="entrya"><p id="i152427">2</p></p></td>
	<td id="i152428"    valign="top" width="51.3%" class="sluttKol">

<p class="entrya"><p id="i152429">Overgang til morsmelk er liten. Se aminoglykosider  <a id="arowX145643" class="ref" href="../G/G8.htm#i145643" title="Aminoglykosider">Aminoglykosider</a></p></p></td>
	</tr>
 <tr id="i152430" class="body likelinje">
	<td id="i152431"    valign="top" width="28.7%" class="startKol">

<p class="entrya"><p id="i218860">Tocilizumab</p></p></td>
	<td id="i152432"    valign="top" width="20%" class="mellomKol">

<p class="entrya"><p id="i152433">3</p></p></td>
	<td id="i152434"    valign="top" width="51.3%" class="sluttKol">

<p class="entrya"><p id="i152435">Opplysninger om overgang til morsmelk mangler, men den er trolig minimal. Bruk hos ammende anbefales ikke pga. virkningsmekanismen og manglende erfaring</p></p></td>
	</tr>
 <tr id="i152436" class="body oddelinje">
	<td id="i152437"    valign="top" width="28.7%" class="startKol">

<p class="entrya"><p id="i218861">Tokoferol</p></p></td>
	<td id="i152438"    valign="top" width="20%" class="mellomKol">

<p class="entrya"><p id="i152439">2</p></p></td>
	<td id="i152440"    valign="top" width="51.3%" class="sluttKol">

<p class="entrya"><p id="i152441">Se vitamin E  <a id="arowX152889" class="ref" href="../G/G8.htm#i152889" title="Vitamin E">Vitamin E</a></p></p></td>
	</tr>
 <tr id="i152442" class="body likelinje">
	<td id="i152443"    valign="top" width="28.7%" class="startKol">

<p class="entrya"><p id="i218862">Tokofersolan</p></p></td>
	<td id="i152444"    valign="top" width="20%" class="mellomKol">

<p class="entrya"><p id="i152445">3</p></p></td>
	<td id="i152446"    valign="top" width="51.3%" class="sluttKol">

<p class="entrya"><p id="i152447">Erfaring med bruk hos ammende mangler</p></p></td>
	</tr>
 <tr id="i152448" class="body oddelinje">
	<td id="i152449"    valign="top" width="28.7%" class="startKol">

<p class="entrya"><p id="i152450">Tolfenam</p></p></td>
	<td id="i152451"    valign="top" width="20%" class="mellomKol">

<p class="entrya"><p id="i152452">3</p></p></td>
	<td id="i152453"    valign="top" width="51.3%" class="sluttKol">

<p class="entrya"><p id="i152454">Opplysninger om overgang til morsmelk mangler. Se NSAID  <a id="arowX150698" class="ref" href="../G/G8.htm#i150698" title="NSAID">NSAID</a></p></p></td>
	</tr>
 <tr id="i152455" class="body likelinje">
	<td id="i152456"    valign="top" width="28.7%" class="startKol">

<p class="entrya"><p id="i152457">Tolkapon</p></p></td>
	<td id="i152458"    valign="top" width="20%" class="mellomKol">

<p class="entrya"><p id="i152459">3</p></p></td>
	<td id="i152460"    valign="top" width="51.3%" class="sluttKol">

<p class="entrya"><p id="i152461">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i152462" class="body oddelinje">
	<td id="i152463"    valign="top" width="28.7%" class="startKol">

<p class="entrya"><p id="i152464">Tolterodin</p></p></td>
	<td id="i152465"    valign="top" width="20%" class="mellomKol">

<p class="entrya"><p id="i152466">3</p></p></td>
	<td id="i152467"    valign="top" width="51.3%" class="sluttKol">

<p class="entrya"><p id="i152468">Opplysninger mangler. Mulig risiko for antikolinerge effekter i brysternærte barn</p></p></td>
	</tr>
 <tr id="i152469" class="body likelinje">
	<td id="i152470"    valign="top" width="28.7%" class="startKol">

<p class="entrya"><p id="i152471">Tolvaptan</p></p></td>
	<td id="i152472"    valign="top" width="20%" class="mellomKol">

<p class="entrya"><p id="i152473">3</p></p></td>
	<td id="i152474"    valign="top" width="51.3%" class="sluttKol">

<p class="entrya"><p id="i152475">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i152476" class="body oddelinje">
	<td id="i152477"    valign="top" width="28.7%" class="startKol">

<p class="entrya"><p id="i152478">Topiramat</p></p></td>
	<td id="i152479"    valign="top" width="20%" class="mellomKol">

<p class="entrya"><p id="i152480">4</p></p></td>
	<td id="i152481"    valign="top" width="51.3%" class="sluttKol">

<p class="entrya"><p id="i152482">Overgang til morsmelk er høy. Bør unngås til erfaring hos ammende foreligger. Se antiepileptika  <a id="arowX145833" class="ref" href="../G/G8.htm#i145833" title="Antiepileptika">Antiepileptika</a></p></p></td>
	</tr>
 <tr id="i152483" class="body likelinje">
	<td id="i152484"    valign="top" width="28.7%" class="startKol">

<p class="entrya"><p id="i152485">Topotekan</p></p></td>
	<td id="i152486"    valign="top" width="20%" class="mellomKol">

<p class="entrya"><p id="i152487">5</p></p></td>
	<td id="i152488"    valign="top" width="51.3%" class="sluttKol">

<p class="entrya"><p id="i152489">Se cytostatika  <a id="arowX146868" class="ref" href="../G/G8.htm#i146868" title="Cytostatika">Cytostatika</a></p></p></td>
	</tr>
 <tr id="i152490" class="body oddelinje">
	<td id="i152491"    valign="top" width="28.7%" class="startKol">

<p class="entrya"><p id="i152492">Trabektedin</p></p></td>
	<td id="i152493"    valign="top" width="20%" class="mellomKol">

<p class="entrya"><p id="i152494">5</p></p></td>
	<td id="i152495"    valign="top" width="51.3%" class="sluttKol">

<p class="entrya"><p id="i152496">Se cytostatika  <a id="arowX146868" class="ref" href="../G/G8.htm#i146868" title="Cytostatika">Cytostatika</a></p></p></td>
	</tr>
 <tr id="i152497" class="body likelinje">
	<td id="i152498"    valign="top" width="28.7%" class="startKol">

<p class="entrya"><p id="i152499">Tramadol</p></p></td>
	<td id="i152500"    valign="top" width="20%" class="mellomKol">

<p class="entrya"><p id="i152501">3</p></p></td>
	<td id="i152502"    valign="top" width="51.3%" class="sluttKol">

<p class="entrya"><p id="i152503">Overgang til morsmelk er minimal. Risiko for påvirkning av barnet synes liten ved sporadisk bruk i terapeutiske doser. Se opioidanalgetika  <a id="arowX150865" class="ref" href="../G/G8.htm#i150865" title="Opioidanalgetika">Opioidanalgetika</a></p></p></td>
	</tr>
 <tr id="i152504" class="body oddelinje">
	<td id="i152505"    valign="top" width="28.7%" class="startKol">

<p class="entrya"><p id="i152506">Trandolapril</p></p></td>
	<td id="i152507"    valign="top" width="20%" class="mellomKol">

<p class="entrya"><p id="i152508">3</p></p></td>
	<td id="i152509"    valign="top" width="51.3%" class="sluttKol">

<p class="entrya"><p id="i152510">Opplysninger om overgang til morsmelk mangler. Se ACE-hemmere</p></p></td>
	</tr>
 <tr id="i152511" class="body likelinje">
	<td id="i152512"    valign="top" width="28.7%" class="startKol">

<p class="entrya"><p id="i152513">Traneksamsyre</p></p></td>
	<td id="i152514"    valign="top" width="20%" class="mellomKol">

<p class="entrya"><p id="i152515">2</p></p></td>
	<td id="i152516"    valign="top" width="51.3%" class="sluttKol">

<p class="entrya"><p id="i152517">Passerer over i morsmelk, men risiko for påvirkning av barnet synes liten ved terapeutiske doser</p></p></td>
	</tr>
 <tr id="i152518" class="body oddelinje">
	<td id="i152519"    valign="top" width="28.7%" class="startKol">

<p class="entrya"><p id="i152520">Tranylcypromin</p></p></td>
	<td id="i152521"    valign="top" width="20%" class="mellomKol">

<p class="entrya"><p id="i152522">3</p></p></td>
	<td id="i152523"    valign="top" width="51.3%" class="sluttKol">

<p class="entrya"><p id="i152524">Opplysninger om bruk under amming mangler</p></p></td>
	</tr>
 <tr id="i152525" class="body likelinje">
	<td id="i152526"    valign="top" width="28.7%" class="startKol">

<p class="entrya"><p id="i152527">Trastuzumab</p></p></td>
	<td id="i152528"    valign="top" width="20%" class="mellomKol">

<p class="entrya"><p id="i152529">3</p></p></td>
	<td id="i152530"    valign="top" width="51.3%" class="sluttKol">

<p class="entrya"><p id="i152531">Opplysninger mangler. Bør unngås pga. virkningsmekanismen</p></p></td>
	</tr>
 <tr id="i152532" class="body oddelinje">
	<td id="i152533"    valign="top" width="28.7%" class="startKol">

<p class="entrya"><p id="i152534">Travoprost</p></p></td>
	<td id="i152535"    valign="top" width="20%" class="mellomKol">

<p class="entrya"><p id="i152536">3</p></p></td>
	<td id="i152537"    valign="top" width="51.3%" class="sluttKol">

<p class="entrya"><p id="i152538">Øyedråper: Lav systemisk dose og kort halveringstid tilsier at travoprost kan brukes av ammende</p></p></td>
	</tr>
 <tr id="i152539" class="body likelinje">
	<td id="i152540"    valign="top" width="28.7%" class="startKol">

<p class="entrya"><p id="i152541">Tretinoin</p></p></td>
	<td id="i152542"    valign="top" width="20%" class="mellomKol">

<p class="entrya"><p id="i152543">3</p></p></td>
	<td id="i152544"    valign="top" width="51.3%" class="sluttKol">

<p class="entrya"><p id="i152545">Se retinoider  <a id="arowX151587" class="ref" href="../G/G8.htm#i151587" title="Retinoider">Retinoider</a></p></p></td>
	</tr>
 <tr id="i152546" class="body oddelinje">
	<td id="i152547"    valign="top" width="28.7%" class="startKol">

<p class="entrya"><p id="i152548">Triamcinolon</p></p></td>
	<td id="i152549"    valign="top" width="20%" class="mellomKol">

<p class="entrya"><p id="i152550">2 &#x2013;&ML;	lokalbehandling&ML;	3 &#x2013;&ML;	systemisk behandling</p></p></td>
	<td id="i152554"    valign="top" width="51.3%" class="sluttKol">

<p class="entrya"><p id="i152555">Overgang til morsmelk liten. Se glukokortikoider  <a id="arowX148403" class="ref" href="../G/G8.htm#i148403" title="Glukokortikoider">Glukokortikoider</a></p></p></td>
	</tr>
 <tr id="i152556" class="body likelinje">
	<td id="i152557"    valign="top" width="28.7%" class="startKol">

<p class="entrya"><p id="i152558">Triazolam</p></p></td>
	<td id="i152559"    valign="top" width="20%" class="mellomKol">

<p class="entrya"><p id="i152560">3</p></p></td>
	<td id="i152561"    valign="top" width="51.3%" class="sluttKol">

<p class="entrya"><p id="i152562">Opplysninger om overgang til morsmelk mangler. Se benzodiazepiner  <a id="arowX146283" class="ref" href="../G/G8.htm#i146283" title="Benzodiazepiner">Benzodiazepiner</a></p></p></td>
	</tr>
 <tr id="i152563" class="body oddelinje">
	<td id="i152564"    valign="top" width="28.7%" class="startKol">

<p class="entrya"><p id="i152565">Trijodtyronin (T<Sub>3</Sub>= liotyronin)</p></p></td>
	<td id="i152566"    valign="top" width="20%" class="mellomKol">

<p class="entrya"><p id="i152567">2</p></p></td>
	<td id="i152568"    valign="top" width="51.3%" class="sluttKol">

<p class="entrya"><p id="i152569">Se thyreoideahormoner  <a id="arowX152339" class="ref" href="../G/G8.htm#i152339" title="Thyreoideahormoner">Thyreoideahormoner</a></p></p></td>
	</tr>
 <tr id="i152570" class="body likelinje">
	<td id="i152571"    valign="top" width="28.7%" class="startKol">

<p class="entrya"><p id="i152572">Trimegeston</p></p></td>
	<td id="i152573"    valign="top" width="20%" class="mellomKol">

<p class="entrya"><p id="i152574">3</p></p></td>
	<td id="i152575"    valign="top" width="51.3%" class="sluttKol">

<p class="entrya"><p id="i152576">Se gestagener  <a id="arowX148350" class="ref" href="../G/G8.htm#i148350" title="Gestagener">Gestagener</a></p></p></td>
	</tr>
 <tr id="i152577" class="body oddelinje">
	<td id="i152578"    valign="top" width="28.7%" class="startKol">

<p class="entrya"><p id="i152579">Trimetoprim</p></p></td>
	<td id="i152580"    valign="top" width="20%" class="mellomKol">

<p class="entrya"><p id="i152581">2</p></p></td>
	<td id="i152582"    valign="top" width="51.3%" class="sluttKol">

<p class="entrya"><p id="i152583">Overgang til morsmelk er liten. Kan brukes av ammende</p></p></td>
	</tr>
 <tr id="i152584" class="body likelinje">
	<td id="i152585"    valign="top" width="28.7%" class="startKol">

<p class="entrya"><p id="i152586">Trimetreksat</p></p></td>
	<td id="i152587"    valign="top" width="20%" class="mellomKol">

<p class="entrya"><p id="i152588">5</p></p></td>
	<td id="i152589"    valign="top" width="51.3%" class="sluttKol">

<p class="entrya"><p id="i152590">Amming er kontraindisert ved HIV-infeksjon hos mor</p></p></td>
	</tr>
 <tr id="i152591" class="body oddelinje">
	<td id="i152592"    valign="top" width="28.7%" class="startKol">

<p class="entrya"><p id="i152593">Trimipramin</p></p></td>
	<td id="i152594"    valign="top" width="20%" class="mellomKol">

<p class="entrya"><p id="i152595">3</p></p></td>
	<td id="i152596"    valign="top" width="51.3%" class="sluttKol">

<p class="entrya"><p id="i152597">Opplysninger om overgang til morsmelk mangler. Se trisykliske antidepressiva  <a id="arowX152619" class="ref" href="../G/G8.htm#i152619" title="Trisykliske antidepressiva (TCA)">Trisykliske antidepressiva (TCA)</a></p></p></td>
	</tr>
 <tr id="i152598" class="body likelinje">
	<td id="i152599"    valign="top" width="28.7%" class="startKol">

<p class="entrya"><p id="i152600">Trioksalen</p></p></td>
	<td id="i152601"    valign="top" width="20%" class="mellomKol">

<p class="entrya"><p id="i152602">3</p></p></td>
	<td id="i152603"    valign="top" width="51.3%" class="sluttKol">

<p class="entrya"><p id="i152604">Tilbakeholdenhet med PUVA-behandling til ammende mødre. Amming kan gjenopptas 24 timer etter avsluttet terapi</p></p></td>
	</tr>
 <tr id="i152605" class="body oddelinje">
	<td id="i152606"    valign="top" width="28.7%" class="startKol">

<p class="entrya"><p id="i152607"><em>Triptaner</em></p></p></td>
	<td id="i152608"    valign="top" width="20%" class="mellomKol">

<p class="entrya"><p id="i152609">2, 3</p></p></td>
	<td id="i152610"    valign="top" width="51.3%" class="sluttKol">

<p class="entrya"><p id="i152611">Opplysninger om overgang til morsmelk mangler, unntatt for sumatriptan og eletriptan. Til ammende bør sumatriptan foretrekkes pga. mer klinisk erfaring. Se også de enkelte virkestoffene</p></p></td>
	</tr>
 <tr id="i152612" class="body likelinje">
	<td id="i152613"    valign="top" width="28.7%" class="startKol">

<p class="entrya"><p id="i152614">Triptorelin</p></p></td>
	<td id="i152615"    valign="top" width="20%" class="mellomKol">

<p class="entrya"><p id="i152616">0</p></p></td>
	<td id="i152617"    valign="top" width="51.3%" class="sluttKol">

<p class="entrya"><p id="i152618">Ikke aktuell til bruk hos ammende</p></p></td>
	</tr>
 <tr id="i152619" class="body oddelinje">
	<td id="i152620"    valign="top" width="28.7%" class="startKol">

<p class="entrya"><p id="i152621"><em>Trisykliske antidepressiva (TCA)</em></p></p></td>
	<td id="i152622"    valign="top" width="20%" class="mellomKol">

<p class="entrya"><p id="i152623">2, 3</p></p></td>
	<td id="i152624"    valign="top" width="51.3%" class="sluttKol">

<p class="entrya"><p id="i152625">Det er lite data&#160;som gjelder amming ved bruk av TCA. Ved langvarig bruk eller h&#x00F8;y dosering hos ammende, b&#x00F8;r barnet observeres for legemiddeleffekter. Se ogs&#x00E5; antidepressiva&#160; <a id="aentryX145813" class="ref" href="../G/G8.htm#i145813" title="Antidepressiva">Antidepressiva</a>&#160;og de enkelte legemidlene</p></p></td>
	</tr>
 <tr id="i152626" class="body likelinje">
	<td id="i152627"    valign="top" width="28.7%" class="startKol">

<p class="entrya"><p id="i152628">Tropikamid</p></p></td>
	<td id="i152629"    valign="top" width="20%" class="mellomKol">

<p class="entrya"><p id="i152630">2</p></p></td>
	<td id="i152631"    valign="top" width="51.3%" class="sluttKol">

<p class="entrya"><p id="i152632">Øyedråper: Kan brukes av ammende</p></p></td>
	</tr>
 <tr id="i152633" class="body oddelinje">
	<td id="i152634"    valign="top" width="28.7%" class="startKol">

<p class="entrya"><p id="i152635">Tropisetron</p></p></td>
	<td id="i152636"    valign="top" width="20%" class="mellomKol">

<p class="entrya"><p id="i152637">3</p></p></td>
	<td id="i152638"    valign="top" width="51.3%" class="sluttKol">

<p class="entrya"><p id="i152639">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i152640" class="body likelinje">
	<td id="i152641"    valign="top" width="28.7%" class="startKol">

<p class="entrya"><p id="i152642">Tyroksin (T<Sub>4</Sub>= levotyroksin)</p></p></td>
	<td id="i152643"    valign="top" width="20%" class="mellomKol">

<p class="entrya"><p id="i152644">2</p></p></td>
	<td id="i152645"    valign="top" width="51.3%" class="sluttKol">

<p class="entrya"><p id="i152646">Se thyreoideahormoner  <a id="arowX152339" class="ref" href="../G/G8.htm#i152339" title="Thyreoideahormoner">Thyreoideahormoner</a></p></p></td>
	</tr>
 </tbody></table>
 <table id="i152648" width="100%" class="maintable" border="0" cellpadding="5" cellspacing="0">
 <caption> <Uth Id="NUTHid2333386" Type="Halvfet">U</Uth></caption> <thead>
	<tr class = "linjetopp">
	<th id="i152656"  colspan="3"  valign="top"  class="sluttKol">

<p class="entrya"><p id="i152657">Overgang til morsmelk angis som minimal (< 2 %), liten (2&#8211;5 %), moderat (5&#8211;10 %) eller høy (10&#8211;50 %) basert på fraksjon av morens dose/kg kroppsvekt som barnet tilføres. (Barnets relative dose.)&ML;						Over 3&#8211;4 ukers bruk ansees som langtidsbehandling.</p></p></th>
	</tr>
	<tr class = "linjetopp">
	<th id="i152660"    valign="top"  class="startKol">

<p class="entrya"><p id="i152661"><strong>Legemiddel</strong></p></p></th>
	<th id="i152662"    valign="top"  class="mellomKol">

<p class="entrya"><p id="i152663"><strong>MM kategori</strong></p></p></th>
	<th id="i152664"    valign="top"  class="sluttKol">

<p class="entrya"><p id="i152665"><strong>Dokumentasjon vedrørende bruk under amming</strong></p></p></th>
	</tr>
</thead>
<tbody>
<tr id="i152667" class="body likelinje">
	<td id="i152668"    valign="top" width="28.6%" class="startKol">

<p class="entrya"><p id="i152669">Ulipristal</p></p></td>
	<td id="i152670"    valign="top" width="20%" class="mellomKol">

<p class="entrya"><p id="i152671">3</p></p></td>
	<td id="i152672"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i152673">Opplysninger om overgang til morsmelk mangler. Amming bør utsettes 1 1/2 døgn etter tablettinntak</p></p></td>
	</tr>
 <tr id="i152674" class="body oddelinje">
	<td id="i152675"    valign="top" width="28.6%" class="startKol">

<p class="entrya"><p id="i152676">Unoproston</p></p></td>
	<td id="i152677"    valign="top" width="20%" class="mellomKol">

<p class="entrya"><p id="i152678">2</p></p></td>
	<td id="i152679"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i152680">Øyedråper: Minimal systemisk absorpsjon tilsier at overgang til morsmelk er minimal</p></p></td>
	</tr>
 <tr id="i152681" class="body likelinje">
	<td id="i152682"    valign="top" width="28.6%" class="startKol">

<p class="entrya"><p id="i152683">Uracil/tegafur</p></p></td>
	<td id="i152684"    valign="top" width="20%" class="mellomKol">

<p class="entrya"><p id="i152685">5</p></p></td>
	<td id="i152686"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i152687">Se cytostatika  <a id="arowX146868" class="ref" href="../G/G8.htm#i146868" title="Cytostatika">Cytostatika</a></p></p></td>
	</tr>
 <tr id="i152688" class="body oddelinje">
	<td id="i152689"    valign="top" width="28.6%" class="startKol">

<p class="entrya"><p id="i152690">Ursodeoksykolsyre</p></p></td>
	<td id="i152691"    valign="top" width="20%" class="mellomKol">

<p class="entrya"><p id="i152692">3</p></p></td>
	<td id="i152693"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i152694">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i152695" class="body likelinje">
	<td id="i152696"    valign="top" width="28.6%" class="startKol">

<p class="entrya"><p id="i218863">Ustekinumab</p></p></td>
	<td id="i152697"    valign="top" width="20%" class="mellomKol">

<p class="entrya"><p id="i152698">3</p></p></td>
	<td id="i152699"    valign="top" width="51.4%" class="sluttKol">

<p class="entrya"><p id="i152700">Opplysninger om overgang til morsmelk mangler, men den er trolig minimal. Erfaring med bruk hos ammende mangler</p></p></td>
	</tr>
 </tbody></table>
 <table id="i152702" width="100%" class="maintable" border="0" cellpadding="5" cellspacing="0">
 <caption> <Uth Id="NUTHid2330232" Type="Halvfet">V</Uth></caption> <thead>
	<tr class = "linjetopp">
	<th id="i152710"  colspan="3"  valign="top"  class="sluttKol">

<p class="entrya"><p id="i152711">Overgang til morsmelk angis som minimal (< 2 %), liten (2&#8211;5 %), moderat (5&#8211;10 %) eller høy (10&#8211;50 %) basert på fraksjon av morens dose/kg kroppsvekt som barnet tilføres. (Barnets relative dose.)&ML;						Over 3&#8211;4 ukers bruk ansees som langtidsbehandling.</p></p></th>
	</tr>
	<tr class = "linjetopp">
	<th id="i152714"    valign="top"  class="startKol">

<p class="entrya"><p id="i152715"><strong>Legemiddel</strong></p></p></th>
	<th id="i152716"    valign="top"  class="mellomKol">

<p class="entrya"><p id="i152717"><strong>MM kategori</strong></p></p></th>
	<th id="i152718"    valign="top"  class="sluttKol">

<p class="entrya"><p id="i152719"><strong>Dokumentasjon vedrørende bruk under amming</strong></p></p></th>
	</tr>
</thead>
<tbody>
<tr id="i152721" class="body likelinje">
	<td id="i152722"    valign="top" width="28.6%" class="startKol">

<p class="entrya"><p id="i152723"><em>Vaksiner</em></p></p></td>
	<td id="i152724"    valign="top" width="20.1%" class="mellomKol">

<p class="entrya"><p id="i152725">2</p></p></td>
	<td id="i152726"    valign="top" width="51.3%" class="sluttKol">

<p class="entrya"><p id="i152727">Inaktiverte vaksiner representerer ingen kontraindikasjon hos ammende</p></p></td>
	</tr>
 <tr id="i152728" class="body oddelinje">
	<td id="i152729"    valign="top" width="28.6%" class="startKol">

<p class="entrya"><p id="i152730">Valaciklovir</p></p></td>
	<td id="i152731"    valign="top" width="20.1%" class="mellomKol">

<p class="entrya"><p id="i152732">1</p></p></td>
	<td id="i152733"    valign="top" width="51.3%" class="sluttKol">

<p class="entrya"><p id="i152734">Overgang til morsmelk er liten. Se aciklovir  <a id="arowX145402" class="ref" href="../G/G8.htm#i145402" title="Aciklovir">Aciklovir</a></p></p></td>
	</tr>
 <tr id="i152735" class="body likelinje">
	<td id="i152736"    valign="top" width="28.6%" class="startKol">

<p class="entrya"><p id="i152737">Valganciklovir</p></p></td>
	<td id="i152738"    valign="top" width="20.1%" class="mellomKol">

<p class="entrya"><p id="i152739">5</p></p></td>
	<td id="i152740"    valign="top" width="51.3%" class="sluttKol">

<p class="entrya"><p id="i152741">Se antivirale midler  <a id="arowX145939" class="ref" href="../G/G8.htm#i145939" title="Antivirale midler">Antivirale midler</a></p></p></td>
	</tr>
 <tr id="i152742" class="body oddelinje">
	<td id="i152743"    valign="top" width="28.6%" class="startKol">

<p class="entrya"><p id="i152744">Valproat</p></p></td>
	<td id="i152745"    valign="top" width="20.1%" class="mellomKol">

<p class="entrya"><p id="i152746">2</p></p></td>
	<td id="i152747"    valign="top" width="51.3%" class="sluttKol">

<p class="entrya"><p id="i152748">Kan brukes av ammende. Se antiepileptika  <a id="arowX145833" class="ref" href="../G/G8.htm#i145833" title="Antiepileptika">Antiepileptika</a></p></p></td>
	</tr>
 <tr id="i152749" class="body likelinje">
	<td id="i152750"    valign="top" width="28.6%" class="startKol">

<p class="entrya"><p id="i152751">Valsartan</p></p></td>
	<td id="i152752"    valign="top" width="20.1%" class="mellomKol">

<p class="entrya"><p id="i152753">3</p></p></td>
	<td id="i152754"    valign="top" width="51.3%" class="sluttKol">

<p class="entrya"><p id="i152755">Se angiotensin II-reseptorantagonister  <a id="arowX145763" class="ref" href="../G/G8.htm#i145763" title="Angiotensin II-reseptorantagonister">Angiotensin II-reseptorantagonister</a></p></p></td>
	</tr>
 <tr id="i320182" class="body oddelinje">
	<td id="i320183"    valign="top" width="28.6%" class="startKol">

<p class="entrya"><p id="i320184">Vandetanib</p></p></td>
	<td id="i320185"    valign="top" width="20.1%" class="mellomKol">

<p class="entrya"><p id="i320186">3</p></p></td>
	<td id="i320187"    valign="top" width="51.3%" class="sluttKol">

<p class="entrya"><p id="i320188">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i152756" class="body likelinje">
	<td id="i152757"    valign="top" width="28.6%" class="startKol">

<p class="entrya"><p id="i152758">Vankomycin</p></p></td>
	<td id="i152759"    valign="top" width="20.1%" class="mellomKol">

<p class="entrya"><p id="i152760">2</p></p></td>
	<td id="i152761"    valign="top" width="51.3%" class="sluttKol">

<p class="entrya"><p id="i152762">Overgang til morsmelk er liten. Systemisk absorpsjon ubetydelig. Kan brukes av ammende. Se også antibakterielle midler  <a id="arowX145756" class="ref" href="../G/G8.htm#i145756" title="Anestesimidler">Anestesimidler</a></p></p></td>
	</tr>
 <tr id="i152763" class="body oddelinje">
	<td id="i152764"    valign="top" width="28.6%" class="startKol">

<p class="entrya"><p id="i152765">Vardenafil</p></p></td>
	<td id="i152766"    valign="top" width="20.1%" class="mellomKol">

<p class="entrya"><p id="i152767">&#x2013;</p></p></td>
	<td id="i152768"    valign="top" width="51.3%" class="sluttKol">

<p class="entrya"><p id="i152769">Ikke aktuell til bruk hos ammende</p></p></td>
	</tr>
 <tr id="i152770" class="body likelinje">
	<td id="i152771"    valign="top" width="28.6%" class="startKol">

<p class="entrya"><p id="i152772">Vareniklin</p></p></td>
	<td id="i152773"    valign="top" width="20.1%" class="mellomKol">

<p class="entrya"><p id="i152774">3</p></p></td>
	<td id="i152775"    valign="top" width="51.3%" class="sluttKol">

<p class="entrya"><p id="i152776">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i152777" class="body oddelinje">
	<td id="i152778"    valign="top" width="28.6%" class="startKol">

<p class="entrya"><p id="i152779">Vekuron</p></p></td>
	<td id="i152780"    valign="top" width="20.1%" class="mellomKol">

<p class="entrya"><p id="i152781">2</p></p></td>
	<td id="i152782"    valign="top" width="51.3%" class="sluttKol">

<p class="entrya"><p id="i152783">Se nevromuskulære blokkere  <a id="arowX150558" class="ref" href="../G/G8.htm#i150558" title="Nevromuskulære blokkere">Nevromuskulære blokkere</a></p></p></td>
	</tr>
 <tr id="i320189" class="body likelinje">
	<td id="i320190"    valign="top" width="28.6%" class="startKol">

<p class="entrya"><p id="i320191">Vemurafenib</p></p></td>
	<td id="i320192"    valign="top" width="20.1%" class="mellomKol">

<p class="entrya"><p id="i320193">3</p></p></td>
	<td id="i320194"    valign="top" width="51.3%" class="sluttKol">

<p class="entrya"><p id="i320195">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i152784" class="body oddelinje">
	<td id="i152785"    valign="top" width="28.6%" class="startKol">

<p class="entrya"><p id="i152786">Venlafaksin</p></p></td>
	<td id="i152787"    valign="top" width="20.1%" class="mellomKol">

<p class="entrya"><p id="i152788">3</p></p></td>
	<td id="i152789"    valign="top" width="51.3%" class="sluttKol">

<p class="entrya"><p id="i152790">Overgang til morsmelk er moderat. Se antidepressiva  <a id="arowX145812" class="ref" href="../G/G8.htm#i145812" title="Antidepressiva">Antidepressiva</a>&#160;og SNRI&#160; <a id="aentryX151911" class="ref" href="../G/G8.htm#i151911" title="SNRI">SNRI</a></p></p></td>
	</tr>
 <tr id="i152791" class="body likelinje">
	<td id="i152792"    valign="top" width="28.6%" class="startKol">

<p class="entrya"><p id="i152793">Verapamil</p></p></td>
	<td id="i152794"    valign="top" width="20.1%" class="mellomKol">

<p class="entrya"><p id="i152795">2</p></p></td>
	<td id="i152796"    valign="top" width="51.3%" class="sluttKol">

<p class="entrya"><p id="i152797">Overgang til morsmelk er minimal. Se kalsiumantagonister  <a id="arowX149110" class="ref" href="../G/G8.htm#i149110" title="Kalsiumantagonister">Kalsiumantagonister</a></p></p></td>
	</tr>
 <tr id="i221975" class="body oddelinje">
	<td id="i221976"    valign="top" width="28.6%" class="startKol">

<p class="entrya"><p id="i221977">Vernakalant </p></p></td>
	<td id="i221978"    valign="top" width="20.1%" class="mellomKol">

<p class="entrya"><p id="i221979">3 </p></p></td>
	<td id="i221980"    valign="top" width="51.3%" class="sluttKol">

<p class="entrya"><p id="i221981">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i152798" class="body likelinje">
	<td id="i152799"    valign="top" width="28.6%" class="startKol">

<p class="entrya"><p id="i152800">Verteporfin</p></p></td>
	<td id="i152801"    valign="top" width="20.1%" class="mellomKol">

<p class="entrya"><p id="i152802">3</p></p></td>
	<td id="i152803"    valign="top" width="51.3%" class="sluttKol">

<p class="entrya"><p id="i152804">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i152805" class="body oddelinje">
	<td id="i152806"    valign="top" width="28.6%" class="startKol">

<p class="entrya"><p id="i152807">Vigabatrin</p></p></td>
	<td id="i152808"    valign="top" width="20.1%" class="mellomKol">

<p class="entrya"><p id="i152809">3</p></p></td>
	<td id="i152810"    valign="top" width="51.3%" class="sluttKol">

<p class="entrya"><p id="i152811">Begrensede data tilsier at overgang til morsmelk er liten. Observer barnet pga. manglende erfaring med bruk hos ammende. Se antiepileptika  <a id="arowX145833" class="ref" href="../G/G8.htm#i145833" title="Antiepileptika">Antiepileptika</a></p></p></td>
	</tr>
 <tr id="i152812" class="body likelinje">
	<td id="i152813"    valign="top" width="28.6%" class="startKol">

<p class="entrya"><p id="i152814">Vildagliptin</p></p></td>
	<td id="i152815"    valign="top" width="20.1%" class="mellomKol">

<p class="entrya"><p id="i152816">3</p></p></td>
	<td id="i152817"    valign="top" width="51.3%" class="sluttKol">

<p class="entrya"><p id="i152818">Manglende klinisk erfaring. Se også antidiabetika, perorale  <a id="arowX145819" class="ref" href="../G/G8.htm#i145819" title="Antidiabetika, perorale">Antidiabetika, perorale</a></p></p></td>
	</tr>
 <tr id="i152819" class="body oddelinje">
	<td id="i152820"    valign="top" width="28.6%" class="startKol">

<p class="entrya"><p id="i152821">Vinblastin</p></p></td>
	<td id="i152822"    valign="top" width="20.1%" class="mellomKol">

<p class="entrya"><p id="i152823">5</p></p></td>
	<td id="i152824"    valign="top" width="51.3%" class="sluttKol">

<p class="entrya"><p id="i152825">Se cytostatika  <a id="arowX146868" class="ref" href="../G/G8.htm#i146868" title="Cytostatika">Cytostatika</a></p></p></td>
	</tr>
 <tr id="i152826" class="body likelinje">
	<td id="i152827"    valign="top" width="28.6%" class="startKol">

<p class="entrya"><p id="i152828">Vinflunin</p></p></td>
	<td id="i152829"    valign="top" width="20.1%" class="mellomKol">

<p class="entrya"><p id="i152830">5</p></p></td>
	<td id="i152831"    valign="top" width="51.3%" class="sluttKol">

<p class="entrya"><p id="i152832">Se cytostatika  <a id="arowX146868" class="ref" href="../G/G8.htm#i146868" title="Cytostatika">Cytostatika</a></p></p></td>
	</tr>
 <tr id="i152833" class="body oddelinje">
	<td id="i152834"    valign="top" width="28.6%" class="startKol">

<p class="entrya"><p id="i152835">Vinkristin</p></p></td>
	<td id="i152836"    valign="top" width="20.1%" class="mellomKol">

<p class="entrya"><p id="i152837">5</p></p></td>
	<td id="i152838"    valign="top" width="51.3%" class="sluttKol">

<p class="entrya"><p id="i152839">Se cytostatika  <a id="arowX146868" class="ref" href="../G/G8.htm#i146868" title="Cytostatika">Cytostatika</a></p></p></td>
	</tr>
 <tr id="i152840" class="body likelinje">
	<td id="i152841"    valign="top" width="28.6%" class="startKol">

<p class="entrya"><p id="i152842">Vinorelbin</p></p></td>
	<td id="i152843"    valign="top" width="20.1%" class="mellomKol">

<p class="entrya"><p id="i152844">5</p></p></td>
	<td id="i152845"    valign="top" width="51.3%" class="sluttKol">

<p class="entrya"><p id="i152846">Se cytostatika  <a id="arowX146868" class="ref" href="../G/G8.htm#i146868" title="Cytostatika">Cytostatika</a></p></p></td>
	</tr>
 <tr id="i152847" class="body oddelinje">
	<td id="i152848"    valign="top" width="28.6%" class="startKol">

<p class="entrya"><p id="i152849">Vitamin A</p></p></td>
	<td id="i152850"    valign="top" width="20.1%" class="mellomKol">

<p class="entrya"><p id="i152851">3</p></p></td>
	<td id="i152852"    valign="top" width="51.3%" class="sluttKol">

<p class="entrya"><p id="i152853">Se vitaminer  <a id="arowX152903" class="ref" href="../G/G8.htm#i152903" title="Vitaminer">Vitaminer</a></p></p></td>
	</tr>
 <tr id="i152854" class="body likelinje">
	<td id="i152855"    valign="top" width="28.6%" class="startKol">

<p class="entrya"><p id="i152856">Vitamin B<Sub>1</Sub></p></p></td>
	<td id="i152857"    valign="top" width="20.1%" class="mellomKol">

<p class="entrya"><p id="i152858">2</p></p></td>
	<td id="i152859"    valign="top" width="51.3%" class="sluttKol">

<p class="entrya"><p id="i152860">Se vitaminer  <a id="arowX152903" class="ref" href="../G/G8.htm#i152903" title="Vitaminer">Vitaminer</a></p></p></td>
	</tr>
 <tr id="i152861" class="body oddelinje">
	<td id="i152862"    valign="top" width="28.6%" class="startKol">

<p class="entrya"><p id="i152863">Vitamin B<Sub>6</Sub></p></p></td>
	<td id="i152864"    valign="top" width="20.1%" class="mellomKol">

<p class="entrya"><p id="i152865">2</p></p></td>
	<td id="i152866"    valign="top" width="51.3%" class="sluttKol">

<p class="entrya"><p id="i152867">I doser på 100 ganger daglig anbefalt dose kan pyridoksin virke laktasjonshemmende. Se vitaminer  <a id="arowX152903" class="ref" href="../G/G8.htm#i152903" title="Vitaminer">Vitaminer</a></p></p></td>
	</tr>
 <tr id="i152868" class="body likelinje">
	<td id="i152869"    valign="top" width="28.6%" class="startKol">

<p class="entrya"><p id="i152870">Vitamin B<Sub>12</Sub></p></p></td>
	<td id="i152871"    valign="top" width="20.1%" class="mellomKol">

<p class="entrya"><p id="i152872">1</p></p></td>
	<td id="i152873"    valign="top" width="51.3%" class="sluttKol">

<p class="entrya"><p id="i152874">Se vitaminer  <a id="arowX152903" class="ref" href="../G/G8.htm#i152903" title="Vitaminer">Vitaminer</a></p></p></td>
	</tr>
 <tr id="i152875" class="body oddelinje">
	<td id="i152876"    valign="top" width="28.6%" class="startKol">

<p class="entrya"><p id="i152877">Vitamin C</p></p></td>
	<td id="i152878"    valign="top" width="20.1%" class="mellomKol">

<p class="entrya"><p id="i152879">1</p></p></td>
	<td id="i152880"    valign="top" width="51.3%" class="sluttKol">

<p class="entrya"><p id="i152881">Se vitaminer  <a id="arowX152903" class="ref" href="../G/G8.htm#i152903" title="Vitaminer">Vitaminer</a></p></p></td>
	</tr>
 <tr id="i152882" class="body likelinje">
	<td id="i152883"    valign="top" width="28.6%" class="startKol">

<p class="entrya"><p id="i152884">Vitamin D og vitamin D-analoger</p></p></td>
	<td id="i152885"    valign="top" width="20.1%" class="mellomKol">

<p class="entrya"><p id="i152886">2, 3</p></p></td>
	<td id="i152887"    valign="top" width="51.3%" class="sluttKol">

<p class="entrya"><p id="i152888">Se vitaminer  <a id="arowX152903" class="ref" href="../G/G8.htm#i152903" title="Vitaminer">Vitaminer</a> Overvåk barnets kalsiumkonsentrasjon hvis mor bruker farmakologiske doser</p></p></td>
	</tr>
 <tr id="i152889" class="body oddelinje">
	<td id="i152890"    valign="top" width="28.6%" class="startKol">

<p class="entrya"><p id="i152891">Vitamin E</p></p></td>
	<td id="i152892"    valign="top" width="20.1%" class="mellomKol">

<p class="entrya"><p id="i152893">2</p></p></td>
	<td id="i152894"    valign="top" width="51.3%" class="sluttKol">

<p class="entrya"><p id="i152895">Overgang av vitamin E til morsmelk er lav. Vitamin E tabletter kan brukes. Vitamin E-holdige kremer applisert på såre/sprukne brystknopper har ikke gitt farmakologiske effekter hos brysternærte barn, men bør unngås</p></p></td>
	</tr>
 <tr id="i152896" class="body likelinje">
	<td id="i152897"    valign="top" width="28.6%" class="startKol">

<p class="entrya"><p id="i152898">Vitamin K (= fytomenadion.)</p></p></td>
	<td id="i152899"    valign="top" width="20.1%" class="mellomKol">

<p class="entrya"><p id="i152900">2</p></p></td>
	<td id="i152901"    valign="top" width="51.3%" class="sluttKol">

<p class="entrya"><p id="i152902">Se vitaminer  <a id="arowX152903" class="ref" href="../G/G8.htm#i152903" title="Vitaminer">Vitaminer</a></p></p></td>
	</tr>
 <tr id="i152903" class="body oddelinje">
	<td id="i152904"    valign="top" width="28.6%" class="startKol">

<p class="entrya"><p id="i152905"><em>Vitaminer</em></p></p></td>
	<td id="i152906"    valign="top" width="20.1%" class="mellomKol">

<p class="entrya"><p id="i152907">1, 2</p></p></td>
	<td id="i152908"    valign="top" width="51.3%" class="sluttKol">

<p class="entrya"><p id="i152909">Barnet får mange viktige vitaminer gjennom morsmelken. Kolostrum inneholder spesielt høyt nivå av vitaminene E og A. For noen vitaminer vil økt tilførsel av vitaminer føre til økt innhold i morsmelken (B<Sub>6</Sub>, B<Sub>12</Sub>, D, E, K), mens for andre (A, B<Sub>1</Sub>, biotin, folat, C) vil økt tilførsel bare gi økt vitamininnhold i morsmelken når vitaminnivået hos mor er for lavt. Vitaminmangel hos brysternærte barn er blitt observert for vitamin D, K og B<Sub>12</Sub>. Toksisitet er blitt rapportert for vitamin D</p></p></td>
	</tr>
 <tr id="i152910" class="body likelinje">
	<td id="i152911"    valign="top" width="28.6%" class="startKol">

<p class="entrya"><p id="i152912">Vorikonazol</p></p></td>
	<td id="i152913"    valign="top" width="20.1%" class="mellomKol">

<p class="entrya"><p id="i152914">3</p></p></td>
	<td id="i152915"    valign="top" width="51.3%" class="sluttKol">

<p class="entrya"><p id="i152916">Opplysninger mangler</p></p></td>
	</tr>
 </tbody></table>
 <table id="i152918" width="100%" class="maintable" border="0" cellpadding="5" cellspacing="0">
 <caption> <Uth Id = "GK-08-Amming-5542" Type = "Halvfet">W</Uth></caption> <thead>
	<tr class = "linjetopp">
	<th id="i152926"  colspan="3"  valign="top"  class="sluttKol">

<p class="entrya"><p id="i152927">Overgang til morsmelk angis som minimal (< 2 %), liten (2&#8211;5 %), moderat (5&#8211;10 %) eller høy (10&#8211;50 %) basert på fraksjon av morens dose/kg kroppsvekt som barnet tilføres. (Barnets relative dose.)&ML;						Over 3&#8211;4 ukers bruk ansees som langtidsbehandling.</p></p></th>
	</tr>
	<tr class = "linjetopp">
	<th id="i152930"    valign="top"  class="startKol">

<p class="entrya"><p id="i152931"><strong>Legemiddel</strong></p></p></th>
	<th id="i152932"    valign="top"  class="mellomKol">

<p class="entrya"><p id="i152933"><strong>MM kategori</strong></p></p></th>
	<th id="i152934"    valign="top"  class="sluttKol">

<p class="entrya"><p id="i152935"><strong>Dokumentasjon  vedrørende bruk under amming</strong></p></p></th>
	</tr>
</thead>
<tbody>
<tr id="i152937" class="body likelinje">
	<td id="i152938"    valign="top" width="28.5%" class="startKol">

<p class="entrya"><p id="i152939">Warfarin</p></p></td>
	<td id="i152940"    valign="top" width="20%" class="mellomKol">

<p class="entrya"><p id="i152941">2</p></p></td>
	<td id="i152942"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i152943">Overgang til morsmelk er minimal. Kan brukes av ammende</p></p></td>
	</tr>
 </tbody></table>
 <table id="i152945" width="100%" class="maintable" border="0" cellpadding="5" cellspacing="0">
 <caption> <Uth Id = "GK-08-Amming-5543" Type = "Halvfet">X</Uth></caption> <thead>
	<tr class = "linjetopp">
	<th id="i152953"  colspan="3"  valign="top"  class="sluttKol">

<p class="entrya"><p id="i152954">Overgang til morsmelk angis som minimal (< 2 %), liten (2&#8211;5 %), moderat (5&#8211;10 %) eller høy (10&#8211;50 %) basert på fraksjon av morens dose/kg kroppsvekt som barnet tilføres. (Barnets relative dose.)&ML;						Over 3&#8211;4 ukers bruk ansees som langtidsbehandling.</p></p></th>
	</tr>
	<tr class = "linjetopp">
	<th id="i152957"    valign="top"  class="startKol">

<p class="entrya"><p id="i152958"><strong>Legemiddel</strong></p></p></th>
	<th id="i152959"    valign="top"  class="mellomKol">

<p class="entrya"><p id="i152960"><strong>MM kategori</strong></p></p></th>
	<th id="i152961"    valign="top"  class="sluttKol">

<p class="entrya"><p id="i152962"><strong>Dokumentasjon  vedrørende bruk under amming</strong></p></p></th>
	</tr>
</thead>
<tbody>
<tr id="i152964" class="body likelinje">
	<td id="i152965"    valign="top" width="29.1%" class="startKol">

<p class="entrya"><p id="i152966">Xylometazolin</p></p></td>
	<td id="i152967"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i152968">1</p></p></td>
	<td id="i152969"    valign="top" width="51.5%" class="sluttKol">

<p class="entrya"><p id="i152970">Nesedråper/-spray: Kan brukes av ammende i terapeutiske doser</p></p></td>
	</tr>
 </tbody></table>
 <table id="i152972" width="100%" class="maintable" border="0" cellpadding="5" cellspacing="0">
 <caption> <Uth Id="NUTHid2331470" Type="Halvfet">Z</Uth></caption> <thead>
	<tr class = "linjetopp">
	<th id="i152980"  colspan="3"  valign="top"  class="sluttKol">

<p class="entrya"><p id="i152981">Overgang til morsmelk angis som minimal (< 2 %), liten (2&#8211;5 %), moderat (5&#8211;10 %) eller høy (10&#8211;50 %) basert på fraksjon av morens dose/kg kroppsvekt som barnet tilføres. (Barnets relative dose.)&ML;						Over 3&#8211;4 ukers bruk ansees som langtidsbehandling.</p></p></th>
	</tr>
	<tr class = "linjetopp">
	<th id="i152984"    valign="top"  class="startKol">

<p class="entrya"><p id="i152985"><strong>Legemiddel</strong></p></p></th>
	<th id="i152986"    valign="top"  class="mellomKol">

<p class="entrya"><p id="i152987"><strong>MM kategori</strong></p></p></th>
	<th id="i152988"    valign="top"  class="sluttKol">

<p class="entrya"><p id="i152989"><strong>Dokumentasjon vedrørende bruk under amming</strong></p></p></th>
	</tr>
</thead>
<tbody>
<tr id="i152991" class="body likelinje">
	<td id="i152992"    valign="top" width="29%" class="startKol">

<p class="entrya"><p id="i152993">Zanamivir</p></p></td>
	<td id="i152994"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i152995">3</p></p></td>
	<td id="i152996"    valign="top" width="51.6%" class="sluttKol">

<p class="entrya"><p id="i152997">Opplysninger mangler</p></p></td>
	</tr>
 <tr id="i152998" class="body oddelinje">
	<td id="i152999"    valign="top" width="29%" class="startKol">

<p class="entrya"><p id="i153000">Zidovudin</p></p></td>
	<td id="i153001"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i153002">5</p></p></td>
	<td id="i153003"    valign="top" width="51.6%" class="sluttKol">

<p class="entrya"><p id="i153004">Se antivirale midler  <a id="arowX145939" class="ref" href="../G/G8.htm#i145939" title="Antivirale midler">Antivirale midler</a></p></p></td>
	</tr>
 <tr id="i153005" class="body likelinje">
	<td id="i153006"    valign="top" width="29%" class="startKol">

<p class="entrya"><p id="i153007">Ziprasidon</p></p></td>
	<td id="i153008"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i153009">3</p></p></td>
	<td id="i153010"    valign="top" width="51.6%" class="sluttKol">

<p class="entrya"><p id="i153011">Opplysninger om overgang til morsmelk mangler. Se antipsykotika  <a id="arowX145918" class="ref" href="../G/G8.htm#i145918" title="Antipsykotika">Antipsykotika</a></p></p></td>
	</tr>
 <tr id="i153012" class="body oddelinje">
	<td id="i153013"    valign="top" width="29%" class="startKol">

<p class="entrya"><p id="i153014">Zoledronsyre</p></p></td>
	<td id="i153015"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i153016">0</p></p></td>
	<td id="i153017"    valign="top" width="51.6%" class="sluttKol">

<p class="entrya"><p id="i153018">Se bifosfonater  <a id="arowX146417" class="ref" href="../G/G8.htm#i146417" title="Bisfosfonater">Bisfosfonater</a></p></p></td>
	</tr>
 <tr id="i153019" class="body likelinje">
	<td id="i153020"    valign="top" width="29%" class="startKol">

<p class="entrya"><p id="i153021">Zolmitriptan</p></p></td>
	<td id="i153022"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i153023">3</p></p></td>
	<td id="i153024"    valign="top" width="51.6%" class="sluttKol">

<p class="entrya"><p id="i153025">Se triptaner  <a id="arowX152605" class="ref" href="../G/G8.htm#i152605" title="Triptaner">Triptaner</a></p></p></td>
	</tr>
 <tr id="i153026" class="body oddelinje">
	<td id="i153027"    valign="top" width="29%" class="startKol">

<p class="entrya"><p id="i153028">Zolpidem</p></p></td>
	<td id="i153029"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i153030">2</p></p></td>
	<td id="i153031"    valign="top" width="51.6%" class="sluttKol">

<p class="entrya"><p id="i153032">Overgang til morsmelk er minimal. Kan brukes av ammende over kortere tidsperioder</p></p></td>
	</tr>
 <tr id="i153033" class="body likelinje">
	<td id="i153034"    valign="top" width="29%" class="startKol">

<p class="entrya"><p id="i153035">Zonisamid</p></p></td>
	<td id="i153036"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i153037">4</p></p></td>
	<td id="i153038"    valign="top" width="51.6%" class="sluttKol">

<p class="entrya"><p id="i153039">Overgang til morsmelk er høy. Se antiepileptika  <a id="arowX145833" class="ref" href="../G/G8.htm#i145833" title="Antiepileptika">Antiepileptika</a></p></p></td>
	</tr>
 <tr id="i153040" class="body oddelinje">
	<td id="i153041"    valign="top" width="29%" class="startKol">

<p class="entrya"><p id="i153042">Zopiklon</p></p></td>
	<td id="i153043"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i153044">2</p></p></td>
	<td id="i153045"    valign="top" width="51.6%" class="sluttKol">

<p class="entrya"><p id="i153046">Overgang til morsmelk er minimal. Kan brukes av ammende over kortere tidsperioder</p></p></td>
	</tr>
 <tr id="i153047" class="body likelinje">
	<td id="i153048"    valign="top" width="29%" class="startKol">

<p class="entrya"><p id="i153049">Zuklopentixol</p></p></td>
	<td id="i153050"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i153051">3</p></p></td>
	<td id="i153052"    valign="top" width="51.6%" class="sluttKol">

<p class="entrya"><p id="i153053">Overgang til morsmelk er minimal. Se antipsykotika  <a id="arowX145918" class="ref" href="../G/G8.htm#i145918" title="Antipsykotika">Antipsykotika</a></p></p></td>
	</tr>
 </tbody></table>
 <table id="i153055" width="100%" class="maintable" border="0" cellpadding="5" cellspacing="0">
 <caption> Ø</caption> <thead>
	<tr class = "linjetopp">
	<th id="i153063"  colspan="3"  valign="top"  class="sluttKol">

<p class="entrya"><p id="i153064">Overgang til morsmelk angis som minimal (< 2 %), liten (2&#x2013;5 %), moderat (5&#x2013;10 %) eller høy (10&#x2013;50 %) basert på fraksjon av morens dose/kg kroppsvekt som barnet tilføres. (Barnets relative dose.)&ML;						Over 3&#x2013;4 ukers bruk ansees som langtidsbehandling.</p></p></th>
	</tr>
	<tr class = "linjetopp">
	<th id="i153067"    valign="top"  class="startKol">

<p class="entrya"><p id="i153068"><strong>Legemiddel</strong></p></p></th>
	<th id="i153069"    valign="top"  class="mellomKol">

<p class="entrya"><p id="i153070"><strong>MM kategori</strong></p></p></th>
	<th id="i153071"    valign="top"  class="sluttKol">

<p class="entrya"><p id="i153072"><strong>Dokumentasjon vedrørende bruk under amming</strong></p></p></th>
	</tr>
</thead>
<tbody>
<tr id="i153074" class="body likelinje">
	<td id="i153075"    valign="top" width="29%" class="startKol">

<p class="entrya"><p id="i153076">Østradiol</p></p></td>
	<td id="i153077"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i153078">3</p></p></td>
	<td id="i153079"    valign="top" width="51.6%" class="sluttKol">

<p class="entrya"><p id="i153080">Overgang til morsmelk er minimal. Se østrogener  <a id="arowX153095" class="ref" href="../G/G8.htm#i153095" title="Østrogener">Østrogener</a></p></p></td>
	</tr>
 <tr id="i153081" class="body oddelinje">
	<td id="i153082"    valign="top" width="29%" class="startKol">

<p class="entrya"><p id="i153083">Østriol</p></p></td>
	<td id="i153084"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i153085">3</p></p></td>
	<td id="i153086"    valign="top" width="51.6%" class="sluttKol">

<p class="entrya"><p id="i153087">Opplysninger om overgang til morsmelk mangler. Se østrogener  <a id="arowX153095" class="ref" href="../G/G8.htm#i153095" title="Østrogener">Østrogener</a></p></p></td>
	</tr>
 <tr id="i153088" class="body likelinje">
	<td id="i153089"    valign="top" width="29%" class="startKol">

<p class="entrya"><p id="i153090">Østriol/trimegestone</p></p></td>
	<td id="i153091"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i153092">&#x2013;</p></p></td>
	<td id="i153093"    valign="top" width="51.6%" class="sluttKol">

<p class="entrya"><p id="i153094">Ikke aktuell til bruk hos ammende</p></p></td>
	</tr>
 <tr id="i153095" class="body oddelinje">
	<td id="i153096"    valign="top" width="29%" class="startKol">

<p class="entrya"><p id="i153097"><em>Østrogener</em></p></p></td>
	<td id="i153098"    valign="top" width="19.4%" class="mellomKol">

<p class="entrya"><p id="i153099">3</p></p>
<p class="entrya"><p id="i317132"> </p></p>
<p class="entrya"><p id="i317133"> </p></p>
<p class="entrya"><p id="i317136"> </p></p>
<p class="entrya"><p id="i317134">2</p></p></td>
	<td id="i153100"    valign="top" width="51.6%" class="sluttKol">

<p class="entrya"><p id="i153101">Melkeproduksjonen kan hemmes av høye østrogendoser. Redusert melkemengde er rapportert hos ammende. Mulig reduksjon av nitrogen- og proteininnhold i morsmelken. Sjeldne tilfeller av brystforstørrelse hos barnet er blitt rapportert. Se også p-piller  <a id="arowX151249" class="ref" href="../G/G8.htm#i151249" title="P-piller">P-piller</a></p></p>
<p class="entrya"><p id="i317137">Lokalbehandling: Kan brukes av ammende</p></p></td>
	</tr>
 </tbody></table>
 </div></article></section>
</div>
<footer>
		<div class="revidertDato">Generert: 23.01.2013</div>
		<h1>Foreningen for utgivelse av Norsk legemiddelhåndbok</h1>
		<address>Postboks 63 Kalbakken - 0901 OSLO - <a href="http://maps.google.com/maps/place?cid=5501084847365814678&q=Sven+Oftedals+vei+8&sll=59.925912,10.801613&sspn=0.036525,0.115218&ie=UTF8&ll=59.965151,10.745831&spn=0.000086,0.000172&t=m&z=13&vpsrc=0" targe="_blank">Besøksadresse: Sven Oftedals vei 8</a></address>
		<address>Telefon: 22 16 84 90 - telefaks: 22 16 84 99 - <a href="mailto:post@legemiddelhandboka.no">E-post: post@legemiddelhandboka.no</a></address>
	</footer>
</div>

</body>
</html>